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Abstract 
Abstract 
Glycosylphosphatidylinositol (GPI) anchored proteins are a unique group of 
membrane proteins found on the surface and certain intracellular compartments of 
eukaryotic cells. They are bound to the membrane by a GPI moiety and have a 
number of important functions, including digestion, endocytosis and signal 
transduction. GPI anchored proteins also reside within lipid rafts, which are 
microdomains on the phospholipid bilayer composed of sphingolipids and cholesterol. 
Rafts are thought to be capable of forming semi-stable “islands” of lipids and proteins 
that act as a platform for a number of important cellular processes, such as T-cell 
activation, caveolin mediated endocytosis and protein compartmentalisation. The 
majority of research into rafts has been carried out in single cellular organisms or cell 
cultures, and their importance within development has been poorly understood. 
In this project a proteomic analysis of lipid raft and GPI anchored proteins was made 
for the proteome of the model organism Caenorhabditis elegans. We found a total of 
327 predicted GPI anchored proteins from the C. elegans genome via a novel four-
program prediction method and validated three of those proteins with mass 
spectrometric (MS) identification. The GPI biosynthesis pathway genes of C. elegans 
were also elucidated via a bioinformatics search. 41 lipid raft proteins were identified 
using MS, which accounts for the largest number of such proteins found in the worm. 
This project will hopefully become a starting point for the research of GPI anchored 
proteins and lipid rafts within the nematode, and shine a light on the properties of 
these important classes of proteins within the context of a developmentally complex 
organism. 
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1.1 Membrane proteins and protein lipid modifications  
Since the post-genomic era it has become increasingly apparent that, despite the great 
strides made in the elucidation of the genome of many organisms it is still not enough 
for a full understanding of how a cell works. Proteins are responsible for all of the 
processes which allow a cell to function- from energy production to gene regulation, 
structural integrity, environmental interface, communication with other cells, and they 
may even carry hereditary information via the mechanism of epigenetics (Alberts et 
al., 2008). Therefore, the study of proteins is a subject of fundamental importance 
within biology, and focus has shifted greatly to their research in recent years, with a 
view to elucidate all of their functions within the cell and solve one of the greatest 
challenges within science. 
The life of a protein starts from the DNA sequence of its respective gene; the primary 
sequence is transcribed into mRNA in the nucleus of eukaryotic organisms, which is 
then transported out of the nucleus where it is translated into proteins via ribosomes in 
the cytosol. Certain proteins carry sequences which target them to particular cellular 
compartments, such as the Endoplasmic Reticulum (ER), where additional processing 
occurs before they become functional. Many proteins undergo some form of post-
translational modification, including enzymatic processing, glycosylation, 
phosphorylation, and various lipid modifications such as myristoylation, 
palmitoylation, prenylation and C-terminal anchorage via 
glycosylphosphatidylinositol (GPI) moieties (Hooper and Turner, 1992). Lipid 
modifications greatly alter the characteristics of proteins by increasing their 
hydrophobicity, allowing interaction with membranes and facilitate their role in many 
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cellular processes such as signalling and antibody recognition (Carcy et al., 2006; 
Resh, 2006). 
1.1.1 The plasma membrane  
The plasma membrane is the outermost membrane of the cell and separates its 
contents from the extracellular environment. It is also the only point of exchange 
between the intracellular and the extracellular environments, and performs a number 
of crucial functions for the cell, such as the absorption of nutrients, excretion of waste, 
communication with extracellular stimuli, protection from the environment and to 
ensure the correct concentrations of ions and proteins are kept within the cell. Proteins 
on the plasma membrane perform these vital roles and are therefore the subject of 
intense interest within biology.  
 
1.1.2 Lipid raft microdomains 
Plasma membrane proteins are able to move more or less freely within the lipid 
bilayer (Singer and Nicolson, 1972), and are organised according to interactions with 
other membrane proteins or association with parts of the cytoskeleton. In addition, 
distinct lipid domains have also been postulated to have a role in protein organisation 
within the plasma membrane. This hypothesis first began with the observation that 
glycosphingolipids, cholesterol and a variety of proteins were resistant to 
solubilisation in cold non-ionic detergents such as Triton X-100. They were 
hypothesised to reside within lipid rafts, which are defined as a dynamic clustering of 
glycosphingolipids and cholesterol in a liquid ordered phase within the outer leaflet of 
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the plasma membrane (Simons and Ikonen, 1997). The membrane is separated into 
“island” like domains due to the aggregation of the glycosphingolipids and cholesterol, 
and this arrangement of molecules is thought to create a more thermodynamically 
stable lipid bilayer than a random arrangement of lipid molecules (Harder and Simons, 
1997). It is this property of lipid rafts that is postulated to have a profound effect on 
the dynamics of proteins within the membrane. 
1.1.2.1 General functions of lipid rafts  
The unique properties of lipid rafts allows the aggregation of specific proteins within 
lipid domains, such as caveolin, stomatin, GPI anchored proteins, proteins modified 
with a variety of lipid modifications, and raft associated cytosolic proteins such as 
galectins, kinases, and parts of the cytoskeleton. These proteins facilitate a large 
number of functions within the membrane. Lipid rafts are able to direct cell polarity 
by domain specific protein segregation and recruitment of cytoskeletal proteins such 
as actin and microtubules, as has been shown in epithelial cell polarisation (Hoekstra 
et al., 2003), axonal growth in neurons (Kamiguchi, 2006), and fission yeast cell 
division and mating (Wachtler and Balasubramanian, 2006). Lipid raft association of 
certain ligands can be switched on and off depending on modifications such as 
glycosylation, phosphorylation, acylation, palmitoylation, N-myristoylation and 
prenylation (Alfalah et al., 1999; Kabouridis and Jury, 2008; Resh, 2004; Waheed and 
Jones, 2002), which affects their localisation and interactions with target proteins. 
Rafts are also involved with other diverse cellular processes such as cell adhesion 
(Harris and Siu, 2002) and membrane fusion through SNARE proteins (Lang, 2007).  
  
5 
1.1.2.2 Endocytosis with caveolin 
One other major function involving lipid rafts is endocytosis, and this is brought about 
by caveolae (Nichols, 2003), which are smooth, non-clathrin coated invaginations on 
the plasma membrane. Caveolae were first observed over 50 years ago (Yamada, 
1955) and are formed by the 22 kDa protein caveolin (Rothberg et al., 1992). This 
protein has 3 homologues in humans (CAV1, CAV2, CAV3), with CAV1 being the 
most important in the creation of caveolae and has two splice variants, CAV1α and 
CAV1β (Schlegel et al., 1998). Caveolin has one 33 amino acid transmembrane 
domain in the centre of the protein, and its N and C-termini are exposed to the 
cytosolic side of the membrane (Kurzchalia et al., 1994). The structure is assembled 
in the Golgi apparatus before transportation to other cellular compartments, in 
contrast to clathrin mediated transport where the vesicles are formed de-novo on the 
plasma membrane  (Schmid, 1997). Caveolae are maintained by an association of 
caveolin, sphingolipids, cholesterol, and  various raft associated proteins such as GPI 
anchored proteins (Anderson, 1998). Caveolin, however, may exist in non-caveolae 
lipid raft environments, where they have a different set of interacting proteins and 
exhibit different properties (Lajoie et al., 2009).  Caveolae are also extensively 
involved in several signalling pathways including receptor tyrosine kinase (RTK) 
(Mukherjee et al., 2006), G-protein coupled receptors (GPCR) (Patel et al., 2008),  
and T-cell antigen receptor in the immune response (Kabouridis and Jury, 2008). 
Signalling proteins are sequestered within the caveolae structure, which is used as a 
mechanism to partition receptors from their ligands; caveolae also helps in the 
maintenance of the signal giving greater stability to receptor- ligand interactions once 
they are formed. 
  
6 
With involvement in so many cellular processes (especially those in cell signalling 
and endocytosis) it comes as no surprise that lipid rafts are thought to play a major 
role in a variety of disease processes. Rafts are postulated to have a role in cancer 
proliferation, where they contain a number of signalling pathways that cause either 
proliferation or apoptosis (Patra, 2008). The prion protein also reside within lipid rafts, 
which causes Creutzfeldt-Jakob disease in humans (Taylor and Hooper, 2006). The 
processing of the amyloid precursor protein (APP) in Alzheimer‟s disease is raft 
associated, with recent evidence pointing to the cholesterol synthesis inhibitor statin 
as a possible drug target in treatment of the disease (Reid et al., 2007; Whitfield, 
2006). Caveolae have an important role as an entry point for viruses and their toxins, 
and is involved in the infectivity of  simian virus 40 (SV40) (Anderson et al., 1996) 
and used as one of the routes of entry for the cholera toxin (Parton, 1994).  Lastly, 
vascular diseases such as hypertension are affected by caveolae, due to the large 
number of signalling pathways present within this lipid domain (Callera et al., 2007; 
Insel and Patel, 2009). 
1.1.2.3 The controversial nature of lipid rafts 
Lipid raft research has made immense strides in the past 20 years, with the discovery 
of many new mechanisms of membrane biochemistry in important areas such as 
signalling, transport, and protein-protein interactions. However the concept of the raft 
is still not fully understood, with properties for the domain hotly debated within the 
field. Much of the controversy comes from the exact definition of what a raft is, with 
many researchers finding the traditional definition of extraction by cold non-ionic 
detergents to be arbitrary and devoid of biological meaning (Shaw, 2006); moreover, 
different methods of extraction can produce rafts with different lipid content and 
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associated proteins (Gallegos et al., 2006). There is a wealth of evidence in favour of 
the formation of thermodynamically stable, tightly packed associations of 
glycosphingolipids and cholesterol (Boggs, 1987; Sankaram and Thompson, 1990; 
Smaby et al., 1996), and lipid rafts have been visualised in vitro using model 
membranes containing physiological ratios of phospholipids, sphingolipids and 
cholesterol (Prenner et al., 2007). In recent years lipid rafts have also been visualised 
in vivo (Ishitsuka et al., 2005) but the raft structures found are much more transient 
and smaller than the ones obtained with model membranes, prompting questions as to 
just how big a role lipid rafts play within the various cellular mechanisms they take 
part in (Shaw, 2006). The importance of lipid rafts within cell physiology is also a 
subject of debate, with some studies giving the conclusion that rafts are necessary for 
cellular function while others found them to be redundant for certain processes 
ascribed to them (Nichols, 2005). The study of lipid rafts is a very active field with 
implications in a number of diverse fields, and what can be found out in the future can 
only improve our understanding of many important disease processes, and our 
understanding of biology in general. 
 
1.1.3 Glycosylphosphatidylinositol (GPI) anchored proteins 
Certain proteins within the cell can become attached to the outer plasma membrane 
via a GPI anchor. These proteins do not have a transmembrane domain, but are 
covalently bonded to a glycolipid called GPI at the C-terminus of the protein that 
allows the structure to be stably associated with the membrane. The attachment of the 
anchor occurs in the ER lumen and the protein is transported to the outer membrane 
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via the secretory pathway. GPI anchored proteins have a wide variety of functions, 
with the only common feature among them being a secretion signal at the N-terminal 
end of the protein and a GPI anchor attachment sequence at the C-terminus (Paulick 
and Bertozzi, 2008). Although in theory any protein may become GPI anchored as 
long as they contain the signal sequences present at their termini, there exist a number 
of proteins that possess this form of anchoring as an evolutionarily conserved feature 
(Udenfriend and Kodukula, 1995a). GPI anchored proteins were first found in the 
intracellular parasite Trypanosoma brucei, where they are called variant surface 
glycoproteins (VSG), and subsequent experiments have shown them to be crucial in 
the biology of the organism, in which abolition of the GPI anchor destroys the 
infectivity of the parasite (Lillico et al., 2003). They are also important in mice, where 
their absence causes embryonic lethality and is postulated to be responsible for 
sperm/egg fusion during fertilisation (Alfieri et al., 2003). The absence of two GPI 
anchored proteins also cause the X-linked hereditary haemophilic disease paroxysmal 
nocturnal hemoglobinuria in humans (Brodsky and Hu, 2006). Maturation of the 
malaria parasite Plasmodium falciparum depend on GPI anchored proteins, which are 
suggested as a target for drugs against the organism (Naik et al., 2003). GPI anchored 
proteins have been shown to have roles in cell adhesion, catalysis, viral budding and 
antibody recognition (Karagogeos, 2003; Metzner et al., 2008; Sly and Hu, 1995; 
Tarleton, 2007). GPI anchored proteins are associated with lipid rafts and can 
constitute a significant proportion of proteins found within the microdomain (Paulick 
and Bertozzi, 2008). Lipid raft association also allows certain GPI anchored proteins 
to interact with signalling pathways, including GPCRs (Landry et al., 2006), T-cell 
activation (Wollscheid et al., 2004), and the insulin signalling pathway (Sharom and 
Radeva, 2004). GPI anchored proteins are present in all eukaryotic organisms and can 
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represent a significant subset of plasma membrane proteins in some species, such as 
in T. brucei and Leishmania major (Ferguson, 1999). 
1.1.3.1 The structure of the GPI anchor 
There is variation between species in the exact structure and makeup of the GPI 
anchor. The core backbone of the anchor for a number of species is 
phosphoethanolamine- mannose(α1-2)mannose(α1-6)mannose(α1-4)gulcosamine(α1-
6)myo-inositol, and can be found in organisms as diverse as T. brucei, P. falciparum, 
Saccharomyces cerevisiae and mammals (Ferguson et al., 1999; Ikezawa, 2002; Pittet 
and Conzelmann, 2007). GPI anchored proteins in mammals have an additional 
phosphoethanolamine linked to the 2-position of the first mannose (adjacent to 
glucosamine) (Orlean and Menon, 2007). The structure is flexible and can have 
differences between cell types, where additional modifications occur, such as N-acetyl 
hexosamine (HexNAc) modification of the first mannose in rat brain Thy-1 (Homans 
et al., 1988). Modification of the fatty acid chain in the GPI anchor takes place in the 
ER after transport to the Golgi, which is essential for its association with lipid rafts 
(Maeda et al., 2007). There are 12 steps overall for the synthesis of a complete GPI 
anchor, with the attachment of the protein occurring via a transamidase complex in 
the ER (Meyer et al., 2000). The complete GPI anchored protein is then transported to 
the Golgi, where additional modifications to the fatty acid tail occur (Fujita and 
Jigami, 2008), before it finally ends up on the surface of the cell. 
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1.2 Different proteomics techniques and their uses 
With the production of a vast number of EST libraries and genome sequences in the 
last 20 years it has become increasingly clear that transcription level and gene 
annotation data alone are unable to explain the vast complexities of the cellular 
machinery that give rise to life. It was realised that in order to properly study the 
internal workings of living organisms a global method of protein analysis must be 
performed. This, in conjunction with previous organism wide studies based on mRNA 
and DNA, is thought to be able to give a more complete picture of the intricacies of 
metabolism, regulation, development and heredity, putting us one step closer to a 
more complete understanding of cellular biology. 
Traditional techniques for the analysis of proteins generally involve the intensive 
characterisation of a small subset of individual proteins with respect to their 
expression, post translational modifications, sequence, interactions, and 3D structure. 
Work with large protein mixtures did occur but have mostly been confined to 
relatively simple analysis, as methods for the global analysis of proteins were either 
non-specific or time consuming (Giddings, 1984). Protein research became 
revolutionised with the sequencing of the genomes of various organisms in the 90‟s, 
which led directly to the invention of the field of proteomics. Coined from the words 
PROTEin and genOME, the study of the proteome is defined as the total analysis of 
all proteins within a biological system or process. The presence of well annotated 
genomes with EST data allowed the production of predicted protein sequence 
databases, which when combined with proper resolution and the use of mass 
spectrometry allow high-throughput identification of thousands of proteins from 
complex biological samples (Shevchenko et al., 1996). Improvements in mass 
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spectrometry (MS) technology have also contributed to the speed and ease with which 
complex mixtures of proteins are identified (Han et al., 2008). This global analysis 
has been used as a powerful tool in many aspects of biological research, such as 
identification of diseased cell biomarkers, screening for interacting partners, organelle 
protein organisation, and global protein network analysis (Dunkley et al., 2004; 
Motoyama and Yates, 2008; Rogers and Foster, 2009; Zhao et al., 2009). 
 
1.2.1 Separation techniques for proteomics 
Proteomic studies require the use of multiple separation techniques that allow the 
resolution of individual proteins from complex mixtures. The first standard 
procedures involve the use of 2D gels, which is still one of the great workhorses of 
the proteomics field (Lopez, 2007). However, this technique has been increasingly 
superseded by the use of multi-dimensional liquid chromatography (MDLC), which is 
thought to have greater reproducibility, but lack the quantitative analysis that is 
available with gel based systems (Delahunty and Yates III, 2005). Hybrid techniques 
in which the different dimensions are separated by gel and liquid chromatography 
have also recently become popular, especially with the advent of “shotgun” 
sequencing from improved mass spectrometric analysis (Motoyama and Yates, 2008). 
A general workflow for 2D electrophoresis and MDLC proteomes is given in Figure 
1.1; the relative merits and weakness of these different techniques will be discussed 
below. 
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Figure 1.1. Workflow of 2D gel electrophoresis and MDLC in proteomic studies. The process 
is shown from the initial protein sample stage to the final identification of individual proteins. The 
2D gel image is of an S. cerevisiae sample adapted from 
http://abdn.ac.uk/ims/proteomics/2dgelsmaps.shtml. The liquid chromatography equipment is a 
Thermo Fisher Scientific Accela system. The mass spectrometer is a Waters MALDI Synapt 
HDMS system. The PMF spectrum was adapted from 
http://www.york.ac.uk/res/schisto/peptide_mass_fingerprint.htm, and the MS/MS spectrum was 
adapted from http://www.umdnj.edu/proweb/services.htm.  
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1.2.1.1 2D Gel electrophoresis 
2D electrophoresis has been used as a technique for protein analysis long before the 
advent of modern proteomics. It was invented in 1956 and was first used for the 
separation of human serum proteins (Smithies and Poulik, 1956). Several 
advancements followed, culminating in the techniques developed by O‟Farrell in the 
mid 70‟s (O'Farrell, 1975), which became the standard procedure for 2D analysis 
today.  
1.2.1.1.1 Principles of 2D gel electrophoresis 
2D gels separate proteins in the first dimension according to their isoelectric point (pI) 
and in the second dimension by their molecular mass. The pI of a protein is 
determined by its overall charge, and the proteins are resolved via isoelectric focusing 
(IEF), in which a charge is placed along a pH gradient produced by carrier 
ampholytes- small molecules that can act as both an acid and a base- that facilitate the 
migration of each protein to their correct location. The invention of immobilised pH 
gradients (IPG) (Bjellqvist et al., 1982) allowed further improvements for the 
resolution of proteins in the first dimension. Modern proteomic analysis tend to use 
commercially available precast IPG strips, with different companies offering a large 
selection of pH ranges for different sensitivity requirements (Taylor and Coorssen, 
2006).  
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS PAGE) is used for 
the separation of proteins by molecular mass in the second dimension. This method 
has changed relatively little compared to the advancements made in IEF. For protein 
samples of high complexity a gradient gel may be used to improve resolution, and 
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larger gels have greater resolving power than smaller gels (Lopez, 2007). The 
properties of the protein sample and the specific resolution required for the 
experiment dictates what kind of gel is best used for analysis. 
1.2.1.1.2 Visualisation of 2D gels 
Proteins resolve into spots on the gel, which are visualised before analysis can begin. 
The most commonly used stains for 2D gels are Coomassie Brilliant Blue, silver stain, 
and fluorescent dyes such as Sypro Ruby. Coomassie has a generally linear response 
to protein concentration and is used when quantitation of the spots is required. Silver 
stain is generally non-linear for protein concentration, but can have up to 5 times the 
sensitivity of Coomassie Blue. It is mainly used for confirmation of the presence of 
proteins on the gel. Fluorescent dyes have high sensitivity and can be used to quantify 
proteins, and requires the use of a fluorescent scanner for visualisation. Coomassie 
and fluorescent stains are fully compatible with MS identification due to their ability 
to be destained; silver staining can be modified to become compatible with MS 
(Shevchenko et al., 1996). The choice of staining technique in a proteomic 
experiment is dictated by the needs of the experimental design and the sample 
analysed. 
1.2.1.1.3 Computer analysis of 2D gels 
After visualisation the gel is scanned into a computer, where the image is manipulated 
to align different gels together and perform spot matching, with the intensities of the 
spots calculated to give quantitative analysis when required. A number of commercial 
programs are available for this, including PDQuest, Phoretix 2D Advanced, Melanie, 
and others. Each of these programs has their own strengths and weaknesses, but are 
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generally competent when used to examine most protein samples (Marengo et al., 
2005). After annotation of the gel, spots of interest are picked, destained and 
subsequently analysed by MS. 
1.2.1.1.4 Advantages of 2D gel electrophoresis  
One of the major advantages of 2D electrophoresis is its ability to analyse individual 
proteins in a quantitative manner. This allows comparisons of global expression 
patterns between different biologically significant samples. This approach has been 
used to find potential biomarkers (Wong et al., 2009), proteins interacting partners 
(Choi et al., 2004), and the changes in expression profile brought about by specific 
conditions. 
2D electrophoresis can also be used to study post-translational modifications. 
Modifications such as glycosylation that alter the charge of a protein can be easily 
visualised as a horizontal shift within the gel, and the degree of modification worked 
out by its isoelectric point relative to the unmodified protein (Sickmann et al., 2002). 
Immuno-blotting of a protein subfamily or modification can also be performed, 
allowing very accurate analysis of important sub-families of proteins en masse (Balen 
et al., 2006). 
1.2.1.1.5 Limitations of 2D gel electrophoresis  
2D electrophoresis has a number of weaknesses that limits its uses when analysing 
certain proteomes. The technique has a limited dynamic range due to the inherit 
properties of polyacrylamide gels, which means proteins of low abundance such as 
transcription factors cannot be analysed effectively. The limited pH range (3-10 pH) 
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that can be achieved by ampholytes also exclude the analysis of very basic and very 
acidic proteins (Issaq and Veenstra, 2008). Lastly, proteins with extensive 
hydrophobic regions, such as membrane proteins, and proteins with low solubility are 
poorly resolved by IEF. This is due to the need for non-ionic detergents during 
isoelectric focusing so that proteins can migrate to their proper pI. Lipids present 
within the sample also hamper IEF, giving a streaking effect on the gel and poorly 
focused spots (Issaq and Veenstra, 2008). 
One other fundamental problem of 2D electrophoresis has been the lack of 
reproducibility between experiments. In the early days of the technique different 
laboratories had very different protocols for performing 2D electrophoresis, and this 
resulted in different looking gels for the same protein sample. Even gels within the 
same laboratory will run to slightly different dimensions, as the large number of 
variables per run (pipetting errors, gel casting, staining and destaining time, etc) 
makes each gel unique and non super-imposable. In recent years there has been a 
great many advances designed to alleviate this problem (Issaq and Veenstra, 2008). 
Software analysis has improved drastically in its ability to match different gels 
together (Marengo et al., 2005), and the development of 2D differential gel 
electrophoresis (DIGE) allows different protein samples to be visualised on the same 
gel via florescent labelling, which alleviates the problem of variability between 
different gels. 
1.2.1.1.6 2D Differential Gel Electrophoresis (DIGE) 
2D DIGE was developed as a technique to reduce inter-gel variation and improve 
reproducibility of 2D electrophoresis experiments (Unlu et al., 1997). Different 
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protein samples can be labelled with up to three different fluorescent probes (Cy2, 
Cy3, and Cy5) that have the same mass, charge, and different absorbance wavelengths 
(488nm, 532 nm and 633 nm, respectively). This enables different protein samples to 
be run on the same gel and eliminates variation induced by multiple gels. The 
inclusion of an internal standard can also aid the comparison of many different 
samples, improve protein quantification and reduce the number of gels needed to be 
run (Alban et al., 2003). The dyes used have very high sensitivity, so that proteins not 
normally seen with conventional 2D electrophoresis can be detected (Marouga et al., 
2005). 2D DIGE relies on the covalent attachment of the dye to unmodified lysine 
residues within a protein, and in order for quantitative analysis to be performed the 
sample is minimally labelled at on average one dye per protein. This means that 
effectively only 3-5% of the total protein of any sample is labelled, and proteins that 
do not contain lysine will never be detected (Marouga et al., 2005). The proteins must 
also be imaged with a specialised fluorescent scanner, with proprietary software 
(DeCyder) that increases running costs. Despite these shortcomings, 2D DIGE has 
become one of the most important techniques in proteomics today and has been used 
in the analysis of biomarkers (Wong et al., 2009), Arabidopsis thaliana proteins 
(Borner et al., 2005), human liver (Brizard et al., 2009), cancer cells (Schaaij-Visser 
et al., 2009), mitochondria (Mathy and Sluse, 2008), stem cells (Evans et al., 2004), 
and other proteomes. 
1.2.1.2 Multi-dimensional liquid chromatography (MDLC) and “shotgun” 
sequencing  
The field of proteomics experienced a mini revolution with the adoption of tandem 
mass spectrometry (MS/MS). This technique involves fragmenting peptides into their 
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component amino acids, which allows the elucidation of the amino acid sequence of 
the peptide, which increases the accuracy of protein identification over the older 
peptide mass finger printing (PMF) method. MS/MS is also capable of analysing the 
tryptic digests of protein mixtures directly (Link et al., 1999), without the need for the 
resolution of individual proteins prior to digestion. This new way of analysing 
proteomes was termed “shotgun” sequencing (Motoyama and Yates, 2008), after the 
well known DNA sequencing method of the same name (Wilson et al., 1994).  
High performance liquid chromatography (HPLC) was first explored in the 80‟s as a 
technique for the separation of proteins in a 2D plane (Giddings, 1984). Although its 
application to proteomics was initially slow the use of the technique has gained 
momentum in recent years, and has become an advanced method of protein separation 
for proteomic projects today. HPLC is suited to shotgun proteomics due to its high 
resolving power, especially since the number of tryptically digested peptides 
generated from a complex protein sample can be as high as 600,000 (Motoyama and 
Yates, 2008). A milestone for this technique was achieved in 2001 with the invention 
of Multidimensional protein identification technology (MudPIT) (Washburn et al., 
2001), which has shaped the course of MDLC analysis in proteomics. 
1.2.1.2.1 Principles of MDLC analysis  
While it is theoretically possible for any combination of different techniques to be 
used for the two (or more) dimensions of separation, a set of common practices have 
started to become established, in accordance to the specific requirements of the 
experiment. The analysis of proteomes with MDLC can be partially (offline) or fully 
(online) automated. For the first dimension of peptide separation a variety of 
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techniques can be used, which includes LC methods such as size exclusion 
chromatography (SEC) (Peuravuori et al., 2007), strong cation exchange (SCX) 
(Washburn et al., 2001), strong anion exchange (Motoyama et al., 2007), as well as 
non- LC methods such as SDS PAGE (Trelle et al., 2009) and IEF (Cargile et al., 
2005). The second dimension separation can in theory be achieved with any technique 
that is orthogonal to the one used in the first dimension; however this part of MDLC 
analysis is almost always performed with reverse phase LC (RPLC), as this method 
has a high resolving power and has the advantage that the column can be linked 
directly to certain mass spectrometers for coupled peptide elution and analysis 
(Motoyama and Yates, 2008). Offline 2D can be performed with any of the 
techniques in the first dimension, with LC methods for full shotgun experiments 
involving the tryptic digestion of protein samples at the start, and SDS PAGE/IEF 
used for partial shotgun experiments where intact proteins are resolved before being 
digested for the second dimension, allowing for the inclusion of additional 
information such as proteins mass and fraction pI range. There is also scope for 
optimisation of each fraction to achieve the highest number of protein identifications 
for the sample. Online methods require the use of an LC method in the first dimension, 
with computer controlled automated valves that feed the fractions from the first 
dimension to be separated in an orthogonal technique in the second dimension. SCX 
is usually used for the first dimension, though others have also been used for the 
analysis of different protein samples (Nägele et al., 2004). Online LC has less 
resolving power than offline due to the lack of optimisation of each fraction in 
between each dimension of analysis. It is however the preferred method for large 
scale proteomic projects, as its high degree of automation allows a high turnover of 
protein analysis and the uniformity of conditions also allow better comparisons 
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between different samples. This method is also preferred when the protein sample size 
is small, as the amount of sample wastage is minimised during handling between the 
different dimensions (Motoyama and Yates, 2008). 
1.2.1.2.2 Advantages of MDLC analysis  
MDLC has many advantages over 2D electrophoretic techniques as a method of 
proteomic analysis. The technique has a high dynamic range and may detect proteins 
of low abundance, due to a lack of need for protein detection before being identified 
by MS/MS. It is capable of a much higher throughput than 2D electrophoresis, since 
the second dimension can be directly attached to the mass spectrometer for extremely 
rapid analysis. Lastly liquid chromatography allows the analysis of proteins that are 
unsuited for 2D electrophoresis, such as membrane proteins, highly acidic and highly 
basic proteins, as the digestion of proteins prior to analysis reduce problems with 
solubilisation. These advantages have lead to the technique becoming widely adopted 
for proteomics projects in recent years, including post translational modifications 
(Trelle et al., 2009), sub proteomes (Feuk-Lagerstedt et al., 2007), model organisms 
(Baggerman et al., 2005; Husson et al., 2009; Washburn et al., 2001) and biomarker 
discovery (Whelan et al., 2009). 
1.2.1.2.3 Limitations of MDLC analysis 
With recent trends in LC technology becoming increasingly sophisticated some of the 
earlier limitations with the technique, such as an inability to analyse post-translational 
modifications, have been steadily resolved (Rogers and Foster, 2009). The technique 
still has a few weaknesses, such as when peptides of highly abundant proteins are 
preferentially sampled, leading to the peptides of low abundance proteins becoming 
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swamped out and unidentified in the mass spectrometer (Han et al., 2008). This 
situation can be avoided by better pre-digestion fractionation of protein samples, and 
by careful optimisation of eluted fractions from each dimension. The biggest 
limitation of the technology is its difficulty in the analysis of proteins in a quantitative 
manner. Many technologies have been developed to alleviate this problem in recent 
years, and most involve the isotopic tagging of proteins to quantify them in the mass 
spectrometer, such as isotope coded affinity tag (ICAT) (Gygi et al., 1999) and 
isobaric tags for relative and absolute quantification (iTRAQ) (Ross et al., 2004). This 
involves subjecting the protein sample to chemical reactions with isotopically labelled 
tags, which are then detected in the mass spectrometer as a series of peaks with 
stereotyped differences in detected mass. Different protein samples (or an internal 
standard for one sample) may be tagged with different isotopes and the relative 
heights of the isotopic peaks can then be used as a measurement of relative protein 
abundance. Recently massive strides have also been made in non-labelled protein 
quantification, where spectrometrical peaks from ordinary runs of LC MS/MS are 
analysed with computer programs that allow quantitative comparison between 
different experiments (America and Cordewener, 2008). 
 
1.2.2 The use of mass spectrometry in proteomic studies 
Mass spectrometry is one of the oldest techniques for the analysis of compounds in 
organic chemistry (BORMAN et al., 2003). It works by first converting the sample to be 
analysed into gas phase ions with an ion source, which are the placed into a mass 
analyser that separates them based on their mass to charge ratio (m/z), which is 
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recorded by a detector at the end of the instrument. The electron bombardment in the 
first stage of the mass spectrometer fragments the compound into a distinct set of ion 
peaks, and this unique pattern is used to elucidate the structure of the sample under 
test. Proteomic analysis however requires whole peptides to be analysed in a 
relatively intact manner, as extensive fragmentation will produce too much noise in 
the ion peaks, which would hinder the identification of the peptide. Proteomic 
samples therefore need to be subjected to “soft” ionisation, where the peptides are 
ionised in the mass spectrometry instrument for detection, but are otherwise left 
relatively unchanged (Canas et al., 2006).  
1.2.2.1 Development of the ion source 
Several soft ionisation techniques such as fast atom bombardment (Morris et al., 1981) 
and plasma desorption (Macfarlane and Torgerson, 1976) were developed in the 70‟s 
and 80‟s when interest grew in the use of mass spectrometry for the study of proteins. 
The techniques offered unique perspectives on peptide analysis, but were generally 
less sensitive than other widely used peptide sequencing methods such as Edman 
sequencing, requiring much higher amounts of sample and thus were not routinely 
adopted for the analysis of proteins. It was not until the late 80‟s that protein mass 
spectrometry came of age with the invention of electrospray ionisation (ESI) (Fenn et 
al., 1989) and matrix assisted laser desorption/ionisation (MALDI) (Karas and 
Hillenkamp, 1988; Tanaka et al., 1988). These techniques allowed accurate and 
speedy analysis of peptides, which paved the way for the advent of the field of 
proteomics today. Both John Bennett Fenn and Koichi Tanaka, who were the first 
people to develop ESI and laser desorption techniques respectively, each received the 
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2002 Nobel Prize in Chemistry for their pioneering work in the field of protein 
analysis and their overall contributions to biological research. 
1.2.2.2 ESI 
ESI works by forming small charged micro droplets of soluble peptides by passing 
them through a narrow capillary under high voltage, which can be done under 
atmospheric conditions. As the droplets fragment and evaporate ionised peptides are 
formed, which is then analysed in the rest of the instrument. Salts and detergents need 
to be removed from the sample to prevent adduct formation, and this is usually done 
by reverse phase chromatography. Ions produced in ESI tend to be multiple charged, 
which can give a range of m/z ratios for each peptide and aid in the accurate mass 
analysis of the peptide. The multiple charge also allows easier fragmentation of the 
peptide for further analysis with MS/MS (Canas et al., 2006). One disadvantage of 
ESI is its inability to retain the sample once it has been sprayed into the mass 
spectrometer, which allows less scope for optimisation of the sample within the 
instrument. 
1.2.2.3 MALDI 
The principles of MALDI mass spectrometry involve the ionisation of the sample by 
the transfer of energy from a matrix compound via ultraviolet (UV) excitation. 
Peptides are co-dissolved with the matrix compound at a molar ratio of 1 to 10,000, 
which are subsequently plated onto a sample probe. This creates a crystal structure of 
matrix compound with embedded peptides within. After being hit by a pulse UV laser 
under vacuum the matrix absorbs the energy and becomes partially vaporised along 
with some of the embedded peptides (Hillenkamp et al., 1991). The matrix causes the 
  
24 
ionisation of the peptides in the gas phase, which is then passed onto the rest of the 
MS instrument for analysis. MALDI is relatively tolerant of sample contaminants 
such as buffers and salts, and has the advantage that the proteins analysed can be re-
examined many times before they are depleted. The technique however has different 
ionisation properties for peptides of different amino acid sequences, and is less 
amenable to automation than ESI due to the need for the plating of the sample before 
analysis in a mass spectrometer (Canas et al., 2006).  
1.2.2.4 Fragmentation and identification of proteins with mass spectrometry 
Proteins samples are commonly examined with mass spectrometry after digestion 
with an endopeptidase such as trypsin. This procedure produces defined peptides that 
result in less complex fragmentation patterns within the instrument and allows clearer 
interpretation of the results. The first level of peptide identification comes from the 
total mass of the peptide, which is produced by a single MS run. The mass of one 
peptide gives little information about the amino acid constitution of the peptide in 
question; however, the masses of all of the peptide fragments from the tryptic digest 
can be pooled together to form a “fingerprint” of peptide masses for the protein of 
interest. This fingerprint can then be searched with an algorithm (such as MASCOT 
(Perkins et al., 1999)) against theoretical tryptic digestions of protein sequences in 
silico, which results in the identification of the sample protein. This method is called 
peptide mass fingerprinting (PMF) and was one of the first methods adopted in 
proteomic studies for the identification of proteins (Pappin et al., 1993). 
With the advent of tandem MS/MS instruments it has become possible to produce 
further fragmentations of the peptides produced during tryptic digestion, which allows 
  
25 
the sequencing of those peptides from the resulting MS/MS spectra (Hunt et al., 1986). 
MS/MS is a more sensitive method of protein identification than PMF and is also 
compatible with the analysis of peptide mixtures, paving the way for “shotgun” 
MDLC based methods for proteomic studies (Motoyama and Yates, 2008). Recent 
advances in mass spectrometry technology include MS
n
 fragmentation, which is used 
on samples such as phosphorylated peptides that have proven difficult to fragment 
using MS/MS alone (Rogers and Foster, 2009). New instruments such as Orbitrap 
mass spectrometers are able to analyse intact proteins, and have show great promise in 
improving the analysis of post-translational modifications with even greater coverage 
than before (Yates et al., 2009).  
 
1.2.3 The contributions of proteomics to biology 
Proteomics has become one of the most widely used techniques in biology today. 
Proteomic projects have been used on model systems as diverse as viruses, bacteria, 
eukaryotes and whole organisms such as drosophila, Arabidopsis and humans, which 
has contributed greatly to the understanding of the biology of those organisms 
(Engstrom et al., 2004; Han and Lee, 2006; Komatsu et al., 2007; Mathy and Sluse, 
2008). Studies on subcellular locales and post-translational modifications have 
improved our understanding of important processes such as signal transduction in a 
global manner (Mathy and Sluse, 2008; Rogers and Foster, 2009). Quantitative 
proteomic techniques have been used in the study of disease biomarkers, especially 
for a variety of cancers that has yielded many novel potential therapeutic targets and 
new methods for treating the disease (Conrad et al., 2008; Ikonomou et al., 2009; 
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Zhao et al., 2009). Proteomics projects have also been used extensively in the 
emerging field of systems biology, where the technique has been used in the creation 
and validation of models for complex regulatory networks (Ivakhno and Kornelyuk, 
2006; Kreeger and Lauffenburger, 2010; Maurya et al., 2007). The field of proteomic 
research has enjoyed an explosive growth in the past decade and will likely become 
one of the most import techniques in biology for the post genomic era. 
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1.3 Progress in proteomics for lipid raft and GPI anchored proteins 
1.3.1 Proteomic analysis of lipid rafts 
Ever since the explosive growth in proteomic analysis of the past ten years there has 
also been a large amount of interest in using these techniques for the study of proteins 
in lipid rafts. Membrane proteins are notoriously difficult to analyse using 2D 
electrophoresis, due to their alkaline nature and poor insolubility in the non-ionic 
detergents required for IEF (Santoni et al., 2000). Shotgun techniques using MDLC 
MS/MS do not have these disadvantages and are used more frequently for the analysis 
of these proteins (Wu and Yates, 2003). Gel based methods however may reveal 
different sets of proteins to shotgun techniques when used on the same sample (Li et 
al., 2003; Li et al., 2004a). Past studies of lipid raft proteomes include Jurkat T-cells 
(von Haller et al., 2001), bovine Neutrophils (Nebl et al., 2002), HeLa cells (Foster et 
al., 2003), Human smooth muscle (MacLellan et al., 2005), adipocytes (Kim et al., 
2009), the fungus Candida albicans (Insenser et al., 2006) and others. Commonly 
identified proteins were those involved in the make-up of the cytoskeleton, signalling 
molecules such as heterotrimeric G-proteins, stomatin, flotillin, caveolin, lectins, heat 
shock proteins such as hsp90, and endosomal proteins such as components of the 
proton pump V-ATPase. There are two major contaminants within almost all 
proteomic studies of lipid rafts, namely mitochondria proteins and ER associated 
proteins. In fact, these contaminants are so ubiquitous that some have questioned 
whether they might indeed have raft association in some way or other (Bae et al., 
2004); other studies, however, seem to refute such an idea, based on more traditional 
methods of raft determination such as sensitivity to cholesterol depletion (Foster, 
2008; Zheng et al., 2009). 
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1.3.2 Proteomic analysis of GPI anchored proteins 
Progress with GPI anchored proteins using proteomics has been relatively slow 
compared to the analysis of lipid rafts. Most of the proteomic work on this class of 
proteins has been done in the plant model A. thaliana, with the first such study 
performed on 2D gels using antibody staining and N-terminal sequencing for protein 
identification (Sherrier et al., 1999). This was followed up later with a large scale 2D 
DIGE analysis in which 30 GPI anchored proteins were identified with LC-MS/MS 
(Borner et al., 2003). Other proteomic projects include the identification of GPI 
anchored proteins from pollen (Lalanne et al., 2004), myelin sheath (Lalanne et al., 
2004), the parasite P. falciparum (Gilson et al., 2006) and human HeLa cells (Elortza 
et al., 2003). All of these projects follow the same procedure of “Shave and conquer” 
(Elortza et al., 2003), in which membrane proteins were subjected to phosphoinositol-
specific phospholipase C (PIPLC) digestion and the released GPI anchored proteins 
were extracted via Triton X-114 phase partitioning (Bordier, 1981). Phosphoinositol-
specific phospholipase D (PIPLD), an alternative phospholipase with specificity also 
for GPI anchored proteins, was used by Elortza et al. in a study of GPI anchored 
proteins in HeLa cells and A. thaliana, and was found produce a different set of 
proteins when compared with digestion with PIPLC (Elortza et al., 2006; Elortza et 
al., 2003). 
 
1.3.3 Prediction of GPI anchoring using bioinformatics programs 
There has been a large amount of progress made in the past 10 years on the prediction 
of GPI anchored proteins from protein databases. Most prediction programs focus on 
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the C-terminal anchor motif, using the sequences from a learning set of 
experimentally determined GPI anchored proteins to predict protein anchorage and 
the GPI attachment site. The first program came from Eisenhaber et al. and is called 
the BIG PI prediction program, available online at 
http://mendel.imp.ac.at/sat/gpi/gpi_server.html (Eisenhaber et al., 1999). Since then 
the program has been updated (Eisenhaber et al., 2003d), with several other programs 
GPI-SOM http://gpi.unibe.ch/ (Fankhauser and Maser, 2005), DGPI 
(http://129.194.185.165/dgpi/), FragAnchor 
http://navet.ics.hawaii.edu/%E2%88%BCfraganchor/NNHMM/NNHMM.html 
(Poisson et al., 2007) and PredGPI http://gpcr2.biocomp.unibo.it/predgpi/ (Pierleoni 
et al., 2008) also available on the web. The wealth of prediction programs allows an 
in-depth bioinformatic analysis of potential GPI anchored proteins within a genome, 
which paves the way for a comprehensive proteomic study of these proteins within 
the desired organism. 
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1.4 Caenorhabditis elegans and its contributions to biological research 
C. elegans is a small soil living nematode that was first analysed by Sydney Brenner 
over 30 years ago (Brenner, 1974) and has since become one of the most intensely 
studied model organisms in the world. Brenner wanted to find a model organism to 
bridge the gap between simple unicellular organisms such as yeast and 
developmentally complex organisms such as Drosophila melanogaster, and C. 
elegans was chosen for this purpose after much consideration. The multicellular 
nature, ease of genetic manipulation and invariant lineage of C. elegans made the 
nematode an ideal organism for the study of development, growth, and aging.  
 
1.4.1 The biology of C. elegans 
C. elegans worms are easily cultivated, have a short generation time of 3-5 days and 
can be maintained on agar plates with E. coli as its sole food source. Each worm 
develops from an egg and goes through four larval molts (stages L1-L4) before the 
final molt into the adult form (Figure 1.2a). C. elegans has an invariant lineage which 
ends with 959 cells in the adult hermaphrodite and 1,031 cells in the male. Under 
stressed conditions such as a lack of food or overcrowding the nematode can enter 
into a dauer stage after L1, where the animal becomes thin and elongated. Life 
expectancy of dauer stage worms can last for months and is thought to be a 
mechanism for stress resistance in the wild. Upon favourable conditions the worm 
exits this dauer stage and develops straight into the L4 stage of the life cycle. 
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C. elegans mostly mate as a hermaphrodite by self fertilisation. Occasionally males 
are produced as the result of a rare loss of the X chromosome, which occurs with a 
frequency of around 0.05%. Males are more motile than hermaphrodites and have 
special appendages around their tails for mating. Self fertilisation of hermaphrodites 
produce typically 300 offspring, while male-hermaphrodite matings can produce more 
than 1,000 young, and gives an equal ratio of males and hermaphrodites in the 
offspring.  
The invariant lineage of the worm has allowed the characterisation of all of the 
developmental stages of each cell as a lineage map. C. elegans organs include a 
mouth, pharynx, gonad, intestine, cuticle and nerve cells (Figure 1.2b). 
Hermaphrodites have two ovary arms that move away from the middle of the worm 
towards both ends before turning back towards the middle, where they pass through a 
spermatheca before joining into a common uterus. Males are characterised by their 
thin shape, smaller size and modified tail structure which is used in attaching the 
worm to the hermaphrodite during mating. 
Additional background information regarding C. elegans morphology and 
development can be found in the online resources Wormatlas 
(http://www.wormatlas.org/) and Wormbook (http://www.wormbook.org/). 
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Figure 1.2. Overview of development and morphology of C. elegans. 
a) The life cycle of C. elegans, showing the development of a hermaphrodite nematode from 
the egg stage through to the L1-L4 larval stages, before the final molt into the adult. The 
entire life cycle takes around 3-5 days to complete. Worms may enter into a long lived 
dauer stage after L1 due to stress and may live for months in this form.  The diagram was 
adapted from Wormatlas at 
http://www.wormatlas.org/ver1/handbook/anatomyintro/anatomyintro.htm. 
b) Anatomical features of a C. elegans adult hermaphrodite. Adapted from 
http://avery.rutgers.edu/WSSP/StudentScholars/project/introduction/worms.html.  
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1.4.2 C. elegans genetics and genomics 
C. elegans was the first multicelullar organism to have its entire genome sequenced 
(Consortium, 1998). Since then the amount of annotation and manipulation of its 
genome has been steadily increasing. Originally the data was analysed with A C. 
elegans Data Base (AceDB) (Kelley, 2000),  an open-source software developed in 
1992 by Richard Durbin and Jean Thierry-Miegas as a tool for data management for 
the C. elegans genome project, and is maintained today at the Sanger Institute at 
http://www.acedb.org/. The program has since then evolved into a web based 
repository called Wormbase (http://wormbase.org/, (Stein et al., 2001)), which holds 
information for all the current sequence data,  splice models, protein sequences, 
expression profile, RNA interference (RNAi) experiments, phenotypes, ESTs, gene 
ontology (GO) terms, homologies to other species, and the literature references 
available for every C. elegans gene. Wormbase is updated frequently (1-2 months 
between updates) and contains 97 mb of DNA information and more than 20,000 
protein sequences in the latest version. 
C. elegans is a model that is very amenable to genetic manipulation. Many knockout 
strains of worms are available, with new strains being generated continuously for 
researchers from two major knockout consortiums, the Mitani lab at the Women‟s 
Medical University School of Medicine in Japan 
(http://www.shigen.nig.ac.jp/c.elegans/index.jsp) and the C. elegans Gene Knockout 
Consortium at the University of Minnesota, USA (http://biosci.umn.edu/CGC/). The 
mechanism of RNAi, which allows post-transcriptional gene silencing via the 
breakdown of mRNA by the action of double stranded RNA (dsRNA) interference, 
was first observed in C. elegans (Fire et al., 1998). Since then great advances within 
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the field has been made, with the discovery that RNAi can be mediated by simple 
feeding of dsRNA to the worms (Timmons and Fire, 1998). This has lead to the 
establishment of a number of RNAi libraries (Kamath and Ahringer, 2003; Rual et al., 
2004), which helped to produce several genome wide RNAi screens for a diverse 
number of processes such as general metabolism, embryogenesis, cell migration, 
neurotransmission and others (Cram et al., 2006; Gottschalk et al., 2005; Simmer et 
al., 2003; Sonnichsen et al., 2005). There is also extensive data for C. elegans in the 
form of expressed sequence tags (ESTs) (Kohara, 1996; McCombie et al., 1992; 
Waterston et al., 1992), the ORFeome (Reboul et al., 2003), yeast 2-hybrid 
interactome (Li et al., 2004b), and the Promoterome of GFP tagged genes for the 
analysis of expression patterns (Dupuy et al., 2004), which all make the worm an 
excellent model system for large scale genomics studies. 
 
1.4.3 Transcriptomics and proteomics studies in C. elegans 
Many projects have attempted to analyse C. elegans expression profiles on a global 
scale, using transcriptomic techniques such as microarrays (Schena et al., 1995) and 
Serial analysis of gene expression (SAGE, (Velculescu et al., 1995)). Microarrays in 
the worm have been used to elucidate the total expression profiles of its germline, 
heat shock response, aging, dauer formation, non-coding RNA, alternative splicing, 
and many other processes (Barberan-Soler and Zahler, 2008; Blumenthal et al., 2002; 
GuhaThakurta et al., 2002; He et al., 2006; Murphy et al., 2003; Reinke et al., 2000; 
Wang and Kim, 2003). SAGE analysis has been used to study the changes in 
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expressions associated with aging within the nematode (Halaschek-Wiener et al., 
2005; Jones et al., 2001). 
C. elegans research is dominated by genetic studies, but in recent years there has also 
been an increased interest in the use of proteomic techniques to study of the worm 
(Audhya and Desai, 2008). The first proteomic study for the nematode was performed 
on whole worm lysate with 2D gels and MALDI MS peptide mass fingerprinting, 
which identified 12 proteins within the worm (Kaji et al., 2000). A subsequent 
analysis of the same sample was able to produce 152 identified proteins (Schrimpf et 
al., 2001). Both of these studies used relatively harsh techniques such as sonication 
and freeze-thawing for the extraction of proteins from the worms, as C. elegans has a 
tough cuticle that has proven to be problematic for biochemical studies in the past. 
Other 2D electrophoresis analysis have been used on the C. elegans proteome for 
quantitative assessment using 
15
N labelling (Krijgsveld et al., 2003), and to study the 
effects of cholesterol depletion (Choi et al., 2003), heat sensitivity (Madi et al., 2003) 
and the apoptotic signalling pathway (Greetham et al., 2004). More recently studies 
have focused on the use of newer techniques such as 2D DIGE (Tabuse et al., 2005), 
and LC MS/MS analysis for the elucidation of neuropeptides and mitochondria 
proteins (Husson et al., 2007; Li et al., 2009). Proteomics is a growing field within C. 
elegans research, with an increasing integration of proteomic results with the genetic 
data in Wormbase (Rogers et al., 2008). This represents a significant step towards a 
more systematic understanding of C. elegans biology, which will help us gain a 
greater insight into complex processes such as development, signal transduction, 
organelle function and aging. 
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1.4.4 C. elegans as a potential model for lipid raft and GPI anchored proteins 
Lipid rafts and GPI anchored proteins have been relatively poorly studied in C. 
elegans. A lipid raft fraction was extracted from the worm by a previous study, which 
found the presence of the stomatin homologues UNC-1 and UNC-24, as well as an 
interacting partner of UNC-1 named UNC-8 (Sedensky et al., 2004). One GPI 
anchored protein, PHG-1 (also known as PHAS-1), was found to be sensitive to 
PIPLC digestion when it was expressed in a mammalian cell line (Agostoni et al., 
2002). There has been a relatively large body of work on the C. elegans caveolin 
homologues cav-1 and cav-2 within recent years. Studies on cav-1 had shown that the 
protein is expressed strongly throughout embryonic development, and becomes 
localised in the nervous system and body-wall muscles from L1 to adult stages 
(Scheel et al., 1999). CAV-1 has been shown to be involved in the meiotic cell cycle 
and acetylcholine signalling of nematodes, and interacts with dynamin within the 
worm to affect locomotion (Parker et al., 2007). CAV-2 was found to be localised to 
the apical membrane of the C. elegans intestinal cells, where it was shown to be 
required for lipid trafficking (Parker et al., 2009). Predictions of GPI anchored 
proteins with bioinformatics tools has been popular with C. elegans due to the 
presence of a well annotated genome for the nematode (Eisenhaber et al., 2000; 
Fankhauser and Maser, 2005; Poisson et al., 2007), but no experimental work have 
been attempted to follow up on these studies. 
C. elegans has the potential to become an excellent model organism for the study of 
lipid rafts and GPI anchored proteins. Lipid raft and GPI anchored protein research 
tends to be confined to single cellular organisms and cell lines, which do not give a 
good overview of their effect in the complex processes of development and growth. 
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This is even more important when both of these classes of proteins are found to be 
involved in a number of signalling processes, such as GPCR signalling, T-cell 
activation, the insulin signalling pathway, and others (Bickel, 2002; Kabouridis and 
Jury, 2008; Landry et al., 2006).  The well annotated genome, wealth of 
developmental knowledge and the ease of genetic manipulation of C. elegans makes 
the worm an attractive target for the study of lipid rafts and GPI anchored proteins, 
within the context of a developmentally complex organism. This will also help us gain 
a greater insight into C. elegans membrane biology, and help us better understand the 
intricate biological processes within this model organism. 
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1.5 Outline for this thesis 
A report on the study of lipid rafts and GPI anchored proteins in C. elegans is 
presented in this thesis. Chapter 2 contains an in-depth analysis of predicted GPI 
anchored proteins from the C. elegans genome with four bioinformatic programs, BIG 
PI, GPI SOM, FragAnchor and PredGPI. In Chapter 3 an analysis of the GPI anchor 
synthesis pathway is presented for C. elegans, as well as other processes, such as 
dolichyl phosphate mannose synthesis and lipid modifications of the anchor tail, 
which are essential for the production of a fully functional GPI anchored protein. 
Chapter 4 presents an account of the extraction of a lipid raft fraction from nematode 
membranes with Triton X-100 sucrose density gradient centrifugation, and the 
extraction of GPI anchored proteins with PIPLC digestion. In Chapter 5 a proteomic 
analysis of the lipid raft and GPI anchored proteins found in the worm is presented. 
Chapter 6 is the general discussion and the last chapter of this thesis, which 
summarises the findings of this project and their relevance to nematode membrane 
studies. The Chapter also outlines the wider field of research concerning lipid raft and 
GPI anchored proteins, as well as the potential for their further study within the C. 
elegans model organism. 
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2.1 Introduction 
The attachment of a GPI anchor to a protein is a highly conserved and important post-
translational modification in eukaryotic organisms (Paulick and Bertozzi, 2008). They 
were first discovered when researchers found that the Thy-1 antigen in mice and the 
Variant Surface Glycoproteins (VSG) in Trypanosoma brucei behaved like typical 
membrane proteins but contained no transmembrane domains, and were released from 
the cell surface by bacterial phospatidylinositol-specific phospholipase C (PIPLC). 
Similar results with other proteins such as acetylcholine esterase and alkaline 
phosphatase came together in the 80‟s, and a novel mode of attachment of proteins 
onto the cell surface via GPI moieties was proposed (Ferguson and Williams, 1988). 
Data from cDNA of VSGs in Trypanosoma brucei has shown a need for an N-
terminal secretion signal sequence and a C-terminal hydrophobic region, which are 
both cleaved off in the mature protein found on the cell surface (Boothroyd, 1985). 
 
2.1.1 Expression of GPI anchored proteins within the cell 
The life of a GPI anchored protein begins with binding of its N-terminal signal 
peptide sequence with the signal recognition particle (SRP) in the cytoplasm, which 
directs the ribosome onto the translocon where the protein is co-translocated into the 
ER lumen before the cleavage of the signal (Walter and Johnson, 1994). Once inside 
the ER lumen the C-terminal propeptide sequence is proteolytically cleaved by a 
transamidase complex and a GPI moiety becomes attached to the residue at the 
carboxyl terminus of the protein called the ω site (Figure 2.1) (Udenfriend and 
Kodukula, 1995a). Mature GPI anchored proteins mostly contain no stretches of 
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Figure 2.1. Diagrammatical representation of the structure of a GPI anchored protein. 
a) The transcript of the GPI anchored protein codes for an N-terminal secretion signal (with n, 
h, and c regions) and a C-terminal GPI anchor signal. The main body of the protein does not 
contain any Transmembrane domains. 
b) Structure of the C-terminal GPI anchor signal, which contains four sections. Section 1: polar 
residues, section 2: ω, ω +1 and ω +2 residues, section 3: hydrophobic residues, section 4: 
hydrophobic tail. 
c) Final protein structure after attachment to GPI anchor. For the features of the GPI anchor 
moiety refer to Figure 3.1. 
hydrophobic sequences and are transported via the secretory pathway though the 
Golgi apparatus, until they are finally expressed on the outer surface of the plasma 
membrane (Figure 2.1c).  
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2.1.2 Sequence features of a GPI anchored protein 
2.1.2.1 Property and bioinformatic prediction of the N-terminal secretion signal 
GPI anchored proteins found in nature typically contain a secretion signal (Gerber et 
al., 1992), although some synthetic proteins made without the sequence have been 
observed to be capable of GPI anchor attachment (Howell et al., 1994). The signal 
sequence has been very well studied and contains a set of consensus features, which 
include an N-terminal (n)- region of 1-5 charged residues, followed by a central 
hydrophobic (h)- region of 7-15 residues, and finally 3-7 polar uncharged residues at 
the C-terminal (c)- region, with some sequence conservation around the cleavage site. 
The secretion signal has a final size of around 15-30 residues (Figure 2.1a) (von 
Heijne, 1990). Numerous attempts have been made since the 1980‟s on a prediction 
program for the secretion sequence, initially based on simple weight matrix 
approaches (von Heijne, 1986), which was later diversified into other more 
sophisticated machine learning methods. In 1997 Niesel et al. produced a prediction 
program based on a neural network (NN) (Nielsen et al., 1997), which was followed 
up with the addition of a separate predictor based on a hidden Markov model (HMM) 
(Nielsen and Krogh, 1998). These two approaches became integrated into the web 
based program SignalP 3.0 with significant improvements in the quality of sequences 
in the training set (Bendtsen et al., 2004). The prediction program is thought to be 
very robust and has become a de-facto standard in the prediction of signal peptides for 
researchers (Emanuelsson et al., 2007). 
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2.1.2.2 The C-terminal GPI anchor signal 
2.1.2.2.1 Sequence properties of the C-terminal GPI anchor signal 
Characterisation of the C-terminal sequence began with the discovery that the 
terminal signal sequence was not simply proteolytically cleaved for VSGs from 
Trypanosome brucei, but occurred with the addition of ethanolamine to the terminal 
amino acid in an amide linkage (Holder, 1983). Subsequently it was found that this 
reaction happens soon after the translation of the protein in the ER (Bangs et al., 1985; 
Conzelmann et al., 1987). Analysis of the sequences of known GPI anchored proteins 
and their cDNA produced a list of putative rules for this attachment, such as the 
requirement for a small amino acid residue at the ω site, more stringent requirements 
for the two amino acid positions immediately after the ω site, and a run of 
hydrophobic residues at the end of the protein (Ferguson and Williams, 1988). Further 
experiments revealed that the sequence at the C-terminus was sufficient for GPI 
anchoring when expressed at the end of the secreted human growth hormone (hGH) 
(Moran and Caras, 1991). Single amino acid changes within the sequence can abolish 
or rescue GPI anchoring (Moran et al., 1991), and certain features of the C-terminal 
sequence such as the hydrophobic tail were necessary, but insufficient to direct GPI 
anchoring (Caras et al., 1989). Synthetic peptide sequences following the rules of the 
signal motif allowed the attachment of GPI anchors to proteins (Coyne et al., 1993), 
suggesting that it was the combined features of the signal, not the specific residues in 
the sequence per se, that allowed a protein to become GPI anchored. 
The various features of the C-terminal signal sequence were gathered together in the 
90‟s to establish a set of criteria necessary for the GPI anchoring of proteins. Several 
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studies involving sequencing of the C-terminus of GPI anchored proteins have 
established the ω sites for a number of them, which were brought together by Sidney 
Udenfriend for one of the first attempts at a prediction of protein GPI anchoring 
through the amino acid sequence at the C-terminus (Udenfriend and Kodukula, 
1995b). It was reported that the ω site permitted only use of the amino acids Gly, Ala, 
Ser, Cys, Asp and Asn, with different affinities for GPI anchoring for each residue; 
the amino acid type for the ω +1 site was not found to be important (any except for 
Pro and Trp), and the ω +2 site was found to be the most stringent of all of the 
residues at the C-terminus (Gly, Ala and Ser). A simple probability based on 
multiplication of the proportional occurrence of an amino acid at the ω and ω+2 sites 
was produced to determine the likelihood of GPI anchoring for an unknown protein. 
The paper also acknowledged the importance of the flanking sequences of the ω site 
with respect to anchor attachment, noting the need for hydrophobic residues to be 
present at the C-terminus of the protein for efficient GPI anchor attachment. 
Further advances in the field indicated a need for a hydrophilic spacer region of 6-14 
amino acids between the ω site and the hydrophobic tail, with 8 being the optimal 
number (Furukawa et al., 1997). Point mutational analysis in the hydrophobic tail 
suggested that this sequence is also subject to certain rules regarding its amino acid 
preference, such as different requirements for hydrophobicity along the sequence and 
a possible tendency for the tail to form an alpha helix (Yan et al., 1998). It was 
thought that the hydrophobic C-terminal tail may be inserted into the ER membrane to 
assist the protein‟s reaction with the transamidase complex. In 1998 Eisenhaber et al. 
took the available information regarding the properties of the C-terminal peptide 
sequence and produced a comprehensive bioinformatic analysis of the GPI anchor 
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attachment signal (Eisenhaber et al., 1998). In the paper, Eisenhaber et al. used all 
protein sequences found in SwissProt with annotations for GPI anchoring (155 at time 
of writing, with various degrees of confidence) as a reference for the amino acid 
composition of the C-terminal signal, and established a set of criteria for the 
attachment of the anchor. The C-terminal sequence is split up into four sections with 
distinct properties (Figure 2.1b). Section one, which begins at the position around 11 
amino acids in the N-terminal direction of the ω site (through residues ω -11 to ω -2), 
has a generally polar profile that is flexible and unstructured. This is thought to help 
the reaction of the transamidase complex by the minimisation of steric effects around 
the active site. Section two concerns the amino acid residues around the ω site. The 
requirements for the positions ω, ω +1 and ω +2 were found to be similar to previous 
suggestions (Udenfriend and Kodukula, 1995b). In addition, amino acids from 
positions ω -1 to ω +2 were found to occupy a restricted volume, due to the size 
constraints of the active site within the transamidase complex, and the residue makeup 
of the region showed mutual compensatory effects with respect to this restricted 
volume; the volume of the active site was estimated to be around 540 Å
3
. Section 
three covers residues ω +3 to ω +8, and is essentially another linker region with no 
sequence specificity, but a general property of being hydrophilic. The author noted 
some specific properties for a number of amino acids in this section, with was thought 
to allow better interaction of the signal sequence with the transamidase complex. 
Section four runs from ω +9 to the end of the protein, and constitutes a run of 
hydrophobic residues that extends to at least ω +21. The authors also detected 
differences in the features of the C-terminal signal in metazoans and protozoans, 
which prompted them to divide the GPI anchor attachment sequences into these 
categories.  
  
46 
2.1.2.2.2 Bioinformatic prediction programs for the C-terminal GPI anchor 
signal 
The analysis produced by Eisenhaber et al. was later used to produce the first GPI 
anchor predictor program called BIG PI (Eisenhaber et al., 1999). The program is 
capable of producing an output of the likelihood of GPI anchoring of a protein from 
its amino acid sequence. Eisenhaber et al. used 177 proteins as a learning set and the 
program produces a score function (S) based on the addition of two scores, the amino 
acid preference profile at the C-terminus (Sprofile) and the level of conservation of the 
physical properties of the sequence with relation to the four sections previously 
described (Sppt, physical property pattern). The predictor is available in two formats 
for the analysis of metazoan and protozoan protein sequences. This program was 
subsequently used on an early version of the C. elegans genome in which 86 proteins 
were predicted to be GPI anchored (Eisenhaber et al., 2000). The program was later 
refined and used on a variety of genomes, and found strong predictions for eukaryotic 
and some archaea bacteria species, but none for eubacteria (Eisenhaber et al., 2001). 
A plant specific Big PI predictor was made in 2003, with data from various 
Arabidopsis thaliana projects as the source of the learning set (Eisenhaber et al., 
2003c). 
In subsequent years other researchers have also attempted to produce GPI anchor 
prediction programs. Kronegg and Buloz created a program called DGPI in 1999, 
using the amino acid composition around the ω site as the basis for prediction 
(http://129.194.185.165/dgpi/). Borner et al. produced a list of predicted Arabidopsis 
GPI anchored proteins with an in-house developed program based on the detection of 
hydrophobic stretches and co-confirmation with SignalP 2.0 (Borner et al., 2002). 
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Fankhauser and Maser produced a GPI prediction program based on a Kohonen self-
organising map called GPI-SOM, which used a set of GPI anchored protein training 
set to product a neural network with which to find the pattern of amino acids for the 
signal sequence (Fankhauser and Maser, 2005). FragAnchor was produced by Poisson 
et al., who used a two stage process involving a neural network coupled with HMM to 
identify a protein and its ω site (Poisson et al., 2007). Lastly, Pierleoni et al. made 
PredGPI using a combination of HMM and support vector machine (SVM) to predict 
GPI anchored proteins and their ω sites (Pierleoni et al., 2008). There have also been 
other general membrane protein prediction programs with GPI prediction functions 
but do not perform detailed analysis on the ω site (Chou and Shen, 2007). The general 
consensus is that a combination of prediction programs will most likely produce a 
more accurate set of predictions (Elortza et al., 2006). In tests with annotated GPI 
anchored and non-anchored proteins it was found that the programs performed 
equally well, with generally small false positive rates and prediction rates somewhere 
in the 80% range; BIG PI, the original prediction program, was still found to be the 
most stringent predictor, but the program was also found to have the highest number 
of false negatives in its output (Pierleoni et al., 2008; Poisson et al., 2007). 
 
2.1.3 Outline for this Chapter 
In this chapter I will give details of the use of these prediction programs for the 
elucidation of predicted GPI anchored proteins in C. elegans. C. elegans has a very 
well annotated genome which was first published in 1998 (Consortium, 1998). The 
repository for this information is available on the web at www.wormbase.org and is 
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updated frequently. The programs BIG PI, GPI-SOM, FragAnchor and PredGPI were 
used to produce a list of potential GPI anchored proteins, and SignalP 3.0 was used to 
verify the N-terminal secretion peptide for these sequences. In order to further verify 
these predictions the Caenorhabditis briggsae orthologues of the predicted proteins 
from C. elegans were also subjected to the four GPI anchoring programs. C. briggsae 
is a closely related nematode to C. elegans and a great degree of genetic conservation 
has been shown between the two nematodes (Stein et al., 2003); this may result in a 
greater degree of accuracy in the prediction for a particular protein, if it‟s predicted to 
be GPI anchored in both of the nematode species. The list of predicted proteins will 
be used for analysis of the GPI anchoring process in C. elegans, and as a starting point 
for the proteomic analysis of this class of proteins in this model organism. 
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2.2 Methods 
2.2.1 Sequences for C. elegans and C. briggsae 
All annotated and predicted C. elegans protein sequences were downloaded from the 
Wormbase website at 
ftp://ftp.wormbase.org/pub/wormbase/genomes/c_elegans/sequences/protein/ and 
were from release WS183 version of the genome as of November 2007. A total of 
23,541 protein sequences were presented in FASTA format and saved as a 
Microsoft .txt file. C. elegans gene descriptions were retrieved from Wormbase using 
the Batch Genes function at http://wormbase.org/db/searches/batch_genes. C. 
briggsae genes orthologous to C. elegans genes of interest and their protein sequences 
were found via basic local alignment search tool (BLAST) search using the Batch 
Genes website. 
 
2.2.2 Prediction of the N-terminal secretion signal 
Prediction of N-terminal secretion signal was made with SignaP 3.0 program 
available at http://www.cbs.dtu.dk/services/SignalP/. Protein sequences were 
uploaded in FASTA format and analysed using the Eukaryotic parameter group with 
the Neuronal network model. All protein sequences were truncated to the first 70 
amino acids before analysis as recommended by the program. 
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2.2.3 Prediction of the C-terminal GPI anchor signal 
2.2.3.1 Big PI predictor program 
All C. elegans protein sequences from release version WS183 were loaded onto the 
Big PI prediction program at http://mendel.imp.ac.at/gpi/gpi_server.html, with the 
metazoan learning set used as the criteria for prediction. Prediction results contain a 
score for the level of confidence and a putative site of cleavage. The sequences for 
proteins with predicted GPI anchoring were tested for N-terminal secretion signal 
with SignalP 3.0. Proteins with positive prediction from both programs were 
considered to be acceptable. C. briggsae orthologues of the predicted genes were 
taken from Wormbase and also subjected to the Big PI and SignalP 3.0 predictor 
programs to determine their GPI anchoring status. 
2.2.3.2 GPI SOM 
C. elegans release WS183 protein sequences were uploaded to the GPI SOM 
predictor program at http://gpi.unibe.ch/. GPI SOM carries out a tandem prediction 
with SignalP 2.0 built into the program, and the final result is verified for both C-
terminal and N-terminal signal sequences. GPI SOM does not generate a score for the 
protein but does give a putative cleavage site for the C-terminus. The C. briggsae 
orthologues of these genes were taken from Wormbase and GPI anchor prediction 
was also made for them in GPI SOM. 
2.2.3.3 FragAnchor 
The FragAnchor prediction program can be found at 
http://navet.ics.hawaii.edu/~fraganchor/NNHMM/NNHMM.html. C. elegans protein 
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sequences were uploaded as a file to the prediction program. The program 
automatically discards protein sequences with 50 or less amino acids and non-
standard amino acid letters. FragAnchor uses a two stage prediction process in which 
the sequence is analysed with a NN algorithm and then passed through a HMM 
program. Positively identified predictions are placed under four categories based on 
the score of the identification, which are highly probable (HMM score ≥ 5.4), 
probable (5.4 > HMM score ≥ 2.2), weakly probable (2.2 > HMM score ≥ 0.2) and 
potentially false positive (0.2 > HMM score), and generates a putative cleavage site 
for GPI anchoring. Predicted genes from the highly probable, probable and weakly 
probable were put through SignalP 3.0 to generate a final list of predicted GPI 
anchored proteins. C. briggsae orthologues of these proteins were also put through the 
FragAnchor and SignalP 3.0 predictor programs to determine their GPI anchor status. 
2.2.3.4 PredGPI 
PredGPI can be found at http://gpcr.biocomp.unibo.it/predgpi/. C. elegans proteins 
were analysed with the program in batches of 500 or less sequences due to a 
restriction placed by the website. The outcomes are presented with a putative cleavage 
site and a score for the protein identification as highly probable (p ≥ 99.9), probable 
(99.9 > p ≥ 99.5), or lowly probable (99.5 > p ≥ 99.0). Sequences from all three 
categories were subjected to SignalP 3.0 to test for the presence of an N-terminal 
secretion motif. Proteins with both predictions were considered to be putative GPI 
anchored proteins. Sequences for the C. briggsae orthologues were taken from 
Wormbase and subjected to both PredGPI and SignalP 3.0 prediction programs. 
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2.2.4 Gene Ontology (GO) terms for the predicted terms 
The GO term for each prediction were taken from the Wormbase website using the 
batch genes webpage (http://www.wormbase.org/db/searches/batch_genes). GO terms 
were presented in three categories, which are Molecular Function, Biological Process 
and Cellular Component. Where multiple GO terms were present for a gene the most 
representative term was chosen for its description. Finally GO terms with similar 
overall description were placed in broad groups for clarity, such as placing 
GO:0008237 (metallopeptidase activity) and GO:0008236 (serine-type peptidase 
activity) into the Catalytic group for the Molecular Function category. 
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2.3 Results 
23,541 proteins were present in release WS183 of the C. elegans genome. In order to 
find the number of proteins that are GPI anchored from this list the sequences for each 
protein were subjected to 4 different C-terminal sequence GPI prediction programs 
Big-PI, GPI SOM, FragAnchor and PredGPI. BIG PI, FragAnchor and PredGPI give 
a score for the likelihood of their prediction, with FragAnchor and PredGPI 
presenting three different levels of confidence for their predictions. All of the 
programs give a prediction for a putative transamidase cleavage site.  
The presence of the N-terminal secretory sequence is necessary for GPI anchored 
proteins and is predicted by SignalP 3.0. Protein sequences with both N and C termini 
hits were considered to contain true GPI anchor predictions. GPI SOM has SignalP 
3.0 search as a part of its function. 
C. briggsae orthologues of the predicted proteins from each program were taken from 
Wormbase and subjected to GPI anchor prediction with the same program. This is 
used to test the fidelity of the prediction as C. briggsae is a close evolutionary relative 
of C. elegans and has been shown to be a good complimentary organism with regard 
to genetics research (Stein et al., 2003). 
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2.3.1 Individual results from all prediction programs 
2.3.1.1 Big PI 
The BigPI program produced a list of 125 GPI anchored proteins with N-terminal 
secretion signal, which is the smallest number of proteins for the prediction programs 
tested (Figure 2.2). 52 of these proteins also have GPI anchored orthologues from C. 
briggsae predicted with the same program.  
2.3.1.2 GPI SOM 
GPI SOM produced the longest list of predicted GPI anchored proteins with 657 
sequences predicted. 348 of these proteins have orthologues in C. briggsae that are 
also predicted to be GPI anchored with this program. GPI SOM produced the largest 
list of predicted proteins of all of the programs (Figure 2.2). 
2.3.1.3 FragAnchor 
FragAnchor produced 237 proteins as potential GPI anchored proteins. Of these 
sequences 109 are predicted to be highly probable, with 71 predicted to be probable 
and 57 weakly probable by the criteria of the program. C. briggsae orthologues with 
predicted GPI anchoring is present for 146 of these proteins (Figure 2.2). 
2.3.1.4 PredGPI 
362 proteins were predicted from PredGPI to be GPI anchored from the C. elegans 
genome, with 157 classified by the program as highly probable, 111 probable and 94 
as lowly probable. Of these 186 proteins had predicted GPI anchored proteins for their 
C. briggsae orthologues (Figure 2.2).  
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2.3.2 Prediction across all programs 
As expected a large number of proteins are predicted to be GPI anchored with more 
than one program. There are a total of 778 unique proteins overall predicted from all 
four programs (Table 2.1, for a full list of proteins refer to Appendix 1). Of these 81 
protein sequences were found to be GPI anchored from all four programs, 112 
proteins were found with three programs, 134 sequences were scored with two 
programs, and 451 were predicted to be GPI anchored from only one program (Figure 
2.3). 
Figure 2.2. Total number of predictions for the four prediction programs. The 
numbers above each bar indicates the number of predicted proteins. Blue bars represent 
the total number of positive outputs for each program and the red bars represent the 
number of proteins that also have GPI prediction in their C. briggsae orthologue. 
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Total number of unique C. 
elegans proteins 
predicted to be GPI 
anchored  
C. elegans predictions 
with C. briggsae 
orthologues that also 
have GPI anchor 
prediction  
Number of predicted 
proteins from all four 
programs  
778 382 
Number of proteins with 
predictions in two or 
more programs  
327 201 
 
 
 
382 unique C. elegans sequences were found with prediction of GPI anchoring also in 
their C. briggsae orthologues (Table 2.1). 38 of those proteins were found with all 
four programs, 73 predicted from three programs, 90 were predicted with two 
programs, and 181 were found with one program (Figure 2.3). 
 
Table 2.1. Total numbers of GPI anchored proteins predicted for C.elegans. 
Presented here are the total numbers of unique C. elegans GPI anchoring predictions 
across all four prediction programs, the number of those proteins that also have 
orthologues in C. briggsae that are also positive for GPI prediction, and the number of 
proteins in both of the categories that have the more stringent criteria of being predicted 
by two or more programs. 
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Out of the total 778 proteins 451 were found with GPI prediction from just a single 
prediction program. Of these GPI SOM account for the highest proportion of 
predictions (Figure 2.4). GPI prediction was found to be more accurate for humans 
and Arabidopsis when multiple prediction programs were used (Elortza et al., 2006). 
A list of proteins with prediction from two or more programs was made. This reduced 
the total number of predicted proteins to 327, with 201 sequences that also have GPI 
anchored C. briggsae orthologue (Table 2.1).  
 
Figure 2.3. The criteria used to determine of GPI anchor prediction. The graph 
shows the number of proteins with independent hits from 4, 3, 2 or 1 of the prediction 
programs tested. The yellow bars represent the total number of proteins for each category 
and the green bars represent those proteins that also have orthologues in C. briggsae. 
Proteins with 2 hits or more are considered to have positive predictions for GPI 
anchoring. 
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2.3.3 GO terms for predicted GPI anchored proteins 
A list of all available GO terms was analyzed for genes found with two or more 
prediction programs alongside those for genes with C. briggsae orthologues. The GO 
terms fall into three categories, which are Molecular Function, Biological Processes 
and Cellular Component. The proportion of genes with GO terms for each of the 
categories is shown in Table 2.2. A comparison of each GO term was made for all 
predicted proteins versus those predicted with 2 or more prediction programs (Figure 
2.5). 
Figure 2.4. Percentage of proteins with only a single prediction from a program. The 
total number of proteins with only one hit from a predictor is 451. Of these GPI SOM 
accounts for the highest proportion of predictions. 
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Categories  Proteins with 2 or 
more hits  
Proportion 
of total  
Proteins with 2 or 
more hits that also 
have C. briggsae 
orthologues  
Proportion 
of total  
Molecular 
function  88  27%  61  30%  
Biological 
process  93  28%  63  31%  
Cellular 
component  149  46%  93  46%  
 
 
 
Table 2.2. Proportion of proteins with GO terms. The three broad categories of GO 
terms are Molecular Function, Biological Processes, and Cellular Component. Presented 
here are the number of proteins with GO terms in each of the categories and the proportion 
they represent within the total number of predicted proteins (327 for the number of proteins 
with 2 or more hits from the four prediction programs, and 201 for those proteins that also 
have a C. briggsae orthologue that is also predicted to be GPI anchored). 
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Figure 2.5. Comparison of GO term categories for predicted GPI anchored proteins. The bars 
on the left for each term correspond to all proteins with prediction hits from one or more programs 
while the numbers on the right correspond to proteins with hits from 2 or more prediction 
programs. Graph a) represents GO terms in Molecular Function, b) Biological Process, c) Cellular 
Component. 
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2.3.3.1 Molecular Function 
In the Molecular Function category the majority of the genes are involved in Catalytic 
processes, with 56.8% of proteins having GO terms with this particular function. 
There are also large numbers of genes for binding (21.6%) and transport (15.9%). 2 
genes each were assigned as having receptor function and structural, and one gene had 
a generic “molecular function” term from the database. The proportion for each of the 
terms is similar in genes with C. briggsae orthologues, with no genes present within 
the structural and molecular function GO groups (Figure 2.6). 
2.3.3.2 Biological Process  
In the Biological Processes category the group with the most genes are involved with 
metabolism (48.4%), followed by transport (19.4%) and development (15.1 %). There 
are also a small number of genes involved in regulation, signalling, defence and cell 
adhesion. The number of genes with C. briggsae orthologues also have similar 
percentages to the overall GO groups (Figure 2.6). 
2.3.3.3 Cellular Component 
The majority of GO terms for the Cellular Component category belong to the 
membrane group with 91.9% of the total. There are a small number genes belonging 
to the extracellular, cytoplasmic, nuclear, and cell group. Genes with C. briggsae 
orthologues also have similar proportions of entries within each of these groups, with 
the one nuclear localised gene absent (Figure 2.6). 
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Figure 2.6. Comparison of GO term categories for GPI anchored proteins predicted with 2 or 
more programs. The bars on the left for each term correspond to all C. elegans proteins that fit this 
criterion while the numbers on the right correspond to these proteins that also have a C. briggsae 
orthologue with predicted GPI anchoring. Graph a) represents GO terms in Molecular Function, b) 
Biological Process, c) Cellular Component. 
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2.4 Discussion 
A comprehensive report on the number of potential C. elegans GPI anchored proteins 
is presented in this chapter. SignalP 3.0 was used to predict the N-terminal secretory 
sequence, while four prediction programs using different algorithms for the C-
terminal motif were used to produce a list of proteins that are potentially GPI 
anchored. There was a large amount of overlap with the output of predicted proteins 
from each of the four programs, and in the end 778 unique GPI anchored protein 
predictions were produced in this study. Of these proteins 81 were predicted by all 
four of the prediction programs, 112 by a combination of three prediction programs, 
134 by two, and 451 by only one of the prediction programs (Figure 2.3). 
 
2.4.1 Analysis of the different prediction programs 
2.4.1.1 Big PI 
Big PI is the oldest of these programs and uses a weight matrix approach to produce a 
list of potential GPI anchored proteins. The parameters of the weight matrix is 
determined by Eisenhaber et al.‟s study of C-terminal residue positions of 
experimentally determined GPI anchored proteins (Eisenhaber et al., 1998). Big PI 
produced the lowest number of predictions of all of the programs (Figure 2.2). The 
majority of the Big PI predicted proteins are predicted by two or more programs 
(93%), with a high proportion of those predictions in the 4 hits category (65%) (Table 
2.3a). 
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2.4.1.2 GPI SOM 
GPI SOM uses a Kohonen Self-Organizing Map method for assigning GPI anchoring 
to potential sequences (Fankhauser and Maser, 2005). GPI SOM produced the largest 
number of potential GPI anchored proteins with 657 predictions. While the program 
does have the largest number of proteins with only a single validation (52%) (Table 
2.3a), GPI SOM is also present with most of the proteins with three (98%) or two 
(92%) prediction program validations (Table 2.4a). 
2.4.1.3 FragAnchor 
FragAnchor uses a two stage process of Neural Network and Hidden Markov Model 
to validate potential GPI anchored proteins (Poisson et al., 2007). FragAnchor 
produced 237 proteins and a large proportion of the proteins are validated by two or 
more prediction programs (92%) (Table 2.3a).  
2.4.1.4 PredGPI 
PredGPI is the latest program available to researchers of GPI anchoring and also uses 
a two stage process involving a Support Vector Machine and Hidden Markov Model 
for determination of GPI anchoring (Pierleoni et al., 2008). The number of predictions 
produced by the program was 362. The proportions of proteins with 3 and 2 hits that 
also have prediction with PredGPI is high (94% and 72%, respectively, Table 2.4a). 
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Prediction 
program 
number 
in 4 hits  
proportion 
of total  
number 
in 3 hits  
proportion 
of total  
number 
in 2 hits  
proportion 
of total  
number 
in 1 hit  
proportion 
of total  total  
Big PI  81  65%  25  20%  10  8%  9  7%  125  
GPI SOM  81  12%  110  17%  123  19%  343  52%  657  
FragAnchor  81  34%  96  41%  40  17%  20  8%  237  
PredGPI  81  22%  105  29%  97  27%  79  22%  362  
 
Prediction 
program  
number 
in 4 hits  
proportion 
of total  
number 
in 3 hits  
proportion 
of total  
number 
in 2 hits  
proportion 
of total  
number 
in 1 hit  
proportion 
of total  total  
Big PI  38  73%  6  12%  7  13%  1  2%  52  
GPI SOM  38  11%  73  21%  82  24%  155  45%  348  
FragAnchor  38  26%  68  47%  34  23%  6  4%  146  
PredGPI  38  20%  72  39%  57  31%  19  10%  186  
 
 
 
Table 2.3. The number and proportion of outputs from each prediction program. Number and 
percentages of proteins with a total of 4, 3, 2 and 1 hits are shown for each program. For example 
the Big PI predictor program occurs in 81 of the proteins with 4 hits in the four prediction 
programs, which represents 65% of the total number of Big PI predictions from the C. elegans 
genome (125). Table a) data from all predicted C. elegans proteins. Table b) data from C. elegans 
proteins that also have GPI anchor predicted C. briggsae orthologues. 
a) 
b) 
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Prediction 
program  
proportion of proteins 
with 3 hits  
proportion of proteins 
with 2 hits  
proportion of proteins 
with only one hit  
Big PI  22%  7%  2%  
GPI SOM  98%  92%  76%  
FragAnchor  86%  30%  4%  
PredGPI  94%  72%  18%  
 
Prediction 
program  
proportion of proteins 
with 3 hits  
proportion of proteins 
with 2 hits  
proportion of proteins 
with only one hit  
Big PI  8%  8%  1%  
GPI SOM  100%  91%  86%  
FragAnchor  93%  38%  3%  
PredGPI  99%  63%  10%  
 
 
Table 2.4. Analysis of the fidelity of each prediction program from protein predictions. The 
percentage contribution of each of the four prediction programs to predicted proteins with 3, 2, 
and 1 total hits is shown. For example of the proteins with 3 hits from prediction programs 98% 
have one of their predictions in GPI SOM, while 86% have one of their predictions in 
FragAnchor. Table a) data from all predicted C. elegans proteins. Table b) data from C. elegans 
proteins that also have GPI anchor predicted C. briggsae orthologues. 
a) 
b) 
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2.4.1.5 Comparison between the four prediction programs 
The metric of a good prediction program comes from maximising the number of real 
positive predictions while minimising both false positive and false negative results, so 
that the program is stringent enough to include real potential sequences and at the 
same time generalised enough to not exclude other genuine GPI anchored proteins. 
Out of all of the prediction programs Big PI has emerged with the highest stringency, 
with the highest number of its predictions validated by the other programs (Table 
2.3a). However Big PI predictions are not represented in a large number of the 
proteins that have 3 or 2 hits, suggesting that the program has a high false negative 
rate, which may be due to the relatively strict weight matrix approach used in its 
algorithm. Both FragAnchor and PredGPI performed well with a large proportion of 
genes also validated with three prediction programs. PredGPI has a large percentage 
of proteins validated by two programs (72%) while FragAnchor has a small 
proportion (30%) (Table 2.4a), which indicates that FragAnchor is less general and 
more stringent than PredGPI. GPI SOM has the largest number of predictions which 
makes the program the most generalised of the four tested predictors. The large 
proportion of proteins that are predicted by just GPI SOM (76%, Figure 2.4, Table 
2.4a) suggests that the program also has a high false positive rate. However, the 
proportion of proteins with three and two hits that also have GPI SOM prediction is 
also high (Table 2.4a), suggesting that the program is capable of producing good 
quality predictions. All of the prediction programs show a steady reduction in the 
proportion of proteins within the data that have three hits, two hits and one hit, which 
is to be expected from a data set with various total numbers of predictions. Taken 
together all four programs are capable of producing good GPI predictions that are 
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validated in the expected pattern with other programs, with BigPI being the most 
stringent and least generalised, followed by FragAnchor, PredGPI, and lastly GPI 
SOM as the most generalised and least stringent. 
 
2.4.2 Total GPI anchored protein prediction from the C.elegans genome 
The total number of proteins predicted to be GPI anchored from all programs was 778. 
Of these 327 were validated by at least two prediction programs (Table 2.1, for the 
full list of proteins see Appendix 1). For the proteins with only one validation there is 
a disproportionate number from GPI SOM (76%, Figure 2.4). Analysis of the GO 
terms from the predicted proteins revealed a large proportion of proteins with the 
label of “transport ion” for their Biological Process description (Figure 2.5). Since ion 
transportation involves the formation of transmembrane pores it would be unlikely for 
these proteins to be designated as GPI anchored. Proteins with two or more prediction 
program validations showed a decrease in the proportion of proteins designated with 
transport ion. Previous proteomic studies in human cell lines and Arabidopsis found 
the use of multiple prediction programs improves the fidelity of validation of 
experimentally derived GPI anchored proteins (Elortza et al., 2006). The final number 
of predicted GPI anchored proteins from this analysis is designated to be 327 
sequences as predicted by two or more prediction programs (Appendix 1). 
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2.4.3 Validation of predictions with C. briggsae orthologues 
Out of the total number of C. elegans predicted GPI anchored proteins 382 were also 
found with orthologues in C. briggsae that are also predicted to be GPI anchored, with 
201 of those proteins predicted with two or more programs (Table 2.1, for the full list 
of proteins see Appendix 2). C. briggsae is a well known companion model organism 
for C. elegans and there is close conservation between their genomes (Stein et al., 
2003). It was therefore postulated that conserved genes for GPI anchoring in both 
organisms would lead to better validation of the prediction. Of the 201 genes the 
proportion for the GO terms were similar in all the three categories recorded, 
indicating that there is no marked difference of predictive power by the use of C. 
briggsae orthologue for validation (Figure 2.5). C. briggsae orthologue validated 
proteins may represent a core list of proteins with potential GPI anchor modifications. 
The list of proteins may also be used as a starting point for the study of potential GPI 
anchored proteins in C. briggsae. 
 
2.4.4 Functions of GPI anchored proteins in C. elegans 
2.4.4.1 GO terms of likely functions for the predicted proteins 
GO terms are a set of curated annotations which describe the characteristic of genes in 
a non-species dependent manner. GO terms are split into three broad categories based 
on the gene‟s Molecular function, Biological process and Cellular component. Of the 
327 GPI anchored proteins there were 88 proteins with entries for Molecular Function, 
80 entries for Biological Process, and 149 with entries for Cellular Component (Table 
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2.2). For Molecular Function the majority of the proteins were involved in catalysis, 
with many of the proteins present having carboxypeptidase activity. This is in line 
with the finding that carboxypeptidase M is GPI anchored in mammalian cells 
(Skidgel et al., 1996). A large proportion of GPI anchored proteins also appear to be 
involved in the binding of substrates and transport, with a relatively small number 
involved in receptor binding and structural roles (Figure 2.6a). 
For Biological Processes the majority of GPI anchored proteins appear to be involved 
in metabolic processes. A large percentage of genes are also involved in regulation, 
development and signalling (Figure 2.6b), which is consistent with the roles of GPI 
anchored proteins in other organisms (Ikezawa, 2002). There are a large percentage of 
proteins with the description of transport ion in the prediction, which may represent 
transmembrane proteins that have been identified as false positives. Most of these 
proteins are however validated with three or more prediction programs, and so may be 
genuine GPI anchored proteins with miss-annotations for their GO terms. One protein 
(C05D9.3) is involved in cell adhesion, which is also documented to occur in the 
adhesion of neural cells (Karagogeos, 2003). 
For the Cellular Component part of the prediction programs the vast majority of the 
proteins were annotated as membrane, which supports the presence of GPI anchoring 
(Figure 2.6c). The proteins annotated as extracellular may still possess a GPI anchor 
as certain anchored proteins can be released from the cell surface as a part of their 
function (Yoon et al., 2007). There are 6 proteins designated as cytoplasmic, which 
on further analysis were all curated with predicted GO terms and do not have 
experimental data to verify the annotation. The gene with the cell annotation is 
acetylcholine esterase 2 (ace-2) and is a well known GPI anchored protein in other 
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systems. The one nuclear gene is called bli-4 and has multiple splice variants with 
different C-terminal sequences, one of which could potentially be GPI anchored. 
2.4.4.2 Genes of interest in C. elegans with prediction for GPI anchoring  
Many interesting genes were present within the list of potential GPI anchored proteins 
found in this analysis (Table 2.5). Five genes have descriptions as lysosomal 
carboxylpeptidases, and this sub cellular compartment has been shown to be involved 
in GPI anchored protein sorting and have associated GPI anchored proteins 
(Grunfelder et al., 2002). 20 peptidases, including the acn-1 gene that has lost its 
metallopeptidase active site but is still important for larval development and moulting, 
are also predicted to be GPI anchored. C. elegans contains four acetylcholine esterase 
genes (ace-1, 2, 3 and 4) and three of them, ace-2, ace-3 and ace-4 are present within 
the predicted results. Acetylcholine esterase is a involved in neural transmission at the 
synaptic cleft and has a highly conserved GPI anchored form (Nalivaeva and Turner, 
2001). The genes tre-3 and tre-5 encode trehalases which are also commonly found to 
be GPI anchored in mammalian cells (Netzer and Gstraunthaler, 1993); they account 
for two out of the five putative trehalases in C. elegans. The C. elegans gene odr-2, an 
olfactory neuron gene with homology to Ly-6 (leucocyte antigen-6) (Chou et al., 
2001), was found to have validation in three of the prediction programs tested. 
Related to this are hot-3, 4, and 7, genes of unknown function that are homologues to 
odr-2 are also present on the list of potential proteins, with hot-5 predicted to be GPI 
anchored with GPI SOM only. wrk-1 encodes a widely expressed homologue of a 
GPI-anchored immunoglobin superfamily (IgSF) protein and has five potential 
isoforms, three of which are found here. Two forms of the apical gut protein tag-10 
were found to be GPI anchored. Tag-10 is orthologous to the GA1 apical gut protein 
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of Haemonchus contortus that was demonstrated to be a GPI anchored protein in 
immunisation studies of sheep (Jasmer et al., 1996). Lastly phg-1 (also known as 
phas-1) was predicted to be GPI anchored by two programs in this analysis, in which 
the gene has also been demonstrated to be GPI anchored when expressed in a 
mammalian cell line (Agostoni et al., 2002).  
 
2.4.5 Conclusion 
The proportion of genes with potential GPI anchoring found in this study accounts for 
1.39% of the C. elegans genome. Previous estimates of C. elegans GPI anchored 
protein amount have all been attempted with only one prediction program, with the 
more conservative Big PI estimating the number to be 0.45% (Eisenhaber et al., 2001), 
0.66% for FragAnchor when only the Highly probable category of proteins was 
considered (Poisson et al., 2007), and around 2.8% by GPI SOM (Fankhauser and 
Maser, 2005). This chapter presents the most comprehensive analysis of potential GPI 
anchored proteins in C. elegans, with the stringency of validation from multiple 
programs to reduce potential false positive and false negative predictions of GPI 
anchoring. The results presented here can help C. elegans researchers interested in 
GPI anchored proteins to look at their gene of interest in a different way, and may 
also aid researchers in the field of GPI anchored proteins by offering them another 
resource for the analysis of these proteins. 
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3.1 Introduction 
The glycosylphospatidylinositol (GPI) anchor is a branched glycolipid that requires a 
complex biosynthetic pathway for its production. The use for this molecule as a 
protein anchor is widespread within living organisms, and GPI anchored proteins have 
been ubiquitously found in eukaryotes, including vertebrates, plants, insects, fungi 
and protozoa (Ferguson et al., 1985b; Ferguson and Williams, 1988; Hortsch and 
Goodman, 1990; Morita et al., 1996). The presence of GPI anchoring is less certain 
within the Eubacteria and Archaeobacteria kingdoms, with no evidence found so far 
for any eubacterial species that possess this post-translational modification. There is 
however tentative suggestion that certain Archaeobacteria also possess this protein 
anchor, as postulated by bioinformatic searches (Eisenhaber et al., 2001) and 
experimentally verified in the archaea species Sulfolobus acidocaldarius (Kobayashi 
et al., 1997). The Sulfolobus genus has been considered to be a close relative of 
eukaryotes (Iwabe et al., 1989; Lake et al., 1984; Woese et al., 1990), which raises 
the possibility that this form of membrane attachment had its evolutionary origin in 
the Archaea.  
 
3.1.1 The GPI anchor core structure 
The structural determination of the GPI anchor began in the 1980‟s with the work of 
Fergurson et al. producing a partial structure for the variant surface glycoprotein 
anchor of Trypanosoma brucei (Ferguson et al., 1985b), which led later to its 
determination by a combination of techniques involving nuclear magnetic resonance 
spectroscopy, mass spectrometry, chemical modification, and exoglycosidase 
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digestion (Ferguson et al., 1988). Since then more than 20 different GPI anchor 
structures have been solved from a variety of different organisms, which provided 
much insight into the properties of the anchor within the cell (Ferguson, 1999). All 
GPI anchors contain a highly conserved backbone, which begins with the C-terminal 
residue of the protein (ω site, see below) attached via an amide bond to 
phosphoethanolamine. This in turn is linked to a glycan core with the structure 
mannose(α1-2)mannose(α1-6)mannose(α1-4)glucosamine(α1-6)myo-inositol. Finally, 
the molecule ends with a phospholipid tail that anchors the structure within the 
membrane (Figure 3.1).  
 
 
Figure  3.1. The conserved core structure of GPI anchors. The molecule has the structure 
EtNP-Man(α1-2)Man(α1-6)Man(α1-4)GlcN(α1-6)myo-PI, with the protein attached to the 
EtNP moiety.  
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3.1.2 Modifications to the core structure 
All GPI backbones have a variety of species and cell type specific side chain additions 
in their glycan core. Most of these modifications involve the mannose subunits, with 
the addition of complex arrays of mannose (Man), galactose, N-acetylgalactosamine, 
sialic acid, N-acetylhexosamine and phosphoethanolamine observed in several 
organisms, including several species of protozoan parasites, Saccharomyces 
cerevisiae, plants, rat, human, and others (Brewis et al., 1995; Deeg et al., 1992; 
Ferguson et al., 1988; Fontaine et al., 2003; Homans et al., 1988; Nakano et al., 1994). 
Mannose is the most common side chain addition to the mannose closest to the 
protein in the glycan core. The addition of phosphoethanolamine to either the middle 
or glucosamine attached mannose occurs only in higher eukaryotes and is not found in 
protozoa. All known mammalian GPI anchors are found with this modification on the 
mannose adjacent to glucosamine. Complex side-chains of polysaccharides are found 
mainly on this mannose as well (Paulick and Bertozzi, 2008). The glucosamine of the 
core glycan has been found to be modified in Trypanosoma cruzi with 2-
aminoethylphosphonate (Almeida et al., 2000), but is otherwise unmodified in most 
other cases. It is thought that these side chain modifications occur for the specific 
needs of the anchor in different conditions, such as dense packing in VSGs and other 
steric effects in relation to the lipid bi-layer (Ferguson, 1999; Homans et al., 1989). 
The inositol moiety may become palmitoylated at the 2 position in certain GPI 
anchors (Treumann et al., 1995). This modification makes the anchor resistant to 
cleavage with PI specific phospholipase C (PIPLC), but not resistant to the action of 
PI specific phospholipase D (PIPLD) (Deeg and Davitz, 1995). Lastly, fatty acid 
remodelling in the phosphoinositol tail may occur, which involves replacement of the 
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unsaturated fatty acid chains of phosphotidylinositol to diacylglycerol, 
alkylacylglycerol, myristate or ceramide (Kerwin et al., 1994; McConville and 
Ferguson, 1993; Morita et al., 2000; Sipos et al., 1997). The replacement to a 
saturated chain is essential for the localization of the GPI anchor within lipid raft 
subdomains within the membrane (Maeda et al., 2007), which may be due to the tight 
packing requirements within the environment. 
 
3.1.3 GPI anchor synthesis and modification  
GPI anchor synthesis is a multistage biochemical process and takes place within the 
Endoplasmic Reticulum (ER). The biosynthetic pathway is different with regard to the 
specific organism, with the most notable difference between the protozoan pathway 
and that of higher eukaryotes (Ferguson, 1999). Most research on the biosynthetic 
pathway comes from studies of two organisms, human and S. cerevisiae (here on 
referred to as yeast), in which 23 genes have been found so far to be involved in the 
process (Orlean and Menon, 2007). The making of a GPI anchor starts off on the 
cytoplasmic surface of the ER membrane and finishes with the attachment of the GPI 
anchored protein in the lumen of the ER and takes 12 steps, with one of the steps 
being tissue specific in humans. After the synthesis and attachment of the protein to 
the anchor the GPI structure is further modified in the ER and Golgi before final 
transport to the cell surface. A detailed description of all known processes involved in 
the human and yeast GPI anchor modification is given in figure 3.2. All genes 
referred to in this section are human/yeast unless otherwise specified. 
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Figure 3.2. The GPI biosynthesis and lipid remodeling 
pathways in human and yeast. Genes involved in each 
step are given as human/yeast in the diagram unless 
specified. Fatty acid remodeling process in the Golgi takes 
different pathways between human and yeast. 
Step 1: 
Addition of acetylglucosamine to PI 
Genes involved: 
PIG-A/GPI3, PIG-H/GPI15, PIG-
C/GPI2, PIG-O/GPI1, PIG-P/GPI19, 
PIG-Y/ERI1, DPM-2 
Step 2: 
Deacetylation 
Gene involved: 
PIG-L/GPI12 
Step 3: 
Acylation 
Gene involved: 
PIG-W/GWT1 
Step 4: 
Flippase (unknown gene) 
Step 5: 
Addition of 1
st
 mannose 
Genes involved: 
PIG-M/GPI14, PIG-X/PBN1 
Step 6: 
Addition of phosphoethanolamine 
to 1
st
 mannose 
Gene involved: PIG-N/MCD4 
Step 7: 
Addition of 2
nd
 mannose 
Gene involved: PIG-V/GPI18 
Step 8: 
Addition of 3
rd
 mannose 
Gene involved:  
PIG-B/GPI10 
Step 9: 
Addition of 4
th
 mannose 
Gene involved: 
PIG-Z/SMP3 
Step 10: 
Addition of phosphoethanolamine to 2
nd
 mannose 
Genes involved: PIG-G/GPI7, PIG-F/GPI11 
Step 11: 
Addition of 
phosphoethanolamine to 
3
rd
 mannose 
Genes involved:  
PIG-O/GPI13, PIG-F/GPI11 
Deacetylation of inositol: 
Gene involved: GPAP1/BST1 
Transport 
to Golgi 
(Human) 
Removal of 
lipid tail at 
sn-2 position 
Yeast gene 
involved: 
PER1 (ER) 
Human gene 
involved: GPAP3 
(Golgi) 
Transport 
to Golgi 
(Yeast) 
Addition of 
C26:0 or 
ceramide to 
sn-2 (Yeast): 
Genes 
involved: 
GUP1 or 
CWH43 (ER) 
Addition 
of C18:0 
to sn-2 
(Human): 
Gene 
involved: 
GPAP2 
(Golgi) 
Step 12: 
Transamidase addition of 
GPI anchored protein 
Genes involved: 
PIG-K/GPI8, GPAA1/GAA1, 
PIG-T/GPI16, PIG-S/GPI17, 
PIG-U/GAB1 
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3.1.3.1 The GPI anchor synthesis pathway 
3.1.3.1.1 Step 1: Transfer of α-1-6-N-acetyglucosamine (GlcNAc) to 
phosphoinositol (PI) to form GlcNAc-PI 
The first reaction of GPI anchor synthesis is the formation of GlcNAc-PI from uridine 
diphosphate (UDP)-GlcNAc and PI (Eisenhaber et al., 2003a). This reaction is 
catalysed on the cytoplasmic leaflet of the ER membrane by the UDP-GlcNAc 
transferase complex (Vidugiriene and Menon, 1993), which so far has seven 
components implicated for its function (Murakami et al., 2005). The enzyme is also 
negatively regulated by Ras in yeast (Sobering et al., 2004), but such regulation is not 
detected in mammalian systems (Murakami et al., 2005).  
PIG-A/GPI3 
The PIG-A/GPI3 component of the GlcNAc transferase is the catalytically active part 
of the enzyme in humans and yeast. The human PIG-A is 484 amino acids long and 
the yeast protein is 452 amino acids in size. PIG-A has a single transmembrane 
domain near the C terminus of the protein with its catalytic subunit exposed to the 
cytosolic side of the ER membrane, with its short C terminal ER luminal domain 
implicated as a signal for its orientation within the ER membrane (Watanabe et al., 
1996). PIG-A is vital for GPI anchor production, and the lack of this protein causes 
the onset of the haemophilic disease, Paroxysmal nocturnal haemonglobineria, in 
humans through the loss of the regulatory proteins CD55 and CD59 (Parker, 1996), 
and female infertility in mice (Alfieri et al., 2003). 
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PIG-H/GPI15 
PIG-H forms a complex with PIG-A and is essential to achieving physiological levels 
of GPI anchors in humans, but a measurable amount (<1% normal) can be detected in 
its absence (Watanabe et al., 1996). The protein is 188 amino acids in humans and 
229 amino acids in yeast, and forms a tight hairpin loop with both the N and C termini 
pointing into the cytoplasm of the cell.  
PIG-C/GPI2 
GPI2 was found in a yeast temperature sensitive lethal strain that had interactions 
with GPI1 (Leidich et al., 1995). PIG-C in humans has a hydropathy plot typical of a 
transmembrane protein and is predicted to have 8 transmembrane regions, with both 
its N and C termini on the cytoplasmic side of the ER (Inoue et al., 1996; Tiede et al., 
2000). It is speculated that PIG-C/Gpi2p acts as a scaffolding protein for the enzyme 
complex, so that the transferase is secured to the cytosolic side of the ER membrane. 
PIG-C has a size of 297 amino acids and GPI2 is 280 amino acids long.  
PIG-Q/GPI1 
GPI1 was found in a conditionally lethal strain of yeast in a screen for GPI synthesis 
genes (Leidich et al., 1994). PIG-Q/Gpi1p are predicted to have 6 transmembrane 
domains with both of its amino acid termini emerging onto the cytoplasmic side of the 
ER (Tiede et al., 2000). PIG-Q loss of function in humans results in a significant 
reduction of transferase activity in humans. The loss of PIG-Q leads to reduced 
cellular levels of PIG-C and PIG-H, and causes inhibition of association between 
PIG-C, PIG-A and PIG-H. PIG-Q is thought to have the role of stabilizing the 
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transferase by protecting it from cellular degradation (Hong et al., 1999b). The human 
PIG-Q protein is 581 amino acids and the yeast protein is 609 amino acids long.  
PIG-P/GPI19 
Human PIG-P produces a small protein (158 amino acids) that interacts with PIG-A 
and PIG-Q. It is found to be essential for the first step of GPI biosynthesis, but its 
exact mode of function has not yet been elucidated (Watanabe et al., 2000a). The 
yeast homologue has recently been found to have a similar phenotype with a size of 
140 amino acids, and is predicted to form a hairpin loop within the ER membrane 
with both ends pointing into the cytoplasm (Newman et al., 2005).  
PIG-Y/ERI1 
PIG-Y was found in a human cell line with a severe defect in surface GPI anchor 
protein expression (Murakami et al., 2005). PIG-Y encodes a 71 amino acid protein 
that directly binds to PIG-A, although a 6 member UDP-GlcNAc transferase complex 
can be formed in its absence. The protein bears some sequence similarities to yeast 
Eri1p, which has also been shown to be involved in the first step of GPI anchor 
synthesis (Sobering et al., 2004).  
DPM2 
DPM2 exist in mammals as a cytoplasmic protein of 88 amino acids and is the 
regulatory subunit of dolichol phosphate mannose (Dol-P-Man) synthase enzyme 
complex (Maeda et al., 2000). The protein weakly interacts with PIG-A, PIG-C and 
PIG-Q and has been shown to enhance the transferase activity by 3 fold (Watanabe et 
al., 2000a). No ortholog has been found so far in yeast. 
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3.1.3.1.2 Step 2: De N-acetylation of GlcNAc-PI to form glucosaminyl (GlcN)-PI 
PIG-L/GPI12 
The second reaction within the GPI anchor synthesis also occurs on the cytosolic side 
of the ER membrane (Vidugiriene and Menon, 1993). The reaction involves the 
deacetylation of the GLcNAc-PI by PIG-L/GPI12 into 
glucosaminylphosphatidylinositol (GlcN-PI) (Nakamura et al., 1997a) and was shown 
to be essential in yeast (Watanabe et al., 1999). PIG-L is a type I membrane protein of 
252 amino acids with a single transmembrane domain and has two independent ER 
retention signals (Pottekat and Menon, 2004). Further analysis identified the protein 
to be a zinc metalloenzyme and a possible target for an antiprotozoan drug (Urbaniak 
et al., 2005).  
3.1.3.1.3 Step 3: Acylation of inositol ring on GlcN-PI to form GlcN-acyl-PI 
PIG-W/GWT1 
Step 3 of GPI anchor synthesis involves the addition of an acyl group (usually 
palmitate) to the inositol ring of GlcN-PI at position 2 to produce GlcN-acyl-PI. This 
process is carried out on the cytosolic side of the ER membrane and is carried out by 
the PIG-W/GWT1 gene. The protein consists of 504 amino acids in humans and 498 
amino acids in yeast. GWT1 deletion confers lethality in yeast (Umemura et al., 2003), 
and a study on PIG-W implicates a role for the acyl group in the addition of 
phosphoethanolamine to the third mannose (Murakami et al., 2003). 
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3.1.3.1.4 Step 4: Flipping of GlcN-acyl-PI into the lumen 
Since the rest of the reactions of the GPI biosynthetic pathway occur within the ER 
lumen the GlcN-PI molecule needs to be “flipped” across the membrane bilayer 
before it can be further processed into a functional anchor. Flipping of 
glycerophospholipids is an energetically expensive process that rarely occurs 
spontaneously, and requires the action of special “flippase” enzymes for their efficient 
transfer (Pomorski and Menon, 2006). No GPI specific flippase has been found so far, 
but research has discovered that flipping of GlcN-PI occurs in model membranes in 
the presence of a number of ER phospholipid flippases, indicating the possibility that 
this process is shared with the general phospholipid flipping pathways within the ER 
(Vishwakarma and Menon, 2005). 
3.1.3.1.5 Step 5: Addition of 1
st
 mannose subunit to GlcN-acyl-PI to form Man-
GlcN-acyl-PI 
GPI-manosyltransferase-I (GPI-MT-I, PIG-M/GPI14) 
The main catalytic subunit of this enzyme is called PIG-M in humans and GPI14 in 
yeast (Maeda et al., 2001c). The human and yeast proteins are 423 and 403 amino 
acids in length, respectively. GPI14 loss of function alleles causes cell wall instability 
in yeast and an increase in transcription of cell wall related genes (Davydenko et al., 
2005).  
PIG-X/PBN1 
PIG-X/PBN1 is an essential interaction partner of PIG-M with a size of 252 amino 
acids in human and 416 amino acids in yeast (Ashida et al., 2005b). This protein 
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forms an association with PIG-M and stabilises it in the ER. Pbn1p is also required for 
folding and stability of a number of other proteins in yeast and act as an essential 
chaperone-like protein within the ER (Subramanian et al., 2006). 
3.1.3.1.6 Step 6: Modification of Man-GlcN-acyl-PI with ethanolphosphoamine 
(EtnP) at the 1
st
 mannose to form (EtnP)-Man-GlcN-acyl-PI 
PIG-N/MCD4 
PIG-N catalyses the addition of EtnP to the 1
st
 mannose in humans and has a size of 
931 amino acids (Hong et al., 1999a), with the yeast gene MCD4 as its homolog with 
a size of 919 amino acids (Gaynor et al., 1999). This modification is important for the 
addition of the third mannose in yeast, and has been shown to be important for 
subsequent remodelling of the lipid anchor in the Golgi (Wiedman et al., 2007; Zhu et 
al., 2006). In humans the gene is not essential but significantly affects surface 
expression of GPI anchored proteins by the recognition of this moiety by the 
transamidase complex (Vainauskas and Menon, 2006). 
3.1.3.1.7 Step 7: Addition of 2
nd
 mannose to Man-GlcN-acyl-PI to form Man-
(EtnP)-Man-GlcN-acyl-PI 
GPI-MT-II (PIG-V/GPI18) 
PIG-V was recently found to be the gene responsible for GPI-MT-II activity in 
humans (Kang et al., 2005). The gene codes for a protein of 493 amino acids, and has 
the ortholog gene GPI18 in yeast (433 amino acids), which shows a weakened cell 
wall phenotype (Fabre et al., 2005). Both proteins are predicted to have 8 
transmembrane domains and functionally conserved regions in their ER luminal 
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sequences. Human cells mutated in PIG-V accumulated EtnP modified Man-GlcN-
acyl-PI, while yeast mutants have both modified and unmodified Man-GlcN-acyl-PI, 
which indicates alternative routes within the biosynthetic pathway in yeast.  
3.1.3.1.8 Step 8: Addition of 3
rd
 mannose to Man-(EtnP)-Man-GlcN-acyl-PI to 
form Man-Man-(EtnP)-Man-GlcN-acyl-PI 
GPI-MT-III (PIG-B/GPI10) 
The addition of the 3
rd
 mannose mediated by PIG-B in humans (Takahashi et al., 1996) 
and GPI10 in yeast (Sutterlin et al., 1998). The human gene encodes a protein that is 
554 amino acids long and the yeast protein length is 616 amino acids. PIG-B was 
found to have 12 transmembrane domains in a bioinformatic comparison of related 
mannosyltransferases (Oriol et al., 2002). 
3.1.3.1.9 Step 9: Addition of 4
th
 mannose to Man-Man-(EtnP)-Man-GlcN-acyl-PI 
to form (Man)-Man-Man-(EtnP)-Man-GlcN-acyl-PI 
GPI-MT-IV (PIG-Z/SMP3) 
The addition of the 4
th
 mannose is essential in yeast but appears to be tissue specific 
in humans, where it occurs in the brain (Orlean and Menon, 2007; Stahl et al., 1992; 
Taron et al., 2004a). The fourth mannose transferase for humans is named PIG-Z and 
has a size of 579 amino acids. The yeast homologue of the gene is called SMP3 and 
has a size of 516 amino acids (Grimme et al., 2001).   
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3.1.3.1.10 Step 10: Addition of EtnP to 2
nd
 mannose of (Man)-Man-Man-(EtnP)-
Man-GlcN-acyl-PI to form  (Man)-Man-(EtnP)-Man-(EtnP)-Man-GlcN-acyl-PI 
PIG-G/GPI7 
PIG-G encodes a protein of 975 amino acids in humans and is responsible for the 
addition of EtnP to the 2
nd
 mannose in the core glycan (Shishioh et al., 2005). The 
yeast gene, GPI7 is 831 amino acids and disruption of the gene causes cell wall 
defects, such as protein anchoring and cell wall separation (Benachour et al., 1999; 
Fujita et al., 2004; Richard et al., 2002). In humans, however, the modification has 
little effect on GPI anchor attachment, and produces a minor type of GPI anchor that 
may also be present on the cell membrane without protein attachment (Shishioh et al., 
2005).  
3.1.3.1.11 Step 11: Addition of EtnP to 3
rd
 mannose of (Man)-Man-(EtnP)-Man-
(EtnP)-Man-GlcN-acyl-PI to form  EtnP-(Man)-Man-(EtnP)-Man-(EtnP)-Man-
GlcN-acyl-PI 
PIG-O/GPI13 
PIG-O/GPI13 is responsible for the addition of the EtnP to the glycan backbone at the 
3
rd
 mannose, which is the final structure needed for the completion of the core GPI 
anchor (Hong et al., 2000; Taron et al., 2000). The human PIG-O gene produces a 
protein of 1089 amino acids and the yeast GPI13 gene encodes a protein of 1017 
amino acids, with both essential for GPI anchor synthesis in each organism.  
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3.1.3.1.11.1 Additional gene involved in steps 10 and 11 
PIG-F/GPI11 
PIG-F/GPI11 both encode proteins of 219 amino acids in humans and yeast (Inoue et 
al., 1993; Taron et al., 2000). They are involved in the EtnP modification of the 2
nd
 
and 3
rd
 mannose and interact directly with PIG-G/GPI7 and PIG-O/GPI13. PIG-F in 
human is essential for the action of PIG-O in the addition of EtnP to the third 
mannose (Hirose et al., 1992; Puoti and Conzelmann, 1993; Sugiyama et al., 1991), 
with the PIG-G gene implicated in the regulation of PIG-O via competition for PIG-F 
proteins (Hong et al., 2000). GPI11 was found to be an essential gene in yeast but was 
shown not to be a requirement for EtnP addition by GPI13, implicating it in other 
cellular processes (Taron et al., 2000). 
3.1.3.1.12 Step 12: attachment of GPI anchor via the GPI transamidase complex 
The attachment of the GPI anchor to a protein is catalysed by the GPI transamidase 
(GPIT) complex. This enzyme consists of 5 confirmed subunits, PIG-K, GPAA1, 
PIG-T, PIG-S and PIG-U, which co-immunoprecipitate to form the functional 
transamidase (Hong et al., 2003). GPIT does not have any sequence specificity but 
recognises a conserved C-terminal sequence motif, with the amino acid residue of 
attachment on the protein called the ω site. The motif can be split into 4 regions; the 
first contain 11 mostly polar residues acting as a linker to the main protein, the second 
contain small residues including the ω site, the third region is a spacer region of 
around 7 moderately polar residues, and the last section consists a sequence of 
hydrophobic amino acids up to the C-terminus (fig.3.3) (Eisenhaber et al., 1998). It 
was recently found that the GPIT subunit PIG-U was upregulated in bladder cancer 
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(Guo et al., 2004) and that GPAA1 and PIG-T over-expression causes invasiveness in 
breast cancer (Wu et al., 2006). A study of all 5 GPIT subunits in 19 different cancers 
implicated these genes in a variety of oncogenic roles, including upregulation in 
cancers of the breast, ovarian, uterus, lymphoma, lung, and deregulation in a number 
of other cancer types (Nagpal et al., 2008). Taken together, it seems that GPIT 
subunits are of immense interest to medical science, and the importance of GPI 
anchoring is just beginning to be explored within human biology. 
 
 
 
PIG-K/GPI8 
PIG-K is the human gene that encodes the catalytic subunit of the GPI transamidase. 
The protein product for this gene is 395 amino acids, with its yeast ortholog at 411 
Figure 3.3. Reaction of the transamidase complex. GPI anchored proteins 
contain a C-terminal consensus motif with 4 characteristic regions. The second 
region (2) contains the ω site, which is the residue of attachment to the GPI 
anchor.  
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amino acids long. This protein functions as a cysteine endopeptidase with a pair of 
conserved active sites at His157 and Cys199, and has a segment of TM region around 
30 amino acids at the C-terminus (Meyer et al., 2000). The TM domain is not 
essential for the function of the protein (Ohishi et al., 2000). Gpi8p was found to form 
a prolonged association with the C-terminal signal sequence of unanchored proteins 
and catalyses the reaction at the ω site by forming a thioester intermediate with the 
proprotein (Chen et al., 2003a; Spurway et al., 2001). Knockout of the PIG-K 
ortholog in African trypanosomes (gpi8) abolished the attachment of GPI anchored 
proteins (Lillico et al., 2002). PIG-K is enzymatically active when expressed as a 
recombinant protein in E. coli (Kang et al., 2002), but it‟s activity is greatly 
attenuated in vivo by the subunits associated with it (Chen et al., 2003a; Ohishi et al., 
2003). 
GPAA1/GAA1 
The human gene GPAA1 encodes a protein of 621 amino acids with 7 transmembrane 
domains. The yeast ortholog of the gene is 614 amino acids long. The protein interacts 
with the other GPIT subunits through a large ER lumenal domain in between the first 
and second transmembrane domains (Vainauskas et al., 2002). GPAA1 forms a 
complex with PIG-K where it is required for the recognition of the proprotein 
substrate (Chen et al., 2003a). GPAA1 also has a proline residue in the C-terminal 
TM region found to be essential for GPI anchor recognition (Vainauskas and Menon, 
2004b), suggesting a role in the recognition of both of the substrates of transamidase.  
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PIG-T/GPI16 
PIG-T encodes a protein of 578 amino acids in human. The yeast ortholog GPI16 is 
610 amino acids long and exists as an integral membrane protein with a single 
transmembrane domain (Fraering et al., 2001). This protein has structural similarities 
to prolyl oligopeptidase, a porcine protein with a novel beta-propeller structure which 
may be able to confer specificity to the PIG-K cysteine protease (Eisenhaber et al., 
2003a). An intermolecular disulfide bridge forms between Cys92 on PIG-K and 
Cys182 of PIG-T, and this covalent modification is essential for normal levels of 
transamidase activity within the cell (Ohishi et al., 2003). Affinity purification of 
GPIT in yeast resulted in a complex of Gpi16p, Gpi8p and Gaa1p, suggesting that 
these three proteins form a core structure within which transamidase activity occurs 
(Fraering et al., 2001). 
PIG-S/GPI17 
PIG-S in humans encodes a protein of 555 amino acids with two putative 
transmembrane domains at each ends of the protein. The yeast ortholog is called 
GPI17 and is 534 amino acids long. PIG-S is an essential gene for transamidase 
activity and has been implicated in a structural role for the complex, and may confer 
species specific selectivity for protein targets (Eisenhaber et al., 2003a; Ohishi et al., 
2001). Unlike Gpi16p and Gaa1p, Gpi17p associates transiently with the GPIT 
complex in yeast (Zhu et al., 2005). 
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PIG-U/GAB1 
PIG-U is a recently found subunit of human transamidase and encodes a protein of 
435 amino acids. Its ortholog in yeast is called GAB1 (394 amino acids) and the 
protein is predicted to have 8 to 10 transmembrane domains, which partially rescues 
PIG-U knockout in human (Hong et al., 2003). The function of PIG-U has been 
speculated to be recognition of either the GPI attachment signal or the lipid portion of 
GPI. Gab1p was found to form a complex with Gpi17p in yeast, suggesting the GPIT 
complex functions as two multi-subunit components (Grimme et al., 2004). Gab1p 
may also have other functions in yeast, as depletion of the protein causes actin bar 
formation, suggesting the protein has functions in actin organization. 
3.1.3.2 Synthesis of Dol-P-Man, the mannose donor 
The mannose donor Dol-P-Man required by GPI synthesis are produced in human and 
yeast by the gene DPM1/DPM1. This involves the reaction between Dol-P and GDP-
Man, which occurs at the cytosolic side of the ER membrane and is transported into 
the luminal side of the ER via a flippase (Eisenhaber et al., 2003a). Dol-P-Man is 
used extensively within the cell to modify various structures with mannose, including 
O-mannosylation and N-glycosylation of proteins (Orlean, 1990a). In yeast, only 
Dpm1p is required for this reaction, and the enzyme has a membrane transmembrane 
domain at the C-terminus which tethers it to the ER membrane. DPM1 in humans lack 
this domain, and needs to be stabilised by DPM2 and DPM3 in order to function 
(Ashida et al., 2005c). DPM3 has been shown to have the domain required for 
anchoring to the ER membrane, and interacts with DPM1 to stabilise it for the 
reaction. DPM3 interaction also prevents DPM1 from becoming degraded by the cell 
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machinery, possibly by blocking its ubiquitination. DPM2 acts to stabilise DPM1 
within the complex (Maeda et al., 1998b), and is also directly implicated in the 
complex used in the first step of GPI biosynthesis.  
3.1.3.3 Lipid remodelling 
3.1.3.3.1 Inositol deacylation  
PGAP1/BST1 
Inositol deacylation occurs after anchor attachment of the protein and is important for 
transport of the GPI anchored protein to the Golgi (Orlean and Menon, 2007). 
PGAP1/BST1 encodes membrane proteins of 922 and 1029 amino acids in human and 
yeast and performs inositol deacylation within the ER (Tanaka et al., 2004). BST1 is 
also involved in quality control of GPI anchored proteins, where a delay in the 
deacylation process reduces the efficiency of degradation of misfolded GPI anchored 
proteins (Fujita et al., 2006b). 
3.1.3.3.2 Fatty acid remodelling 
The relatively short unsaturated lipid tail of the GPI anchor is subjected to 
modification in both human and yeast before the structure is transported to the surface 
of the cell. The yeast lipid tails can either be replaced by longer saturated fatty acids 
or ceramide (Sipos et al., 1997), while in humans the modification involves 
replacement with a saturated lipid tail (Ikezawa, 2002). The process starts with the 
removal of the acyl group on the sn-2 position of the glycerol backbone of the GPI 
anchor, which is catalysed by PGAP3 (320 amino acids) in humans in the Golgi, and 
in yeast by its ortholog Per1p (357 amino acids) in the ER (Fujita et al., 2006a). 
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Subsequently a saturated (C18:0) fatty acid is added to the anchor by PGAP2 (315 
amino acids) in the Golgi in human (Tashima et al., 2006), while in yeast the sn-2 
position is first filled in the ER with a long saturated C26:0 chain catalysed by Gup1p 
(560 amino acids) (Bosson et al., 2006), and may subsequently be modified with a 
ceramide in a multistep pathway within the ER and Golgi by as yet unidentified genes 
(Reggiori et al., 1997). Yeast does contain a homologue to human PGAP2, which is 
called CWH43 (953 amino acids) and adds a ceramide moiety to the GPI anchor tail 
(Ghugtyal et al., 2007). Fatty acid remodelling is important for protein transport to the 
surface of the cell, where it is also required for association of the protein within lipid 
rafts (Maeda et al., 2007). 
 
3.1.4 The C.elegans model system and contributions to genetics research 
The nematode C. elegans has a reputation as an excellent model system for 
elucidating the role of individual genes within a developmental context. C. elegans 
has a transparent appearance and has an invariant lineage from the first meiotic 
division to the adult (Brenner, 1974), which allows detailed analysis of temporal and 
spatial gene expression under a light microscope. Transformation of C. elegans with 
knock in of genes is relatively straightforward compared with other developmentally 
complex models. A common technique involves the injection of the DNA of interest 
into the germline of the worm, which causes stable inheritance and expression of the 
gene, allowing a variety of developmental questions to be answered. This technique 
was first demonstrated with the suppression of sex transformation in an amber 
suppressible tra-3 strain, following injection of tRNAs from a sup-7 amber suppressor 
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mutant (Kimble et al., 1982). Fire demonstrated the versatility of this approach by 
showing that injection of a lacZ gene fused at the 5‟ end with a Drosophila heat shock 
promoter is able to produce its gene expression pattern in vivo (Fire, 1986). The 
injection procedure of Fire produced genomically integrated genes of 1-10 copies 
with very similar expression levels to the wildtype; it was however technically 
demanding due to the need for the DNA to be injected into oocytes. A more 
accessible protocol of injecting into the germline syncytium of the worm was 
developed by Stichcomb et al., which forms the basis for the most popular method of 
transformation used today (Stinchcomb et al., 1985). Stinchcomb‟s protocol is 
technically less demanding but creates large extrachromosomal arrays of 80-300 
tandem repeats of the injected plasmid with varying levels of inheritance stability. 
The development of green florescent protein (GFP) reporter constructs (Chalfie et al., 
1994) paved the way for the analysis of a gene‟s expression pattern in real time. 
Selectable markers for positive injection were also developed to aid the identification 
of successful DNA integration, with the use of the dominant rol-6 gene giving an 
easily scorable “rolling” phenotype when co-injected with the desired vector (Mello et 
al., 1991). The technique of micro particle bombardment, which involves the 
introduction of DNA into the worm germline via microcarrier gold beads, was also 
adapted for transformation, with the rescue of the unc-119 mutant worms strain 
(Maduro and Pilgrim, 1995) used as a selectable marker for successful integration 
(Praitis et al., 2001). Transformation of worms using this technique yielded 
chromosomally integrated lines with low copy numbers of the injected DNA. 
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3.1.5 Expression pattern analysis in C. elegans  
Expression patterns of C. elegans genes were first analysed with the introduction of 
promoter::reporter fusions made from the insertion of genomic fragments within a 
lacZ reporter plasmid (Hope, 1991). More precise methods for the creation of DNA 
fusion products followed, culminating with the highly versatile and accurate Gateway 
recombination approach, which uses the site specific recombination of bacteriophage 
lambda to create promoter::reporter fusion constructs (Hartley et al., 2000). This 
approach was first used to produce a library of 12,000 open reading frames (ORF) 
from the C. elegans genome, which was termed the ORFeome of the worm (Reboul et 
al., 2003). A library of promoter::reporter constructs was then created from 6,000 C. 
elegans gene promoters fused to GFP, and was named the Promoterome version 1.1 
(Dupuy et al., 2004). Transformation of 366 nematode lines for worm transcription 
factor promoters was recently performed with the Promoterome using a combination 
of microparticle bombardment and injection techniques, which yielded extensive 
information on the developmental expression pattern of a number of transcription 
factor gene families (Reece-Hoyes et al., 2007). The promoter regions used for the 
Promoterome are all under 2,000 bp in length, which represents the size of 5‟ 
intergenic regions of a large proportion of genes (60%) and is likely to contain most 
of the cis regulatory elements of the gene. However, the size of the promoter regions 
may still be too small for some genes with large intergenic regions, and some of their 
crucial regulatory elements may not be present within their Promoterome construct. 
The Promoterome constructs also do not take into account of regulatory elements 
outside of the 5‟ region of the gene, such as in introns, 3‟ untranslated regions and 
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trans acting elements, which may hinder its accuracy as a representation of the gene‟s 
expression pattern in vivo. 
 
3.1.6 Plan for this chapter 
In this chapter a detailed bioinformatic analysis of C. elegans and C. briggsae GPI 
anchor synthesis pathway genes was made with respect to the known human and yeast 
genes. C. briggsae is an excellent companion model organism to C. elegans with a 
completed genome (Stein et al., 2003), which may shed insight into some of the 
homologues found in C. elegans. We also speculated into the nature of GPI anchor 
modifications within the nematode, and presented a possible structure and synthesis 
pathway for the anchor inside the worm. Expression profiles for important synthesis 
genes was also carried out via microparticle bombardment and injection analysis, with 
the use of the Promoterome and novel promoter::GFP constructs made with Gateway 
recombination. An analysis of the GPI synthesis pathway may give us a greater 
understanding of GPI anchoring within the worm, and an expression profile of these 
genes may provide insight into the role of GPI anchors within the context of tissue 
specific processes and development.  
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3.2 Method 
3.2.1 Search for C. elegans homologues of GPI anchor synthesis pathway genes 
from humans 
Human and yeast genes in the GPI anchored synthesis pathway were found through 
the literature search and their sequences were taken from the Ensembl web genome 
browser (http://www.ensembl.org/index.html). Sequences from the human pathway 
genes were searched against the C. elegans and C. briggsae genomes via BLAST at 
the Wormbase website (http://wormbase.org/db/searches/blast_blat). Sequence 
alignment was done with the ClustalX 2.0 tool (Larkin et al., 2007).  
 
3.2.2 Maintenance of C. elegans strains 
Wild type C. elegans worms came from the N2 Bristol strain as described by Brenner 
(Brenner, 1974) and unc-119 strain worms were provided courtesy of the Hope lab. 
Worms were kept on in 55 mm diameter agar plates made from nematode growth 
media (NGM, 50 mM NaCl, 1 mM CaCl2, 25 mM KH2PO4, 1 mM MgSO4, 5 µg/ml 
Cholesterol, 0.25% (w/v) peptone, 1.7% (w/v) agar) and seeded with OP50 strain E. 
coli bacteria (Brenner, 1974). Worms were kept at 20°C for 4 days or until most of 
the food was consumed and need renewal, which was done by moving 3-4 worms to 
freshly seeded plates with a platinum wire.  
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3.2.3 Liquid culture of C. elegans 
Unc-119 strain worms from 2 fully grown NGM plates were washed into 100 ml of S 
basal solution (0.1 M NaCl, 0.05 M potassium phosphate, pH 6, 5 μg/ml cholesterol) 
via pipetting. 100 μl of Streptomycin (50 mg/ml), 100 μl of Nystatin (50 mg/ml) and 
4.5 ml of HB101 bacterial suspension were added to the S basal solution and the total 
mixture was incubated at 20°C shaking for 3 days, after which 1 ml of worms from 
the previous liquid culture was used to inoculate a new batch. The culture solution 
was checked daily and fresh bacteria were added as necessary.  
 
3.2.4 Bacteria strains 
Bacteria strains were kept at 4°C on 90 mm diameter agar plates with Luria-Bertani 
(LB) agar formula (8.6 mM NaCl, 1% (w/v) peptone, 0.5% (w/v) yeast extract, 1.5% 
(w/v) bacteriological agar). Strains requiring selection were streaked onto plates with 
supplied with the appropriate antibiotic at a final concentration of 100 µg/ml. 
3.2.4.1 OP50 E. coli strain 
E. coli OP50 strain was acquired courtesy of Hope lab and kept on agar plates as 
described above. OP50 bacteria for NGM plates were grown in 100mL LB media (8.6 
mM NaCl, 1% (w/v) peptone, 0.5% (w/v) yeast extract) at 37°C shaking overnight 
(o/n) and 5-6 drops were added to each NGM plate in a laminar flow hood and left to 
dry for 24 hours.  
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3.2.4.2 HB101 E. coli strain 
HB101 E. coli strain was acquired courtesy of Hope lab. HB101 stock was kept on 
140 mm diameter LB agar plates with streptomycin (50 μg/ml). Bacteria for worm 
liquid culture were grown in 1L LB media at 37°C shaking o/n and spun at 3,000g for 
5 minutes. The supernatant was discarded and the bacterial pellet was resuspended in 
an equal volume of S basal and stored at 4°C. Typically 12 ml of final bacterial 
suspension was made per 1l of LB media. 
 
3.2.5 Extraction of plasmids with miniprep 
Plasmid extraction was performed using QIAprep Miniprep kit from Qiagen. A single 
colony of the desired strain of E. coli was taken from a selective plate and incubated 
in 2.5 ml of LB media (10 g tryptone, 5 g yeast extract and 5 g of NaCl in 1l of dH2O) 
at 37
o
C overnight while shaking. The bacteria were spun at 6,000 g for 3 mins and the 
supernatant was discarded. The pellet was resuspended in 250 μl of QIAprep buffer 
P1 (RNAase added, LyseBlue solution at 1:1,000) and shaken gently. 250 μl of 
QIAprep buffer P2 was the added to the solution and mixed thoroughly until a 
homogenous blue solution was visible. 350 μl of QIAprep buffer N3 was then added 
to the solution and mixed with inversion until the blue colour turns colourless and a 
cloudy precipitant is visible. The solution was then centrifuged on a benchtop 
centrifuge for 10 mins at approx. 10,000 g (13,000 rpm). The supernatant was then 
applied to a QIAprep spin column and centrifuged at 13,000 rpm for 60 sec. The 
flow-through was discarded and 0.75 μl of QIAprep buffer PE (with added EtOH) 
was applied to the column and spun at 13,000 rpm for 60 sec. The flow-through from 
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this was also discarded and the column was spun again at 13,000 rpm to remove 
residual PE buffer. The spin column was then placed onto a 1.5 ml tube and 50 μl of 
buffer EB (10 mM Tris-HCL, pH 8.5) was added to the column and let stand for 60 
sec, and then spun at 13,000 rpm for 60 sec. The final eluted DNA solution as 
checked by running in an agarose gel. 
 
3.2.6 Polymerase Chain Reaction (PCR) 
PCR was performed with Expand High Fidelity PCR system from Roche. Two master 
mixes of PCR reagents were prepared prior to loading onto the PCR machine (PCR 
Express, Hybaid). Master mix A consists of 0.5 μl of dNTP, 0.15 μl of upstream 
primer (in 10 mM Tris-HCl, pH 8.5), 0.15 μl of downstream primer (in 10 mM Tris-
HCl, pH 8.5), 0.5 μl of template in (10 mM Tris-HCl, pH 8.5) and 23.7 μl of dH2O for 
a total volume of 25 μl per reaction; Master mix B consists of 5 μl of Expand High 
fidelity buffer (x10 without MgCl2), 6 μl of MgCl2 (25 mM stock solution, final 
solution 3 mM), 0.75 μl of Expand High Fidelity Enzyme mix (2.6U/reaction stored 
in 20 mM Tris-HCl, pH 7.5 (25°C), 100 mM KCl, 1 mM dithiothreitol (DTT), 0.1 
mM EDTA, 0.5% Nonidet P40 (v/v), 0.5% Tween 20 (v/v), 50% glycerol (v/v)), and 
13.25 μl dH2O for a total volume of 25 μl per reaction. 25 μl of Master mix A and 25 
μl of Master mix B were added to one PCR tube and placed in the PCR machine. The 
program used was as follow- step 1: 94°C for 2 min, x1 repeat; step 2: 94°C for 15 
sec, 59°C for 30 sec, 68°C for 5 min, x10 repeat; step 3:- 94°C for 15 sec, 59°C for 30 
sec, 68°C for 5 min +5 sec per cycle, x10 repeat; step 4: 72°C for 7 min, x1 repeat. 
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Final hold step was at 4°C. DNA prepared from PCR were visualised with DNA 
agarose gel. 
 
3.2.7 DNA sample running in agarose gel and visualization 
DNA gels were made by mixing 0.4 g of agarose with 50 ml of Tris –acetate EDTA 
buffer (TAE, 40 mM acetate, 1 mM EDTA) and boiling the solution in a microwave. 
3μl of ethidium bromide (EtBr) was added to the solution, which was then poured into 
a gel box with lane separators and left to set for 30 minutes. The gel was then placed 
into a gel tank and submerged in TAE buffer.  10 μl of each DNA sample was mixed 
with 1 μl of DNA loading buffer (10X buffer made up of 0.025 g bromophenol blue, 
1.25 ml of 10% SDS, 12.5 ml of glycerol and 6.25 ml of dH2O) and loaded onto into 
the lanes of the gel, with 6 μl of size markers (Fermentas Generuler 1KB DNA 
ladder) loaded into the lanes at each end. The gel was then run at 90 V for 45 mins or 
until the bromophenol blue front had reached the desired distance. The gel was 
visualised with a CCD camera under UV light. 
 
3.2.8 Genomic cosmids 
Genomic cosmid for D2085 was obtained from the Wellcome Trust Sanger Institute. 
The clone arrived as a stab culture and was plated on ampicillin-selective agar plates 
and stored at 4°C. The bacteria colonies were selected and subjected to Miniprep for 
the extraction of the cosmid. 
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3.2.9 Restriction digestion of DNA  
All restriction enzymes were purchased from New England Biolabs (NEB). Reaction 
mixtures were made with 0.5 μl enzyme, 2 μl of desired DNA, 1 μl of buffer 
appropriate for the enzyme (x10 solution), and 6.5 μl of dH2O. The reaction mixture 
was then incubated in a PCR machine at 37°C for 2 hours. Digested DNA was 
visualised on an agarose gel. 
 
3.2.10 Gold particle bombardment of DNA constructs from the Promoterome 
Promoter::GFP fusion DNA constructs from the Promoterome were supplied courtesy 
of Dr. Jane Shingles from the Hope lab. Promoterome strains for the gene of interest 
were unfrozen from -80°C and maintained on bacteria agar plates. Plasmids 
containing the Promoter::GFP fusion were prepared with Miniprep and linearised with 
restriction digestion as described. A gold particle solution was prepared by mixing 60 
mg of gold particles (0.3–3 m, Chempur, Germany) to 2ml of 70% ethanol, which 
was then spun briefly and the supernatant discarded; the pellet was washed 3 times 
with dH2O and resuspended in 1 ml of 50% glycerol. 30 l of linearised DNA (approx. 
7 g of DNA) was added dropwise to 70 l of gold suspension. 300l of 2.5M CaCl2 
and 112 l 0.1M spermidine were also added dropwise and the solution was 
centrifuged at 3,000 g for 30 sec and the supernatant discarded. The pellet was 
resuspended in 800 l of 70% ethanol and centrifugated again at 3,000 g for 30 sec. 
The supernatant was again discarded and the pellet was resuspended in 70 l of 100% 
ethanol. The DNA- gold particle solution was vortexed regularly to prevent clumping 
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of the gold particles. 10 l of gold particle solution was spread on microcarriers in the 
hepta macrocarrier holder of the gold bombardment machine (PDS-1000/He from 
BioRad). Unc-119 strain of worms were taken from liquid culture and suspended in a 
wide test tube under gravity at 4°C and harvested as a pellet at bottom of the tube. 1 
ml of worms was distributed evenly over the seven target spots of a 90mm diameter 
NGM plate. The bombardment procedure from the PDS-1000/He Biolistic was 
followed and 1 ml of M9 buffer (3 g of KH2PO4, 6 g of Na2HPO4, 5 g of NaCl, 1 ml 
of 1 M MgSO4 in 1 l of dH2O) was added to the worms and rested for 1 hour. 4 ml of 
M9 was then added to the plates for resuspension and 0.5 ml of the worms was added 
to eight NGM plates each. Each plate was incubated at 20°C under normal conditions 
and 8 transformed lines (into wildtype phenotype) were chosen after 3-4 weeks. 4 
worms from each plate with a transformed line were transferred to individual 50 mm 
NGM plates and assessed for stability after 7 days. The line with the highest 
transmission of GFP was taken and the rest discarded.  
 
3.2.11 Promoter::GFP fusion of D2085.6 with GATEWAY recombination 
GATEWAY recombination was performed with the Invitrogen GATEWAY Cloning 
kit. The promoter region for the Promoter::GFP fusion of D2085.6 was chosen 5,155 
bases upstream of the start codon of the gene according to sequences from Wormbase. 
Oligos for the promoter were designed online with Primer3 
(http://frodo.wi.mit.edu/primer3/). Gateway recombination site attB4 was fused to 21 
bp of the sequence at the 5‟ end of the promoter the to produce the forward primer 
(sequence- GGGGACAACTTTGTATAGAAAAGTTGTCGGTAACATCTTTCCAA 
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TCC) and Gateway recombination site attB1r was fused with 22 bp of the sequence at 
the 3‟ end of the promoter (including the start methionine ATG) to produce the 
reverse primer (sequence- GGGGACTGCTTTTTTGTACAAACTTGTCATGCATT 
AAAGTGATTATTGT), which were ordered from Sigma-Genosys. Forward and 
reverse primers were used in a PCR reaction (Expand High Fidelity PCR system, 
Roche) with the D2085 cosmid as a template to produce a D2085.6 promoter 
sequence flanked with attB4 and attB1r sites. The Gateway BP reaction mixture was 
made using 1.15 l of D2085.6 promoter PCR product (20 fmol), 0.25 l 
pDON_P4_P1r vector (in TE buffer- 10mM Tris-HCl, pH 7.5, 1mM EDTA, from The 
Andrew Fire vector kit, courtesy of Dr. Sophie Bamps), 2.6 l of TE buffer and 1 l 
of BP Clonase II enzyme mix and incubated at 25°C overnight in a PCR machine 
(PCR Express, Hybaid). The BP reaction was stopped with the addition of 0.5 l 
proteinase K and incubated at 37°C for 10 min and at 95°C for 5 min. BP reaction 
products were then transformed into E. coli DH5α strain cells by the addition of 5 l 
of BP reaction to 50 l of DH5α cells on ice for 30 min, which were then placed in a 
42°C waterbath for 90 sec for heat shock. Induced dh5α cells were incubated in 1ml 
LB media at 37°C for 1 hour, then plated on KAN (kanymycin, 100 g/ml) selective 
agar plates and incubated at 37°C overnight. Colonies from KAN plates were 
subjected to miniprep and digested with restriction enzymes HindIII (cuts twice for 
2,350 bp and 5,448 bp fragments) and EcoRV (cuts thrice for 1,103 bp, 2,662 bp and 
4,033 bp fragments) for validation. 1 l of validated BP reaction products was then 
added to 1.5 l of destination vector pJS02_469 (linearised with SalI restriction 
enzyme, contains GFP construct, courtesy of Dr. Sophie Bamps), 5.5 l of TE buffer, 
and 2 l of LR Clonase II reaction mix and incubated at 25°C overnight in the PCR 
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machine, and then stopped with the addition of 0.5 l proteinase K, incubated at 37°C 
for 10 min and at 95°C for 5 min. 5 l of LR reaction products were added to 50 l 
dh5α cells on ice for 30 min and heat shocked in a 42°C waterbath for 90 sec for 
induction, incubated in 1ml LB media at 37°C for 1 hour and then placed on AMP 
(ampicillin) section agar plates, which was incubated at 37°C overnight. Colonies 
from AMP plates were miniprepped and digested with restriction enzymes BamHI 
(cuts twice for 3,629 bp and 7,597 bp fragments) and XbaI (cuts twice for 1,696 bp 
and 9,530 bp fragments) for validation of the correct product. 
 
3.2.12 Injection of worms 
Injection of reporter constructs was performed on C. elegans N2 hermaphrodites by 
standard microinjection techniques (Mello et al., 1991). Agarose pads were made by 
placing a drop of 2.5% agarose (w/v) in between two 22 x 50 mm coverslips for 2 min, 
taking them apart and leaving the coverslip with agarose to dry overnight. Needles for 
injection were made from a needle puller (Narishige Scientific Instruments, Japan) 
with borosilicate microcapillary glass tubes (Clark Electromedical Instruments, UK). 
D2085.6 promoter::GFP construct was diluted to 20 ng/l in TE buffer and was 
mixed with 100 ng/l plasmid DNA containing the C. elegans rol-6 gene sequence 
(pRF4 plasmid in TE buffer, courtesy of Dr. Hannah Craig). The mixed DNA was 
then loaded into the needle with mouth pipetting from a drawn out glass tube. The 
needle was mounted onto the injection equipment which consists of an inverted optics 
microscope (Zeiss Axiovert 10), micromanipulator arm (Narishige Scientific 
Instruments, Japan) and a N2 cylinder set at 50 Barr pressure, with the tip of the 
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needle broken with abrasion against an agarose pad. Young adult worms were placed 
onto the agarose pad with a drop of mineral oil (Sigma-Aldrich Co. Ltd., UK) and 
injected with DNA into the syncytium of the distal arm of the gonad. After injection a 
drop of M9 buffer was placed on the worms and they were allowed to recover for 20 
min before transfer to NGM plates. F1 transformants displaying the dominant rol-6 
phenotype were transferred to fresh NGM plates for propagation and observation of 
the stability of transmission. After the F3 generation worms still displaying the rol-6 
phenotype were visualised for GFP activity. 
 
3.2.13 Visualisation of GFP tagged worms 
Worms transformed with promoter::GFP constructs were subjected to visualisation 
with fluorescence microscopy. C. elegans worms were grown on NGM plates for 2-3 
days until most of the bacteria food have been consumed and were washed off with 1 
ml M9 solution and settled out in an Eppendorf tube for 10 min at 4°C. The worm 
pellet was distributed on 8 well microscope slides and 0.5 l of 20 mM levamisole 
was added to each well. Slides were mounted on a Zeiss Axioplan microscope 
equipped with DIC optics and visualised through Chroma Technology Corp. filter set 
41012. Spatial and temporal expression patterns of GFP were determined for all 
stages of development. Representative images of the observed expression pattern 
were collected with Improvision Openlab software on a Photometrics CoolSNAP 
camera. 
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3.3 Results 
3.3.1 Homology search of C. elegans and C. briggsae genes 
3.3.1.1 GPI synthesis pathway genes 
Genes involved in the synthesis of the GPI anchor in the ER were found with 
literature search for humans and S. cerevisiae (yeast). The human genes chosen for 
the homology search are listed in Table 3.1, with the C. elegans and C. briggsae 
homologues found by BLAST search from Wormbase. Of the 23 genes in the 
synthesis pathway 16 have homologues within C. elegans and C. briggsae, with C. 
briggsae also containing an additional 2 homologues that were absent in C. elegans. 
Homologues for most of the GPI synthesis steps are present within both nematodes. 
Three out of the seven genes involved in the first step of synthesis have no 
homologues in either nematode species, as well as the interacting partner PIG-X in 
step 5 and PIG-Z from step 9, which adds the fourth mannose to the structure. Of note 
are PIG-L and PIG-F (GPI anchoring steps 2 and 10/11, respectively) which have 
homologues within C. briggsae but did not have significant hits within the C. elegans 
genome. 
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Table 3.1. Homology search of GPI anchor synthesis pathway genes in C. elegans and C. 
briggsae. All known genes of the GPI anchor synthesis pathway from humans and yeast are 
presented here with a brief description and their predicted size in amino acids (aa). C. elegans and 
C. Briggsae homologues were obtained from BLAST searches against the human pathway genes 
and are presented with their BLAST scores (significance at p< 0.05) and their size in amino acids. 
Stage Human 
gene Description 
Size 
(aa) 
Yeast 
gene 
Size 
(aa) 
C. elegans 
gene Blast score 
Size 
(aa) 
C. briggsae 
gene 
Blast 
score 
Size 
(aa) 
step 1 
PIG-A Enzymatic part of 
complex 484 GPI3 452 D2085.6 1.30E-112 444 CBG00513 4.60E-112 393 
PIG-H Binds PIG-A, helps 
catalysis 188 GPI15 229 n/a n/a n/a n/a n/a n/a 
PIG-C Scaffolding of complex, 
bind PIG-Q 297 GPI2 280 T20D3.8 2.10E-32 282 CBG21692 3.80E-28 267 
PIG-Q Stabilise complex 581 GPI1 609 F01G4.5 5.50E-30 269 CBG06019 1.70E-31 248 
PIG-P Interact with PIG-A + Q 158 GPI19 140 Y48E1B.2 1.20E-10 890 CBG20762 7.70E-11 871 
DPM2 Regulate DPM1, 
enhances GlcNAc  82 n/a n/a n/a n/a n/a n/a n/a n/a 
PIG-Y Binds to PIG-A 114 ERI1 68 n/a n/a n/a n/a n/a n/a 
step2 PIG-L GlcNAc-PI deacetylase 252 GPI12 304 n/a n/a n/a CBG07954 8.50E-24 147 
Step 3 PIG-W Addition of acyl group to 
inositol ring 504 GWT1 490 Y110A2AL.12 2.00E-33 480 CBG19615 3.00E-31 827 
Step 5 
PIG-M Add 1st mannose to 423 GPI14 403 B0491.1 4.90E-79 417 CBG02919 5.80E-73 394 
PIG-X Interaction partner of 
PIG-M 217 PBN1 416 n/a n/a n/a n/a n/a n/a 
step 6 PIG-N Add phoshoethanolamine 
to 1st mannose 931 MCD4 919 
Y54E10BR.1 4.80E-134 912 CBG04200 4.40E-137 920 
F28C6.4 5.40E-16 745 CBG00550 1.10E-09 721 
CBG01149 0.01 483 
step 7 PIG-V Add 2nd mannose 493 GPI18 433 T09B4.1 4.60E-24 672 CBG12553 7.20E-15 673 
Step 8 PIG-B Add 3rd mannose 554 GPI10 616 T27F7.3 1.00E-71 496 CBG02293 1.20E-74 495 
Step 9 PIG-Z Add 4th mannose  579 SMP3 516 n/a n/a n/a n/a n/a n/a 
Step 10 PIG-G Add phoshoethanolamine 
to 2nd mannose 975 
GPI7 
(LAS21) 830 
F28C6.4 2.30E-77 745 CBG00550 1.20E-71 721 
C27A12.9 4.50E-39 883 CBG20246 2.10E-34 453 
Y54E10BR.1 1.60E-08 912 CBG04200 1.10E-08 920 
Step 11 PIG-O Add phoshoethanolamine 
to 3rd mannose 1089 GPI13 1017 
C27A12.9 1.30E-92 883 CBG20246 1.90E-59 453 
F28C6.4 8.30E-31 745 CBG00550 1.50E-35 721 
Y54E10BR.1 2.00E-05 912 CBG04200 1.30E-05 920 
Step 
10/11 PIG-F 
Required for 2nd/3rd 
mannose modification 219 GPI11 219 n/a n/a n/a CBG05911 2.40E-08 554 
step 12 
PIG-K Transamidase protease 395 GPI8 411 T05E11.6 3.90E-86 319 CBG06010 2.00E-86 319 
T28H10.3 3.60E-24 462 CBG23516 6.10E-28 463 
GPAA1 May bind free GPI lipid 
anchor 621 GAA1 614 F33D11.9b 3.40E-21 676 CBG04019 3.10E-16 508 
PIG-T May regulate active site 
of PIG-K 578 GPI16 610 F17C11.7 6.60E-40 531 CBG23063 3.30E-39 531 
PIG-S May be structural 555 GPI17 534 T14G10.7 3.30E-15 544 CBG03410 1.70E-15 695 
CBG17621 0.0092 106 
PIG-U May be involved in 
substrate recognition 435 GAB1 394 
T22C1.3 1.80E-33 421 
CBG08253 1.70E-32 419 B0491.1 0.00065 417 
srz-103 0.0016 326 
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3.3.1.2 Genes involved in Dol-P-Man synthesis 
Genes involved in the synthesis in Dol-P-Man, an essential component of GPI anchor 
synthesis were also searched against the C. elegans and C. briggsae genomes for 
homology. Three human genes are involved in this process and of these DPM1 and 
DPM3 have homologues in both nematodes (Table 3.2), with DPM1 having multiple 
hits in BLAST. DPM2 is also a component of step 1 of GPI anchor synthesis, but does 
not have a homologue in either C. elegans or C. briggsae (Table 3.1). 
Human 
gene Description  
Size 
(aa)  
Yeast 
gene  
Size 
(aa)  
C. elegans 
gene  Blast score 
Size 
(aa)  
C. briggsae 
gene  Blast score 
Size 
(aa)  
DPM1 Catalytic unit for 
Dol-P-Man synthesis 260 DPM1 267 
Y66H1A.2 
(dpm-1) 1.10E-81 239 
CBG13497 
(Cbr-dpm-1) 3.40E-84 343 
H43I07.3 4.80E-08 339 
CBG01437 7.70E-09 338 
gly-8 0.00096 421 
DPM2  Regulate DPM1, 
enhances GlcNAc  82  n/a  n/a n/a  n/a  n/a  n/a  n/a  n/a  
DPM3 tethers DPM1 to 
membrane 122 n/a  n/a  
F28D1.11 
(dpm-3) 9.20E-07 95 
CBG03325 
(Crb-dpm-3) 3.30E-06 95 
 
 
3.3.1.3 Lipid remodelling 
The fatty acid chains of GPI anchors are modified within the ER and Golgi apparatus 
before they are transported to the surface of the cell. Human and yeast differ slightly 
in the types of modifications they perform to the anchor, most notably at the sn-2 
position of the lipid where the human protein PGAP2 replaces the fatty acid with a 
saturated C18:0 chain, while the yeast protein Gup1p adds a longer saturated C26:0 
Table 3.2. Homology search of Dol-P-Man synthesis genes in C. elegans and C. briggsae. 
Known genes within the human and yeast pathways are presented with a description and their 
size in amino acids (aa). C. elegans and C. briggsae homologues were obtained with BLAST 
searches from Wormbase against the human genes. BLAST scores for significant results (p< 
0.05) and their predicted size in amino acids are presented.  
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species to the position, which can be modified further by other genes such as CWH43. 
The human fatty acid remodelling genes GPAP1, GPAP2 and GPAP3 all have 
homologues in both C. elegans and C. briggsae (Table 3.3), with GPAP2 having 
multiple significant hits by BLAST search in the two nematodes (5 in C. elegans and 
4 in C. briggsae). The yeast protein Gup1p has a weak homologue in C. elegans 
(hhat-2, p= 0.026) which is a putative palmitoyltransferase in the hedgehog signalling 
pathway (Burglin and Kuwabara, 2006), while no significant homologues were found 
for C. briggsae with BLAST. 
 
Human 
gene Description 
Size 
(aa) 
Yeast 
gene 
Size 
(aa) 
C. elegans 
gene Blast score 
Size 
(aa) 
C. briggsae 
gene Blast score 
Size 
(aa) 
PGAP1 Inositol 
deacylation  922 BST1  1029 T19B10.8 3.00E-25 733 CBG23146 6.00E-25 1550 
PGAP3 
Removes acyl 
group on sn-2 
position 
320 PER1  357 R01B10.4 7.00E-25 320 CBG09260 6.00E-28 326 
PGAP2 
Addition of 
saturated fatty 
acid to sn-2 
315 CWH43  953  
T04A8.12 
(tag-189) 6.00E-36 263 
CBG18005 
(Crb-tag-189) 5.00E-35 263 
Y38F1A.8 1.00E-08 303 CBG02772 5.00E-09 299 
T23B12.5 4.00E-04 224 CBG26903 0.005 253 
Y11D7A.9 0.010 297 
CBG15066 0.012 297 
ZK185.4 0.015 281 
n/a  n/a  n/a  GUP1  560 Y57G11C.17a 
(hhat-2) 0.026 524 n/a n/a n/a 
 
 
Table 3.3. Homology search of fatty acid modification genes in C. elegans and C. 
briggsae. Known genes within the human and yeast pathways are presented with a 
description and their size in amino acids (aa). C. elegans and C. briggsae homologues 
searched against the human genes with BLAST, with significant scores (p< 0.05) and the 
protein‟s predicted size (aa) presented. 
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3.3.2 Analysis of C. elegans PIG-K homologues 
3.3.2.1 Sequence analysis  
PIG-K is the catalytic part of the GPI transamidase involved in the final stage of GPI 
anchor attachment. Mutation of PIG-K homologues in humans, yeast and 
trypanosome brucei have all shown a phenotype lacking in GPI anchoring, suggesting 
that the protein is essential for the addition of GPI to proteins (Kang et al., 2002; 
Meyer et al., 2000; Ohishi et al., 2000).  Both C. elegans and C. briggsae contain two 
homologues to the PIG-K protein after BLAST search (Table 3.1). T05E11.6 is the 
highest scoring C. elegans homologue followed by T28H10.3, and in C. briggsae the 
CBG06010 gene had the highest BLAST score followed by CBG23516. A 
CLUSTALX alignment was made for all the PIG-K homologues (Figure3.4.a). 
T05E11.6 and CBG06010 are homologues of each other and have 95.9% sequence 
identity, while T28H10.3 and CBG23516 are homologous to each other and also have 
high sequence identity (90.3%) (Figure 3.4.b). PIG-K contains two active site residues 
His157 and Cys199 and they are both present within all of the homologous sequences 
(Figure 3.2.a). The T05E11.6 and CBG06010 protein sequences lack the hydrophobic 
C-terminal domain found in PIG-K, while the T28H10.3 and CBG23516 protein 
sequences appear to contain the domain. 
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Figure 3.4. Analysis of the protein sequences of PIG-K homologues. Sequences for human 
PIG-K, yeast Gpi8p, and the C. elegans and C. briggsae homologues were analysed with 
CLUSTAX version 2.0.12.  
a) Multiple sequence alignment of the four protein sequences. Descriptions for the symbols 
in the graph can be found in Figure 3.8. Red arrows represent the active site residues 
His157 and Cys199 (PIG-K) and the blue arrow indicates the position where the disulfide 
bridge forms with PIG-T (Cys92 on PIG-K). 
b)  Cladogram of the six protein sequences. 
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3.3.2.2 Expression analysis of C. elegans PIG-K homologue T28H10.3 
3.3.2.2.1 Properties of promoter region 
C. elegans T28H10.3 was found to be present within the Promoterome, a repository of 
promoter::GFP fusions for expression analysis available from the Hope Lab (Dupuy 
et al., 2004). T28H10.3 is present on Chromosome V on the C. elegans genome 
(Figure 3.5.c) between positions 12,512,999 and 12,514,925 and lies within a gene 
rich area, with eight other gene models present within the surrounding 25 kb region 
(Figure 3.5.b). T28H10.3 also has 28 EST sequences attributed, suggesting that the 
gene is highly expressed (Figure 3.5.a).  
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Figure 3.5. Wormbase display of genomic region around C. elegans T28H10.3. The 
gene‟s position along chromosome V, gene model (pink and blue rectangles) and know ESTs 
aligned by BLAT (green rectangles) are shown. Filled boxes represent the exons of genes in 
the gene model. The direction of transcription is indicated by arrows at the end of the gene 
models.  
a) the display of region 1 kb upstream and 100 bp downstream of T28H10.3.  
b) display of 25kb region around T28H10.3.  
c) display of chromosome V. The position of T28H10.3 is indicated by the yellow line. 
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3.3.2.2.2 The T28H10.3 construct from the Promoterome 
The T28H10.3 promoter was present within the Promoterome as a Gateway entry 
clone with 868 bp of 5‟ upstream sequence inserted into a pDON_P4-P1r vector 
(Figure 3.6.a). This vector has a size of 3,515 bp and was tested with restriction 
enzymes EcoRV (single fragment) and SacI (double fragments of sizes 1,138 bp and 
2,377 bp) (Figure 3.6.b). The promoter::GFP construct was made with LR Gateway 
recombination reaction into the GFP destination vector pDEST-DD04 (Figure 3.6.a). 
The construct contains an unc-119 rescue gene which was used as a selective marker 
by the rescue of unc-119 worms to wildtype (Figure 3.6.a). The T28H10.3 
promoter::GFP was 11,347 bp and was digested with three restriction enzymes to 
confirm its size, which were with HindIII (single cutter), SacI (double cutter with 
fragment sizes 1,819 bp and 9,528 bp) and XbaI (triple cutter with fragments of 547 
bp which appears as a faint band at the bottom of the gel, 5,081 bp and 5,719 bp in 
length) (Figure 3.6.c). 
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Figure 3.6. Gateway LR reaction for the T28H10.3 Promoterome entry clone. 
a) The Gateway LR reaction between the T28H10.3 entry clone and the GFP containing pDEST-
DD04 destination vector. More details of the LR reaction can be found in figure 3.12. 
b) Restriction digests of T28H10.3 entry clone with EcoRV (Eco) and SalI (Sal). EcoRV 
linearises the plasmid to produce a single fragment of 3515 bp while SalI produces two 
fragments of 1138 bp and 2377 bp in length. 
c) Restriction digests of T28H10.3 promoter::GFP construct. The total size of the construct is 
11,347 bp. The restriction enzyme HindIII (Hin) linearises the plasmid, SacI (Sac) which 
produces two fragments of 1819 bp and 9528 bp, and XbaI (Xba) which produces three 
fragments of 547 bp, 5081 bp and 5719 bp. The band at 547 bp was present on the gel but was 
too faint to be photographed. 
 
  
117 
3.3.2.2.3 Expression pattern of T28H10.3 promoter::GFP construct 
The construct was inserted into unc-119 C. elegans worms via gold particle 
bombardment. Transformed worms were analyzed for GFP expression by 
fluorescence microscopy. C. elegans has a complex morphology and contains many 
tissue types for such a small organism (Figure 3.7.a). The T28H10.3 promoter::GFP 
construct was shown to be expressed in the intestinal cells of the worm (Figure 3.7.b). 
The expression started just after the worms reached the comma stage and shows a 
constantly strong level throughout its various developmental stages. The expression 
level was especially strong in cells at the ends of the intestinal tract and was 
ubiquitously strong within the adult intestine. The construct contained a nuclear 
localization signal as can be seen by the nuclear expression within the L3 worm 
(Figure 3.7.b).  
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Figure 3.7. Expression patterns generated with the T05E11.6 promoter::GFP construct. 
a) Diagram of C. elegans adult showing positions of major organs including the pharynx, ovary, 
intestines, and vulva. Adapted from 
http://avery.rutgers.edu/WSSP/StudentScholars/project/introduction/worms.html.  
b) GFP expression pattern of transformed worms in the embryo, L3 and adult stages. The pictures 
on the left show the GFP expression and a bright field view of the same image are presented on 
the right. Expression was observed early during development in the intestine and continued 
throughout all life stages of the worm. Certain anatomical features are highlighted for the L3 
and adult worms (blue arrows). Scale bar shows actual length in millimeters.  
a) 
b) 
Embryo 
Adult 
L3 
(juvenile) 
Bright field image GFP expression pattern 
Pharynx Cuticle Intestine Embryo 
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3.3.3 Analysis of C. elegans PIG-A homologue 
3.3.3.1 Sequence analysis  
PIG-A is an important part of the enzyme complex involved in the first step of GPI 
biosynthesis. PIG-A catalyses the reaction between GlcNAc and PI to form GlcNAc-
PI. Knockout of PIG-A orthologues has been shown to result in the loss of GPI 
anchoring in a variety of organisms (Alfieri et al., 2003; Shichishima and Noji, 2002; 
Vossen et al., 1997). C. elegans contains one homologue for PIG-A with the name 
D2085.6 (Table 3.1). Protein sequences for PIG-A and its homologues in yeast, C. 
elegans and C. briggsae display a large amount of sequence conservation with each 
other (Figure 3.8.a). The human sequence displays a 25 amino acid overhang at the N-
terminus which is not present within the other sequences. C. briggsae also lacks a 43 
amino acid domain (in between amino acid positions 129 and 172 in the PIG-A 
sequence) that is highly conserved in the other three sequences. Conservation between 
the amino acid positions of C. elegans and C. briggsae is higher than for the other two 
proteins (Figure 3.8.b) as can be expected from their relatively close evolutionary 
relationship. 
 
  
120 
Figure 3.8. Analysis of the protein sequences of PIG-A homologues. Sequences for human 
PIG-A, yeast Gpi3p, and homologues in C. elegans and C. briggsae were analysed with 
CLUSTALX version 2.0.12.  
a) Multiple sequence alignment of the four protein sequences. Light grey boxes indicate an 
alignment of two amino acids, darker grey boxes indicate three amino acids alignment, 
and black boxes indicate total conservation of amino acid sequence at the position. 
Symbols under the amino acids come from CLUSTALX output, with “.” indicating semi-
conservative substitution, “:” indicating conservative substitution according to amino acid 
type, and “*” indicating total conservation of the residue.  
b)  Cladogram of the four protein sequences. 
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3.3.3.2 Expression analysis of C. elegans PIG-A homologue D2085.6  
3.3.3.2.1 Selection of promoter region 
The C. elegans gene D2085.6 was chosen for expression analysis with Gateway 
homologous recombination. D2085.6 is found near the centre of chromosome II 
between positions 8,661,644 and 8,659,714 (Figure 3.9.c). The sequence is found 
within a gene rich region, with five other genes inside a region of 25 kb that does not 
appear to include very much repetitive sequences (Figure 3.9.b). The sequence 5,152 
bp upstream of the start codon was chosen for the production of the promoter::GFP 
reporter construct (Figure 3.9.a). The finished Gateway product is to be injected into 
the gonad of worms to induce transformation. 
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Figure 3.9. Wormbase display of genomic region around C. elegans D2085.6. Display 
consists of position along chromosome II, gene model (pink and blue rectangles), and know 
ESTs aligned by BLAT (green rectangles). Exons of genes are displayed as filled boxes in the 
gene model. Arrows at the end of gene models indicate direction of transcription.  
a) The display of region 6 kb upstream and 1 kb downstream of D2085.6.  
b) Display of 25kb region around D2085.6.  
c) Display of chromosome II in its entirety. The yellow region indicates the position of D2085.6. 
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3.3.3.2.2 PCR of attB flanked promoter 
Oligonucleotide primers were designed for the promoter with the homologous 
recombination site attB4 added as an overhang onto the forward primer at the 5‟ end 
of the promoter sequence and an attB1r site on the reverse primer at the promoter‟s 3‟ 
end (Figure 3.10.a). The start methionine codon was also inserted into the sequence 
on the reverse primer for compatibility with the subsequent GFP sequence. The 
D2085 cosmid (obtained from the Sanger Institute, Hinxton) was used to clone the 
promoter of D2085.6 via PCR and a 5,206 bp product was produced with attB4 and 
attB1r sites flanking at the 5‟ and 3‟ ends, respectively (Figure 3.10.b).  
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Figure 3.10. Making of the D2085.6 promoter template for Gateway recombination.  
a) Forward and reverse primers of promoter region.  21 bp of sequences at the 5‟ and 3‟ 
ends of the desired promoter region were joined with attB4 and attB1r sites for 
subsequent BP reaction.  The ends of the primers were capped with four guanine 
residues. 
b) Gel purified results of promoter PCR, which shows the sequence at above 5 kb in 
length.  Samples were diluted 1/2 and 1/10 fold before loading.  The final concentration 
of the DNA was approx. 30ng/µl. 
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3.3.3.2.3 Making of entry clone with BP reaction 
The PCR product was then subjected to a BP reaction with the donor vector 
pDON_P4-P1r to produce an entry clone that contains a kanamycin resistance 
selection marker (Figure 3.11.a). After selection six colonies were chosen for 
miniprep (BP 1-6) and digested with restriction enzymes HindIII (cuts twice to give 
fragments of 2,350 bp and 5,448 bp) and EcoRV (cuts thrice to give fragments of 
1,103 bp, 2,662 bp and 4,033 bp). Colonies BP2, BP4 and BP6 produced the expected 
fragments for each of the enzymes (Figure 3.11.b). Plasmids from BP2 were 
linearised with the restriction enzyme BstYI which produced a single band that 
corresponds to the expected length of the entry clone (7,798 bp, Figure 3.11.c). The 
unlinearised version of the BP2 plasmid was used for the subsequent LR reaction. 
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Figure 3.11. Gateway BP reaction for the 
D2085.6 promoter.  
a) The Gateway BP reaction. AttB sites 
flanking the promoter react with attP sites 
on the vector and recombination of DNA 
occurs to produce attL and attR sites at the 
end of the reaction. The promoter sequence 
is inserted into the entry clone. The ccdB 
gene is a negative selection marker that 
causes lethality in E. coli and ensures 
bacteria transformed with the by-product do 
not survive. 
b) Restriction digest of BP transformants 
named BP 1-6. Con stands for control 
(unlinearised plasmid), Hind stands for 
HindIII digestion, and Eco stands for 
digestion with EcoRV. 
c) BP2 product linearised with BseYI. DNA 
concentration was approx. 30ng/µl. 
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3.3.3.2.4 Production of Promoter::GFP construct with LR reaction 
Entry clone BP2 was subjected to LR reaction with the destination vector pJS02_469 
(Figure 3.12.a). pJS02_469 contains an ampicillin selection marker and a GFP 
sequence in frame with the attB1r site, which is joined in frame with the promoter 
sequence after the LR reaction to produce the promoter::GFP construct. The 
destination vector was first linearised with the SalI restriction enzyme to allow greater 
efficiency during the reaction (Figure 3.12.b). After selection colonies LR 1, 2, 3, 4, 
and 5 were checked with restriction enzymes BamHI (cuts twice, 3,629 bp and 7,597 
bp fragments) and XbaI (cuts twice, 1,696 bp and 9,530 bp fragments) for correct 
insertion of the promoter (Figure 3.12.c). LR 4 and LR5 showed fragments of the 
correct sizes. Plasmids from both of the colonies were linearised with SacI which 
produced the expected size of the product (11,226 bp). 
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Figure 3.12. Gateway LR reaction for the D2085.6 
promoter.  
a) The Gateway LR reaction. In a reverse of the BP 
reaction attL and attR sites on the entry and destination 
vectors react to produce the promoter::GFP construct 
and a ccdB containing by-product.  The destination 
vector contains an ampicillin resistance gene which is 
used for selection. The GFP sequence joins in frame to 
the promoter sequence at the end of the reaction. 
b) Restriction digestion of pJS02_469 vector with SalI for 
linearisation. Plas indicate the non-linearised version 
and Lin indicate the linearised vector. 
c) Restriction digests of transformed colonies LR 1-5. C 
stands for undigested control, B stands for digestion 
with BamHI and X stands for XbaI digestion. 
d) Restriction digestion of LR4 and LR5. S stands for SacI 
which linearises the sequence. LR4 and LR5 are 
approximately 60ng/µl and 140ng/µl, respectively. 
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3.4 Discussion  
Known human and yeast GPI biosynthesis genes were used in a bioinformatic search 
to find their homologues in C. elegans and C. briggsae. Of the 23 genes found in the 
human pathway 16 of them have C. elegans homologues, while C. briggsae contains 
an additional 2 more homologues in the pathway genes (Table 3.1). Other important 
components of GPI anchoring, such as Dol-P-Man synthesis (Table 3.2) and lipid 
remodelling (Table 3.3), also have homologues in both of the worms. An account of 
the nematode genes involved in the various steps of GPI biosynthesis is given below. 
 
3.4.1 GPI biosynthesis genes  
3.4.1.1 Step 1 
Seven human genes have been found so far for the first step of GPI biosynthesis, 
where they have been postulated to form a complex for their catalytic activity (Tiede 
et al., 2000). Both C. elegans and C. briggsae contain homologues for four of the 
genes involved in this process. The PIG-A gene is the catalytic subunit of the complex 
and is one of the four genes that have a homologue in both nematodes. PIG-C, PIG-Q 
and PIG-P also have homologues within the nematodes and are important for the 
activity of the enzymatic complex in humans and yeast (Leidich et al., 1995; Newman 
et al., 2005; Tiede et al., 2001). The PIG-H protein, which is postulated to form a 
complex with PIG-A, does not have homologues in the nematodes (Watanabe et al., 
1996). Homologues of PIG-Y were also absent from both nematodes; this relatively 
small protein interacts with PIG-A and the Ras pathway in yeast and may act as a 
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regulator of GPI biosynthesis (Sobering et al., 2004). PIG-Y has also been shown to 
be important for human PIG-A function but a complex can still be formed in its 
absence (Murakami et al., 2005). PIG-Y appears to regulate the function of PIG-A, 
and this mode of regulation may be absent in both C. elegans and C. briggsae. Lastly 
DMP2 is involved in GPI biosynthesis in humans and is absent in yeast, where it 
affects the rate of reaction of the first step of GPI anchor synthesis (Watanabe et al., 
2000b). DMP2 is also involved in Dol-P-Man synthesis in humans and may act in a 
regulatory role to coordinate between the two biosynthetic processes. Both C. elegans 
and C. briggsae lack a homologue for DMP2, suggesting that the Dol-P-Man 
synthesis pathway is not involved in the regulation of GPI biosynthesis in both of the 
nematodes. 
3.4.1.2 Step 2 
PIG-L/GPI12 is the human/yeast gene responsible for deacetylation of the GLcNAc-
PI in the second step of GPI biosynthesis. This step was shown to be crucial for GPI 
synthesis in a number of organisms including Trypanosoma brucei, yeast, and 
mammals (Urbaniak et al., 2005; Watanabe et al., 1999), but interestingly has no 
homologue in C. elegans. C. briggsae however was shown to contain a homologue to 
PIG-L called CBG07954, which also does not have a homologue in C. elegans, 
suggesting that the gene has been lost during the evolution of C. elegans. PIG-L is a 
zinc metalloenzyme (Urbaniak et al., 2005), and its role in GPI anchor synthesis in C. 
elegans may have been taken up by an unrelated deacetylase. 
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3.4.1.3 Step 3 
PIG-W is the human gene responsible for the addition of an acyl group onto the 
inositol ring in the third step of GPI biosynthesis (Murakami et al., 2003). Both the 
human and the yeast homologue have been shown to cause defective GPI anchoring 
and affect the maturation of GPI anchored proteins (Umemura et al., 2003), and 
acylation is also a common feature in Trypanosoma brucei (Ferguson, 1999). Both C. 
elegans and C. briggsae have homologues for PIG-W, suggesting that inositol 
acylation might also be an important step in GPI anchor addition of both of these 
nematodes.  
3.4.1.4 Localisation to the luminal side of the ER and addition of mannoses to the 
GPI anchor: Steps 4, 5, 7, 8, and 9 
Step 4 of GPI biosynthesis is carried out by a flippase which is still uncharacterised in 
human and yeast. Step 5 of GPI biosynthesis occurs within the lumen of the ER and 
involves the addition of the first mannose subunit, which is catalysed by PIG-M in 
humans (Maeda et al., 2001b). Both C. elegans and C. briggsae contain one 
homologue for the gene. PIG-X/Pbn1p in human/yeast interacts with PIG-M/Gpi14p 
and acts to stabilise the protein in the ER via its chaperone-like activity (Ashida et al., 
2005a; Subramanian et al., 2006). This gene however does not have a homologue in C. 
elegans or C. briggsae.  It may be that the nematode PIG-M homologues do not 
require stabilisation for their function; alternatively an unrelated chaperone protein 
may stabilise the homologues within the ER of the nematodes. 
Steps 7 and 8 in GPI biosynthesis involve the addition of the second and third 
mannoses to the GPI structure. The genes responsible for both of these steps in 
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human/yeast are PIG-V/GPI18 and PIG-B/GPI10, respectively. C. elegans and C. 
briggsae have homologues for both of these mannosylation genes. The three core 
mannose subunits are essential in GPI biosynthesis and is a common feature of all 
GPI anchors found so far (Ikezawa, 2002). 
In human and yeast, a fourth mannose is sometimes added to the GPI structure via 
PIG-Z/SMP3 in step 9 of GPI biosynthesis. This modification is not required in 
human cells but is essential for anchoring of proteins in yeast (Grimme et al., 2001). 
This modification in humans appears to be tissue specific, and GPI anchors with three 
or four mannose subunits have been observed (Taron et al., 2004b). Both of the 
nematode species analysed here do not contain a homologue for this process, 
suggesting that the addition of the fourth mannose does not occur within C. elegans 
and C. briggsae and that this may be a species specific modification. 
3.4.1.5 Addition of phosphoethanolamine to mannoses: steps 6, 10, and 11 
In both humans and yeast, phosphoethanolamine is added to the three core mannose 
subunits via the genes PIG-N/MCD4, PIG-G/GPI7 and PIG-O/GPI13 in steps 6, 10 
and 11, respectively (Benachour et al., 1999; Hong et al., 2000; Hong et al., 1999a). 
Both C. elegans and C. briggsae have homologues for each of these genes, with the 
best result for PIG-N (Y54E10BR.1/CBG04200), PIG-G (F28C6.4/CBG00550) and 
GPI-O (C27A12.9/CBG20246) in C. elegans/C. briggsae, respectively. Interestingly 
the nematodes homologues for each individual gene are also homologues for the 
others, with Y54E10BR.1 found to be also homologous to PIG-G and PIG-O, 
F28C6.4 also homologous to PIG-N and PIG-O, and C27A12.9 also homologous to 
PIG-G (Table 3.1). A sequence comparison of the C. elegans genes with ClustalW 
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shows conserved motifs within the three predicted proteins but otherwise poor 
conservation for the rest of their sequences (Figure 3.13); the conserved nematode 
motifs corresponds to similar motifs on the three human genes, which may represent 
sites of important biological function, such as ligand binding sites, for this class of 
enzymes. Further analysis will be needed to elucidate exactly which of the 
homologues in C. elegans and C. briggsae are responsible for each of the 
phosphoethanolamine addition reactions. The addition of the first 
phosphoethanolamine is important for GPI anchor synthesis in both human and yeast 
(Vainauskas and Menon, 2006; Zhu et al., 2006) while the addition of the third 
phosphoethanolamine is essential as the protein is attached to the anchor via this 
moiety (Hong et al., 2000). Addition of the second phosphoethanolamine however is 
only important in yeast (Fujita et al., 2004), whereas in humans the modification is 
needed for just a subset of GPI anchors (Shishioh et al., 2005). It will be interesting to 
see how important the presence of this moiety on each mannose subunit is in both C. 
elegans and C. briggsae, and elucidate their influence on different tissue types in 
development and other physiological processes. 
PIG-F/Gpi11p in human and yeast interact with PIG-G/Gpi7p and PIG-O/Gpi13p in 
the addition of the second and third mannoses in GPI anchor biosynthesis. PIG-F is an 
essential interaction partner of PIG-O in humans (Hong et al., 2000), however defects 
in Gpi11p in yeast was shown not to be a requirement for this step (Taron et al., 2000). 
C. elegans does not contain a homologue for this gene, while C. briggsae has a 
homologue to PIG-F but the gene has a predicted size of more than double its human 
counterpart (Table 3.1). The difference between the two nematodes posses interesting 
questions from an evolutionary perspective. It may be that the gene is ancestral and 
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Figure 3.13. ClustalW analysis of the three human phosphoethanoamine addition proteins 
and their C. elegans homologues. The symbols in the graph are described in Figure 3.8. Blue 
bars indicate areas of high homology between all sequences, which may indicate areas of 
important functions. Only the partial sequences of the proteins with conservation between all of 
the genes are presented here. 
has been lost in the C. elegans lineage and not C. briggsae. Alternatively the gene 
may have taken on different roles in the two nematodes, with the C. briggsae version 
still possibly retaining some of its original function in GPI anchor synthesis. It will 
also be interesting to investigate the properties of the C. elegans PIG-O homologue 
compared to the human protein to elucidate the mechanism with which PIG-F acts in 
PIG-O regulation.  
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3.4.1.6 Step 12 
The last step in GPI biosynthesis involves the attachment of the protein to the anchor 
via the GPI transamidase (GPIT) complex. Each of the five subunits that make up the 
GPIT in human and yeast have homologues in both C. elegans and C. briggsae. PIG-
K/Gpi8p, GPAA1/Gaa1p and PIG-T/Gpi16p are postulated to form the core structure 
of GPIT with PIG-K as the catalytic subunit, with GPAA1 important for substrate 
recognition and PIG-T having a role in conferring specificity for the enzyme 
(Eisenhaber et al., 2003b; Fraering et al., 2001; Kang et al., 2002; Vainauskas and 
Menon, 2004a). PIG-S/GPI17 and PIG-U/GAB1 are postulated to be responsible for 
structural and substrate recognition (Ohishi et al., 2001). In yeast Gpi17p and Gab1p 
form a complex with each other and appear to associate transiently with the rest of the 
GPIT complex, suggesting that the whole complex functions as two different subunits 
(Grimme et al., 2004; Zhu et al., 2005). It will be interesting to see if the nematode 
homologues also form these complexes, and elucidate their mode of regulation with 
regards to different tissue types and developmental stages. 
One of the most extensively characterised genes for the last step of GPI biosynthesis 
is PIG-K, the catalytic component of the GPIT complex. PIG-K is a cysteine protease 
and plays a crucial role in GPI biosynthesis (Spurway et al., 2001). Both C. elegans 
and C. briggsae contain two homologues to this protein. The C. elegans homologues 
are T05E11.6 and T28H10.3; the T05E11.6 protein has a higher homology BLAST 
score (Table 3.1). Both of these proteins contain the two conserved residues, His157 
and Cys199, within the PIG-K active site that are necessary for the enzymatic 
function of the protein (Figure 3.4.a) (Meyer et al., 2000). PIG-K also contains a 
transmembrane domain at the C-terminus of the protein, which is believed to anchor 
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the protein to the ER membrane. T28H10.3 contains a hydrophobic region at the C-
terminus whereas T05E11.6 does not, however it has also been observed that the 
absence of the transmembrane domain in PIG-K does not impact on its activity in vivo 
(Ohishi et al., 2000). PIG-K forms an intermolecular disulphide bridge with PIG-T in 
the GPIT complex at Cys92 which is important but not essential for full transamidase 
activity (Ohishi et al., 2003); interestingly this residue is conserved in T05E11.6 but is 
absent in T28H10.3, where it is replaced by an asparagine; this also raises the 
possibility that the C. elegans PIG-K and PIG-T homologues form a part of the 
complex similar to the human proteins. Information from Wormbase reports only one 
partial EST assigned to T05E11.6 while T28H10.3 appears to be highly transcribed 
with 28 full length and partial ESTs attributed to it (Figure 3.14). Both of these genes 
have deletion mutants that generate sterile and lethal phenotypes, suggesting that they 
carry out essential processes within the worm. Both of the PIG-K homologues could 
potentially be a part of the GPI anchor synthesis pathway within C. elegans. An 
interesting possibility may be that the two genes are expressed in different temporal 
and spatial patterns, and that both proteins are needed for GPI anchoring during 
different stages of C. elegans development. An expression pattern has been generated 
for T28H10.3 from the Promoterome (Dupuy et al., 2004) which will be discussed in 
detail below.  
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3.4.2 The Dol-P-Man synthesis genes 
Dol-P-Man is an important mannose donor within the cell and is required for GPI 
anchor biosynthesis (Orlean, 1990b). Three genes are involved in Dol-P-Man 
production in humans with only one involved in yeast. The protein for the yeast 
DPM1 gene contains a TM domain at its C-terminus that tethers the protein onto the 
ER membrane, while the human DPM1 lacks this domain and is instead stabilised by 
DPM3 to the ER, where DPM3 also prevents degradation of DPM1 (Ashida et al., 
2006). DPM2 in humans has two functions within the complex, the first for 
Figure 3.14. Wormbase gene model for the C. elegans PIG-K homologues. (a) 
shows the gene model for T05E11.6 and (b) shows the gene model for T28H10.3. 
The curated exons for each gene are shown as blue rectangles for T05E11.6 and pink 
rectangles for T28H10.3. ESTs attributed to the gene are displayed as green 
rectangles under the gene models. T05E11.6 contains one partial EST while 
T28H10.3 contains 28 full length and partial ESTs.  
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stabilisation of DPM1 and the second as a component of the first step of GPI 
biosynthesis, suggesting that there is a regulatory link between Dol-P-Man synthesis 
and the GPI anchor biosynthesis pathway in humans (Maeda et al., 1998a; Watanabe 
et al., 2000b).  Both C. elegans and C. briggsae have homologues for DPM1 and 
DPM3 but lack homologues for DPM2 (Table 3.2). Comparison of the human DPM1 
and yeast Dpm1p sequences with C. elegans DPM-1 (Y66H1A.2) and C. briggsae 
CBR-DPM-1 (CBG13497) shows that C. elegans DPM-1 lacks the C-terminal TM 
domain similar to the human protein, while C. briggsae contains an extended C-
terminal sequence that was predicted not to be a TM domain by the program 
TMHMM (Chen et al., 2003b), and may in fact be a part of a different gene following 
other gene models (figure 3.15c). The human DPM1 sequence also has higher scores 
of homology to both of the nematode protein sequences than to Dmp1p in yeast. 
These together suggest that the synthesis of Dol-P-Man has greater similarity between 
nematodes and human than with yeast. The absence of DPM2 homologues in both of 
the nematode species, however, suggests that there is no direct regulatory link 
between Dol-P-Man synthesis and the GPI anchor synthesis pathway, which is more 
similar to yeast. Taken together, it appears that the mechanisms of the Dol-P-Man 
synthesis pathway in nematode sits evolutionarily between that of the human and the 
yeast, with the human mechanism evolved to have a greater role within GPI anchor 
synthesis. Further evidence from genetic and expression analysis will be needed to 
test this hypothesis, as well as elucidate the role of Dol-P-Man synthesis pathway 
components in C. elegans and C. briggsae. 
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Figure 3.15. Analysis of the protein sequences of DPM1 homologues.  
a) ClustalW alignment of human DPM1, yeast Dpm1p, C. elegans DPM-1 and C. briggsae CBR-
DPM-1. The red bar indicates the position of the hydrophobic TM sequence in yeast Dpm1p. 
b) TMHMM prediction results for yeast Dpm1p and C. briggsae CBR-DPM-1. The yeast sequence 
contains a prediction for TM domain at the C terminus while the C. briggsae sequence does not. 
c) Wormbase gene view for C. briggsae cbr-dpm-1. At least four splice site prediction programs do 
not include the C-terminal region of the curated gene. Three of those programs place that region as 
a part of a different gene.  
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3.4.3 Lipid remodelling 
Remodelling of the lipid portion of the GPI anchor occurs after the attachment of 
protein in human and yeast and is essential for its transport to the plasma membrane 
in both of these organisms (Maeda et al., 2007). The anchor is first modified in the 
ER with removal of the acyl group on the inositol moiety with the deacetalyase 
PGAP1/BST1 (Tanaka et al., 2004). Both C. elegans and C. briggsae contain a 
homologue for this protein (Table 3.3), implying that the GPI anchored proteins 
expressed on the cell surface of these nematodes is also deacetylated. This has 
implications for the analysis of GPI anchored proteins within the worms with the 
commonly used enzyme phosphatidylinositol-specific phospholipase C (PIPLC), as 
this enzyme is only active against deacetylated versions of the GPI anchor (Roberts et 
al., 1988). 
GPI anchor fatty acid chains are modified in the Golgi before the protein is targeted to 
the surface of the cell. The remodelling process involves replacement of the relatively 
short and unsaturated lipid tail with a longer and saturated one, which is thought to 
allow greater packing of the GPI anchor with other saturated lipids in the plasma 
membrane that is essential for their incorporation into lipid rafts (Maeda et al., 2007). 
The first step of remodelling involves the removal of the lipid tail at the sn-2 position 
and is carried out by PGAP3/PER1 in humans and yeast (Fujita et al., 2006a). Both of 
the nematodes species contain a homologue for this gene. Subsequent steps differ 
greatly between human and yeast. In humans a saturated C18:0 fatty acid is 
incorporated into the sn-2 position by the gene PGAP2, while in yeast the Gup1p 
protein adds a long saturated C26:0 chain to replace the lipid tail (Bosson et al., 2006; 
Tashima et al., 2006). C. elegans and C. briggsae both contain numerous homologues 
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to PGAP2, which suggests that nematode GPI anchors might be modified in a similar 
manner to those in humans. The C. elegans homologue to GUP1 has a low homology 
score in BLAST (p=0.026, Table 3.3) and is postulated to be a hedgehog 
acyltransferase (Burglin and Kuwabara, 2006). It is therefore likely that the C. 
elegans and C. briggsae lipid tail modifications are more closely related to human 
than yeast. Lipid modification is a relatively poorly understood process and several 
modifications are known to exist for the GPI anchor within the cell in a variety of 
organisms (Ernesto S Nakayasu et al., 2009). The presence of multiple PGAP2 
homologues in both the nematodes raises the possibility that the GPI anchor can also 
be remodelled with a variety of lipid tails, and hints at interesting interactions of GPI 
anchored proteins within the two worms. 
 
3.4.4 Expression patterns of homologues of PIG-K and PIG-A 
Expression patterns for a particular gene can be generated in the worm which 
provides information on the temporal and spatial expression of the gene, giving us a 
better picture for its role in the various processes of development. The PIG-K and 
PIG-A homologues were chosen for expression pattern analysis due to the crucial role 
these proteins have in the synthesis of GPI anchors. The C. elegans PIG-K 
homologues are T05E11.6 and T28H10.3, with T05E11.6 having a higher homology 
score under BLAST alignment. Dupuy et al. have created a library of promoter::GFP 
DNA constructs for C. elegans genes called the Promoterome, which can be used for 
their expression analysis (Dupuy et al., 2004). The PIG-K homologue T28H10.3 was 
available from the library (courtesy of Hope lab) as a plasmid with 868 bp of 5‟ 
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upstream sequence in the promoter::GFP construct, and was used to elucidate the 
expression pattern of the gene in vivo. T28H10.3 is expressed early in the C. elegans 
embryo and had stable expression throughout the various life stages of the worm 
(Figure 3.7). The gene is strongly expressed in the intestine of the worm, especially at 
where the organ joins with the pharynx. GPI anchored gut enzymes may well be 
involved the digestion of ingested food, with other proteins having potential roles in 
cell adhesion, signalling and the prevention of pathogen entry (Harris and Siu, 2002; 
Sharom and Radeva, 2004; Sly and Hu, 1995; Yatsuda et al., 2003). The GPI anchor 
is also an important apical sorting signal that allows proteins to be located to the 
correct surface of the cell within the gut, and may be the reason for the high level of 
T28H10.3 expression within the organ (Benting et al., 1999). It would be interesting 
to also observe the expression pattern of T05E11.6 to see how much the PIG-K 
homologues overlap with each other within the worm. GPI anchored proteins have 
been shown to be important for certain neuronal functions (Karagogeos, 2003) and it 
may be that T05E11.6 is expressed within neurons and has its activity separated from  
T28H10.3 in a tissue specific manner. More research is needed to elucidate the exact 
mechanism with which the PIG-K homologues operate within C. elegans, which may 
shed light on the importance of GPI anchoring to the nematode in its growth and 
development. 
The 5‟ promoter sequences used in the Promoterome constructs are typically 1 to 2 kb 
in length, which may not be the complete regulatory sequence of the gene (Dupuy et 
al., 2004). It has been suggested that the use of a larger portion of the 5‟ promoter 
sequence may give a more accurate expression pattern for a given gene, which was 
attempted for the C. elegans PIG-A homologue D2085.6. 5 kb of the 5‟ upstream 
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sequence of the gene was cloned into an appropriate vector with the Gateway 
expression system (Walhout et al., 2000) to produce a promoter::GFP construct. The 
construct was tested with restriction digestion and produced bands of the expected 
sizes, which indicates that the Gateway recombination was carried out successfully 
(Figure 3.12.d). Trial injections were attempted with the rol-6 marker only and 
produced transformed worms with the rolling phenotype (data not shown), however 
there was not enough time left in the project to attempt a transformation with the 
D2085.6 Promoter::GFP reporter construct. Hopefully this experiment can be 
attempted in the near future where it may shed light onto the expression pattern of the 
C. elegans PIG-A homologue, and infer on the importance of GPI anchoring in the 
nematode. 
 
3.4.5 Conclusion 
Most of the known steps of GPI synthesis are accounted for in both C. elegans and C. 
briggsae, suggesting that they possess the biosynthetic machinery needed for the 
production of GPI anchored proteins. GPI synthesis in the nematodes may be 
evolutionarily closer to the human pathway than to that of the yeast. This is suggested 
by the absence of a homologue for the PIG-Z/SMP3 in nematodes for the addition of 
the fourth mannose, which is essential in yeast but non-essential in human. Both 
nematodes also contain homologues for human DPM1 and DPM3, and sequence 
analysis of DPM1 homologues in nematodes and yeast suggests that an important C-
terminal TM domain in yeast is absent in the nematode and human proteins. DPM2 
homologues however are not found in the nematode genomes, which is more similar 
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to the situation in yeast. C. elegans and C. briggsae also contain homologues for the 
human lipid remodelling gene PGAP2, whereas only C. elegans has a weak 
homologue to the yeast lipid modification gene GUP1. Some differences also appear 
to exist between the GPI synthesis pathway of the nematodes when compared to 
human and yeast. The nematodes do not contain homologues for PIG-H and PIG-Y 
which bind to PIG-A in the first step of synthesis, suggesting that the worm PIG-A 
homologues may be less regulated than their human and yeast counterpart. The PIG-X 
protein which interacts with PIG-M in addition of the first mannose is also absent in 
nematodes. PIG-F, the interacting partner for the addition of the second and third 
ethanolamine is absent in C. elegans but has a homologue in C. briggsae, suggesting 
that there may be differences in GPI anchor synthesis between the two nematode 
species. Lastly, the absence of a homologue in C. elegans for the PIG-L gene raises a 
fundamental question about the GPI synthesis within the worm. PIG-L is a 
deacetylase responsible for the second step of GPI biosynthesis and was shown to be 
indispensible for GPI production in mammals and yeast (Nakamura et al., 1997b; 
Watanabe et al., 1999). The reaction for step 2 in C. elegans may be carried out by an 
as yet unknown deacetylase within the organism. Taken together a model for the 
production of GPI anchored proteins is given in figure 3.16, with the basic structure of 
a likely GPI anchor presented for both of the nematodes. GPI structures found in 
many organisms undergo extensive modifications depending on their environment 
(Ferguson, 1999). It will be interesting to see what modifications are present for GPI 
anchors within C. elegans and C. briggsae, where these modifications occur during 
development, and whether they contain tissue specific modifications that impact on 
the grown and behaviour of the worms. 
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C. elegans is a model organism that is very amenable to expression pattern analysis, 
which offers insight into the role of genes within a developmental context. A 
preliminary expression pattern was generated for one of the GPI synthesis pathway 
genes (C. elegans D2085.6, homologue of PIG-K) which showed that the gene is 
expressed in the intestine of the worm for most of its life cycle. Expression patterns 
for the other GPI biosynthesis genes can also be generated using the Gateway 
recombination process, which would allow the analysis of this important pathway in a 
developmental context that has hitherto only been examined in single cellular 
organisms and cell lines. C. elegans thus may provide a unique perspective on this 
important biological process. The presence of a homologue for the inositol 
deacetylase PGAP1/BST1 also suggests that the C. elegans GPI anchor can be cleaved 
with PIPLC, which will allow the use of this enzyme in the analysis of GPI anchored 
proteins within the worm. C. elegans GPI anchoring is a poorly understood process 
but the model organism has shown great potential in the study of this important 
biological process, which may enrich the understanding of GPI anchored proteins in 
biology, especially within the context of development, growth, tissue specific 
processes and aging.  
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Figure 3.16. Postulated GPI biosynthesis and lipid 
remodeling pathways in C. elegans and C. briggsae. 
The nematode GPI structures may lack the fourth 
mannose found in human and yeast, and are likely to have 
a C18:0 modification to the lipid tail similar to the 
remodeling in humans. Additional modifications to the 
GPI anchor may also occur in worms based on cell 
specific processes and stage of development.  
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4.1 Introduction  
4.1.1 The lipid raft membrane 
The fluid mosaic model of membrane structure was proposed in 1972 and describes 
the membrane as an arrangement of globular proteins embedded within a bilayer of 
phospholipids, with freedom of movement for the proteins to carry out important 
cellular processes (Singer and Nicolson, 1972). This model, while broadly accurate, 
was later found to be inadequate to describe the multitude of interactions that proteins 
are able to form within the membrane environment. Proteins can be tethered into 
functional aggregates on the membrane by the action of the cytoskeleton, or by 
specific mechanisms such as clathrin coated pits (Kusumi and Sako, 1996; 
Ungewickell and Hinrichsen, 2007). One of the more controversial membrane 
protein-lipid interactions, considered by many to be functionally important, involves 
the formation of domains of glycolipids called lipid rafts. These domains contain 
collections of sphingolipids and cholesterol with a tight packing density that 
segregates them from the rest of the membrane phospholipids, creating distinct “rafts” 
of lipids that move as a unit within the lipid bilayer (Figure 4.1). Evidence for their 
existence and their functional significance has been hotly debated within the scientific 
literature ever since they were first discovered. In 1997 a model of the lipid raft was 
presented in the journal Nature, which was taken up as a semi-official definition of 
lipid rafts within the scientific community, and attracted comment from all sides of 
the debate (Simons and Ikonen, 1997). The paper defined rafts as a dynamic 
clustering of sphingolipids and cholesterol within the lipid bilayer that acts as a 
platform for protein-protein interaction, and protein attachment for transport within 
the cell. Lipid rafts have been postulated to be involved in a diverse number of 
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important cellular processes, including transport, cell recognition, endocytosis and 
signalling (Anderson, 1993; Anderson et al., 1992; Fiedler et al., 1994; Solomon et al., 
2002). 
 
 
 
 
4.1.2 Extraction of lipid rafts from the cell 
Lipid rafts are resistant to solubilisation when treated with cold non-ionic detergents. 
This property is thought to be due to the tight packing of the sphingolipids and 
Figure 4.1. Diagrammatic representation of lipid raft membranes. Raft membranes contain 
an aggregation of sphingolipids with saturated fatty acid chains and cholesterol. GPI anchored 
proteins and other integral membrane proteins may associate with the raft domain, some of 
which may contain glycosylation. This diagram was adapted from 
http://cellbiology.med.unsw.edu.au/units/science/lecture0803.htm. 
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cholesterol that are the major structural components of lipid rafts (Chamberlain, 2004), 
and forms the basis for the most popular methods for raft extraction. Lipid raft 
proteins are distinguished from non-raft integral membrane proteins in that they are 
not readily solubilised by detergents at low temperatures, and results in the extraction 
of a fraction commonly termed as the detergent resistant membrane (DRM). At higher 
concentrations of detergents or a higher temperature the protection gained from the 
tight packing is lost and lipid raft proteins become solubilised (Chamberlain and 
Gould, 2002). Raft proteins may also display varied levels of insolubility depending 
on the concentration of the detergent (Prior et al., 2001). To date the most popular 
detergent used for the extraction of lipid rafts is Triton-X 100 (TX-100), though some 
researchers have opted for other detergents such as Brij 96, Brij 98, Lubrol WX, and 
others (Drevot et al., 2002; Madore et al., 1999; Roper et al., 2000). The choice of 
detergent has been the subject of trial and error within the field, as each detergent has 
different solubilisation properties that allow them to dissolve different subsets of 
membrane proteins within the cell (Chamberlain, 2004). Detergent chemistry can be 
complex as each of them can have different properties regarding the size and 
propensity of micelle formation and phase separation, which directly influence lipid 
subdomain solubilisation. These properties can be hard to predict when more than one 
detergent is present, which explains why mixtures of detergents are rarely employed 
for lipid raft isolation (Linke, 2009). The raft isolation procedure involves a 
discontinuous sucrose gradient for the separation of detergent soluble and insoluble 
protein fractions (Brown and Rose, 1992). Rafts are found as a low density fraction 
that floats at the interface between the 5% and 30% sucrose layers of the density 
gradient (Hope and Pike, 1996). 
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4.1.2.1 Detergents used for raft extraction  
Early experiments with Brij 96 found this detergent could be used to extract lipid rafts 
from lymphoid cells (Draberova et al., 1996), with Brij 98 chosen as a detergent by 
Drevot et al. for the extraction of T cell coupled receptors (TCR) from rafts (Drevot et 
al., 2002). One of the advantages of Brij 96 and Brij 98 is that the detergent works at 
37°C, which is thought to represent the extraction of a more physiologically relevant 
lipid raft fraction (Chamberlain, 2004). Brij 96 was shown to give better selectivity of 
raft domains than TX-100 when solubilising lipid rafts from neurons (Madore et al., 
1999). However, detergent-resistant fraction from myelin membranes extracted by 
Brij 96 was shown to float to a lower density compared to TX-100, which was 
postulated to represent a subpopulation of rafts within the membrane (Taylor et al., 
2002). 
Lubrol WX was first used in the extraction of lipid rafts from epithelial cells and was 
shown to extract a distinct raft fraction from the microvilli of the cell (Roper et al., 
2000). Lubrol WX extracted rafts were also shown to give different solubilisation of 
raft proteins than TX-100 for proteins involved in apical trafficking (Slimane et al., 
2003), further reinforcing the idea of the presence of distinct “Lubrol rafts” within cell 
membranes.  
TX-100 has been used extensively for the analysis of sphingolipid and cholesterol 
enriched domains from an early stage of lipid raft analysis (Brown and Rose, 1992; 
Hertz and Barenholz, 1977). The detergent has excellent properties when it comes to 
enrichment of the lipids found in rafts, with a 3-5 fold increase in cholesterol content, 
15% increase in sphingolipids, and a marked decrease in non-raft lipids such as 
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phosphatidylcholine, phosphatidylethanolamine and lipids of the inner membrane 
leaflet (Pike, 2003; Pike et al., 2002; Prinetti et al., 2000). Schuck et al. tested 
different detergents for their suitability for lipid raft extraction and showed that TX-
100 was able to solubilise more non-raft proteins than Brij 96, Brij 98 and Lubrol WX. 
TX-100 was also able to concentrate raft lipids comprising cholesterol and 
sphingomyelin with greater selectively than the other detergents, and to produce a 
much „purer‟ fraction of raft lipids from model membranes than Brij 96 and Lubrol 
WX (Garner et al., 2008; Schuck et al., 2003). The consensus seems to be that the 
different detergents used for lipid raft extraction are able to segregate rafts of different 
properties according to stringency. Weaker detergents such as Brij 96, Brij 98 and 
Lubrol WX are able to extract proteins which may only be transiently associated with 
rafts, while stronger detergents such as TX-100 extract a smaller subset of proteins 
that may represent the core lipid raft proteins found on the plasma membrane 
(Chamberlain, 2004; Schuck et al., 2003).  
4.1.2.2 Non-detergent extraction methods 
An important caveat with detergents comes from the finding that their use may 
encourage lipid domain formation in biological membranes (Heerklotz, 2002; Mayor 
and Maxfield, 1995), with the result that the lipid rafts extracted might be an artefact 
of the experimental procedure, and not be representative of physiological rafts that 
occur naturally within the cell. Some researchers have tried to alleviate this potential 
artefact by developing detergent-free methods of raft extraction. One of the first such 
methods was performed by Smart et al. and involved the separation of a caveolae-
enriched raft fraction using their lighter density (Smart et al., 1995). The unique 
features of caveolae have also been used to isolate rafts by the pulldown of caveolin 
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containing membranes with antibody coated beads (Macdonald and Pike, 2005; 
Schnitzer et al., 1995; Stan et al., 1997). These protocols however require multiple 
sucrose gradient steps, and as a result produce low yields of proteins for further 
characterisation and analysis. 
4.1.2.3 Extraction methods used in proteomic projects 
Studies of the protein constituents of lipid rafts with proteomic techniques have 
become increasingly frequent in the wake of the genomic era. One of the first 
proteomic analysis of lipid rafts was made in human T cells and identified over 70 
proteins (von Haller et al., 2001). Subsequent projects have looked at lipid rafts from 
a wide variety of cells and organisms, including Candida albicanas, rat liver cells, 
human HeLa cells, adipocytes, and others (Bae et al., 2004; Foster et al., 2003; 
Insenser et al., 2006; Kim et al., 2009). With a few exceptions (Bini et al., 2003), the 
majority of lipid raft proteomic analysis used the now classical TX-100 detergent 
extraction method with flotation on sucrose gradients to extract their proteins, with 
some researchers using Opitprep
TM
 medium to create the desired gradient (Blonder et 
al., 2004; Li et al., 2003; Li et al., 2004a; Nebl et al., 2002). TX-100 extraction has 
the advantage of a relatively easy set up, and an ability to be scaled up to purify the 
significant amount of proteins needed for proteomic studies. The higher stringency of 
TX-100 prepared rafts compared with Brij 96 or Lubrol WX is also an important 
factor for its widespread use in proteomic analysis, as the ubiquitous nature of 
proteomic studies means that contamination from other fractions can easily become 
misidentified as raft associated.  
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4.1.3 Extraction of GPI anchored proteins 
It was found very early on that the GPI moiety of anchored proteins can become 
cleaved following digestion by the enzyme phosphatidylinositol-specific 
phospholipase C (PIPLC) (Ferguson et al., 1985a; Ikezawa et al., 1976). The enzyme 
was found to cleave the anchor at the P-O position of the phosphate group adjacent to 
the lipid backbone (Figure 4.2). PIPLC has been found in a number of organisms, 
including Bacillus cereus, Bacillus thuringiensis, Trypanosoma brucei, and others 
(Bulow and Overath, 1986; Ikezawa et al., 1976; Taguchi et al., 1980) . It was found 
that PIPLC cannot cleave GPI anchors with an acylation modification on the inositol 
ring; GPI anchors with this modification can however be cleaved by the enzyme 
phosphatidylinositol-specific phospholipase D (PIPLD), which was discovered in 
mammals and cleaves the GPI anchor on the phosphate group at the P-O position 
adjacent to the inositol ring (Figure 4.2) (Davitz et al., 1987; Ikezawa, 2002). Cleaved 
GPI anchored proteins are no longer attached to the membrane and exhibit properties 
of soluble aqueous proteins upon release. This property and the specificity of the 
enzyme for GPI anchors has lead to the use of PIPLC as the de-facto route for the 
extraction of GPI anchored proteins from cells (Ikezawa, 2002). 
One of the most popular methods for GPI anchored protein enrichment was created by 
Bordier and involves the use of Triton X-114 (TX-114) in their extraction (Bordier, 
1981). The method utilises the property that TX-114 has a relatively low cloud point 
of 20°C that permits the separation of membrane proteins from their cytosolic 
counterparts into two phases, the detergent phase (detergent-rich) and the aqueous 
phase (detergent-poor). GPI anchored proteins usually partition into the detergent 
phase due to their amphipathic nature, however after treatment with PIPLC the 
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proteins become hydrophilic and will partition instead to the aqueous phase (Hooper 
and Turner, 1988). This technique has been the basis of a number of proteomic studies 
into GPI anchored proteins, including studies of the GPI proteomes of Arabidopsis 
thaliana, Plasmodium falciparum and human HeLa cells (Borner et al., 2003; Elortza 
et al., 2003; Gilson et al., 2006; Lalanne et al., 2004; Sherrier et al., 1999). These 
studies utilised what was described as a “shave and conquer” method (Elortza et al., 
2003), by enriching for membrane proteins, treating them with PIPLC , and finally 
extracting the released GPI anchored proteins with TX-114 phase separation. PIPLD 
was also used in one of these studies for A. thaliana and human HeLa cells (Elortza et 
al., 2006) 
 
 
 
Figure 4.2. Site of cleavage for PIPLC and PIPLD. PIPLC cleaves the GPI anchor at the 
P-O bond next to the phospholipid backbone while PIPLD cleaves the anchor at the P-O 
bond adjacent to the inositol ring. Structure of the GPI anchored protein adapted from 
Chapter 3 figure 3.1. 
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4.1.4 C. elegans lipid raft and GPI anchor studies 
C. elegans as a model organism has a relatively poor track record for membrane 
protein studies. Part of the reason comes from the worm‟s thick cuticle which makes 
protein extraction difficult. TX-100 and Lubrol PX were used in a solubilisation trial 
for the nicotinic acetylcholine receptor in C. elegans (Lewis and Berberich, 1992). 
Sedensky et al. were able to extract lipid raft from C. elegans by the use of TX-100 
and show that the fraction contains two mammalian stomatin homologues UNC-1 and 
UNC-24, and a sodium channel subunit (UNC-8) which interacts with UNC-1 
(Sedensky et al., 2004). There is currently one GPI anchored protein identified in C. 
elegans called phg-1 (alternative name phas-1), which is a homologue of the 
mammalian GPI anchored protein gas-1 involved in embryogenesis. PHG-1 was 
found to be released by PIPLC when expressed in a mammalian cell line (Agostoni et 
al., 2002). In silico studies of C. elegans GPI anchored proteins have also been 
performed previously (Eisenhaber et al., 2000; Fankhauser and Maser, 2005; Poisson 
et al., 2007). 
4.1.5 Outline for lipid raft and GPI anchored protein extraction in C .elegans 
In this chapter I will detail the methods used for the extraction and enrichment of C. 
elegans lipid raft and GPI anchored proteins. Worms were grown in liquid culture and 
cleaned by flotation on a sucrose cushion (Hope, 1999). Protein extraction in C. 
elegans proteomic projects generally aim to break open the tough cuticle of the worm, 
which can be achieved by freeze-thawing of the worms, sonication, and glass 
homogenisation (Li et al., 2009; Schrimpf et al., 2001; Tabuse et al., 2005). 
Membrane proteins can then be extracted via differential ultracentrifugation, with 
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lipid rafts enriched from the crude membrane preparation by TX-100 solubilisation 
and sucrose gradient density centrifugation. Since GPI anchored proteins are already 
enriched in lipid rafts (Brown and Rose, 1992) we felt that there was no need for the 
TX-114 extraction procedure, as the previous proteomics studies of GPI anchored 
protein all used general membrane preparations as their starting material (Borner et al., 
2003; Elortza et al., 2003). PIPLC was used on the lipid raft fraction and the released 
proteins were separated from the membrane fraction via ultracentrifugation. Presented 
in this chapter are the results from the extraction, which was applied later in chapter 5 
for proteomic analysis. 
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4.2 Method 
4.2.1 Worm strain 
Wildtype N2 nematode strains were kept as described in Chapter 3.2.2. 
4.2.2 Growth of bacteria 
4.2.2.1 OP50 strain 
E. coli OP50 strain was acquired courtesy of Hope lab. OP50 stock was kept at 4°C 
on 140 mm diameter agar plates with Luria-Bertani (LB) agar formula (8.6 mM NaCl, 
1% (w/v) peptone, 0.5% (w/v) yeast extract, 1.5% (w/v) bacteriological agar) and 
OP50 bacteria for NGM plates were grown in 100mL LB media (8.6 mM NaCl, 1% 
(w/v) peptone, 0.5% (w/v) yeast extract) at 37°C shaking overnight (o/n) and 5-6 
drops were added to each NGM plate in a fume hood and left to dry for 24 hours.  
4.2.2.2 HB101 strain 
HB101 E. coli strain was acquired courtesy of Hope lab. HB101 stock was kept on 
140 mm diameter LB agar plates with streptomycin (50 μg/ml). Bacteria for worm 
liquid culture were grown in 1 l LB media at 37°C shaking o/n and spun at 3,000 g for 
5 minutes. The supernatant was discarded and the bacterial pellet was resuspended in 
an equal volume of S. basal (0.1 M NaCl, 0.05 M Potassium phosphate pH 6, 5 μg/ml 
cholesterol) and stored at 4°C. Typically 12 ml of final bacterial suspension was made 
per 1 l of LB media. 
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4.2.3 Liquid culture of C. elegans 
Worms from 2 fully populated (but not starved) NGM plates were washed into 100 ml 
of S Basal solution. 100 μl of Streptomycin (50 mg/ml), 100 μl of Nystatin (50 
mg/ml) and 4.5 ml of HB101 bacterial suspension were added to the S Basal solution 
and the total mixture was incubated at 20°C shaking for 3 days, after which 1 ml of 
worms from the previous liquid culture was used to inoculate a new batch. The 
culture solution was checked daily and fresh bacteria were added as necessary.  
 
4.2.4 Sucrose floatation extraction of C. elegans 
Nematodes from four 100 ml liquid cultures were placed in 15 cm long test tubes and 
suspended on ice (4°C) for 10 minutes. The supernatant was discarded and the worm 
pellet was resuspended in 25 ml of 0.1 M NaCl in a 50ml falcon tube. An equal 
volume of 60% (w/v) sucrose was added to the worm suspension which was then 
centrifuged at 500 g for 2 minutes at 4°C. Worms floating on the surface were 
aspirated with a Pasteur pipette cut at the shoulder and diluted 10 times in cold 0.1 M 
NaCl. The suspension was centrifuged at 500g for 3 minutes and the supernatant 
discarded. Worms were then resuspended in 0.1 M NaCl and incubated for 1 hour at 
20°C while shaking. Afterwards, the worms were placed on ice for 15 mins and 
centrifuged at 500g for 3 minutes and the pellet of worms was collected and the 
supernatant discarded. The worm pellet was then resuspended in an equal volume 
containing protease inhibitor solution (x2 concentration, Complete Protease Inhibitor 
Cocktail from Roche in 100 mM HEPES), flash frozen in liquid N2, and stored at -
70°C until required. 
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4.2.5 Extraction of membrane proteins 
Washed C. elegans (18 ml) was taken from the freezer and left on ice to thaw. The 
worms were spun at approx. 10,000 g (13,000 rpm) for 1 minute on a Heraeus 
Biofuge Pico benchtop centrifuge and the supernatant was discarded. The worms were 
then flash frozen with liquid N2 and ground with a pestle and mortar, subjected to 
sonication  (ten bursts, 10 sec per burst, MSE Scientific Instruments), and further 
broken down in a glass homogenizer (10 plunges); all procedures were carried out at 
4°C. The homogenate was spun at 500 g for 10 minutes and the supernatant was spun 
again at 3000 g for 15 minutes and the pellets discarded. The supernatant was then 
centrifuged at 50,000 g for 1 hour at 4°C, after which the remaining membrane pellet 
was taken and resuspended in 800 μl of protease inhibitor solution (x2 concentration, 
Complete Protease Inhibitor Cocktail from Roche in 100 mM HEPES). The remaining 
supernatant was spun again at 70,000 g for 1 hour at 4°C to produce a second 
membrane pellet, which was resuspended in 400 μl of protease inhibitor solution (x2 
concentration). The membrane preparations from the first and second 
ultracentrifugation steps were flash frozen in liquid N2 and stored at -20°C. 
4.2.6 Lactose wash 
Crude membrane proteins were thawed on ice and washed with cold 100 mM lactose 
made up to 1 ml (in protease inhibitor cocktail, x1 concentration) for 1 hour with 
occasional agitation. Membranes were collected by centrifugation (100,000g for 1 
hour) and resuspended in the same volume of protease solution (x2 concentration) as 
before the wash. 
  
161 
 
4.2.7 Discontinuous sucrose gradient extraction of lipid rafts 
All subsequent steps were performed at 4°C to maintain lipid raft integrity.  Six 
batches of lactose washed membrane (6 x 200 μl aliquots) were each resuspended in 
3.55 ml of MES (morpholineethanesulfonic acid) Buffered Saline (MBS, 25 mM 
MES, 150 mM NaCl, pH 6.5) with trials of 1%, 2% or 4% TX-100 (v/v). The solution 
was mixed with 3.75 ml of 80% sucrose solution (80% sucrose (w/v) in MBS) to 
make up a 40% sucrose solution containing the membrane samples. Sucrose gradients 
were set up in 6 centrifuge tubes (25x 89 mm, thin wall Ultra-clear, cat no. 344058, 
Beckman Coulter) by adding 15 ml of 5% sucrose solution (5% sucrose (w/v) in MBS) 
to the tubes and subsequent layering of 15 ml of 35% sucrose solution (35% sucrose 
(w/v) in MBS) under the first layer from the base of the tube using a blunted long 
syringe needle. The 40% sucrose membrane samples were loaded into the tubes from 
the base and the gradients were then centrifuged at 100,000 g for at least 18 hours in a 
SW25 swing out rotor (Beckman Coulter). Fractions were taken from the base of the 
centrifuge tubes at 3.75ml intervals. A total of 10 fractions were taken from each tube 
with the pellet resuspended in MBS. All fractions were subsequently diluted 10 fold 
with MBS and spun at 100,000 g for 1 hour 30 minutes with the pellet resuspended in 
400 μl MBS.  
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4.2.8 Bicinchoninic acid (BCA) protein concentration assay 
BCA assays were carried out as per the manufacturer‟s instructions (Pierce). BCA 
reagent A (1 mg sodium bicinchoninate, 2 mg sodium carbonate, 0.16 mg sodium 
tartrate, 0.4 mg NaOH, 0.95 mg sodium bicarbonate in 100 ml dH2O, pH 11.25) and 
B (0.4 mg cupric sulfate (5 x hydrated) in 10 ml dH2O) were mixed in the ratio 100:2 
to make BSA working reagent. A dilution series of Bovine Serum Albumin (BSA, in 
50 mM HEPES) standards were prepared from 0.1 mg/ml to 2.0 mg/ml. 50 μl of each 
standard, sample and one blank containing buffer were added to labelled tubes with 
1.0 ml of BSA working reagent. The tubes were mixed via inversion and incubated at 
60°C for 30 minutes. The absorbance of the final solution at 562nm wavelength was 
measured in a colorimeter for each tube. The protein concentrations of the samples 
were measured against the graph plot of the standards.  
 
4.2.9 PIPLC digestion of lipid rafts 
PIPLC was obtained from Molecular Probes (100 U/ml in 20 mM Tris-HCl, pH 7.5, 1 
mM EDTA, 0.01% sodium azide and 50% glycerol). 5 μl of PIPLC (0.5U activity) 
and 5 μl of dH2O were added to two lots of 200 μl of lipid raft membrane (approx. 
0.92 mg of protein each) and incubated at 4°C overnight with gentle shaking. The 
solution was centrifugated at 100,000g in a Beckman Optima benchtop ultracentrifuge 
at 4 °C for 1 hour and the supernatant was separated from the pellet. The pellets were 
resuspended in 200 μl of MBS. 
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4.2.10 1D-electrophoresis 
1D-electrophoresis was carried out with the Protean III gel system from Bio-Rad. The 
glass plates were set up per manufacturers‟ instructions. 10% running gel (2.1 ml 
dH2O, 1.67 ml polyacrylamide, 1.25ml of 1.5 M Tris HCl pH 8.8, 50 μl 10% SDS, 5 
μl TEMED and 50 μl Ammonium persulfate (APS) per gel) was poured into the plates 
followed by 5% stacking gel (1.7 ml dH2O, 0.42 ml polyacrylamide, 0.32 ml of 1.5 M 
Tris HCl pH 8.8, 25 μl 10% SDS, 2.5 μl TEMED and 25 μl APS per gel) on top with 
spacers and left on the bench to set. The gel was then placed in a gel tank with 
running buffer (3 g Tris base, 14.4 g glycine, 10 ml of 10% SDS in 1 l of dH2O). 
Samples were prepared by making up each of the desired volume of samples up to 9 
μl with dH2O and mixing them with 3 μl of 4x SDS sample buffer (4 ml glycerol, 0.8 
g SDS, 2.5 ml of 1M Tris-HCl pH 6.8, 80 μl of 5 mg/ml bromophenol blue slurry, 0.2 
ml β-mercaptoethanol (BME) and dH2O up to 10 ml), which were heated to 90°C for 
10 minutes and then spun down briefly at 6,000 rpm on a benchtop centrifuge. 5 μl of 
size marker and all of the samples were added to the desired wells and the gels were 
ran at 100 V constant voltage for 10 minutes and subsequently 150 V until the blue 
front had reached the bottom of the gel. 
 
4.2.11 Coomassie staining of gels 
Gels were placed in 20 ml of Coomassie stain (40% methanol, 10% acetic acid, 50% 
water and 0.1 % (w/v) Coomassie Brilliant Blue R250) for 30 minutes while shaking. 
Gels were then washed with destaining solution (40% methanol, 10% acetic acid and 
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50% water) while shaking with regular replacement of the destaining solution at 15 
minute intervals until the background stain has been mostly removed. 
 
4.2.12 Silver staining 
Gels from electrophoresis were placed in fixer solution (50% H2O, 40% methanol and 
10% acetic acid) for at least 1 hour. Each gel was then washed 3 times in 100ml of 
30% ethanol for 20 minutes each with shaking. Gels were then each placed in 100ml 
of 0.02% sodium thiosulphate (in dH2O) in  for 90 seconds with gentle shaking, 
washed 3 times in dH2O for 20 seconds each, and placed in 100 ml of silver stain 
solution (0.2 g silver nitrate and 20 μl formaldehyde in 100 ml dH2O, made fresh) for 
20 minutes while shaken. Gels were then washed 3 times with dH2O for 20 seconds 
each, placed in 100 ml of developer solution (3g sodium carbonate, 0.875 mg sodium 
thiosulphate and 100 μl formaldehyde in 100 ml dH2O) and shaken for 3-5 minutes 
until the bands on the gel have developed to the desired intensity. The gels were 
washed twice again with dH2O for 30 seconds each and placed in 100 ml of stopper 
solution (0.5 g glycine in 100 ml dH2O) for 10 minutes with shaking. The gels were 
kept at the end in 100ml of dH2O. 
 
4.2.13 Western blot 
1D gels of desired protein samples were run as per instruction. Nitrocellulose 
membranes (0.45 μm pore size, Amersham Hybond ECL) were cut to the desired size 
and pre-soaked in transfer buffer (3 g Tris base, 14.4 g glycine, 20% methanol (v/v) in 
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1 l of dH2O) for 10 minutes. Two thin sponges and four pieces of 3M paper cut to the 
size of the membrane were also pre-soaked in transfer buffer. The protein transfer 
cassette was then made in the following manner: place one sponge on the black side 
of the cassette followed by two pieces of 3M paper, then the gel was added with the 
membrane placed on top while making sure there were no air bubbles, and finally two 
more pieces of 3M paper were added with a sponge on top and the cassette was then 
closed. The cassette was placed in a western blot frame and added to a gel box with an 
ice pack, a magnetic flea and filled transfer buffer, and was run at 100 V at 4°C for 2 
hours while being stirred. Transferred membranes were placed in 20 ml primary 
antibody solution (primary antibody at 1/1000 concentration and 4% powdered milk 
in phosphate buffered saline (PBST, 137 mM NaCl, 12 mM phosphate, 2.7 mM KCl, 
pH 7.4, 0.05% Tween-20) and incubated at 4°C overnight. The primary antibody for 
C. elegans CAV-1 was raised in mouse against a peptide with the sequence 
CNFNIRKTGINQETTA, which covers a region at the C-terminus of the protein. The 
primary antibody for C. elegans ENT-1 was raised in rabbit (raised to a peptide with 
the sequence RAERQRNKNDEAVDSEGKV corrisponding to amino acid positions 
245-263 in the ENT-1 protein, courtesy of Mrs. J. Ingram, Prof. Baldwin‟s lab). 
Membranes were then washed three times in PBST for 10 minutes each and incubated 
in secondary antibody solution (species specific secondary antibody conjugated to 
horse radish peroxidase (HRP) at 1/10,000 concentration and 4% powdered milk in 
PBST) for 2 hours at room temperature. Secondary antibodies for mouse were used 
for CAV-1, and rabbit used for ENT-1. The membranes were washed again three 
times in PBST for 10 minutes each and placed in 1.5 ml of HRP detection reagent 
(SuperSignal West Pico, Pierce) on top of Saran wrap and incubated at room 
temperature for 5 minutes. Excess detection reagent was dried off with 3M paper and 
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visualized with either developer film (Enhanced Chemiluminesence film, GE 
healthcare) or CCD detection camera. 
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4.3 Results 
4.3.1 Extraction of membrane fraction 
C. elegans membrane material was extracted via differential ultracentrifugation. C. 
elegans was grown in liquid culture in order to provide enough material for analysis 
by proteomics. Sucrose floatation was used to extract the worms as this method 
allows live nematodes to be separated from cell debris and dead worms, and to 
minimise bacterial contamination by allowing the worms to digest any remaining 
bacteria in their gut. The worms extracted were of a mixed stage in their life cycles 
when observed under a light microscope (data not shown). In order to break the tough 
cuticle, nematodes were subjected to three rounds of homogenisation by freeze-
thawing, sonication and grinding with a glass homogeniser. Membrane extraction was 
performed at 50,000g in a Beckman ultracentrifuge. Another membrane fraction was 
made with 70,000g spin after it was found that some membrane material was still 
present in the supernatant after the first spin (Figure 4.3). The membrane was washed 
with lactose to remove excess galectin proteins before the isolation of lipid rafts 
(Figure 4.7).  
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4.3.2 Extraction of lipid rafts  
C. elegans lipid raft was extracted using TX-100 in a discontinuous sucrose gradient 
from the 50,000g membrane preparation. Figure 4.4 shows the setup of the gradient 
with the membrane material at the bottom, which after ultracentrifugation separates 
the lipid raft components from the rest of the membrane. Trials of 1%, 2% and 4% 
TX-100 were performed to assess the concentration of detergent used for the 
extraction of lipid raft. 10 fractions were made from the sucrose gradient after 
ultracentrifugation. For the 1% TX-100 trial the majority of the proteins were 
confined to the TX-100 dissolved fractions 1-3, with a reduction of proteins in 
fraction 4, while protein concentration was increased again in fractions 5 and 6 and 
Figure 4.3. Fractions isolated during membrane extraction. Gel was stained with 
Coomassie Blue. Lane 1) insoluble pellet from 500g spin, 2) insoluble pellet from 
3000g spin, 3) protein material before centrifugation, 4) membrane pellet from 50,000g, 
5) supernatant from 50,000g, 6) membrane pellet from 70,000g and 7) supernatant from 
70,000g. 
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were virtually absent from fraction 7-10 (Figure 4.5). This is consistent with the 
observed presence of the light scattering band at the interface between the 5% and 
30% sucrose concentrations caused by the floatation of TX-100 insoluble proteins and 
lipids, which corresponds to fractions 5 and 6 on in the protein extraction (figure 4.6). 
The light scattering band was not observed for TX-100 concentrations of 2% and 4% 
(data not shown) and the corresponding protein profiles for their respective fractions 
show the majority of the proteins to be present in fractions 1-3 with no enrichment in 
fractions 5 and 6 (figure 4.5b and 4.5c). Therefore a TX-100 concentration of 1% was 
used to for lipid raft extraction. Proteins from fractions 5 and 6 were pooled and 
referred to as the lipid raft fraction. 
 
 
Figure 4.4. Diagram of sucrose gradient density extraction of lipid rafts. Membrane 
proteins are solubilised in a solution containing TX-100 and 40% sucrose and loaded into the 
bottom of the gradient. After ultracentrifugation at 100,000g o/n 10 sucrose fractions and 1 
pellet fraction were taken from the gradient. Fractions 5 and 6 are at the boundary between 
5% and 30% sucrose and contains purified lipid rafts. 
Ultra-
centrifugation 
Sucrose 
concentration 
Sucrose 
concentration 
Pellet 
40% 40% 
30% 30% 
5% 5% 
Fractions 
Lipid 
raft 
1 
2 
8 
7 
6 
5 
4 
3 
10 
9 
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Lipid raft extraction with 1% TX-100 was also performed for the 70,000g membranes. 
The proteins showed poor separation and a sizeable proportion ended up in fractions 
7-10 of the sucrose gradient (figure 4.5d). There was also no light scattering band 
observed at the 5% to 30% sucrose interface. The membrane fraction from 70,000g 
was therefore not used and only membranes from 50,000g were used for lipid raft 
extraction. 
 
 
Figure 4.5. Fractions 1-9 of sucrose density extractions from various experiments. All 
gels were stained with silver nitrate. Gel a) 50,000g membrane protein extracted with 1% 
TX-100, b) 50,000g membrane protein extracted with 2% TX-100, c) 50,000g membrane 
protein extracted with 4% TX-100, d) 70,000g membrane protein extracted with 1% TX-
100. 
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Figure 4.6. Sucrose density extraction of lipid raft proteins from C. elegans. a) 
fractions 1-10 of the sucrose density with the insoluble pellet run on two separate gels 
stained with Coomassie Blue, b) a photograph of the Beckman SW25 ultracentrifuge 
tube showing the presence of the light scattering band at the 5%/30% sucrose interface. 
5% sucrose 
Light scattering band 
40% sucrose 
30% sucrose 
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4.3.3 Washing of lipid raft fraction 
In order to reduce the number of membrane associated proteins and keratin 
contamination from the samples the lipid raft fraction was sequentially washed with 
HPLC grade H2O, 1M NaCl and then HPLC grade H2O again (figure 4.7). The 
remaining raft proteins were redissolved in HPLC grade H2O. Keratin contamination 
was also minimised by carrying out all procedures in a fume hood. The concentration 
of washed lipid raft proteins was determined to be 4.6 mg/ml by BCA assay. 
 
 
 
 
Figure 4.7. Protein fractions from various wash stages. Gel was stained with 
Coomassie Blue. Lane 1) total membrane from 50,000g, 2) total membrane after 
lactose wash, 3) supernatant from 100mM lactose wash 4) supernatant from first 
wash of lipid raft with HPLC water, 5) supernatant from lipid raft wash with 1M 
NaCl, 6) supernatant from second wash of lipid raft with HPLC water.  
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4.3.4 Verification of lipid raft fraction  
Antibodies against a peptide sequence at the C-terminal section of C. elegans caveolin 
CAV-1 were raised in mice, and blotted against the fractions to verify the existence of 
lipid rafts. CAV-1 was observed to be enriched in lipid raft fraction compared to the 
total membrane (figure 4.8a and 4.8b). A blot of the sucrose gradient fractions shows 
the presence of CAV-1 in the TX-100 insoluble fractions 5-6 and TX-100 1-3, but not 
in fraction 4, suggesting that there are two distinct forms of caveolin within the 
protein sample examined, one of which is TX-100 soluble and the other TX-100 
insoluble (Figure 4.8c). A control blot of CAV-1 was made in the presence of the 
peptide that was used to generate the antibody, which did not produce a band (data not 
shown). A blot of the sucrose gradient fractions against C. elegans ENT-1 shows the 
protein to be confined to the TX-100 soluble fractions 1-3 (figure 4.8d). ENT-1 is a 
nucleoside transporter and is not reported to be a lipid raft associated protein 
(Appleford et al., 2004).  
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Figure 4.8. Western blots of protein fractions. a) Coomassie Blue staining of protein 
fractions. Lane 1- supernatant from membrane extraction at 50,000g, lane 2- membrane 
extracted at 50,000g (1/10 dilution), lane 3- lipid raft proteins(pooled fractions 5 and 6, 
1/10 dilution), b) blot of gel (a) with CAV-1 antibody, c) blot of sucrose fractions 1-7 with 
CAV-1 antibody, d) blot of sucrose fractions 1-7 with ENT-1 antibody. 
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4.3.5 PIPLC digest of lipid raft fraction 
PIPLC digestion was performed at 4°C overnight. Numerous proteins were released 
from the lipid raft fraction with only a small amount of high molecular weight 
proteins released from the control (figure 4.9.a). Fraction 5 from membrane proteins 
extracted with 4% TX-100 was also digested with PIPLC (figure 4.9b). This produced 
a relatively large release of proteins in the control digestion, indicating that fraction 
contains membrane associated protein contaminants and is unsuitable for GPI anchor 
protein analysis. 
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Figure 4.9. Lipid raft fraction digested with PIPLC.  
a) Raft fraction extracted with 1% TX-100.  
lane 1- supernatant of control of fraction 5, lane 2- membrane of control of fraction 5, 
lane 3- supernatant of digest of fraction 5, lane 4- membrane of digest of fraction 5, 
lane 5- supernatant of control of fraction 6, lane 6- membrane of control of fraction 6, 
lane 7- supernatant of digest of fraction 6, lane 8- membrane of digest of fraction 6, 
lane 9- PIPLC enzyme. 
b) Raft fraction extracted with 4% TX-100.  
lane 1- supernatant of control of fraction 5, lane 2- membrane of control of fraction 5, 
lane 3- supernatant of digest of fraction 5, lane 4- membrane of digest of fraction 5, 
lane 5- PIPLC enzyme. 
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4.4 Discussion 
In this chapter the details of adapting a lipid raft isolation protocol to C. elegans are 
presented. C. elegans was grown in liquid culture rather than NGM plates to provide 
the large amount of proteins needed for the extraction of lipid rafts and associated GPI 
anchored proteins, and their downstream analysis with proteomics techniques. Liquid 
culture produces worms in a mixed stage of development with an increase in the 
number of small worms in the dauer stage. Sucrose density floatation was used to 
separate the dead worms from live ones and remove other contaminants such as cell 
debris and bacteria. The growth media contains the antifungal agent nystatin, which 
binds to sterols and is used as chemical for cholesterol depletion in lipid raft analysis 
(Stuart et al., 2003). The growth media however also contain cholesterol as C. elegans 
cannot synthesize the compound de-novo, which may minimise the effect of nystatin 
on cholesterol depletion. Observation under a light microscope also confirms the 
presence of healthy worms at various stages. 
 
4.4.1 Membrane extraction 
C. elegans is covered by a layer of tough cuticle that requires strong mechanical 
action to break apart. Previous protein extraction procedures for the nematode have 
used a combination of freeze-thaw, sonication and ground glass tissue grinders to 
homogenise the worms for proteomic studies (Kaji et al., 2000; Li et al., 2009; 
Tabuse et al., 2005). All of these techniques were used here to ensure a thorough 
break up of worms, and the tissues were shown to be adequately homogenised when 
examined under a light microscope. Several stages of low level centrifugation were 
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needed to remove the broken down cuticle material. Two different membrane 
preparations were extracted from the homogenate centrifuged at 50,000g and 70,000g 
respectively. The presence of the two different membrane fractions may have been 
due to the extraction of different sub cellular locales. The 70,000g membrane was 
subsequently shown to be unsuitable for lipid raft extraction via TX-100. Part of the 
reason may be that the fraction contains a relatively small amount of membranes that 
contain lipid rafts, such as the plasma membrane, and is therefore unsuitable for raft 
purification. 
 
4.4.2 Lipid raft purification 
Extraction of lipid rafts involves the solubilisation of the membrane proteins with 1% 
TX-100, based on their property of insolubility by weak non-ionic detergents at cold 
temperatures. Proteins extracted with a discontinuous sucrose gradient typically 
shows the presence of a light scattering band at the 5% to 30% sucrose concentration 
interface due to the lower buoyancy of lipid raft components (Sedensky et al., 2004). 
Extraction of proteins with discontinuous sucrose density typically show a high 
concentration of proteins in the bottom fractions (1-3) that are solubilised by TX-100, 
a reduction of proteins in fraction 4, an increase in protein concentration 
corresponding to the light scattering band containing fractions 5 and 6, and little or no 
proteins in fractions 7-10 that corresponds to the 5% sucrose part of the gradient. This 
was shown to be the case for proteins extracted with 1% TX-100. The presence of C. 
elegans CAV-1 was confirmed with antibody blots in fractions 5 and 6 (Figure 4.8c). 
CAV-1 was also detected in fractions 1-3 of the blot, but was absent in fraction 4, 
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indicating that there may be two distinct populations of caveolin within the membrane 
that are associated with raft and non-raft fractions, respectively. Figure 4.8b shows 
CAV-1 to be enriched in the pooled fractions 5 and 6 compared to the total membrane, 
which suggests that lipid rafts are enriched within these fractions. Caveolin is 
typically found as a marker of lipid raft fractions within the cell, and C. elegans CAV-
1 was found to be localised selectively to the post-synaptic membrane of neurons in 
the worm, where it was shown to function in acetylcholine signalling (Parker et al., 
2007). Higher concentrations of TX-100 was suggested to improve the solubility of 
GPI anchored proteins specifically (Dr. Parkin and Prof. Hooper, personal 
communication) and concentrations of 2% and 4% TX-100 were used to extract rafts, 
which were found not to produce distinct lipid raft fractions (Figure 4.6b and 4.6c). 
This may have been due to the increased solubilisation of the raft fraction from the 
higher detergent content.  
 
4.4.3 Washes and handling 
Washes of the membrane material were performed to remove membrane associated 
proteins. It was found within preliminary proteomic analysis (Chapter 5) that there 
was an over abundance of galectins in the sample. Galectins are sugar binding 
proteins commonly associated with lipid rafts (Hansen et al., 2005) and their presence 
is encouraging for the confirmation of the extraction of rafts; however it was found 
that the amount of the galectins present within the sample was having an adverse 
effect on the identification of other proteins. A lactose wash was carried out to 
remove most of the associated galectins before the sucrose gradient step in order to 
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reduce their presence in the final raft preparation. Rafts were then washed with high 
salt concentrations (NaCl) to remove other proteins not directly associated with rafts. 
Washes with HPLC grade dH2O were intended to minimise keratin contamination, 
and the water used for the rest of the experimental procedures all came from MilliQ 
grade dH2O, as keratin can become a major contaminant when concentrated from 
large volumes of water (Dr. Keen, personal communication). All procedures were 
carried out in flow-lamina fume hoods whenever possible to reduce airborne keratin 
contamination from dust and skin particles. 
 
4.4.4 PIPLC release of proteins 
Proteins were extracted from the lipid raft fraction by digestion with PIPLC, an 
enzyme which specifically cleaves the GPI anchor and allows the membrane bound 
proteins to be released into the aqueous phase. These released proteins were separated 
from the rest of the raft via ultracentrifugation. Results show that GPI anchored 
proteins were released from the 1% TX-100 extracted raft fraction, with the control 
digestion showing all but two contaminating bands with high molecular weights 
(Figure 4.9a). There was a greater number of contaminating bands found within the 
PIPLC digest for the 4% TX-100 extracted rafts (Figure 4.9b). The PIPLC enzyme 
from Molecular probes produced one band of the correct size for the protein 
indicating that the enzyme is of good quality (Figure 4.9a, lane 9). GPI anchored 
proteins released by PIPLC show a typical increase in apparent mass on SDS-PAGE 
gels due to the properties of the remaining sugar molecules attached to the protein 
after cleavage (Littlewood et al., 1989). This effect was seen on several bands for the 
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released proteins and indicates the presence of properly solubilised GPI anchored 
proteins (Figure 4.9a).  
4.4.5 Future directions 
One of the enduring controversies in lipid raft biology is the concerns the definition of 
the raft with respect to its method of extraction. It is observed that rafts extracted with 
different types and concentrations of detergents such as Brij96, Lubrol WX, and other 
non-detergent methods contain different subsets of proteins. Pike summarised three 
models for the makeup of lipid rafts that allows the existence of different raft domains 
(Pike, 2004) (Figure 4.10). In model I the lipid rafts are homogenous, but layered 
according to the selectivity of the various detergents such that the more selective 
amongst them (such as TX-100) extract the core raft components and the less 
selective (such as Brij 96) extracts a more general component. Model II proposes rafts 
to be entirely homogeneous and the different detergents extract sub-proteomes from 
the whole due to their specific properties on the membrane. Model III envisages the 
existence of wholly distinct heterogeneous sub-rafts with different properties that are 
susceptible to extraction by the various detergents used. The author proposed that 
current evidence points to model III being more likely to be valid as there are 
fundamental heterogeneities in the proteomes produced from the different detergents. 
An “Induced fit” hypothesis was offered where lipid rafts are grown from small 
“proto” rafts into larger stable structures consisting of a variety of different 
components. Lipid rafts can be very dynamic structures and changes in the 
concentrations of sphingolipids and cholesterol have been shown to drastically change 
their size in model membrane experiments (Prenner et al., 2007). It will be interesting 
to extract lipid rafts from C. elegans using a variety of different detergent and non- 
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Figure 4.10. Three postulated models for the existence of rafts in the membrane. 
Model I) raft proteins and lipids form concentric layers around a core that can be 
extracted by detergents of different strength. Model II) rafts are homogenous and the 
detergents are selective in their extraction of components. Model III) different detergents 
extract distinct rafts with different properties. Diagram was adapted from Pike 2004. 
detergent extraction methods to determine its raft constituents in detail, and to observe 
what kinds of rafts exist within this model organism.  
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The numerous roles of lipid raft have been studied in a variety of cell lines and single 
cellular organisms, but as yet have not been examined fully in a developmentally 
complex system. Raft domains have been shown to play a large role within important 
biological processes such as cell polarity and signal transduction that underpin animal 
development (Lajoie et al., 2009). C. elegans, with its extensively annotated genome, 
well understood genetics and invariant cell lineage is well suited for looking at the 
role of rafts and GPI anchored proteins in important processes such as development, 
behaviour, locomotion and aging. C. elegans development is surprisingly complex for 
an organism of such a small size with four different molting stages during its life 
cycle. Raft proteins can be identified from the various stages of maturation in 
synchronised nematode populations to elucidate the roles they play within worm 
development. Disruption of lipid rafts may also be performed for C. elegans to assess 
their biological role within the organism; this may be achieved by growing the worms 
away from their cholesterol enriched media, and with the use of cholesterol depletion 
agents such as nystatin. The C. elegans genes Y57E12AL.1 and R11H6.2 both 
contain a serine incorporator (SERINC) domain that was shown to be involved in 
sphingolipid biosynthesis in mammalian and yeast cells (Inuzuka et al., 2005). 
Y57E12AL.1 has already been shown to cause slow growth, abnormal egg laying and 
a patchy colouration in RNAi experiments (Kamath et al., 2003) while a deletion 
mutant is available for R11H6.2 with no phenotype reported so far. These two genes 
may disrupt lipid rafts and allow the study of raft dynamics during the life cycle of the 
worm. C. elegans has the potential to become an invaluable tool for the study of lipid 
rafts, and may produce great insights into the biology of this important sub-cellular 
locale.  
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Chapter Five: Proteomic analysis of Caenorhabditis elegans lipid raft 
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5.1 Introduction 
Analyses of biological samples with proteomic techniques have evolved greatly since 
the 1980‟s, and today encompass a wide variety of protocols that are able to elucidate 
the proteomes of many different experimental systems. These techniques make use of 
multiple separation procedures to provide high fidelity and resolving power for the 
proteome of interest. Analytical methods today are based on two core technologies- 2 
dimensional gel electrophoresis (Issaq and Veenstra, 2008) and multidimensional 
liquid chromatography (Motoyama and Yates, 2008)– from which efficient separation 
of proteins and peptides can be made for subsequent mass spectrometry analysis. 
 
5.1.1 2D electrophoresis 
2D electrophoresis is a protein separation technique with high resolving power and 
has been one of the workhorses for proteomic projects from an early age. The 
technique was first attempted in 1956 by the sequential application of two different 
electrophoretic processes at right angles to each other to produce a flat square shaped 
gel (Smithies and Poulik, 1956). The resulting gel not only improved the resolution of 
a complex blood serum sample but also was able to differentiate the various 
modifications of a protein present within the sample that would have otherwise been 
missed with a 1D gel. Many different combinations of techniques for the first and 
second dimensions were tried subsequently. In 1975 O‟Farrell established what is 
now the standard configuration of 2D gel electrophoresis, by separating E. coli 
proteins according to their isoelectric point via isoelectric focusing (IEF) in the first 
dimension, followed by molecular weight via sodium dodecyl sulphate 
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polyacrylamide gel electrophoresis (SDS-PAGE) in the second dimension (O'Farrell, 
1975). In 1982 Bjellqvist et al. described the use of immobilised pH gradient (IPG) 
strips for the separation of proteins in the first dimension, which allowed the 
formation of a stable pH gradient for IEF and greatly improved the resolution and 
reproducibility of 2D gels (Bjellqvist et al., 1982). One of the major advantages of 2D 
gel electrophoresis is the ability to compare quantitatively protein levels of spots 
between different protein samples. Reproducibility between gels however is poor due 
to the slightly different conditions that gels are subjected to during an experimental 
run, and a variety of computer programs have been made over the years to facilitate 
spot matching and quantitative comparisons between different samples (Righetti et al., 
2004). A method called differential in-gel electrophoresis (DIGE) was developed by 
Unlu et al. that allowed two or more samples of proteins to be run on the same gel. 
This technique used minimal labelling of Lys residues by different fluorophores for 
each sample, which were subsequently ran together and visualised separately using a 
fluorescence scanner (Unlu et al., 1997); this resulted in a greater resolution of the 
proteins and an improved comparison between different samples. Solubilisation of 
membrane proteins is difficult with 2D electrophoresis because of the need to use 
weak non-ionic detergents compatible with IEF (Rabilloud, 2009); however 
membrane proteins can still be analysed with 2D gels when an optimal mixture of 
detergents for the first dimension is used (Churchward et al., 2005). 
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5.1.2 Multidimensional liquid chromatography (MDLC) 
Separation of proteins using combinations of two or more orthogonal high 
performance liquid chromatography (HPLC) techniques has gained steady momentum 
within the field and has become an increasingly popular method for the analysis of 
proteomes (Motoyama and Yates, 2008). The concept for MDLC existed in the 
1980‟s, when Giddings outlined that the separation of proteins from two different 
HPLC systems would be orthogonal, with the result that the overall resolving power 
becomes the product of the resolution of each of the individual dimensions, which 
greatly increases the separation that can be achieved for the sample (Giddings, 1984). 
Progress within the field was overshadowed by improvements in 2D gel 
electrophoresis, until the invention of tandem mass spectrometry (MS/MS), which 
allowed direct peptide sequencing and accelerated the use of MDLC for proteomics 
(Yates et al., 1995). MS/MS gave rise to a new branch of proteomic analysis called 
shotgun proteomics, which involves the separation of pre-digested peptides (rather 
than intact proteins) that are directly sequenced within the mass spectrometer, which 
are then matched to protein sequences in silico. This dramatically improved the 
number of proteins that can be identified for a given proteome, and has the added 
advantage that previously difficult proteomes such as membrane proteins can now be 
analysed with relative ease. The first large scale MDLC MS/MS project was called 
multidimensional protein identification technology (MudPIT) and has been a 
watershed in the application of this method for the study of proteomes (Washburn et 
al., 2001). The standard setup for MDLC is for pre-digested peptides to enter the first 
dimension and separated into fractions, which are then applied to the second 
dimension and eluted directly into the mass spectrometer for sequencing. Reverse 
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phase (RP) chromatography, which separates peptides based on hydrophobicity, is 
usually used for the second dimension as this system has very good resolving power, 
and can be fed directly to an electrospray ionisation (ESI) mass spectrometer for 
automation (Claessens and van Straten, 2004; Motoyama and Yates, 2008). The first 
dimension can be any method which gives good orthogonality with respect to the 
second dimension, with separation techniques such as size-exclusion chromatography 
(SEC), strong cation-exchange (SCX), IEF, SDS PAGE and others being used for a 
number of different projects (Chen et al., 2002; Machtejevas et al., 2004; Opiteck and 
Jorgenson, 1997; Peng et al., 2008; Washburn et al., 2001). One of the major 
disadvantages of MDLC over 2D electrophoresis is its reduced ability to effectively 
quantify protein levels and analyse post-translational modifications; improvements in 
these areas however have steadily been made, with new techniques such as isotope 
coded affinity tag (ICAT) and isobaric tags for relative and absolute quantification 
(iTRAQ) allowing better quantitative analysis within a given proteome (Gygi et al., 
1999; Ross et al., 2004; van den Broek et al., 2008). 
 
5.1.3 MS protein identification by peptide mass fingerprint 
The identification of proteins via mass spectrometry starts with limited cleavage of 
the protein via tryptic digestion. Trypsin cleaves the C-terminal peptide bond after 
Arg and Lys residues and has been shown to be extremely reliable in its peptidase 
action (Olsen et al., 2004). The enzyme also digests proteins into fragments of a good 
range of masses that are compatible with mass spectrometry. For the analysis of a 
single protein (such as from a spot on a 2D gel) the mass to charge ratios (m/z) of all 
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of the digested peptides are collected into a unique pattern for the protein, which is 
called a peptide mass fingerprint (PMF) (Pappin et al., 1993). PMF allows rapid to 
protein identification by comparing the observed patterns with in silico digested 
fragments of predicted proteins, which are generated by specialised search algorithms 
such as MASCOT (Perkins et al., 1999). Peptides from a mixture of proteins can 
confound the protein identification by giving conflicting PMFs for the search 
programs, which means that proteins need to be separated intact at high resolution 
before they can be subjected to tryptic digestion and MS analysis. This makes 2D 
electrophoresis the method of choice for protein identification by PMF. Proteins from 
1D SDS-PAGE can also be analysed using this method, provided that the protein band 
in question is separated with sufficient resolution. 
 
5.1.4 MS/MS sequencing 
With the advent of MS/MS technology it became possible to directly sequence the 
peptides produced from a tryptic digest of proteins. Peptides analysed with the first 
MS are further fragmented by collision induced dissociation (CID) with inert gas to 
produce a set of partially broken peptide species, which are then analysed within a 
second MS instrument (Hunt et al., 1986). Fragmentation of the peptide can occur at 3 
positions for each amino acid on the peptide backbone, producing a neutral and a 
charged product that can be detected in the mass spectrometer. Depending on the 
position of the break and where the charge is assigned a total of six different types of 
peptide ions (a, b, c and x, y, z) can result for each amino acid position in the peptide 
(Figure. 5.1) (Hernandez et al., 2006). The most common ions generated are from the 
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b and y series, as they are formed after breakage of the amide bond. This allows a 
build up of the peptide for each amino acid lost in the collision, from the b1, b2,… and 
the y1, y2,… series of peptide peaks, allowing the production of a complete sequence 
of the peptide (Figure. 5.2) (Hunt et al., 1986; Rioli et al., 2003). Analysis of the 
sequence data with bioinformatic programs such as MASCOT and SEQUEST results 
in the identification of the protein (Perkins et al., 1999; Wolters et al., 2001). Protein 
identification from MS/MS results is much more precise than PMF due to the 
availability of sequence information for each of the peptides, and can be effectively 
used for protein mixtures in a shotgun proteomics experiment to generate a large 
number of identifications in a short amount of time. 
 
 
 
 
Figure 5.1. Diagram showing MS/MS fragmentation of a peptide. Six different 
kinds of fragments (a, b, c, x, y and z) can be produced for each amino acid in the 
peptide depending on which bond within the backbone is broken. The b and y 
represent the series of ions produced after breakage of the amide bond and are the 
ions most frequently seen in the mass analyser. Adapted from Hernandez et al 
(2006).  
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5.1.5 Previous work on lipid raft proteomics 
There are a growing number of proteomics projects aimed at the identification of 
proteins within lipid rafts, which have uncovered a large number of genuine raft 
proteins within a number of model systems. Commonly identified proteins include 
cytoskeletal proteins such as F-actin, raft associated proteins such as hsp90 and lectins, 
V-ATPase, proteins involved in signal transduction such as Gα subunits, and GPI 
anchored proteins (Bini et al., 2003; Foster et al., 2003; Insenser et al., 2006; Kim et 
al., 2009; Li et al., 2004a; von Haller et al., 2001). An interesting result of these 
Figure 5.2. Representative output of a typical MS/MS spectrum. Output for a 
peptide with the sequence PVNFKFLSH is presented here. The peptide was identified 
with the y series of ions, with most of the b series and some of the a series also present. 
Adapted from Rioli et al (2003).  
m/z 
A
b
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n
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studies is the presence of mitochondria proteins in most of the studies, with some 
reporting as much as 24% of the total raft proteins identified as mitochondrial, 
prompting some researchers to suggest the existence of lipid rafts in this organelle 
(Bae et al., 2004; Mellgren, 2008). Experiments with cholesterol depletion however 
do not support the notion that mitochondrial proteins are present within rafts (Foster, 
2008; Zheng et al., 2009). Nuclear membrane proteins have also been identified in 
these studies, which have been suggested to be a common contaminant of lipid raft 
preparations (Say and Hooper, 2007). In general, the ubiquitous nature of proteomic 
analysis means that the presence of some minor contaminating identification is 
expected in the final result. 
 
5.1.6 GPI anchored protein proteomics 
There have been a small number of proteomics studies of GPI anchored proteins, 
which were mainly carried out in humans, Arabidopsis thaliana and the malaria 
parasite Plasmodium falciparum. In P. falciparum 26 GPI anchored proteins were 
identified by PIPLC release (Gilson et al., 2006). More than 40 proteins were found in 
Arabidopsis from a number of studies (Borner et al., 2003; Elortza et al., 2006; 
Elortza et al., 2003). Elorza et al. analysed human HeLa cells in two studies with the 
release of GPI anchored proteins by PIPLC and PIPLD. PIPLC digestion yielded 6 
protein identifications which included several known GPI anchored proteins, which 
are alkaline phosphatase, carboxypeptidase M, CD55 and CD59 (Elortza et al., 2003). 
PIPLD treatment identified 5 more proteins, bringing the total of GPI anchored 
proteins identified in humans to 11 (Elortza et al., 2006). 
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In silico prediction programs were also used complementarily as a part of the 
proteomic analyses of GPI anchored proteins. There was broad agreement between 
prediction programs and experimental results for human and Arabidopsis, with the use 
of multiple prediction programs found to be necessary to gain a comprehensive 
validation for the proteins (Elortza et al., 2006). Protein prediction however matched 
poorly with results from P. falciparum, which may have been due to the 
phylogenetically distant protein training sets used for the prediction programs that 
made them less compatible with the P. falciparum genome (Gilson et al., 2006). 
 
5.1.7 Outline for this chapter 
In this chapter the identification of lipid raft and GPI anchored proteins extracted 
from C. elegans is presented. Proteomic analysis of lipid raft proteins was carried out 
with the MDLC shotgun method at the Cambridge Centre for Proteomics (CCP), with 
SDS-PAGE separation of the proteins in the first dimension, followed by subsequent 
digestion of proteins with trypsin, before a second dimension separation with RPLC 
and final sequencing of the peptides with MS/MS. Protein identification was 
performed with MASCOT (www.matrixscience.com) by an in-house server at the 
CCP. Overall 41 proteins were identified from the preparation of lipid rafts from C. 
elegans. Three GPI anchored proteins were also identified with a combination of 1D 
and 2D electrophoresis followed by PMF. The identified proteins were also validated 
with GPI anchoring prediction programs. To date this is the largest analysis of lipid 
raft and GPI anchored proteins in the nematode C. elegans, and paves the way for 
further analysis of these two important classes of proteins within this model organism. 
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5.2 Method 
5.2.1 Trichloroacetic acid (TCA) precipitation 
Trichloroacetic acid (25 μl, 100% w/v) solution was added to 100 μl of a protein 
mixture and incubated at 4 °C for 10 min. The solution was centrifuged at approx. 
10,000 g (13,000 rpm) on a table top microcentrifuge for 5 min and the supernatant 
was removed. The pellet was then washed with 200 μl of acetone at 4°C and spun at 
13,000 rpm on a table top centrifuge for 5 min, the acetone discarded and the pellet 
washed again in the same manner. The pellet was finally dried at 95°C for 5 – 10 min. 
 
5.2.2 1D-electrophoresis 
The 1D-electrophoresis protocol was carried out as per instructions from Chapter 
4.2.10.  
 
5.2.3 2D-electrophoresis 
Protein samples precipitated with TCA was solubilised in rehydration buffer (7 M 
urea, 2 M thiourea, 100 mM DTT, 0.5% (v/v) ampholytes, 4% (w/v) CHAPS, 1% 
(v/v) Triton X-100, trace of bromophenol blue) and equilibrated overnight on IPG 
strips (24 cm, pH 3-10, Bio-Rad). IEF was performed on a Protean IEF system 
(BioRad) at 8,000 V for 70,000 Vh. IEF strips were then incubated in equilibration 
buffer (50 mM Tris-HCl, pH 8.8, 6 M urea, 20% (v/v) glycerol, 2% (w/v) SDS) 
containing 0.5% (w/v) DTT for 15 min and again in equilibration buffer containing 
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4% (w/v) iodoacetamide for 15 min. IPG strips were placed onto  precast Criterion 2D 
gels (8-16% resolving, Bio-Rad) with unstained molecular weight markers added 
adjacent to the anodic end of the strip and sealed with 1% (w/v) agarose. SDS-PAGE 
was performed in a Criterion electrophoresis tank (Bio-Rad) at 200 V for 1.5 h. 
Finished gels were silver stained as described in Chapter 4.2.12. 
 
5.2.4 PMF of protein samples 
PMF of protein samples was performed by Dr. J. N. Keen at the University of Leeds. 
Polypeptide bands of interest from 1D gels were excised using a razor blade and 
chopped into pieces c. 1-2 mm
2
. Spots from 2D gels were excised using a 
micropipette tip. Individual gel pieces were transferred to a microtitre plate for 
automated digestion using a MassPREP workstation (Waters). 
The gel pieces were first subjected to automated destaining using 50 mM ammonium 
bicarbonate/50% (v/v) acetonitrile (for Coomassie blue stained gel pieces) or freshly-
prepared 50 mM sodium thiosulphate/15 mM potassium ferricyanide (for silver-
stained gel pieces).  The proteins were reduced using 10 mM dithiothreitol (in 100 
mM ammonium bicarbonate, 30 min) and alkylated using 55 mM iodoacetamide (in 
100 mM ammonium bicarbonate, 20 min); then the gel pieces were washed with 100 
mM ammonium bicarbonate and dehydrated using acetonitrile prior to the addition of 
25 μl trypsin (Promega) solution (6 ng/μl in 50 mM ammonium 
bicarbonate).  Digestion was allowed to proceed for 5 h at 37 ºC.  Peptides were then 
extracted using 30 μl 1% (v/v) formic acid/2% (v/v) acetonitrile and an aliquot (1 μl) 
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applied to a stainless steel MALDI plate together with 1 μl matrix solution (2 mg/ml 
-cyano-4-hydroxycinnamic acid in 60% (v/v) acetonitrile/0.08% aqueous TFA). The 
dried plate was transferred to a mass spectrometer (M@LDI L/R, Waters) and each 
digest was analysed in reflectron mode using standard operating parameters. Briefly, 
the instrument used a N
2
 laser at 337 nm, source voltage was set at 15000 V, 
microchannel plate detector voltage was set at 1950 V, pulse voltage was set at 2450 
V, reflectron voltage was set at 2000 V, coarse laser energy was set to medium, with 
fine adjustment used for each sample to optimize signal. At least 100 laser shots were 
accumulated and combined to produce a raw spectrum. Spectra were processed 
(background subtraction, smoothing and peak centroiding) and calibrated externally 
using a tryptic digest of alcohol dehydrogenase and then internally using a trypsin 
autolysis product (m/z 2211.105 or 1045.564) as a "lockmass" point. 
The set of monoisotopic peptide masses for each sample was used to search the 
SwissProt and/or NCBInr databases using the Mascot search engine 
(http://www.matrixscience.com) in order to identify the parent protein. Searches were 
typically performed using an unrestricted protein molecular mass range, variable 
modifications of carbamidomethyl-Cys, propionamido-Cys and oxidized-Met, 
searching tryptic peptides from all species, allowing one missed cleavage site and 100 
ppm error tolerance in the peptide mass. 
 
5.2.5 LC MS/MS 
The LC MS/MS protocol was performed by Dr. Michael J Deery at the Cambridge 
Centre for Proteomics, Department of Biochemistry, University of Cambridge. 
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Two aliquots of 50 μl of lipid raft proteins were ultracentrifuged at 50,000g and the 
pellet retained, which yielded approximately 75 μg of lipid raft proteins each. The 
pellets were dissolved in SDS sample buffer, run on a 1D gel in lanes 1 and 3 and 
visualised with Coomasie Blue staining. Ten gel bands were excised from lane 3 of 
the gel and transferred into a 96-well PCR plate with the labels 3a to 3j. Sample 
preparation was performed in a Mass Prep Station (Micromass, UK).  The gel bands 
were destained, reduced with DTT, alkylated with iodoacetamide and digested with 
trypsin at 37°C overnight. Digested supernatant (10 µl) was loaded onto an 
autosampler for LC-MS/MS analysis using an Eksigent NanoLC-1D Plus (Eksigent 
Technologies, Dublin, CA) HPLC system and an LTQ Orbitrap mass spectrometer 
(ThermoFisher, Waltham, MA). Reverse-phase chromatography was used to separate 
the peptides at a flow rate of 300 nl/min in an LC-Packings (Dionex, Sunnyvale, CA) 
PepMap 100 column (C18, 75 μm i.d. x 150 mm, 3 μm particle size). Peptides were 
loaded onto a precolumn (Dionex Acclaim PepMap 100 C18, 5 μm particle size, 100 
A, 300 μm i.d x 5mm) from the autosampler with 0.1% formic acid for 5 minutes at a 
flow rate of 10 μl/min. The ten port valve was then switched to allow peptide elution 
from the precolumn onto the analytical column. A mixture of solvent A (0.1% formic 
acid in HPLC grade H2O) and solvent B (0.1% formic acid in acetonitrile) was used to 
elute the peptides with a gradient of 5-50% solution B in 40 minutes. The eluted 
peptides were sprayed into the mass spectrometer with a New Objective nanospray 
source. All the m/z values of eluted ions were measured at a resolution of 7500 in the 
Orbitrap mass analyzer.  Peptide ions with charge states of 2+ and 3+ were isolated 
and fragmented in the LTQ linear ion trap by collision-induced dissociation and 
MS/MS spectra were taken from the peptides. Spectral data was analyzed using 
Bioworks Browser (version 3.3.1 SP1, ThermoFisher) by conversion to dta (text) files 
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using the Sequest Batch Search tool (within Bioworks), which was then converted to a 
single mgf file using a SSH script in the SSH Secure Shell Client program (Version 
3.2.9 Build 283, SSH Communications Corp.). Lastly the combined files were 
submitted to the Mascot search algorithm (Matrix Science, London UK) with a fixed 
modification of carbamidomethyl and a variable modification of oxidation (M) and 
searched against the Wormbase database for protein identification. 
 
5.2.6 Western blot of DAF-21 protein 
Western blot protocol was adapted from the method used in Chapter 4. 1D gel of 
protein samples were transferred to nitrocellulose membranes (0.45 μm pore size, 
Amersham Hybond ECL) at 100 V at 4°C for 2 hours while stirred. Membranes were 
then incubated in primary antibody solution (primary antibody raised in rabbit to a 
recombinant protein of the C-terminal 238 amino acid sequence of B. pahangi HSP90, 
known to cross react with C. elegans DAF-21 (Devaney et al., 2005), courtesy of Prof. 
Devaney at the University of Glasgow) at 1/1000 concentration in PBST (137 mM 
NaCl, 12 mM phosphate, 2.7 mM KCl, pH 7.4, 0.05% Tween-20) with 4% powdered 
milk and at 4°C overnight. Membranes were washed for 10 minutes in PBST three 
times. The membranes were then incubated in rabbit secondary antibody conjugated 
to horse-radish peroxidase (HRP) at 1/10,000 concentration in PBST and 4% 
powdered milk for 2 hours at room temperature. The membranes were washed again 
in PBST for 10 minutes for three times. Washed membranes were incubated in 1.5 ml 
of HRP detection reagent (SuperSignal West Pico, Pierce) for 5 minutes at room 
temperature and visualised with CCD detection camera. 
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5.3 Results 
5.3.1 1D gel electrophoresis and PMF identification of proteins 
Protein identification with PMF involves the elucidation of an accurate tryptic digest 
for a single protein, which requires the protein to be separated at a high enough 
resolution to minimise cross contamination. Proteins from the PIPLC released fraction 
were subjected to1D gel electrophoresis, which after silver staining appeared to be of 
sufficiently low complexity to sequence with PMF (Figure. 5.3). Bands were cut from 
the 1D gel of PIPLC releasate and analysed with MALDI MS, two of which were 
identified as C. elegans ZK6.11 and DOD-19 (Figure. 5.4). ZK6.11 was predicted to 
be GPI anchored by all four prediction programs, and DOD-19 had GPI anchor 
predictions in both GPI-SOM and PredGPI (Table. 5.1). The 1D gel for the lipid raft 
membrane fraction was deemed to have an insufficient resolution, and was therefore 
not subjected to PMF analysis (Figure. 5.3). 
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Table 5.1. PMF protein identifications from 1D gel. Proteins from bands 1 and 2 were 
identified following tryptic digest and MS analysis with a MALDI instrument. MASCOT 
search score, number of peptides used in the identification, percentage sequence coverage, 
molecular weight, pI values, prediction for GPI anchoring (predicted with two or more 
prediction programs), and the prediction result of the four programs (filled circle ● 
represents positive prediction while open circle ○ represents negative prediction) for each 
of the identified proteins is presented. Score is -10 log(p) where p is the probability of the 
match is a random event. Scores at > 50 indicate identification of the sequence at p < 0.05.  
 
 
 
Band 
number  
Protein 
identified  
Score  
Peptides 
matched  
Sequence 
coverage 
(%)  
Molecular 
weight 
(KDa)  
pI  
GPI 
anchor 
prediction 
Big 
PI 
GPI 
SOM 
Frag 
Anchor 
Pred 
GPI 
1  dod-19 92 10 18 48.4 8.87 y ●  ●  ●  ●  
2  ZK6.11a 108 11 27 42.4 8.62 y ○  ●  ○  ●  
 
Figure 5.3. 1D gel of lipid raft and PIPLC released proteins used for proteomic 
analysis. Samples were visualised with silver stain. Lane 1: control releasate after 
incubation of raft fraction with dH2O, lane 2: PIPLC released fraction, lane 3: lipid 
raft proteins. Two bands from the PIPLC released fraction (labelled 1 and 2 in red) 
were identified with PMF. Proteins from the lipid raft fraction were separated 
insufficiently for MS analysis. 
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Figure 5.4. Output of MALDI MS data for PIPLC released protein bands from 1D 
gel. Results for spot 1 are shown in (a) and Results for spot 2 are shown in (b). Mass 
peaks correspond to the m/z value of tryptically digested peptides. After automated and 
manual removal of common peaks, eg. from trypsin and contaminating keratin, the 
remaining sets of m/z values (shown in table for each band) were subjected to PMF 
analysis with MASCOT. Peptide masses in red were found to be part of the PMF that 
identified the protein. Ten peptides were used in the identification of DOD-19 from 
band 1 and eleven peptides were used in the identification of ZK6.11 from band 2. 
Peptide masses (m/z) used in PMF for band 1 (DOD-19) 
Peptide masses (m/z) used in PMF for band 2 (ZK6.11) 
m/z 
m/z 
A
b
u
n
d
a
n
c
e
 
A
b
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n
d
a
n
c
e
 
a) 
b) 
2342.982 
1418.656 
1041.471 
 
1142.683 
1434.697 
1996.994 
1019.461 
1285.723 
1929.965 
1001.484 
1202.646 
1902.034 
993.477 
1181.740 
1546.762 
915.702 
1169.667 
 
1532.702 
1169.674 
 
1185.727 
1611.767 
 
1158.711 
1413.600 
2058.021 
1036.493 
1397.613 
2042.039 
1019.465 
1336.757 
1628.763 
962.568 
1242.608 
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5.3.2 2D gel electrophoresis and PMF identification of proteins 
Both the PIPLC released fraction and the lipid raft fractions were subsequently 
analyzed with 2D gel electrophoresis to improve the resolution of the proteins for 
identification (Figure. 5.5). The resolution of the PIPLC releasate was better than the 
lipid raft samples, which may have been due to the relatively hydrophobic nature of 
the proteins of the lipid raft causing streaking within the IEF strip. Eight spots were 
taken from each gel and digested with trypsin for PMF analysis. Spots 1-8 were 
assigned to the PIPLC released proteins and spots 9-16 were assigned to the lipid raft 
fraction (Table. 5.2). Two C. elegans proteins were identified from the PIPLC 
released fractions, which were LEC-2 and F56F10.1 from spots 3 and 6, respectively. 
LEC-2 (galectin 2) is a cytosolic protein that is not predicted to be GPI anchored 
while F56F10.1 is a putative serine protease that contains GPI anchored predictions 
from four predictive programs. Four of the spots from the lipid raft samples contained 
C. elegans protein identifications, with spot 10, 11 and 12 identified as LEC-3, LEC-2 
and LEC-4 respectively, and spot 16 identified a mixture of LEC-4, LEC-2 and LEC-
1. Keratin contamination was present in spots 2 and 13, while all other spots produced 
insufficient data for identification. 
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Figure 5.5. 2D electrophoretic gels for proteomics analysis. a) shows the gel for PIPLC 
released proteins and b) shows the gel for lipid raft proteins. Both of the gels were run with a 3 
to 10 pH gradient in IEF. Eight protein spots were excised from each gel for tryptic digestion 
and P.M.F. analysis with spots 1-8 from the PIPLC release and spots 9- 16 from the lipid raft 
fraction. Circles indicate the position of excised spots and filled circles indicate spots with 
positive C. elegans protein identification.  
a) 
b) 
Size 
(kDa) 
Size 
(kDa) 
3 
3 10 
pH 
10 
pH 
1 
3 
 
10 14 
2 
7 5 8 4 
9 15 
13 
6 
 
11 
12 
16 
250 
150 
100 
50 
37 
25 
15 
10 
250 
150 
100 
50 
37 
25 
15 
10 
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Spot 
number 
Protein 
identified 
Score 
Peptides 
matched 
Sequence 
coverage 
(%) 
Molecular 
weight 
(KDa) 
pI 
GPI anchor 
prediction 
1 None n/a n/a n/a n/a n/a n/a 
2 
K2C1, Human 
Keratin 
80 22 38 66.0 8.16 n/a 
3 
LEC-2, 
C. elegans 
116 10 50 31.3 6.19 n 
4 None n/a n/a n/a n/a n/a n/a 
5 None n/a n/a n/a n/a n/a n/a 
6 
F56F10.1, 
C. elegans 
56 7 14 60.5 5.31 y 
7 None n/a n/a n/a n/a n/a n/a 
8 None n/a n/a n/a n/a n/a n/a 
 
Spot 
number 
Protein identified Score 
Peptides 
matched 
Sequence 
coverage (%) 
Molecular 
weight (KDa) 
pI 
9 None n/a n/a n/a n/a n/a 
10 LEC-3, C. elegans 176 11 37 32.4 6.82 
11 LEC-2, C. elegans 112 9 35 31.3 6.19 
12 LEC-4, C. elegans 95 9 28 32.4 6.02 
13 
K2C1, Human 
keratin 
70 17 33 66.0 8.16 
14 None n/a n/a n/a n/a n/a 
15 None n/a n/a n/a n/a n/a 
16 LEC-4, C. elegans 100 15 52 32.4 6.02 
 
LEC-2, C. elegans 63 10 41 31.3 6.19 
 
LEC-1, C. elegans 63 10 37 31.8 6.12 
 
 
Table 5.2. PMF analysis results of protein spots from 2D gels. Table a) shows results from the 
PIPLC released sample and table b) shows results from the lipid raft sample.  MASCOT search 
score, number of peptides used in the identification, percentage sequence coverage, molecular 
weight, pI values and prediction for GPI anchoring (predicted with two or more prediction 
programs in Chapter2) for each of the identified proteins is presented. The relevant C. elegans 
proteins are highlighted for each table. Spot number 16 contained multiple identifications that may 
have been the result of incomplete separation during IEF. Score is -10 log(p) where p is the 
probability of the match is a random event. Scores at > 50 indicate identification of the protein at p 
< 0.05.  
a) 
b) 
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5.3.3 Liquid chromatography and MS/MS 
Lipid raft proteins were sent to the Cambridge Centre for Proteomics (CCP) to be 
sequenced using LC MS/MS. Two protein samples were sent to the centre and 
separated on a 1D gel (Figure. 5.6). The SDS gel of sample 3 was cut into 10 strips 
(labelled bands 1 to 10) with each strip digested with trypsin and subjected to reverse 
phase chromatography, which eluted directly into an Orbitrap mass analyzer for 
MS/MS sequencing. A total of 287 proteins were identified from the raw proteomic 
analysis with significant hits from one or more peptides (Appendix 3). Many of the 
identified proteins contained non-significant and duplicated peptides in the analysis 
(Figure. 5.7), and this led to the imposition of a minimum of two or more unique 
peptides as a criterion for the positive identification of a protein. Forty five proteins 
from the initial list were found to satisfy this criterion, of which F52H3.7a and 
F52H3.7b were found to have the same set of identified peptides and encode for the 
same LEC-2 protein. F52H3.7b was chosen over F52H3.7a as it contained a larger 
number of uniquely identified peptides. The final list of validated proteins from LC 
MS/MS analysis was 44 (Table 5.3). 
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Figure 5.6. 1D gel of lipid raft proteins used for LC MS/MS. Lanes 
labelled 1 and 3 were identical samples sent to the CCP. Proteins from lane 3 
were cut into ten gel bands (3a to 3j, labelled 1 to 10 respectively) which were 
subsequently digested with trypsin and separated with an RP column for 
MS/MS analysis.  
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a) 
b) 
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Figure 5.7. (Previous page) Examples of MS/MS output from MASCOT. The first line 
contains the name of the protein followed by its molecular weight, a non-probabilistic protein 
score derived from the ions scores and the number of peptide matches. An Exponentially 
Modified Protein Abundance Index (emPAI) value for an estimation of quantitation is provided 
if the number of queries is 100 or more. The table columns contain values for each individual 
peptide assigned to the protein, and starts off with the hyperlinked number of the peptide, 
followed by its experimental m/z value, molecular mass calculated from m/z, calculated relative 
molecular mass, difference (error) between experimental and calculated masses, number of 
missed enzyme cleavage sites, ions score (calculated as -10*Log(p), where individual ions 
scores > 33 indicate identity or extensive homology (p<0.05); duplicated matches with lower 
scoring are shown in brackets), expectation probability for the peptide match (significance p< 
0.05), rank of the ion (1 to 10,where 1 is the best match), and sequence of the peptide (residues 
adjacent to the peptide are shown either side of the periods. Modifications of any residues are 
underlined and listed after the sequence). 
a) Results for the protein K10C2.1 from band 4. MASCOT attributes 18 peptides to the protein 
in which some are duplicates and others have an expected probability of >0.05. After 
inspection 12 unique peptides (K.DNGLAVTR.Q, K.VADLGQQR.F, R.SQFLAPPQK.T, 
R.TATDTYLALK.D, K.AAHILIIDSPR.G, K.TLFENVYSWNK.A, 
R.GMGIGNGMVSAVNDVR.T, R.VWNLPGITYGLNFK.Q, K.QLLPQYQPAPVTVPR.R, 
R.AADVSPFLPSTLFVDQAK.K, K.TALDTYTALEDFFVTYPPHR.N, and 
K.YYIQQYPDTTPVFQFLVDSGYPLK.V) were found that also had significant probability 
scores for each of them.  
b) Results for the protein K11C4.5 from band 1, which is also known as unc-68 and encodes a 
ryanodine receptor in C. elegans. MASCOT assigned 3 peptides to the protein. Closer 
inspection, however, uncovers two identical peptide sequences within the analysis. 
Furthermore none of the peptides had a significant expected probability. This means that there 
are no unique significant peptides assigned to the protein and K11C4.5 is not counted towards 
the final total of identified lipid raft proteins. 
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Public 
name  description  
unique 
peptides  score  size  
GPI 
prediction  Big PI  
GPI 
SOM  
Frag 
Anchor  
Pred 
GPI  
tag-10  apical gut membrane protein  3  245  473  y  ○  ●  ●  ●  
act-4  cytoskeleton  3  169  332  n  ○  ○  ○  ○  
act-4  cytoskeleton  2  145  376  n  ○  ○  ○  ○  
daf-21  molecular chaperone  2  140  702  n  ○  ○  ○  ○  
pho-1  phosphatase  6  348  449  y  ○  ●  ●  ○  
F56F10.1  carboxypeptidase  4  358  540  y  ●  ●  ●  ●  
F32A5.3  carboxypeptidase  6  373  574  y  ●  ●  ●  ●  
K10C2.1  carboxypeptidase  12  783  2314  y  ●  ●  ●  ●  
Y16B4A.2  carboxypeptidase  8  597  2167  y  ○  ●  ○  ●  
Y40D12A.2  carboxypeptidase  2  107  512  y  ○  ●  ●  ●  
pcp-2  lysosomal carboxypeptidase  5  449  1080  y  ○  ●  ●  ●  
pcp-3  lysosomal carboxypeptidase  8  593  1080  y  ●  ●  ●  ●  
pcp-4  lysosomal carboxypeptidase  4  354  1042  y  ○  ●  ○  ●  
C26B9.5  lysosomal carboxypeptidase  4  252  516  n  ○  ○  ○  ○  
T25B6.2  metalloprotease  2  107  798  n  ○  ○  ○  ○  
F54F11.2  metalloprotease  11  734  1589  n  ○  ○  ○  ○  
dct-17  insulin pathway daf-16 controlled 
proteins  2  225  739  y  ○  ●  ●  ●  
dod-19  insulin pathway daf-16 controlled 
proteins  4  333  406  y  ○  ●  ○  ●  
F57F4.4  unc-68 ryanodine receptor 
associated proteins (Ca
2+
 pathway)  5  337  2090  y  ●  ●  ●  ●  
gfi-1  unc-68 ryanodine receptor 
associated proteins (Ca
2+
 pathway)  3  181  2153  y  ●  ●  ●  ●  
lec-1  galactoside binding lectin  5  340  279  n  ○  ○  ○  ○  
lec-2  galactoside binding lectin  7  487  278  n  ○  ○  ○  ○  
lec-4  galactoside binding lectin  6  399  283  n  ○  ○  ○  ○  
lec-5  galactoside binding lectin  3  262  314  n  ○  ○  ○  ○  
tre-3  sugar metabolism  2  89  588  y  ○  ●  ○  ●  
stl-1  stomatin like  3  226  327  n  ○  ○  ○  ○  
vha-1  vacuolar proton-translocating 
ATPase (V-ATPase)  2  130  169  n  ○  ○  ○  ○  
vha-19  vacuolar proton-translocating 
ATPase (V-ATPase)  2  148  451  n  ○  ○  ○  ○  
vps-32.1  vacuolar protein sorting  3  255  221  n  ○  ○  ○  ○  
T19D12.4  
 
3  249  1028  n  ○  ○  ○  ○  
Y54G2A.18  
 
2  134  213  n  ○  ○  ○  ○  
C29F3.7  
 
7  594  491  n  ○  ●  ○  ○  
ZK6.11  
 
6  395  386  y  ●  ●  ●  ●  
Y41D4B.16  
 
5  347  453  y  ○  ●  ●  ●  
F54E2.1  
 
3  210  391  y  ○  ●  ●  ●  
K08D8.6  
 
3  200  491  y  ○  ●  ●  ●  
F35E12.10  
 
2  125  487  y  ●  ●  ●  ●  
F53C11.1  
 
2  144  494  n  ○  ●  ○  ○  
B0024.4  
 
2  138  390  y  ○  ●  ●  ●  
Y12A6A.1  
 
2  79  209  y  ●  ●  ●  ●  
R05G6.7  channel Protein  5  319  283  n  ○  ○  ○  ○  
npp-21  nuclear Pore complex Protein  2  85  1982  n  ○  ○  ○  ○  
eft-4  translation elongation factor  2  162  463  n  ○  ○  ○  ○  
F21D5.3  copper oxidase  5  338  743  n  ○  ○  ○  ○  
 
  
210 
 
 
5.3.4 Western blot of lipid raft fraction 
A literature search of the 44 lipid raft proteins identified from the LC MS/MS analysis 
revealed three proteins with available antibodies. These proteins are LEC-1, DAF-21 
and VPS-32.1. The LEC-1 antibody was last used in a paper in 1996 and is 
unavailable from the authors (Arata et al., 1996), while antibodies for both DAF-21 
and VPS-32.1 were available from their respective authors (Devaney et al., 2005; 
Michelet et al., 2009). The DAF-21 antibody was raised against the HSP90 
orthologue of the filarial nematode Brugia pahangi and was shown to have cross 
reactivity against the C. elegans protein. DAF-21 was shown to be enriched in the 
lipid raft fraction compared to total membrane (Figure. 5.8). No staining was 
observed for the VPS-32.1 antibody (data not shown). 
 
 
 
Table 5.3. (Previous page) Results of the LC MS/MS analysis of proteins from the 
lipid raft fraction. All proteins were identified with two or more unique peptides with 
statistically significant scores. F52H3.7a was also found in the analysis but contained 
duplicated peptides with F52H3.7b and encodes the same protein lec-2, and as such was 
not included in this list. Protein scores are derived from ions scores as a ranking of protein 
hits on a non-probabilistic basis (Matrix Science). Public name, Wormbase ID, gene 
description, gene size and GO terms were taken from www.wormbase.org.  GPI prediction 
was taken from Chapter 2 with confirmation when two or more prediction programs have 
validated the result (highlighted in orange). For each individual prediction program a ● 
denotes a positive prediction while a ○ indicates a negative prediction.  
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Figure 5.8. Blot of protein fractions with DAF-21 specific antibody. a) Ponceau 
staining of proteins before blot development and b) shows the results of the blot 
after probing with DAF-21 antibody at 1:1,000 concentration. Lane 1 contains the 
supernatant fraction after membrane extraction, lane 2 contains a 10 fold dilution 
of the membrane fraction and lane 3 contains the lipid raft fraction. All protein 
contents were diluted to their approximate cellular ratios. 
b) a) 
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5.4 Discussion 
C. elegans lipid raft and GPI anchored proteins were identified and analyzed with 
proteomic techniques for the first time. Both gel based techniques (including 2D 
electrophoresis) and multidimensional LC were used to give adequate separation of 
proteins, which were then subjected to a combination of PMF and MS/MS peptide 
sequencing for identification. 
 
5.4.1 Gel analysis and PMF of GPI anchored proteins and lipid rafts 
Both lipid raft and GPI anchored proteins released by PIPLC were initially subjected 
to 1D and 2D gel electrophoresis for the identification of proteins. Identification with 
PMF requires high resolution of the protein of interest as the technique is very 
sensitive to the presence of peptide masses from other contaminating proteins. A 
preliminary analysis of GPI anchored proteins separated by 1D gels showed that 
certain bands were sufficiently separated for analysis with PMF, which produced 
identifications for two C. elegans proteins ZK6.11a and ZK6.10 (DOD-19). ZK6.11a 
is an uncharacterized protein with GPI anchoring prediction in four of the prediction 
programs used in Chapter 2 (Big PI, GPI SOM, FragAnchor and PredGPI), while dod-
19 (stands for down-stream of daf-16) is an unknown gene predicted by two programs 
(GPI SOM and PredGPI) and is regulated by daf-16, which acts within the insulin 
mediated pathway to affect development in dauer formation, life span and 
reproduction (Murphy et al., 2003). Bands from the lipid raft fraction however were 
insufficiently separated due to its higher complexity and no protein identification was 
attempted from 1D gel analysis. 
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The GPI anchored proteins and lipid raft proteins were then separated with 2D gel 
electrophoresis in order to improve resolution and increase the number of proteins that 
can potentially be identified with PMF. A greater degree of separation was achieved 
for the released GPI anchored proteins, and individual spots were resolved which 
showed the presence of many spots with the same mass but different pI, which 
indicates the presence of possible post translational modifications (Figure. 5.5a). 
Lipid raft proteins were less well separated with 2D gel electrophoresis, with 
extensive smearing present on the gels (Figure. 5.5b). This may have been due to the 
first dimension of separation requiring mild non-ionic detergents so as to not interfere 
with native charge of the protein during isoelectric focusing, which are ill suited for 
solubilisation of the highly hydrophobic membrane proteins. The presence of raft 
lipids also compounds the problem. Lipids such as sphingolipids and sphingomyelin 
have saturated long chain fatty acids within their structure that allow tight packing 
and further reduce their solubility with mild detergents. Never-the-less the 2D 
analysis was able to offer greater resolving power that 1D electrophoresis for the lipid 
raft proteins, which were separated to an appropriate resolution for PMF identification. 
Overall two spots from the GPI anchored protein gel produced positive C. elegans 
identifications after analysis with mass spectrometry (table 5.2). F56F10.1 was 
identified from spot 6 and encodes a putative carboxypeptidase with predictions in all 
four GPI anchor prediction programs. Some mammalian carboxylpeptidases are found 
to be GPI anchored and are involved in signalling (Reverter et al., 2004). Taken 
together the evidence suggests that F56F10.1 may be a genuine GPI anchored protein. 
LEC-2 identified from spot 3 is involved in the binding of sugar moieties on the cell 
surface of C. elegans (Nemoto-Sasaki et al., 2008). LEC proteins are galectins with 
sugar binding domains and are a class of cytosolic proteins that are strongly 
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associated with membrane sphingolipids. They are found to be a major component of 
lipid rafts in a number of eukaryotic species (Lajoie et al., 2009). Galectins appear to 
be highly expressed in C. elegans (see below) and are likely to represent a common 
contamination within the PIPLC released sample due to the method of their extraction. 
Spot 2 from the GPI anchored protein gel identified human keratin which is a 
common contaminant of proteomic studies. Four proteins were identified from the 
lipid raft fraction. LEC-3, LEC-2 and LEC-4 were identified from spots 10, 11 and 12 
respectively, while spot 16 contained identification from LEC-1, LEC-2 and LEC-4, 
with spot 13 identified as a human keratin. All of the LEC proteins were identified 
with good scores (above 50) and sequence coverage (28% or more) (Table. 5.2). LEC 
proteins are commonly found within lipid rafts and have been a well validated raft 
marker in a number of studies in a variety of mammalian cell lines (Hansen et al., 
2001; Hsu et al., 2009; Li et al., 2004a). However the level of abundance of the 
lectins in the sample appeared to have had an adverse effect on the identification of 
other lipid raft components. 
 
5.4.2 2-dimensional LC MS/MS of lipid raft proteins 
It was clear from the results of 2D electrophoresis that the technique was unsuitable 
for lipid raft proteins and a more sensitive method was need for their identification, 
and 2D LC MS/MS was chosen to separate and analyse the proteins for this fraction. 
LC based techniques have improved dramatically in the past few years and are able to 
separate proteomes with a high resolution and fidelity (Motoyama and Yates, 2008). 
MS/MS analysis is able to achieve direct sequencing of the peptide, which gives 
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greater confidence in the assignment of peptide peaks to proteins and allows improved 
identification over PMF (Gage et al., 2009). Excess galectin proteins from the lipid 
raft fraction were washed off with lactose, as the presence of extremely abundant 
proteins may affect the efficiency of identification by causing ionization suppression 
and detector saturation within the limited loading capacity of LC columns (Lasonder 
et al., 2002). 1D SDS-PAGE was used in the first dimension as it allows better 
separation of the proteins before peptide separation with LC. RPLC was used in the 
second dimension after trypsin digestion as this technique offers good orthogonality 
with 1D SDS PAGE, and can be directly linked to the mass spectrometer for MS/MS 
sequencing with minimal loss of material during handling. A total of 287 proteins 
were identified with the results from the LC MS/MS, however not all of these proteins 
have appropriate predictions upon closer inspection. There are instances where 
several different proteins were predicted with the same peptide (data not shown), 
which may represent a conserved sequence, and many of the proteins were identified 
with only one peptide sequence- so called “one hit wonders” that lack specificity and 
do not present a confident prediction (Figure 5.7). Identification was considered valid 
when two or more unique peptides with significant sequence identity (p<0.05) have 
been attributed to the protein in question, which is an increasingly common criterion 
for the validation of MS/MS data in proteomics analyses (Gage et al., 2009). This 
approach reduced the number of proteins identified with LC MS/MS to 44 for the C. 
elegans lipid raft fraction. Properties for each of the proteins were taken from 
Wormbase, and a comprehensive analysis of their function and their relationship to 
known lipid raft components from other systems is given below. 
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5.4.2.1 Apical gut membrane protein 
The identified C. elegans protein comes from the tag-10 gene and encodes a gut 
apical protein with homology to the GA1 gut apical protein of Heamonchus contortus, 
a blood parasite of ruminant animals. GA1 is a polyprotein processed into two 
isoforms, p52
GA1
 which is GPI anchored and p46
GA1
 which is associated to the 
membrane with a GPI anchored protein (Jasmer et al., 1996). The protein is being 
actively developed as a target for vaccine production against the parasite (Jasmer et 
al., 2007). Previous research has implicated the tag-10 gene to have homology to the 
p52
GA1 
form of GA1 (Rehman and Jasmer, 1998) and analysis from chapter 2 has 
shown that the protein is predicted to be GPI anchored with three prediction programs 
(GPI SOM, FragAnchor and PredGPI) indicating that TAG-10 may be a GPI 
anchored protein. GA1 is a part of a group of secreted proteins from H. contortus, and 
has also been identified in a proteomic search of such proteins in the nematode 
(Yatsuda et al., 2003). Lipid rafts are involved extensively in apical sorting in 
epithelial cells (Hoekstra et al., 2003) and the C. elegans cav-2 homologue has also 
been shown to be localised on the apical surface of the intestine (Parker et al., 2009), 
which point to the validity of this identification as a genuine raft protein. 
5.4.2.2 Cytoskeletal protein 
Both of the proteins identified are produced by alternate splicing of the C. elegans 
gene act-4, namely M03F4.2a and M03F4.2b. Analysis of the peptides that gave rise 
to these identification revealed unique hits for each of the isoforms, and justifies the 
inclusion of both on the list of predicted proteins. The actin cytoskeleton is involved 
in raft formation and maintenance, forming a lattice structure that associates with raft 
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components, which creates greater stability in protein and lipid interactions (Chichili 
and Rodgers, 2009). Lipid rafts recruit the actin cytoskeleton in maintaining the T cell 
activation signal (Kabouridis and Jury, 2008), as well as establishing cell polarity in 
neuron axon growth and fission yeast mating (Kamiguchi, 2006; Wachtler and 
Balasubramanian, 2006); the actin cytoskeleton has also been shown as a regulator of 
endocytosis by caveolae (Lajoie and Nabi, 2007). 
5.4.2.3 Molecular chaperone 
Daf-21 is the C. elegans homologue of the mammalian gene heat shock protein 90 
(Hsp90). Hsp90 is a well studied cytosolic protein of 90 kDa and is up regulated in 
conditions of elevated temperature. The protein also has many functions in unstressed 
conditions, including protein folding, intracellular transport, protein degradation and 
signalling (Csermely et al., 1998). HSP90 has a major role in cancer biology, where it 
prevents apoptosis through stabilization of PI3K/AKT signalling (Mohsin et al., 2005), 
promotes cancer cell proliferation (Calderwood et al., 2006), induces angiogenesis via 
phosphorylation of
 
eNOS (Fontana et al., 2002), and has a role in many other key 
oncogenic processes. 
Hsp90 interacts with many lipid raft proteins, particularly those within signalling 
pathways. The protein associates with the Dengue Virus Receptor within raft domains 
to facilitate its entry into cells (Reyes-Del Valle et al., 2005). Hsp90 localises the 
heterotrimeric G protein Gα12 to lipid rafts, where it functions to produce cytoskeletal 
rearrangements and induce oncogenic transformation (Waheed and Jones, 2002). 
Fever induction and maintenance is regulated by HSP90 in humans, in association 
with caveolin and the JAK-STAT3 signalling pathway (Shah et al., 2002). Recently it 
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has been found that HSP90 has a pro-apoptotic role by its interaction with c-Jun N-
terminal kinase (JNK) in rafts (Nieto-Miguel et al., 2008). Daf-21 was also found to 
be relatively enriched within the raft fraction compared to total membrane via 
Western blotting (Figure. 5.8), which further validates the protein as a genuine raft 
component within C. elegans. The C. elegans caveolin homologues cav-1 and cav-2 
have been found to be upregulated in heat shock conditions, which implicates a 
function for lipid rafts in this environmental response for the worm (Parker and Baylis, 
2009). Daf-21 has a number of functions within the worm such as chemosensation, 
cell cycle control, responses to heat shock and dauer formation (Ailion and Thomas, 
2000; Inoue et al., 2006; Vowels and Thomas, 1994; Wang and Kim, 2003). Daf-21 
has also been shown to be involved in a number of signalling pathways such as TGF-
beta and heterotrimeric G protein pathways for the induction of the dauer stage and 
chemosensation (Bargmann, 2006; Bastiani and Mendel, 2006; Savage-Dunn, 2005). 
Interestingly the Hsp90 inhibitor geldanamicin does not bind to DAF-21 and has no 
observed effects on C. elegans phenotype, which was suggested to be the result of 
adaptive evolution within the worm (David et al., 2003; Him et al., 2009).  
5.4.2.4 Phosphatase 
The C. elegans gene EGAP2.3 (also known as pho-1) encodes an intestinal acid 
phosphatase which may have a role in digestion. It is localized in the intestinal brush 
border in the worm (Beh et al., 1991). Pho-1 expression in the intestines starts in late 
embryogenesis and is maintained at a high level throughout the worm‟s development 
(Maduro and Rothman, 2002). The intestinal brush border of other systems have well 
characterized lipid raft domains, and this may be due to its function as an absorptive 
surface for nutrients and a barrier for pathogen entry (Danielsen and Hansen, 2003, 
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2008). Prostatic acid phosphatase, a prostate cancer marker, has recently been shown 
to be raft associated (Quintero et al., 2007). Pho-1 also has GPI anchor predictions 
from two predictor programs (GPI SOM and FragAnchor). 
5.4.2.5 Carboxypeptidase 
Nine carboxypeptidases were found by the proteomic analysis, with five (F56F10.1, 
F32A5.3, K10C2.1, Y16B4A.2 and Y40D12A.2) involved in non-lysosomal 
compartments. Carboxypeptidases are enzymes that hydrolyse the C-terminal end of 
peptides. They were first studied in protein digestion, but were later found to have a 
large number of roles, including protein maturation and regulation of biological 
processes. Both Carboxypeptidase E and Prohormone convertase 2 are involved in 
prohormone targeting and is resident within rafts, where this feature is essential for 
their sorting into the regulated secretory pathway (RSP) (Assadi et al., 2004; 
Dhanvantari and Loh, 2000). Carboxypeptidase M is also a regulator of hormones, 
where it can change the receptor specificity of kinins and the inflammatory response 
(Reverter et al., 2004; Zhang et al., 2008); it exists on the surface membrane via a 
GPI anchor linkage, and may also be released for its function (Li and Skidgel, 1999; 
Skidgel et al., 1996). All of the five carboxylpeptidases have two or more predictions 
for GPI anchoring (Table. 4) with F56F10.1 also found in the PIPLC released fraction, 
suggesting that the proteins are likely to be true lipid raft residents within C. elegans. 
5.4.2.6 Lysosomal carboxypeptidase 
Four of the carboxypeptidases (pcp-2, pcp-3, pcp-4 and C26B9.5) found in the lipid 
raft preparation are considered to come from the lysosomal compartment of C. 
elegans cells. The PCP-2, PCP-3 and PCP-4 proteins have been predicted by two or 
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more programs for GPI anchoring, while C26B9.5 is not a predicted GPI anchored 
protein. Lysosomes are known to contain lipid rafts (Kobayashi et al., 1998; Simons 
and Gruenberg, 2000), and rafts form a part of the endosome sorting pathway in 
conjunction with caveolae endocytosis (Helms and Zurzolo, 2004). Lysosomes also 
contain a number of carboxypeptidases (Skidgel and Erdos, 1998) that function in 
protein turnover and cell signalling, and these enzymes may also be associated with 
lipid rafts within the lysosome (Obermajer et al., 2008; Roshy et al., 2003). 
5.4.2.7 Metallopeptidase 
Both of the metallopeptidases found within the study (T25B6.2 and F54F11.2a) are 
members of the C. elegans neprilysin family.  Neprilysin (NEP) is a zinc dependent 
metalloprotease integral to the plasma membrane that functions by turning off certain 
peptide signalling at the cell surface and is involved in many nervous, cardiovascular, 
inflammatory and immune signalling pathways (Turner et al., 2001). Interestingly 
both of the metallopeptidases found in C. elegans are also homologues of the H. 
contortus neprilysin protein MEP1 (Redmond et al., 1997) after search with BLAST. 
One of the most intensively studied functions of NEP is its role in amyloid β peptide 
(Aβ) processing in Alzheimer‟s disease (Carson and Turner, 2002). NEP has been 
shown to have caveolae localization, with this feature possibly significant for its role 
in Aβ processing (Cordy et al., 2006; Riemann et al., 2001). 
5.4.2.8 Insulin pathway daf-16 controlled proteins 
F35E12.7a (dct-17) and ZK6.10 (dod-19) are found to act downstream of the 
insulin/insulin-like growth factor-1 pathway related transcription factor daf-16 and are 
implicated to have functions within the development, innate immunity and aging of 
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the worm (Murphy et al., 2003; Pinkston-Gosse and Kenyon, 2007; Styer et al., 
2008). Both DCT-17 and DOD-19 proteins have predictions in two or more prediction 
programs for GPI anchoring and therefore may reside within the lipid raft component. 
While their functions are not known they may play a role in signal transduction 
pathways due to their implied functions within the growth and development of the 
worm. 
5.4.2.9 unc-68 ryanodine receptor associated proteins (Ca
2+
 pathway) 
Both C. elegans genes F57F4.3 (gfi-1) and F57F4.4 have been shown to interact 
directly with UNC-68 in yeast two hybrid assays (www.wormbase.org, Sakube and 
Kagawa, 1999,). Unc-68 encodes a ryanodine receptor membrane protein involved in 
Ca
2+
 signalling (Maryon et al., 1996). It is expressed in the sarcoplasmic reticulum 
(SR) of all muscle cells and is the major protein involved in the proliferation of 
Calcium induced Calcium release (CICR) in C. elegans (Maryon et al., 1998). Lipid 
rafts have been shown to have a role in calcium signalling (Noble et al., 2006), and 
ryanodine receptor was found in lipid raft fractions extracted with Triton X-100 along 
with other members of the signalling pathway in rat cells (Weerth et al., 2007). Both 
F57F4.3 and F57F4.4 are predicted to be GPI anchored with all four prediction 
programs and this feature may help its interaction with UNC-68 in the SR; some 
proteins in the SR, such as carbonic anhydrase IV, have also been shown to be GPI 
anchored (Waheed et al., 1992). Interestingly UNC-68 was also identified in the 
proteomic analysis but did not pass the threshold for significant hits (Figure 5.7b and 
Appendix 3). 
5.4.2.10 Sugar binding lectins 
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The C. elegans lectins LEC-1, 2, 4 and 5 were identified in the proteomic search, with 
LEC-3 not identified in any of the searches. The LEC proteins are galectins that bind 
β-galactosides, and are soluble proteins that exist within the cytoplasm. A study of 11 
lectin genes in C. elegans showed that LEC-1,2 and 4 have β-galactoside binding 
activity as well as different affinities for other sugar molecules, while LEC-5 had a 
predicted ER targeting signal and was shown previously to be N-glycosylated, 
implicating it as a secreted protein (Fan et al., 2005; Nemoto-Sasaki et al., 2008). 
LEC-1 is the most well studied of the C. elegans galectins. It was found to be a novel 
tandem repeat 32 kDa sugar binding protein, with two domains for binding that each 
had different affinities for the same target sugar molecule (Arata et al., 2001; Arata et 
al., 1997). LEC-1 was shown to be localized to the cuticle of the worm (Arata et al., 
1996). A proteomic study of gene expression with 2D DIGE on C. elegans 
development identified LEC-1 and LEC-2, where their expression increased sharply 
after hatching and was maintained at high levels throughout the life of the worm 
(Tabuse et al., 2005). 
Galectins exhibit a wide variety of functions in the cell, such as polarized sorting of 
proteins, axonal regeneration, apoptosis, signalling and immunity (Delacour et al., 
2008; Kohatsu et al., 2006; Miura et al., 2004; Paz et al., 2001; Perillo et al., 1995). 
Galectins are associated with lipid rafts (Hansen et al., 2005) and some can bind to 
modified cholesterol (Ideo et al., 2007). There is evidence that galectins form their 
own membrane microdomains by their interaction with glycoproteins (Ahmad et al., 
2004), which are called lectin-glycoprotein lattices (Lajoie et al., 2009); this structure 
is postulated to have roles in signalling at the cell surface and may compete for 
signalling factors from lipid rafts (Lajoie et al., 2007). 
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5.4.2.11 Sugar metabolism 
W05E10.4 was identified as a trehalase (tre-3) in C. elegans involved in sugar 
metabolism, where it was shown by RT-PCR to be expressed in all life stages of the 
worm (Pellerone et al., 2003). Trehalase is a classical GPI anchored protein found in 
early studies of GPI anchoring in rabbits (Ruf et al., 1990; Takesue et al., 1986), and 
C. elegans TRE-3 is also predicted to possess a GPI anchor from two of the GPI 
prediction programs (GPI SOM and PredGPI). 
5.4.2.12 Stomatin-like protein 
Stl-1 in C. elegans encodes a stomatin-like protein and was shown to have an 
increased transcription level in the worm in response to the addition of ethanol (Kwon 
et al., 2004). Stomatin is a 32kDa membrane bound protein with a role in the 
regulation of Na+/K- ion transport (Stewart, 1997). Its mutation causes the rare 
anaemic disease Overhydrated Hereditary Stomatocytosis (OHSt), and its mode of 
action involves regulation with cytoskeletal components (Stewart et al., 1993). 
Stomatin is raft associated in erythrocytes, platelets and epithelial cells (Fricke et al., 
2003; Mairhofer et al., 2002; Salzer and Prohaska, 2001), and is used as a marker for 
the presence of lipid rafts (Salzer et al., 2008; Umlauf et al., 2006). Recently it was 
shown that the stomatin-like protein STP-2 regulates T-cell activation, giving a role 
for such proteins in raft- associated signalling (Kirchhof et al., 2008). 
5.4.2.13 Vacuolar proton-translocating ATPase (V-ATPase) 
R10E11.8 (vha-1) and Y55H10A.1 (vha-19) were found to encode for components of 
the C. elegans V-ATPase complex. V-ATPase is related to the F-ATPase of 
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mitochondria, and works as a membrane bound proton pump in a variety of organelles 
such as endosomes, lysosomes, the Golgi apparatus, and others (Anderson and Orci, 
1988). It consists of two major complexes V1 (cytosolic) and V0 (membrane), which 
are both made up of multiple subunits (Saroussi and Nelson, 2009). The primary role 
of V-ATPase is to acidify the pH of various organelles, and to create a proton motive 
force to drive secondary transport processes within them (Beyenbach and Wieczorek, 
2006). V-ATPase has been isolated from lipid raft preparations of endothelial cells, 
phagosomes and synaptic vesicles (Dermine et al., 2001; Sprenger et al., 2006; 
Yoshinaka et al., 2004). Rafts were found to regulate the activity of V-ATPases by 
attenuating V1 and V0 subunit association (Lafourcade et al., 2008). Both of the C. 
elegans proteins found in this analysis are related to subunits of the membrane bound 
V0 complex of V-ATPase, with vha-1 homologous to subunit c and vha-19 encoding 
a non-homologous replacement for the fungal subunit c‟ called Ac45, which is found 
only in multicellular organisms (Oka et al., 1997; Schoonderwoert and Martens, 
2002). V-ATPase is involved in cell fusion and apical sorting/secretion in C. elegans, 
and is required for ovulation and embryogenesis (Kontani et al., 2005; Liegeois et al., 
2006; Oka and Futai, 2000). 
5.4.2.14 Vacuolar protein sorting 
Another vacuolar protein found within the study was C56C10.3 (vps-32.1) which is 
related to the yeast vacuolar protein sorting (Vps) factor and is a part of the ESCRT-
III complex within C. elegans (Michelet et al., 2009). Lipid rafts are involved in 
protein sorting in vacuolar compartments and Vps is heavily implicated in protein 
sorting within endosomes (Kobayashi and Hirabayashi, 2000; Piper and Luzio, 2001). 
Interestingly the VPS-32.1 protein was found in C. elegans to occupy distinct 
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domains within the endosome compared to other ESCRT-III proteins (Michelet et al., 
2009), which may be due to lipid raft partitioning. A small amount of antibody to 
VPS-32.1 was obtained courtesy of the Legouis lab, but the western blot experiment 
was unsuccessful in detecting any bands. 
5.4.2.15 Proteins without Wormbase descriptions 
Eleven of the remaining proteins do not have clear descriptions of function from 
Wormbase. Of these T19D12.4a and Y54G2A.18 do not have prediction for GPI 
anchoring, while C29F3.7a and F53C11.1 possess GPI anchoring prediction in only 
one of the prediction programs (GPI SOM). The rest of the seven proteins (ZK6.11a, 
Y41D4B.16, F54E2.1, K08D8.6, F35E12.10, B0024.4 and Y12A6A.1) have GPI 
anchoring predicted in at least two prediction programs, with ZK6.11a also found 
within the PIPLC released fraction, making them likely raft components. 
5.4.2.16 Potential false positives 
There are four proteins identified within the analysis that may be false positives in the 
light of their function. The first protein is R05G6.7, which functions as a channel 
protein with predicted localisation in mitochondria. Mitochondria have been shown to 
form lipid domains with non-raft properties (Grijalba et al., 1999) and both raft 
associated and mitochondrial ion channels are involved in apoptosis, with sometimes 
a large amount of cross-talk (Garcia et al., 2003; Szabo et al., 2004). However there is 
no direct evidence that mitochondria contain rafts, with a recent study placing 
mitochondrial proteins as contaminants of raft extraction (Zheng et al., 2009). The 
second potential contaminant is R07G3.3a (npp-21) which encodes a nuclear pore 
protein that is very unlikely to be resident in rafts, as the nuclear envelope is not likely 
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to form raft-like domains. Previous reports have also indicated that certain raft 
associated proteins cause common cross-contamination during nuclear membrane 
extraction (Say and Hooper, 2007). R03G5.1a (eft-4) is the third identified protein 
that may have been falsely predicted to be raft associated. eft-4 encodes a translation 
elongation factor in C. elegans and works in concert with ribosomes in the cytosol to 
ensure proper protein translation, so it is unlikely to be lipid raft associated (Proud, 
1994). Lastly F21D5.3 encodes a laccase copper oxidase, which is secreted onto the 
cell wall of Cryptococcus neoformans and has a role in its virulence to humans (Zhu 
and Williamson, 2004). A recent study of lipid rafts in Cryptococcus has shown that 
laccase does not associate with either raft or non-raft membrane (Siafakas et al., 
2006). All of these proteins show compelling evidence in the literature for their non-
raft association and are therefore excluded from the list of lipid raft proteins found in 
C. elegans. 
 
5.4.3 Conclusion 
Overall the 2-dimensional LC MS/MS analysis produced 40 likely candidates of lipid 
raft proteins in C. elegans, with 36 of them showing features of known lipid raft 
components and homology to lipid raft proteins from other organisms. This added 
with the LEC-3 protein identified with 2D electrophoresis makes the final number of 
lipid raft proteins found in C. elegans to be 41 (Table. 5.4). The proteins identified are 
involved in a number of processes including signalling, sugar binding, transport, 
proteolysis, molecular chaperone and the cytoskeleton. This study represents the 
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largest number of raft proteins identified in the nematode to date, and sheds light on 
the importance of this sub-membrane proteome in the biology of C. elegans. 
Of interest are the 21 proteins found within the lipid raft fraction that have GPI anchor 
prediction in at least two GPI anchored prediction programs, which represents just 
over 50% of the raft proteins identified (Table. 5.4). The caveat present is that 
prediction programs do not necessarily reflect anchoring of the protein in vivo; 
however a conservative estimate using only proteins with validation from four 
prediction programs still yields a high percentage of GPI anchoring in the 41 
identified proteins (9 proteins, 22% of the total), while three of these proteins 
(F56F10.1, ZK6.11 and DOD-19) have had their GPI anchoring validated by PIPLC 
digestion. GPI anchored proteins have not been extensively studied in C. elegans and 
it is interesting that the organism has such a high proportion of GPI anchoring within 
its raft proteome. This may reflect the importance of this post translational 
modification on the biology of the worm. Most of the GPI anchor synthesis pathway 
is conserved in C. elegans (Chapter 3) with the two homologues of the catalytic 
subunit of the transamidase complex (PIG-K in humans) both containing the active 
site residues of the enzyme. GPI anchored proteins could play a major role within the 
biology of the worm and may be involved in a variety of processes such as 
development, various signalling processes, digestion, transport, sugar metabolism and 
organelle maintenance. It would be interesting to further study the role GPI anchored 
proteins and lipid rafts have within C. elegans, which coupled with its extensive 
genetic knowledge can offer a greater understanding of these important classes of 
proteins. 
  
228 
Gene name  description  
size 
(amino 
acids)  
identified 
in LC 
MS/MS  
identified with 
2D 
electrophoresis  
GPI prediction with 
two programs or 
more  
released by 
PIPLC  
tag-10  apical gut membrane protein  473  y  n  y  n  
act-4  cytoskeleton  332  y  n  n  n  
act-4  cytoskeleton  376  y  n  n  n  
daf-21  molecular chaperone  702  y  n  n  n  
pho-1  phosphatase  449  y  n  y  n  
F56F10.1  carboxypeptidase  540  y  n  y  y  
F32A5.3  carboxypeptidase  574  y  n  y  n  
K10C2.1  carboxypeptidase  2314  y  n  y  n  
Y16B4A.2  carboxypeptidase  2167  y  n  y  n  
Y40D12A.2  carboxypeptidase  512  y  n  y  n  
pcp-2  lysosomal carboxypeptidase  1080  y  n  y  n  
pcp-3  lysosomal carboxypeptidase  1080  y  n  y  n  
pcp-4  lysosomal carboxypeptidase  1042  y  n  y  n  
C26B9.5  lysosomal carboxypeptidase  516  y  n  n  n  
T25B6.2  metalloprotease  798  y  n  n  n  
F54F11.2  metalloprotease  1589  y  n  n  n  
dct-17  insulin pathway daf-16 controlled 
proteins  739  y  n  y  n  
dod-19  insulin pathway daf-16 controlled 
proteins  406  y  n  y  y  
F57F4.4  unc-68 ryanodine receptor 
associated proteins (Ca
2+
 pathway)  2090  y  n  y  n  
gfi-1  unc-68 ryanodine receptor 
associated proteins (Ca
2+
 pathway)  2153  y  n  y  n  
lec-1  galactoside binding lectin  279  y  y  n  n  
lec-2  galactoside binding lectin  278  y  y  n  n  
lec-3  galactoside binding lectin  297  n  y  n  n  
lec-4  galactoside binding lectin  283  y  y  n  n  
lec-5  galactoside binding lectin  314  y  n  n  n  
tre-3  sugar metabolism  588  y  n  y  n  
stl-1  stomatin like  327  y  n  n  n  
vha-1  vacuolar proton-translocating 
ATPase (V-ATPase)  169  y  n  n  n  
vha-19  vacuolar proton-translocating 
ATPase (V-ATPase)  451  y  n  n  n  
vps-32.1  vacuolar protein sorting  221  y  n  n  n  
T19D12.4  
 
1028  y  n  n  n  
Y54G2A.18  
 
213  y  n  n  n  
C29F3.7  
 
491  y  n  n  n  
ZK6.11  
 
386  y  n  y  y  
Y41D4B.16  
 
453  y  n  y  n  
F54E2.1  
 
391  y  n  y  n  
K08D8.6  
 
491  y  n  y  n  
F35E12.10  
 
487  y  n  y  n  
F53C11.1  
 
494  y  n  n  n  
B0024.4  
 
390  y  n  y  n  
Y12A6A.1  
 
209  y  n  y  n  
 
Table 5.4. Final list of identified lipid raft and GPI anchored proteins from C. elegans. A total of 
41 raft proteins were found in the C. elegans lipid raft fraction with LC MS/MS and 2D electrophoresis. 
Of these proteins, 21 were found to have GPI anchoring predicted by two or more programs 
(highlighted in light grey). Three GPI anchored proteins were experimentally verified with PIPLC 
digestion and also appear in the list of identified lipid raft proteins (highlighted in dark grey).  
  
229 
 
Chapter Six: General discussion 
 
 
Chapter 6 
 
General discussion 
 
 
 
 
 
 
 
  
230 
6.1 GPI anchored proteins 
6.1.1 The function of GPI anchored proteins 
The study of proteins is an area of immense interest within molecular biology. Almost 
all biological processes are carried out by proteins, and their biochemistry shapes our 
understanding of the various mechanisms and pathways that take place within the cell. 
Proteins have also been recently implicated in the passage of genetic information via 
the mechanism of epigenetics, which has challenged the idea that hereditary 
information is passed exclusively by DNA. The study of proteins has enriched our 
understanding of biology and evolution, and is likely to continue to have a large 
impact in the future. 
Membrane proteins and protein modifications are important areas of study within the 
field of protein biochemistry. Membrane proteins are thought to make up 
approximately 30% of all proteins with a cell (Wallin and von Heijne, 1998). They are 
responsible for a large number of cellular processes and maintain the internal 
environment of the cell by allowing selective exchange of materials with the outside 
world. Membrane proteins are also critical for the transmission of information from 
outside of the cell, which allow the cell to respond to changes in the environment, 
adapt to various external stimuli, and communicate with other cells during 
development. Almost all proteins carry some level of post translational modification 
for their activity. Modifications such as phosphorylation may regulate the activity of a 
protein for a particular enzymatic reaction, and others such as palmitoylation and 
glycosylation may act as markers that allow the protein to be transported to the correct 
sub-cellular compartments for their function.  
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Modification with a GPI moiety allows an otherwise aqueous protein to become 
anchored to the membrane. Because of this GPI anchored proteins behave in a similar 
fashion to integrated membrane proteins and yet at the same time contain no 
transmembrane (TM) domains (Brown, 1992). The anchor itself acts as a signal that 
localises the protein to the apical part of polarised cells as well as lysosomal 
compartments during endocytosis (Fivaz et al., 2002; Lisanti and Rodriguez-Boulan, 
1991). GPI anchored proteins have a range of functions including catalysis, signal 
transduction, cell recognition, parasite invasion and others. They have been shown to 
be important in host invasion by Trypanosoma brucei, embryonic development in 
mice, and are responsible for onset of the haemophilic disease paroxysmal nocturnal 
hemoglobinuria (PNH) in humans (Alfieri et al., 2003; Ferguson, 2000; Parker, 1996). 
 
6.1.2 Roles within raft and endocytosis 
GPI anchoring requires a complex biosynthetic machinery to be produced in the cell. 
The most well characterised pathways are found in humans and Saccharomyces 
cerevisiae (yeast). Both species require more than 20 genes for the production of a 
GPI anchored protein (Paulick and Bertozzi, 2008). The GPI anchor also undergo 
extensive fatty acid remodelling in the ER and the Golgi before the protein becomes 
located to its final destination (Fujita and Jigami, 2008). Why does a cell need such an 
energetically expensive method for associating a protein to the membrane when a less 
complex method, such as the inclusion of a hydrophobic TM domain at the C-
terminus, will also achieve the same end? An important property of the GPI anchor 
comes from its association with the sphingolipid/cholesterol enriched membrane 
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micro domains called lipid rafts (Brown, 1992).  GPI anchored proteins such as the 
folate receptor aggregate in raft domains on the cell surface, in which replacement of 
the anchor with a TM domain abolishes this association and produces a random 
distribution of the protein on the plasma membrane (Varma and Mayor, 1998). It has 
been proposed that GPI anchored proteins participate in a novel pinocytotic pathway 
involving the GPI-anchored protein enriched endosomal compartment (GEEC), which 
is distinct from internalisation with clathrin coated pits or caveolae mediated 
endocytosis (Lakhan et al., 2009). Endocytosis of GEECs is regulated by the GTPase 
Cdc42 as was seen in the uptake of folate via the folate receptor (Sabharanjak et al., 
2002). In the disease neurodegenerative spongiform encephalopathy GPI anchored 
prion proteins are converted from a soluble PrP
C
 form to an insoluble infective PrP
Sc
 
form, which causes amyloid plaques to form in the neurones of patients (Prusiner, 
1996). While the GPI anchor has been shown not to be necessary for the conversion 
of prion proteins to their infective form, their unique endocytotic mechanisms have 
been implicated in the maintenance of infectivity within this disease (Priola and 
McNally, 2009). Raft association is also implicated in the role of signalling for GPI 
anchored proteins. The GPI anchored protein uPAR (uPA Receptor), which binds to 
uPA (urokinase type Plasminogen Activator) and facilitates cell migration via 
phosphorylation of focal adhesion kinase and epidermal growth factor receptor 
(EGFR) in cancer cells (Tang and Wei, 2008), was shown to be disrupted by the 
action of elevated lipid raft gangliosides GT1b and GM3 that may have acted to 
sequester the protein from its targets (Wang et al., 2005). GPI anchored proteins may 
also be released from the cell surface by phospholipases via the cleavage of the 
anchor, and this mechanism is used by CR-1 (Cripto-1) for signalling in development 
and tumour progression (Watanabe et al., 2007). The biology of GPI anchored 
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proteins is intimately associated with their presence within lipid rafts, and they are 
thus able to take on roles within the cell that would not be possible if the protein was 
bound to the membrane via a TM domain. 
 
6.1.3 Lipid raft and GPI anchored proteins in C. elegans 
GPI anchored proteins have important roles in development and signalling, however 
most of the research carried out for this class of proteins have been made in 
mammalian cell lines such as human HeLa cells (Metz et al., 1994), Madin-Darby 
canine kidney (MDCK) cells (Urquhart et al., 2005) and Chinese hamster ovarian 
(CHO) cells (Priola and McNally, 2009), single cellular organisms such as yeast 
(Pittet and Conzelmann, 2007), and protozoan internal parasites such as Trypanosoma 
brucei and Trypanosoma cruzi (Ferguson, 1999; Tarleton, 2007). C. elegans is a 
model organism with an extensive history of study within development, in which all 
of its cell fates have been determined using microscopy. There has been limited 
research in lipid rafts and GPI anchored proteins for C. elegans. Sedensky et al. had 
found the stomatin homologue UNC-1, the stomatin-like protein UNC-24 and the 
sodium ion channel UNC-8 in a Triton X-100 (TX-100) extracted nematode raft 
preparation (Sedensky et al., 2004). Agostoni et al. were able to express the C. 
elegans protein PHG-1 (PHAS-1) in a mammalian cell system and showed that it was 
GPI anchored via cleavage with phosphatidylinositol-specific phospholipase C 
(PIPLC) (Agostoni et al., 2002). In this thesis I have explored the use of C. elegans as 
model for the study of lipid raft and GPI anchored proteins. C. elegans homologues of 
all known genes involved in the GPI synthesis pathway were elucidated and analysed, 
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with a possible pathway and final GPI anchor structure postulated for the nematode. 
The C. elegans genome was put through four GPI anchoring prediction programs with 
different algorithms to produce a comprehensive list of hypothetical GPI anchored 
proteins for the worm. Finally a lipid raft fraction was extracted from C. elegans 
membrane preparations using TX-100 sucrose density floatation, which was then 
treated with PIPLC to release GPI anchored proteins; these two samples were then 
subjected to separation with 2D gel electrophoresis and multi-dimensional liquid 
chromatography (MDLC), with the separated proteins identified using mass 
spectrometry. To date this is the largest number of lipid raft and GPI anchored 
proteins identified within C. elegans. A discussion of the results obtained, what they 
mean to lipid raft and GPI anchored protein research, as well as their implications for 
research within the nematode model system is given below. 
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6.2 GPI anchored synthesis pathway and lipid modifications in C. elegans 
6.2.1 GPI anchored synthesis and lipid modification in T. brucei 
The GPI synthesis pathway is a well studied system and the majority of the 
discoveries of its components were found in human and yeast, with several genes also 
elucidated in T. Brucei (Ferguson, 1999). The core structure of the GPI anchor is 
conserved within all eukaryotic species found so far, with prokaryotic organisms 
lacking the modification completely (Ikezawa, 2002). Several archaebacterial species 
were also proposed to contain GPI anchored proteins via a bioinformatics search 
(Eisenhaber et al., 2001). Both humans and yeast contain 12 steps for GPI anchored 
synthesis (outlined in Chapter 3), with the majority of the genes within each of the 
steps conserved between the two species. The biosynthesis pathway however is 
markedly different for T. Brucei, which is a protozoan parasite that causes African 
sleeping sickness in humans. T. brucei has two distinct proliferative stages, the blood 
stream form which is resident within the host mammal, and the procyclic from which 
resides inside its vector the tsetse fly. GPI anchored proteins (known as variant 
surface glycoproteins (VSG) in the blood stage and procyclins in the vector stage of 
the parasite) on the surface of T. brucei are thought to be important for both of its life 
cycle stages and have been shown to be essential for its infectivity in humans (Hong 
and Kinoshita, 2009). The parasite is densely coated with VSGs on the surface, which 
creates antigenic variation on the organism that is thought to allow the blood stream 
form to evade host immune responses (Pays and Nolan, 1998). The GPI structures are 
different within each of the life stages, with the procyclic form containing an acyl 
group on the inositol ring that makes it resistant to PIPLC (Field et al., 1991). There 
are a total of seven genes found so far in T. brucei GPI biosynthesis, with three found 
  
236 
also in fatty acid remodelling. The T. brucei gene for the second step of biosynthesis 
(TbGPI12) contains different substrate and inhibitor specificity with respect to the 
human version of the gene (PIG-L) (Sharma et al., 1999; Smith et al., 2001). 
TbGPI10 was found to be the T. brucei gene responsible for the addition of the third 
mannose onto the GPI structure and is able to substitute for its orthologues in human 
and yeast (Nagamune et al., 2000). Five subunits for the transamidase complex of step 
12 were found in T. brucei, in which three of the components, TbGAA1, TbGPI8 and 
TbGPI16, were found to be homologues to the human genes GAA1, PIG-K and PIG-T 
respectively, but the other two genes (TTA1 and TTA2) were found to have 
homologues only in other protozoan species (Nagamune et al., 2003). GAA1, PIG-K 
and PIG-T are proposed to form a small subunit which interacts with another small 
subunit composed of PIG-S and PIG-U to form the transamidase complex in humans 
(Zhu et al., 2005), which indicates that there may have been an evolutionary spilt 
between the protozoans and higher eukaryotes for their TTA1/TTA2 and PIG-S/PIG-
U part of the transamidase complex. T. brucei contains two GPI inositol deacylases 
TbGPIdeAc and TbGPIdeAc2, in which TbGPIdeAc was found to be non-essential 
for GPI anchor production (Guther et al., 2001), while TbGPIdeAc2 was found to be 
essential (Hong et al., 2006). A homologue for the yeast sn-2 acyltransferase GUP1 is 
also present within T. brucei (TbGup1), with the protozoan enzyme demonstrated to 
prefer the addition of a myristate (C14:0) moiety onto the anchor instead of the C26:0 
moiety that is added by yeast (Hong et al., 2006).  Lipid remodelling of the GPI 
anchor occurs on both the sn-1 and sn-2 positions of T. brucei, in contrast to 
mammalian systems and yeast where the anchors are usually only modified in the sn-
2 position (Hong and Kinoshita, 2009). T. brucei GPI anchors also may contain side 
chain modifications such as galactose and sialic acid that are not present within 
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mammalian or yeast GPI structures (Ferguson et al., 1993; Ikezawa, 2002). The GPI 
anchored synthesis machinery in T. brucei appear to have essential differences to the 
ones in human and yeast, which may be due mainly to its specialised role as a parasite, 
dual stage life cycle characterised by a procyclic vector and an invasive blood cycle 
stage, and a difference in evolutionary complexity between protozoan and higher 
eukaryotes. Since C. elegans is a metazoan with a relatively complex developmental 
process it would be more likely that its GPI biosynthesis pathway would be closer to 
the ones present in human and yeast than that of T. brucei. A bioinformatic search for 
homologues of T. brucei TTA1 and TTA2 in C. elegans returned no results (data not 
shown), while the worm does contain homologues for the human PIG-S and PIG-U 
genes, which further underscores the similarity of the nematode GPI biosynthesis 
pathway with that of other higher eukaryotes.  
 
6.2.2 The C. elegans GPI synthesis pathway  
The GPI biosynthesis pathway in C. elegans contains 16 of the 23 genes found in the 
human pathway. Most of the human synthesis steps have homologues in C. elegans, 
with the exception of the GlcNAc-PI deacytalase of step 2 and the fourth 
mannosyltransferase of step 9. The gene for step 2 has been shown to be essential in 
human, yeast and T. brucei (Sharma et al., 1999; Watanabe et al., 1999) and creates a 
bottleneck for the production of GPI anchors. The closely related nematode species C. 
briggsae does contain a homologue for PIG-L, the human gene for this step, but the C. 
briggsae gene also unusually does not have a homologue in C. elegans. It could be 
that the C. elegans version of the gene was lost in evolution and another unrelated 
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GlcNAc deacytalase has since taken up the role for the second step of GPI synthesis. 
A Wormbase search with the GO term GlcNAc deacytalase found the C. elegans gene 
F59B2.3 with this biological process, which may be a potential candidate for the 
second step of GPI biosynthesis. For the mannosyltransferase in step 9 both C. 
elegans and C. briggsae lack a homologue for the enzyme involved in this reaction. 
The fourth mannose is an essential addition for GPI anchors in yeast (Grimme et al., 
2001) but appears to be tissue specific in humans (Taron et al., 2004b), which implies 
that the modification may not be essential in metazoans and may have been lost 
during the evolution of the nematodes. 
 
6.2.3 The GPI transamidase complex 
There is a remarkable amount of conservation in C. elegans for the 12
th
 and last step 
of GPI biosynthesis, which involves the transamidase reaction that attaches the 
protein to the GPI anchor. Five components of the complex responsible for the 
transamidase reaction have been found so far in both human and yeast (PIG-K/GPI8, 
GPAA1/GAA1, PIG-T/GPI16, PIG-S/GPI17 and PIG-U/GAB1 for human/yeast, 
respectively) and all of the genes have homologues within C. elegans. PIG-K in 
humans is the catalytic subunit within the transamidase complex and has two 
homologues in C. elegans, T05E11.6 and T28H10.3. The proteins for these two genes 
both have high blast scores for the PIG-K protein and they also possess the two 
conserved residues of its active site (Ohishi et al., 2000), which indicates that both of 
the homologues may be able to attach proteins to GPI anchors within C. elegans. 
T28H10.3 was shown in this study to be expressed strongly in the intestine of the 
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worm in all life cycle stages, from the early embryo to the adult. RNAi studies for 
T05E11.6 have yielded no phenotypes, while RNAi on T28H10.3 has resulted in 
embryonic lethality within the worm (Maeda et al., 2001a). Recently a deletion 
mutant became available for each of the genes and they both have shown an 
embryonically lethal phenotype, indicating that both of the genes may be important 
for worm viability. It would be interesting to see if this effect on worm survival is due 
to the lack of GPI anchoring of proteins disrupting processes such as signalling within 
the worm, which may have a profound effect on its development. Recently a wealth of 
research has been made that implicates the GPI transamidase components as 
oncogenes in a variety of human cancers. The PIG-U gene was first found to be 
unregulated in human bladder and is associated with an overexpression of the GPI 
anchored protein uPAR, which caused an increase in STAT-3 signalling and is 
thought to mediate the oncogenic properties of PIG-U (Guo et al., 2004). This 
upregulation was later confirmed to exist for both the mRNA and protein of PIG-U in 
bladder urothelial cell carcinoma (Shen et al., 2008). GPAA1, PIG-T and PIG-U were 
found to be involved in breast cancer, with GPAA1 and PIG-T implicated in 
tumorigenesis and invasiveness of the cancer, possibly through interactions with 
paxillin (Wu et al., 2006). GPAA1 expression was also found to be upregulated in 
head and neck squamous carcinoma, with an increase in copy number in these 
tumours (Jiang et al., 2007). A large study of all five GPI transamidase subunits in 19 
different cancers showed that all of the components have roles in a variety of cancers 
(Nagpal et al., 2008). PIG-U was found to be overexpressed in colon and ovarian 
cancer, while PIG-T was upregulated in uterine, thyroid, melanoma, and breast 
cancers. GPAA1 showed increased expression in uterine cancer and PIG-S expression 
was shown to be increased in lung, thyroid, ovarian and liver cancers. The catalytic 
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unit PIG-K showed overexpression in ovarian and breast cancers but was significantly 
downregulated in bladder, liver and colon carcinoma cases. The study also found a 
significant increase in PIG-U and PIG-K expression in lymphoma, where in normal 
lymph node tissues the GPI transamidase subunits showed universally low levels of 
expression. PIG-K and PIG-S increased proliferation of SKBR3 breast cancer cells 
after transfection. The study also observed a large amount of variability in expression 
for all the tissue types tested, and GPI transamidase components were also found in 
the cytoplasm of cancer cells; the GPI transamidase complex normally acts inside the 
ER lumen for the attachment of GPI anchors to proteins, and their presence within the 
cytosol of cancer cells may point to additional roles for these proteins in the cell. C. 
elegans is well positioned for the study of these transamidase components within the 
role of development, and knock-ins of overexpressed versions of these genes will also 
be possible for the study of their effect in growth and tissue formation, which will 
hopefully aid in the understanding of the role they play within human cancers.  
 
6.2.4 Lipid remodelling, Dolichol phosphate mannose (Dol-P-Man) synthesis and 
similarities with the human GPI anchor synthesis pathway 
Both human and yeast GPI anchors are modified after the attachment of the protein 
via the GPI transamidase, while for T. brucei these modifications comes before this 
step (Fujita and Jigami, 2008; Hong and Kinoshita, 2009). The first step of 
remodelling for both human and yeast takes place within the ER and involves the 
deacetylation of the inositol ring by PGAP1/BST1 (Tanaka et al., 2004). This reaction 
has been shown to be important for the translocation of the protein in to the Golgi 
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apparatus (Vashist et al., 2001), downstream remodelling of other fatty acid chains 
(Maeda et al., 2007), and for quality control of misfolded GPI anchored proteins in 
yeast (Fujita et al., 2006b). After the deacetylation reaction the human and yeast 
pathways take a divergence in their modes of action. In humans the protein is 
transported to the Golgi, and the acyl chain at the sn-2 position of the anchor is 
removed by the GPI-phospholipase A2 enzyme PGAP3 (Fujita and Jigami, 2008), 
while in yeast the same reaction occurs in the ER via the homologue PER1 (Fujita et 
al., 2006a). After this reaction in yeast a C26:0 fatty acid is added to the sn-2 position 
in the ER via GUP1 (Bosson et al., 2006) while a C18:0 species is added to the sn-2 
position in human cells in the Golgi by the unrelated GPAP2 (Tashima et al., 2006). 
Yeast also contains a homologue to GPAP2 called CWH43 that was shown to be 
involved in the addition of ceramides to the anchor (Ghugtyal et al., 2007). C. elegans 
contains a large number of homologues for human GPAP2 but only one weak 
homologue for the yeast specific GUP1, suggesting that the nematode lipid 
remodelling pathway is more similar to the one in mammals than the one in yeast. 
Lipid remodelling of GPI anchored proteins is essential for their association with lipid 
rafts (Maeda et al., 2007), and the disruption of their C. elegans homologues may be a 
method for the study of raft association of GPI anchored proteins in the worm. 
Dol-P-Man is the mannose donor molecule for steps 6, 7, 8 and 9 of GPI biosynthesis 
and is synthesised on the luminal side of the ER membrane. Dol-P-Man synthesis in 
humans require three genes DPM1, DPM2 and DPM3, while in yeast only DPM1 is 
required (Maeda and Kinoshita, 2008).  Yeast Dpm1p protein differs from human 
DPM1 by the presence of a C-terminal TM domain that tethers the protein onto the 
ER membrane, and represents two classes for the structure of the enzyme (Colussi et 
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al., 1997; Tomita et al., 1998). Human DPM1 requires interaction with the membrane 
bound DPM3 protein in order to become stably associated with the ER membrane, 
and the lack of this association leads to the degradation of the DPM1 protein via the 
proteosome (Ashida et al., 2006). The C. elegans DPM-1 appears to possess the 
sequence features more similar to the structure of human DPM1, and this is reinforced 
by the presence of a DPM3 homologue in the worm, which further point to the 
increased similarity of the nematode‟s GPI synthesis machinery to the one present in 
humans. 
Overall the various processes involved in the production of a GPI anchored protein in 
C. elegans is presented here. Many of these genes have immense interest within 
biology and medicine, especially for the GPI transamidase subunits that have been 
implicated as potential oncogenes in various cancers. The C. elegans GPI synthesis 
and modification components show a great degree of similarity to the human 
pathways based on bioinformatics analysis, which may improve the relevance of 
discoveries within this organism to human diseases. The study of expression patterns, 
behaviour traits and knockout models in the worm will hopefully give use a greater 
understanding of the roles these genes play within growth and development. 
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6.3 Predictions of GPI anchored proteins from the C. elegans genome 
One of the major advantages of working with C. elegans is the availability of one of 
the most comprehensively annotated genomes for bioinformatics studies. GPI 
anchored proteins contain two signal sequences, one at the N-terminus for ER 
targeting, and another at the C-terminal end for recognition and cleavage by the GPI 
transamidase complex (Udenfriend and Kodukula, 1995a). The C-terminal sequence 
has become the subject of special interest within recent years. This GPI anchored 
protein specific signal does not have a consensus sequence but contains specific 
motifs of amino acids centred on the ω site, which is the amino acid residue of anchor 
attachment. The work of Eisenhaber et al. established the requirements for amino acid 
and sequence properties within the C-terminal signal peptide (Eisenhaber et al., 1998), 
which was followed up with their use in the first GPI anchored protein prediction 
program, BIG PI (Eisenhaber et al., 1999). Subsequently a number of programs were 
also developed based on machine learning algorithms, such as GPI SOM (Fankhauser 
and Maser, 2005), DGPI (http://129.194.185.165/dgpi/, unavailable at time of writing), 
FragAnchor (Poisson et al., 2007), and PredGPI (Pierleoni et al., 2008). Due to the 
need for the presence of the N-terminal ER sequence in a GPI anchored protein, 
predictions from genomes usually follow a two stage stringency method, with positive 
predictions for both the N-terminal secretion signal and C-terminal GPI anchoring 
signal needed before the protein can be considered to be potentially GPI anchored. 
The N-terminal prediction is usually carried out with SignalP 3.0 (Bendtsen et al., 
2004), which was shown to have a high degree of accuracy in previous studies 
(Emanuelsson et al., 2007).   
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6.3.1 A method of GPI anchor prediction using four programs 
GPI anchored protein prediction was first used on an early version of the C. elegans 
genome as a test for the BIG-PI predictor, which found 86 proteins with potential GPI 
anchoring C-terminal sequences (Eisenhaber et al., 2000). A recent proteomic study 
of GPI anchored proteins in human and Arabidopsis thaliana showed that an 
integrated approach of the usage of several GPI prediction programs gave the most 
stringent results, which matched experimentally identified GPI anchored proteins 
(Elortza et al., 2006). A novel approach of using SignalP 3.0 and the four available 
GPI prediction programs (BIG-PI, GPI-SOM, FragAnchor and PredGPI) was 
developed for this project in order to assess, with a high degree of accuracy, the total 
number of potential GPI anchored proteins within the C. elegans genome. Prediction 
results from each of the programs were correlated against each other, such that 
proteins were grouped into categories of increasing stringency based on the number of 
prediction programs that validated them. After analysis it was found that the 
stringency of each individual prediction program differed considerably, with BIG-PI 
having the most strict criteria returning the lowest number of predictions (125 genes), 
and GPI-SOM containing the most relaxed criteria with the highest number of 
predictions (657 genes). The prediction results however correlated well between 
programs, and it was decided that a cut off point of simultaneous prediction by at least 
two different prediction programs would be used for a protein to be counted as a 
candidate GPI anchored protein. Overall 327 proteins from C. elegans were found to 
fit this criterion and represent the final list of potential GPI anchored proteins in the 
worm. This accounts for 1.39% of the total number of genes within the genome. In an 
effort to validate these results further available orthologues of these genes were taken 
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from C. briggsae and subjected to the same analysis to see if they correlated with the 
C. elegans data. Of these 201 genes were found to fit the criterion for their C. 
briggsae orthologues. GO term analysis for these genes did not differ greatly from 
that of the 327 predicted genes, indicating that this approach of correlation between 
related species may not be strictly necessary for accurate GPI anchoring prediction, 
but does add extra stringency to the results. GPI anchored proteins predicted with the 
method developed in this thesis also have different levels of confidence, with proteins 
predicted with all four programs have a higher likelihood of GPI anchoring than 
proteins with three predictions, which in turn are more likely to be GPI anchored than 
proteins with only two predictions. This is the first time that such a method has been 
used for the genome wide prediction of GPI anchored proteins in a model organism. It 
will be interesting to test the validity of such an approach with further experimental 
data for the verification of the predictions. 
 
6.3.2 The predicted GPI anchored proteins in C. elegans 
Among the prediction results were proteins that have well documented GPI anchored 
homologues in other systems, such as acetylcholine esterase (C. elegans ace-2, 3 and 
4) (Nalivaeva and Turner, 2001), trehalase (tre-3 and tre-5) (Netzer and Gstraunthaler, 
1993), apical membrane protein of gut epithelial cells (tag-10) (Jasmer et al., 1996), 
Ly-6 superfamily of GPI-linked signalling proteins (odr-2, hot-3, 4, and 7) (Chou et 
al., 2001), and a large number of carboxypeptidases (Skidgel et al., 1996). 
Interestingly the well known GPI anchored protein alkaline phosphatase was not 
represented in this list. BLAST search with both human and yeast alkaline 
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phosphatases produced no homologues in the C. elegans genome; however an assay 
for the enzyme in the worm was able to produce a positive result (data not shown). It 
may be that C. elegans contains an unrelated phosphatase that is able to carry out the 
same reaction. GO terms of biological processes were available for 93 of the predicted 
proteins. Of these genes, 15% were involved in development, 8% in regulation, and 
6% were classified as signalling proteins, which indicates that a substantial proportion 
of the GPI anchored proteins in C. elegans may be involved in signal transduction 
pathways. 48% of the genes were grouped as having metabolic activity, some of 
which such as tag-10 may be involved in the digestion of nutrients on the apical 
surface of the intestine. This hypothesis is also suggested by the result that T28H10.3, 
the GPI biosynthesis gene PIG-K homologue, had shown strong expression within the 
intestine of the worm. 19% of the genes were found to have roles in cellular transport, 
which may correlate with an involvement with the GEEC endocytic pathway. 2% of 
the proteins were classified as defence while 1% was grouped with a role in cell 
adhesion, which was observed in some GPI anchored proteins in neuronal cells 
(Karagogeos, 2003). Overall C. elegans GPI anchored proteins show a diverse range 
of functions and may be involved in many different processes within the worm.  
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6.4 Proteomic analysis of GPI anchored and lipid raft proteins in C. elegans 
The field of proteomics has been progressing at a rapid pace within the last 10 years. 
Technological improvements in protein separation, mass spectrometry (MS), and 
bioinformatics have greatly improved the fidelity of protein identifications, with the 
rising use of multi-dimensional liquid chromatography (MDLC) and tandem MS/MS 
fragmentation allowing more data to be extracted from proteomic samples than ever 
before (Motoyama and Yates, 2008). Older methods such as 2D electrophoresis have 
also been updated to keep up with the speed of innovations within the field (Issaq and 
Veenstra, 2008). These techniques are used for the elucidation of increasingly 
complex proteomes such as organelles, subcellular compartments, signalling cascades 
and protein modifications (Dunkley et al., 2004; Rogers and Foster, 2009; Voshol et 
al., 2009), offering a global view of their protein interactions and a greater insight into 
the roles they play within the organism. 
Both lipid raft and GPI anchored proteins have been the subject of proteomic analysis 
in a diverse range of organisms. Lipid rafts are patches of lipids on the membrane 
composed of sphingolipids and cholesterol that are proposed to form distinct domains 
from the rest of the membrane lipids. Research into rafts have been fraught with 
controversy as many different definitions exist based on the method of their extraction 
from the cell (Pike, 2004). Rafts have been observed to form spontaneously in model 
membranes with physiological levels of the various lipids present within the plasma 
membrane (Prenner et al., 2007), however domains observed in vivo are generally of 
much smaller sizes and are formed much more transiently compared to their in vitro 
models (Lagerholm et al., 2005). Over the course of lipid raft research numerous 
definitions of the subdomain have been proposed, with the most recent consensus 
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describing rafts as heterogeneous membrane domains of 10-200 nm in diameter, 
which are dynamic structures composed of sterol- and sphingolipids that 
compartmentalise cellular processes (Pike, 2006). Rafts may also coalesce to form 
larger platforms for cell signalling via protein-protein and protein-lipid interactions, 
such as in T-cell activation where rafts are proposed to recruit signalling partners and 
cytoskeletal components for the maturation of the immunological synapse (Meiri, 
2005).  
Extractions of lipid rafts were first attempted with non-ionic detergents such as Triton 
X-100 (TX-100) under cold conditions (Brown and Rose, 1992). The extracted 
fraction was insoluble in TX-100 at 4°C and floated to a characteristic density in a 
sucrose density gradient. The fraction was called detergent resistant membrane (DRM) 
and showed an enrichment of raft components such as GPI anchored proteins and 
sphingolipids. The method was also sensitive to cholesterol depletion and has been 
used for the analysis lipid rafts in a variety of systems. As the field of lipid raft 
research matured it became apparent that detergent extraction may have several 
shortcomings as the de-facto method of raft extraction. Criticisms come from the 
procedure of extracting rafts at 4°C, which may not represent actual raft structures at 
the physiological temperature of 37°C. Detergents have also been shown to induce the 
formation of domains in cell membranes that may not reflect actual structures within 
the cell (Shogomori and Brown, 2003). However, despite the artefactual nature of 
detergent extraction for lipid raft analyses it is still one of the workhorse techniques 
within the field, and is often the first port of call for the isolation of raft proteins in a 
novel system. This is especially apparent in the relatively new field of lipid raft 
proteomics, in which the majority of projects use TX-100 insolubility as the method 
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for raft extraction (Insenser et al., 2006; Kim et al., 2009; Nebl et al., 2002). 
Proteomic projects tend to require relatively large amounts of proteins for analysis, 
which detergent extraction methods are able to provide. 
The most common method for the extraction of GPI anchored proteins involves 
cleavage of the GPI anchor with PIPLC from crude membrane fractions. This 
procedure is relatively straightforward with commercial sources of the enzyme 
available purified from bacteria (such as Bacillus thuringiensis). Proteomic studies 
however require greater stringency as the sensitivity of mass spectrometry instruments 
are likely to pick up even trace amounts of contaminating proteins from the digestion, 
which leads to falsely identified proteins. Most proteomic projects on GPI anchored 
proteins therefore perform an additional sucrose density purification step on the crude 
membrane before PIPLC digestion to improve specificity and reduce false positive 
results (Borner et al., 2003; Elortza et al., 2003; Gilson et al., 2006).  
 
6.4.1 Lipid raft proteomics in C. elegans  
The C. elegans lipid raft proteome was analysed in this project with a combination of 
2D electrophoresis and MDLC, with both MS peptide mass fingerprinting (PMF) and 
tandem MS/MS methods used for the identification of the proteins. Overall 45 
proteins were identified with these techniques from TX-100 extracted nematode DRM. 
Four of these proteins were found to belong to subcellular fractions that are unlikely 
to contain lipid rafts, such as mitochondria (Zheng et al., 2009), nuclear membrane 
(Say and Hooper, 2007), ribosomes (Proud, 1994) and a secreted protein (Siafakas et 
al., 2006), and were therefore removed from the final list. In the end 41 potential lipid 
  
250 
raft proteins were identified in C. elegans, which makes this the largest study of raft 
associated proteins in the nematode to date. Five C. elegans galectins (LEC-1, 2, 3, 4 
and 5) were found within the study, which has been found in other systems to be a 
group of proteins commonly associated with rafts. Galectins may also form distinct 
lattices with glycoproteins on the plasma membrane that act in concert with lipid rafts 
for their function (Lajoie et al., 2009).  Genes that may be involved in raft mediated 
signalling were also present in the analysis, such as two ryanodine receptor associated 
proteins of the Ca
2+
 pathway and two proteins that act downstream of the 
insulin/insulin like growth factor pathway. Other proteins such as carboxypeptidases, 
stomatin-like proteins, apical gut protein, the HSP90 homologue daf-21, trehalase, 
actin, components of the V-ATPase complex and vacuolar protein sorting proteins 
were also found within the study, which corresponds well with the results of lipid raft 
proteomic studies in other systems (Foster et al., 2003; Insenser et al., 2006; Kim et 
al., 2009; von Haller et al., 2001). One of these vacuolar genes was found to be the C. 
elegans vacuolar protein sorting factor vps-32.1, which had been shown to be 
localised in distinct domains to other proteins within endosomes (Michelet et al., 
2009). Of special interest is the finding that 21 of the identified proteins are in the list 
of predicted GPI anchored proteins generated for C. elegans. These accounts for over 
50% of the raft proteins identified and may point to a significant role for GPI 
anchoring within the biology of the nematode. One of these proteins, TAG-10 is a 
homologue of the GA1 apical gut protein of the ruminant parasite Haemonchus 
contortus. GA1 was shown to have a GPI anchored form (Jasmer et al., 1996) and has 
been demonstrated as a valid target for vaccination against the parasite (Yatsuda et al., 
2003). It will be interesting to see what the role of TAG-10 is in C. elegans and what 
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function the protein has within the worm intestine, which may also lead to a greater 
understanding of the biology of GA1 in H. contortus.  
6.4.2 GPI anchored proteomics in C. elegans  
C. elegans GPI anchored proteins were also analysed specifically with the PIPLC 
digestion of extracted raft preparations. Due to the low yield of proteins we were 
unable to analyse them with MDLC, and instead identified them from 1D and 2D gel 
electrophoresis. Three proteins were identified from gel bands and spots with PMF. 
These were F56F10.1, a carboxypeptidase, ZK6.10 (DOD-19), a protein that acts 
downstream of the insulin pathway gene daf-16, and ZK6.11a. All three of these 
proteins were also present within the list of predicted nematode GPI anchored proteins, 
which indicate the validity of using a combinatorial in silico and in vitro approach for 
the identification of GPI anchored proteins. The number of GPI anchored proteins 
identified in proteomic projects have been generally low, with 11 identified in human 
HeLa cells (Elortza et al., 2006) and 11 proteins in the malarial parasite Plasmodium 
falciparum (Gilson et al., 2006). The number of identification of GPI anchored 
proteins in A. thaliana have been relatively high, with some projects reporting  up to 
44 GPI anchored proteins identified in their proteomic analysis (Elortza et al., 2003). 
The results here present a tentative first look at the GPI anchored proteome of C. 
elegans, and offer a technique for further refinement, which may potentially yield a 
higher number of identified proteins in the future. 
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6.5 Future directions and conclusion 
Studies of GPI anchored proteins and lipid rafts have been steadily gathering pace in 
recent years. C. elegans makes a compelling model organism for their study. The ease 
of making GFP expression patterns within the worm allows the study of the GPI 
biosynthesis genes within the context of development, which has hitherto not been 
possible with the common model organisms used to study this process. Expression 
profiles of the different transamidase genes could be made in the worm, as they 
appear to have important roles for the regulation of growth in many human cancers 
and are very well conserved within the C. elegans genome. The presence of 
transamidase components in the cytosol of many cancers also suggests additional 
roles for these genes within the cell beyond the attachment of GPI anchors (Nagpal et 
al., 2008), which may also be investigated within the worm with RNAi knockout and 
deletion mutants. Currently the C. elegans PIG-K homologues T05E11.6 and 
T28H10.3, and one of the PIG-U homologues B0491.1, have deletion mutants 
according to Wormbase, and they all show an embryonically lethal phenotype, 
suggesting that the genes play important roles within the biology of the worm. 
Genetic analysis of the other C. elegans GPI synthesis and lipid modification genes 
may also be performed to give us a more robust understanding of the role of GPI 
anchoring within the nematode. Knockouts of the lipid modification genes with RNAi 
may also disrupt the association of GPI anchored proteins to lipid rafts, which would 
allow the analysis of the importance of lipid rafts on this class of proteins for 
nematode growth and development. 
Lipid rafts may also be disrupted within the worm to find exactly how this subdomain 
functions within development. C. elegans does not have de-novo cholesterol synthesis 
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and requires extracellular sources of the sterol for their normal development (Brenner, 
1974). Analysis of the sterol requirements of C. elegans found that the worm does not 
need a large amount of cholesterol to survive, and the level of cholesterol intake was 
apparently not large enough for it to have a role in lipid raft formation (Entchev and 
Kurzchalia, 2005). If sterols are not present in large amounts in C. elegans 
membranes, then does the worm contain physiologically relevant rafts? Distribution 
studies of cholesterol with the fluorescent cholesterol analog dehydroergsterol (DHE) 
and the cholesterol stain filipin have shown the accumulation of the sterol in specific 
cells of the nematode, such as pharynx, nerve ring, excretory gland cells, gut apical 
surface cells, oocytes and spermatozoa (Matyash et al., 2001; Merris et al., 2003). 
This raises the possibility that rafts are not uniformly distributed in all cell types 
within the worm and that important properties of rafts, such as signal complex 
formation and apical sorting, may be used by the nematode in a tissue specific manner. 
This is also supported by previous work with C. elegans cav-1 and cav-2, which 
showed that the genes were expressed in a cell specific manner after the embryonic 
stage of development (Parker et al., 2007; Parker et al., 2009). Alternatively C. 
elegans may be able to produce heterogeneity within its membranes using a 
cholesterol-independent method, such as the LEC-4 mediated microdomains that exist 
in the brush border membrane of enterocytes (Hansen et al., 2001). C. elegans 
contains two homologues (R11H6.2 and Y57E12AL.1) for the gene SERINC, which 
incorporates serines into lipids and is a highly conserved gene for the production of 
sphingolipids (Inuzuka et al., 2005). Knockouts of these genes could potentially 
disrupt lipid rafts within the worm, giving us a unique insight into the way these lipid 
domains act within a developmentally complex organism. 
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There is also scope for the expansion of proteomic studies for lipid raft and GPI 
anchored proteins in C. elegans. Proteomics projects of nematodes have become 
increasingly popular within recent years with many subcellular fractions such as 
glycoproteins and mitochondria been the subject of research (Audhya and Desai, 2008; 
Kaji et al., 2007; Li et al., 2009). The analysis of the lipid raft proteome presented 
here is unlikely to be complete as common components such as caveolin were not 
present within the final list of identified proteins, even though antibody staining had 
shown the presence of CAV-1 within the raft fraction. Previous work with the C. 
elegans CAV-1 showed that the protein is differentially localised on the post-synaptic 
membrane of neurons (Parker et al., 2007), while cav-2 was found to be involved in 
apical lipid trafficking in worm intestinal cells (Parker et al., 2009). Raft components 
have been found to be responsible for polarised membrane formation in neurons 
(Kamiguchi, 2006) and apical sorting in epithelial cells (Schuck and Simons, 2004), 
which further suggests that CAV-1 and CAV-2 are a part of lipid rafts within the 
worm. Other techniques for the separation of peptides such as Strong Cation 
Exchange (SCX) or size exclusion chromatography (SEC) can be used in the first 
dimension to better separate the peptides (Motoyama and Yates, 2008), and more 
sensitive mass spectrometry instruments such as Orbitrap may also be used on the 
C.elegans lipid raft proteome for an improved quality of peptide sequencing (Han et 
al., 2008), which may lead to a higher number of proteins identified. Nematodes can 
be grown in a synchronised manner, and raft proteins can be conceivably extracted 
from defined stages of their life cycle for proteomics analysis, which will give us 
insight into the global changes of the lipid raft proteome during the development and 
molting of the worms. Quantitative analysis of proteins can also be achieved with 
sample labelling such as isotope-coded affinity tags (ICAT) and isobaric tag for 
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relative and absolute quantitation (iTRAQ) (Gygi et al., 1999; Ross et al., 2004); 
alternatively worms metabolically labelled with 
15
N have been described in the 
literature which may be used for quantitative proteomics (Krijgsveld et al., 2003). A 
larger sample size of C. elegans GPI anchored proteins could be obtained to allow 
MDLC analysis, which may produce a larger list of identified proteins. C. elegans 
GPI anchored proteins can also be cleaved from the membrane fraction with the 
enzyme phosphatidylinositol-specific phospholipase D (PIPLD), which cleaves the 
GPI anchor at a different point to PIPLC and allows the release of proteins from GPI 
anchors that have retained the acyl moiety on their inositol ring (Davitz et al., 1987). 
Previous analysis with PIPLD have shown a different subset of proteins released in 
both human and A. thaliana cells (Elortza et al., 2006; Elortza et al., 2003), and it 
would be interesting to see if a different set of GPI anchored proteins would be 
released by this enzyme in the worm. Studies can also be performed for other 
important proteomes within the nematode, such as phosphorylated proteins and 
organelles, which would open up new doors for protein biochemistry within C. 
elegans. 
In this study an analysis of GPI anchor biosynthesis, the GPI anchored proteome and 
the lipid raft proteome of C. elegans was performed. A comprehensive list of C. 
elegans homologues involved in all know aspects of GPI biosynthesis was presented 
here. An analysis of all potential GPI anchored proteins was also performed with four 
specialised prediction programs on the C. elegans genome, which yielded a list of 327 
proteins that may be of value for further GPI anchored protein research. 41 lipid raft 
and 3 PIPLC released GPI anchored proteins were found from enriched fractions of 
the C. elegans membrane, which represents the largest number of identifications for 
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these classes of proteins in the nematode to date. C. elegans can offer a unique 
perspective on the functions of GPI anchored proteins and lipid rafts in the context of 
tissue types, growth, aging, and development, and there is great potential for the 
nematode to become an important model organism in the study of these proteins and 
subcellular domains. 
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Appendix 
Appendix 
 
Appendix 1.  
All C. elegans proteins predicted by prediction programs containing 778 predicted 
proteins, 327 of which have predictions with two or more programs. Columns 1 to 3 
contain the Wormbase gene ID, gene name and a brief description of the protein. 
Columns 4 to 6 contain the GO terms for the proteins where available. Columns 7 to 
10 contain the programs with which the protein was predicted, with ● indicating a 
positive prediction and ○ a negative. Column 11 denotes the number of prediction 
programs that gave the protein a positive result. 
 
 
Wormbase gene ID gene name brief description 
Molecular 
function 
Biological 
process 
Cellular 
component 
Big 
PI 
GPI 
SOM 
Frag 
Anchor 
Pred 
GPI 
No. of 
hits 
WBGene00009700 F44F4.1 n/a n/a n/a membrane ● ● ● ● 4 
WBGene00017969 F32A5.3 
Serine 
carboxypeptidase 
Catalytic metabolism n/a ● ● ● ● 4 
WBGene00016627 C44B7.5 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00018043 F35D11.1 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00020248 T05C1.1 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00015803 C15H9.9 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00004370 rig-3  n/a n/a n/a n/a ● ● ● ● 4 
WBGene00008509 F01G10.6 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00017978 F32B5.4 n/a n/a n/a membrane ● ● ● ● 4 
WBGene00009431 dct-17 n/a binding metabolism cytoplasm ● ● ● ● 4 
WBGene00001581 gfi-1  n/a n/a regulation n/a ● ● ● ● 4 
WBGene00019017 F57F4.4 n/a n/a regulation n/a ● ● ● ● 4 
WBGene00019660 K11H12.4 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00019663 K11H12.7 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00008870 F15H9.1 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00013969 ZK337.1 
Alpha-2-
macroglobulin 
family (3 
domains) 
Catalytic metabolism extracellular ● ● ● ● 4 
WBGene00014194 ZK1037.6 n/a n/a n/a membrane ● ● ● ● 4 
WBGene00017416 F13B6.1 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00017494 F15E11.5 n/a n/a n/a membrane ● ● ● ● 4 
WBGene00020995 W03F8.6 n/a n/a n/a membrane ● ● ● ● 4 
WBGene00012439 Y12A6A.1 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00018507 F46F5.16 n/a n/a n/a membrane ● ● ● ● 4 
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WBGene00007299 C04F12.5 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00018787 cutl-20 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00021452 Y39F10A.1 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00008868 F15G9.5 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00009679 F44D12.2 n/a binding n/a membrane ● ● ● ● 4 
WBGene00021880 
Y54G2A.1
5 
n/a n/a development n/a ● ● ● ● 4 
WBGene00003956 pcp-1 n/a Catalytic metabolism n/a ● ● ● ● 4 
WBGene00022246 acp-7 n/a Catalytic n/a n/a ● ● ● ● 4 
WBGene00000038 ace-4 
Acetylcholine-
esterase 
Catalytic n/a membrane ● ● ● ● 4 
WBGene00006869 vab-2 n/a binding Signalling anchored ● ● ● ● 4 
WBGene00007911 C34B7.1 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00017296 F09E10.6 n/a n/a n/a membrane ● ● ● ● 4 
WBGene00020195 T03G6.3 
plasma cell 
membrane protein 
and phosphor-
diesterase I 
(weak) 
Catalytic metabolism n/a ● ● ● ● 4 
WBGene00000037 ace-3 n/a Catalytic Signalling n/a ● ● ● ● 4 
WBGene00018576 F47G3.1 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00001988 hot-3 n/a n/a n/a membrane ● ● ● ● 4 
WBGene00001989 hot-4 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00016979 C56G2.4 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00006987 zmp-1 
matrix 
metalloproteinase 
Catalytic metabolism cell surface ● ● ● ● 4 
WBGene00019320 K02E10.6 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00007652 C17G1.5 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00011879 pho-7 
histidine acid 
phosphatase 
Catalytic n/a n/a ● ● ● ● 4 
WBGene00013959 ZK265.7 n/a n/a development n/a ● ● ● ● 4 
WBGene00018115 F36H9.7 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00022645 ZK6.11 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00011498 T05G5.1 
Caldesmon-like 
repeats 
n/a n/a membrane ● ● ● ● 4 
WBGene00010150 F56D5.6 n/a n/a n/a membrane ● ● ● ● 4 
WBGene00018984 F56F10.1 peptidase Catalytic metabolism n/a ● ● ● ● 4 
WBGene00017594 F19C7.4 
lysosomal 
carboxypeptidase 
Catalytic metabolism n/a ● ● ● ● 4 
WBGene00007722 C25D7.15 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00006621 try-3  peptidase Catalytic metabolism n/a ● ● ● ● 4 
WBGene00009969 F53B7.7 n/a n/a development n/a ● ● ● ● 4 
WBGene00011314 T01B7.9 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00015472 C05D9.3 n/a binding cell adhesion membrane ● ● ● ● 4 
WBGene00003056 lon-2  n/a binding development cell surface ● ● ● ● 4 
WBGene00001163 efn-2  n/a n/a n/a membrane ● ● ● ● 4 
WBGene00008776 F13H10.5 n/a Catalytic metabolism membrane ● ● ● ● 4 
WBGene00009428 F35E12.4 n/a n/a n/a membrane ● ● ● ● 4 
WBGene00012073 T27A8.1 carboxypeptidase Catalytic metabolism n/a ● ● ● ● 4 
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WBGene00021526 Y41G9A.2 n/a n/a n/a membrane ● ● ● ● 4 
WBGene00002181 kal-1 
WAP-type (Whey 
Acidic Protein) 
'four-disulfide 
core', Fibronectin 
type III domain (3 
domains) 
inhibitor n/a cell surface ● ● ● ● 4 
WBGene00021791 
Y51H7C.1
3 
n/a n/a n/a membrane ● ● ● ● 4 
WBGene00016707 C46E10.1 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00010113 F55D12.5 
Activin types I 
and II receptor 
domain 
binding n/a membrane ● ● ● ● 4 
WBGene00000283 cah-5 
carbonic 
anhydrase 
Catalytic metabolism membrane ● ● ● ● 4 
WBGene00019617 K10C2.1 
serine 
carboxypeptidase 
Catalytic metabolism n/a ● ● ● ● 4 
WBGene00012202 W02B12.4 esterase n/a n/a n/a ● ● ● ● 4 
WBGene00009434 F35E12.10 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00044446 C06G4.6 n/a n/a n/a membrane ● ● ● ● 4 
WBGene00044484 C09B9.8 n/a n/a n/a membrane ● ● ● ● 4 
WBGene00044556 F38G1.3 n/a n/a n/a membrane ● ● ● ● 4 
WBGene00022827 ZK816.4 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00010059 F54E4.3 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00007864 C32H11.1 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00010747 K10D11.3 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00003958 pcp-3 
lysosomal 
carboxypeptidase 
Catalytic metabolism membrane ● ● ● ● 4 
WBGene00045248 ZK180.7 n/a n/a n/a membrane ● ● ● ● 4 
WBGene00045400 C54D10.13 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00009779 F46C5.2 n/a n/a n/a membrane ● ● ● ● 4 
WBGene00009798 F46G10.4 lipase Catalytic metabolism membrane ● ● ● ○ 3 
WBGene00016354 rig-6  
fibronectin, IG-
like domains of 
NCAM 
binding development membrane ● ○ ● ● 3 
WBGene00020302 T07D1.3 n/a Catalytic metabolism membrane ○ ● ● ● 3 
WBGene00007097 B0024.4 n/a n/a regulation n/a ○ ● ● ● 3 
WBGene00001991 hot-6 n/a n/a n/a membrane ○ ● ● ● 3 
WBGene00008233 C50F4.8 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00008377 D1054.10 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00010236 F58B4.3 n/a n/a n/a n/a ● ● ○ ● 3 
WBGene00015713 C12D12.1 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00017836 F26F12.5 n/a n/a n/a membrane ○ ● ● ● 3 
WBGene00019988 R09F10.5 n/a n/a n/a membrane ○ ● ● ● 3 
WBGene00016752 C48E7.7 n/a n/a n/a n/a ● ● ○ ● 3 
WBGene00017058 D2062.6 n/a n/a n/a membrane ○ ● ● ● 3 
WBGene00003957 pcp-2 
lysosomal 
carboxypeptidase 
Catalytic metabolism membrane ○ ● ● ● 3 
WBGene00000254 bli-4 endoprotease Catalytic metabolism nucleus ○ ● ● ● 3 
WBGene00010578 K04H8.3 n/a n/a n/a n/a ● ● ● ○ 3 
WBGene00020350 T08B2.12 n/a n/a n/a n/a ● ● ○ ● 3 
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WBGene00014135 ZK896.4 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00004173 pqn-94 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00002232 kpc-1 
Furin like serine 
protease Subtilase 
family of serine 
proteases 
Catalytic metabolism n/a ○ ● ● ● 3 
WBGene00009909 F49H6.8 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00015646 mlt-10 n/a n/a n/a membrane ○ ● ● ● 3 
WBGene00018497 F46F5.6 n/a n/a n/a membrane ○ ● ● ● 3 
WBGene00018500 F46F5.9 n/a n/a n/a membrane ○ ● ● ● 3 
WBGene00019260 H34I24.1 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00021503 
Y40D12A.
2 
serine 
carboxypeptidase 
Catalytic metabolism membrane ○ ● ● ● 3 
WBGene00008199 C49C3.9 n/a n/a defence n/a ○ ● ● ● 3 
WBGene00012947 Y47H9C.1 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00007056 crn-7 n/a Catalytic metabolism n/a ○ ● ● ● 3 
WBGene00021519 
Y41D4B.1
7 
n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00021518 
Y41D4B.1
6 
n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00012827 Y43F8C.5 n/a n/a n/a n/a ● ● ○ ● 3 
WBGene00012831 Y43F8C.9 n/a n/a n/a n/a ● ● ○ ● 3 
WBGene00021732 Y49G5B.1 n/a n/a development n/a ○ ● ● ● 3 
WBGene00021779 Y51H7C.1 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00021961 Y57E12B.1 n/a n/a n/a membrane ● ● ○ ● 3 
WBGene00006985 zig-8  n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00003471 mtd-1 n/a n/a Signalling n/a ○ ● ● ● 3 
WBGene00022711 ZK355.1 n/a n/a n/a membrane ● ● ● ○ 3 
WBGene00022715 ZK355.5 n/a n/a n/a membrane ○ ● ● ● 3 
WBGene00016424 C34H4.1 n/a n/a n/a membrane ○ ● ● ● 3 
WBGene00013911 ZC482.2 n/a n/a n/a membrane ○ ● ● ● 3 
WBGene00020921 W01C8.5 n/a n/a regulation n/a ○ ● ● ● 3 
WBGene00001687 gpn-1 glypican binding n/a membrane ○ ● ● ● 3 
WBGene00021558 
Y45G5AM.
6 
n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00015713 C12D12.1 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00015805 C15H9.11 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00044073 tag-244 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00017762 F23H11.7 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00014136 ZK896.5 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00003849 odr-2 n/a 
molecular 
function 
Signalling membrane ○ ● ● ● 3 
WBGene00015328 C02B10.3 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00020497 T14A8.2 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00001165 efn-4  n/a n/a regulation membrane ● ● ○ ● 3 
WBGene00015713 C12D12.1 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00010639 K07F5.15 n/a n/a n/a membrane ○ ● ● ● 3 
WBGene00021964 Y57E12B.4 n/a n/a n/a membrane ○ ● ● ● 3 
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WBGene00019810 R01H2.2 n/a n/a n/a membrane ○ ● ● ● 3 
WBGene00022283 lgc-27 n/a transport transport ion n/a ○ ● ● ● 3 
WBGene00022283 lgc-27 n/a transport transport ion membrane ○ ● ● ● 3 
WBGene00001989 hot-4 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00000039 acn-1 peptidase Catalytic metabolism membrane ● ● ○ ● 3 
WBGene00018823 F54E2.1 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00017418 F13B6.3 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00006611 tre-5  trehalase Catalytic metabolism membrane ● ○ ● ● 3 
WBGene00011452 ugt-55 
UDP-
sugartransferase 
Catalytic metabolism n/a ○ ● ● ● 3 
WBGene00009432 F35E12.8 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00011487 T05E12.6 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00006404 tag-10 
apical gut 
membrane protein 
n/a n/a n/a ○ ● ● ● 3 
WBGene00006404 tag-10 
apical gut 
membrane protein 
n/a n/a n/a ○ ● ● ● 3 
WBGene00022533 cutl-19 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00022533 cutl-19 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00019662 K11H12.6 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00013969 ZK337.1 
Alpha-2-
macroglobulin 
family (3 
domains) 
Catalytic metabolism extracellular ● ● ● ○ 3 
WBGene00016809 C50D2.6 n/a n/a n/a n/a ● ● ○ ● 3 
WBGene00008369 D1053.4 n/a n/a n/a membrane ● ● ○ ● 3 
WBGene00010239 F58B4.6 n/a n/a n/a n/a ● ● ● ○ 3 
WBGene00017976 F32B5.2 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00007041 tag-180 
calcium channel 
alpha-2 subunit 
n/a n/a membrane ○ ● ● ● 3 
WBGene00017483 lgc-22 n/a transport transport ion membrane ○ ● ● ● 3 
WBGene00002977 lev-10 n/a n/a n/a membrane ○ ● ● ● 3 
WBGene00001992 hot-7 
glycosylphosphati
dylinositol (GPI)-
linked signalling 
protein, (Ly-6 
superfamily) 
n/a n/a n/a ○ ● ● ● 3 
WBGene00012009 T25B9.3 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00022645 ZK6.11 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00007339 C05D12.1 n/a n/a n/a membrane ○ ● ● ● 3 
WBGene00004164 pqn-83 n/a n/a development membrane ○ ● ● ● 3 
WBGene00016354 rig-6  
fibronectin, IG-
like domains of 
NCAM 
binding development membrane ● ● ● ○ 3 
WBGene00020096 R144.6 n/a n/a n/a membrane ○ ● ● ● 3 
WBGene00000054 acr-15 
ligand-gated ion 
channel subunit 
receptor transport ion membrane ● ● ○ ● 3 
WBGene00010660 K08D8.6 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00010658 K08D8.4 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00010658 K08D8.4 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00010658 K08D8.4 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00044138 F31F6.8 n/a n/a n/a n/a ○ ● ● ● 3 
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WBGene00009416 F35E2.9 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00009431 dct-17 n/a binding metabolism cytoplasm ○ ● ● ● 3 
WBGene00009431 dct-17 n/a binding metabolism cytoplasm ○ ● ● ● 3 
WBGene00009431 dct-17 n/a binding metabolism cytoplasm ○ ● ● ● 3 
WBGene00044387 C27A2.8 n/a n/a n/a n/a ● ● ○ ● 3 
WBGene00044457 C18H7.11 n/a n/a n/a membrane ○ ● ● ● 3 
WBGene00010971 R01E6.7 n/a n/a n/a n/a ● ● ● ○ 3 
WBGene00017193 F07C3.2 n/a n/a n/a membrane ○ ● ● ● 3 
WBGene00020479 T13C2.3 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00021543 
Y43B11AR
.1 
n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00013292 
Y57G11A.
4 
n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00020497 T14A8.2 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00013788 
Y116A8C.
8 
n/a n/a n/a membrane ○ ● ● ● 3 
WBGene00013968 ZK287.9 n/a n/a n/a membrane ● ● ○ ● 3 
WBGene00017105 E02H9.7 n/a n/a n/a n/a ● ● ○ ● 3 
WBGene00009913 F49H6.12 n/a n/a n/a n/a ● ● ○ ● 3 
WBGene00013494 Y70C5C.3 n/a n/a n/a membrane ● ● ○ ● 3 
WBGene00016152 pho-12 acid phosphotase Catalytic n/a n/a ○ ● ● ● 3 
WBGene00008275 C53B4.6 
Yeast YEA4 like 
protein 
n/a transport membrane ○ ● ● ○ 2 
WBGene00010065 F54F7.3 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00000525 clc-4 n/a n/a n/a membrane ● ● ○ ○ 2 
WBGene00016933 C54G7.1 n/a n/a n/a n/a ○ ● ● ○ 2 
WBGene00004020 pho-1 n/a Catalytic development membrane ○ ● ● ○ 2 
WBGene00017592 F19C7.2 
lysosomal 
carboxypeptidase 
Catalytic metabolism n/a ● ● ○ ○ 2 
WBGene00007607 C15C8.5 n/a n/a n/a membrane ○ ○ ● ● 2 
WBGene00003173 mec-9  
mechanosensory 
protein (mec-9) 
binding Signalling extracellular ○ ● ○ ● 2 
WBGene00008584 F08G5.6 n/a n/a defence n/a ○ ● ○ ● 2 
WBGene00010255 F58E6.6 n/a n/a n/a membrane ○ ● ○ ● 2 
WBGene00011011 R04D3.3 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00011683 phat-6 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00006609 tre-3  trehalase Catalytic metabolism n/a ○ ● ○ ● 2 
WBGene00007264 C02F4.4 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00016686 cyp-33C1 cytochrome P450 binding metabolism membrane ○ ● ● ○ 2 
WBGene00000050 acr-11 
ligand-gated ionic 
channel protein 
receptor transport ion membrane ○ ● ● ○ 2 
WBGene00018447 F45C12.16 n/a n/a n/a membrane ○ ● ○ ● 2 
WBGene00018789 F54C1.1 n/a Catalytic metabolism membrane ○ ● ● ○ 2 
WBGene00011329 T01D3.5 n/a transport transport ion membrane ● ● ○ ○ 2 
WBGene00011948 T23F1.5 n/a n/a n/a membrane ○ ○ ● ● 2 
WBGene00020836 lgc-34 
ionic channel 
protein 
transport transport ion membrane ○ ● ● ○ 2 
WBGene00012211 W02D9.5 n/a structural n/a n/a ○ ● ○ ● 2 
WBGene00013882 ZC410.5 
microfilarial 
antigen like 
n/a n/a membrane ○ ● ● ○ 2 
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WBGene00022751 ZK484.5 n/a n/a n/a membrane ○ ● ○ ● 2 
WBGene00008631 F10A3.1 n/a n/a n/a membrane ○ ● ○ ● 2 
WBGene00008698 F11D11.3 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00010086 F55B11.4 n/a binding n/a cytoplasm ○ ● ○ ● 2 
WBGene00010749 K10D11.5 n/a n/a n/a membrane ○ ● ○ ● 2 
WBGene00010750 K10D11.6 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00012796 Y43F4A.1 
zinc 
metallopeptidase 
(M8 family) 
Catalytic metabolism membrane ○ ● ○ ● 2 
WBGene00013915 ZC482.7 n/a n/a n/a membrane ○ ● ● ○ 2 
WBGene00017493 F15E11.4 n/a n/a n/a membrane ○ ● ○ ● 2 
WBGene00021222 
Y19D10A.
7 
n/a n/a n/a membrane ○ ● ○ ● 2 
WBGene00002232 kpc-1 
Furin like serine 
protease Subtilase 
family of serine 
proteases 
Catalytic metabolism n/a ○ ● ● ○ 2 
WBGene00009412 F35E2.5 n/a n/a n/a membrane ○ ○ ● ● 2 
WBGene00010114 F55D12.6 n/a structural metabolism cytoplasm ○ ● ○ ● 2 
WBGene00019067 F58H7.1 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00021120 W09G12.6 n/a n/a n/a n/a ○ ● ● ○ 2 
WBGene00019213 H20E11.1 n/a n/a n/a membrane ○ ● ○ ● 2 
WBGene00010414 H25K10.5 n/a n/a n/a membrane ○ ○ ● ● 2 
WBGene00019389 K04F1.10 n/a n/a n/a membrane ○ ● ● ○ 2 
WBGene00019393 K04F1.14 n/a n/a n/a membrane ○ ● ○ ● 2 
WBGene00011592 T07F10.6 n/a n/a n/a n/a ○ ● ● ○ 2 
WBGene00012585 lips-15 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00004123 pqn-36 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00018917 F56A4.9 n/a n/a n/a membrane ○ ● ○ ● 2 
WBGene00010637 K07F5.12 n/a n/a development membrane ○ ● ● ○ 2 
WBGene00045459 
Y59A8B.2
6 
n/a n/a n/a n/a ○ ● ● ○ 2 
WBGene00021780 scl-17 n/a n/a n/a extracellular ○ ● ○ ● 2 
WBGene00021809 
Y53G8AR.
1 
n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00003959 pcp-4 peptidase Catalytic metabolism n/a ○ ● ○ ● 2 
WBGene00021960 
Y57E12A
M.1 
n/a n/a n/a membrane ○ ○ ● ● 2 
WBGene00000783 cpr-3 cathepsin protease Catalytic metabolism n/a ○ ● ○ ● 2 
WBGene00015768 C14C11.4 n/a n/a development membrane ○ ● ○ ● 2 
WBGene00003219 mes-1  
tyrosine-protein 
kinase 
Catalytic regulation membrane ○ ● ○ ● 2 
WBGene00000036 ace-2 carboxylesterase Catalytic Signalling cell ● ○ ○ ● 2 
WBGene00022644 dod-19 n/a n/a development n/a ○ ● ○ ● 2 
WBGene00000862 cwp-4  n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00000845 cup-4 
Acetylcholine 
receptor 
transport transport ion membrane ○ ● ● ○ 2 
WBGene00020487 T13C5.7 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00003567 ncx-2 
sodium/calcium 
exchanger protein 
1 
transport transport membrane ○ ● ○ ● 2 
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WBGene00003567 ncx-2 
sodium/calcium 
exchanger protein 
1 
transport transport membrane ○ ● ○ ● 2 
WBGene00006942 wrk-1  n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00006942 wrk-1  n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00006942 wrk-1  n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00016425 C34H4.2 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00009645 F42G10.1 n/a Catalytic metabolism n/a ○ ● ○ ● 2 
WBGene00000799 crn-6 n/a Catalytic metabolism n/a ○ ● ● ○ 2 
WBGene00008634 F10A3.4 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00012857 pbo-5 
Neurotransmitter-
gated ion-channel 
transport transport ion membrane ○ ● ○ ● 2 
WBGene00014125 ZK863.8 n/a n/a n/a membrane ○ ● ● ○ 2 
WBGene00006772 unc-36 n/a n/a n/a membrane ○ ● ● ○ 2 
WBGene00007340 C05D12.2 EGF domains n/a n/a n/a ○ ○ ● ● 2 
WBGene00008964 F19H8.4 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00007746 C26D10.6 n/a n/a n/a n/a ○ ● ● ○ 2 
WBGene00012861 Y45F3A.4 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00015539 C06E7.2 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00017998 F33D4.6 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00000524 clc-3 n/a n/a n/a membrane ○ ○ ● ● 2 
WBGene00011325 T01C3.11 n/a n/a development membrane ○ ● ○ ● 2 
WBGene00011380 T02E1.8 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00012840 grsp-1 n/a n/a regulation membrane ● ● ○ ○ 2 
WBGene00007545 C13B4.1 n/a Catalytic metabolism membrane ○ ● ● ○ 2 
WBGene00008675 F11A5.7 n/a n/a n/a membrane ○ ● ○ ● 2 
WBGene00009399 F35C5.11 n/a n/a n/a membrane ○ ● ● ○ 2 
WBGene00013882 ZC410.5 
microfilarial 
antigen like 
n/a n/a membrane ○ ● ● ○ 2 
WBGene00020484 T13C5.3 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00008560 pho-13 acid phosphatase Catalytic n/a n/a ○ ● ○ ● 2 
WBGene00007041 tag-180 
calcium channel 
alpha-2 subunit 
n/a n/a membrane ○ ● ● ○ 2 
WBGene00009499 F36H2.2 n/a transport transport membrane ○ ● ● ○ 2 
WBGene00004944 sol-1  CUB domain n/a n/a membrane ○ ● ● ○ 2 
WBGene00019392 K04F1.13 n/a n/a n/a membrane ○ ● ○ ● 2 
WBGene00014666 C05D12.3 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00023432 K12B6.9 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00000039 acn-1 peptidase Catalytic metabolism membrane ○ ● ○ ● 2 
WBGene00012857 pbo-5 
Neurotransmitter-
gated ion-channel 
transport transport ion membrane ○ ● ○ ● 2 
WBGene00000048 acr-9 
acetylcholine 
receptor 
transport transport ion membrane ○ ● ○ ● 2 
WBGene00017888 acl-11 n/a Catalytic metabolism membrane ○ ● ○ ● 2 
WBGene00010064 F54F7.2 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00007464 C08H9.3 
Glucosyl-
transferase 
Catalytic metabolism membrane ○ ● ○ ● 2 
WBGene00006942 wrk-1  n/a n/a n/a n/a ○ ● ○ ● 2 
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WBGene00043156 C27F2.9 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00011829 T19A6.4 n/a n/a n/a membrane ○ ● ● ○ 2 
WBGene00044203 T02E9.6 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00044343 clec-77 
clec family, C-
type lectin 
binding n/a n/a ○ ● ○ ● 2 
WBGene00044452 Y102E9.5 n/a n/a n/a n/a ○ ○ ● ● 2 
WBGene00044683 C36E6.8 n/a n/a n/a membrane ○ ● ● ○ 2 
WBGene00020207 T04B8.5 n/a n/a transport membrane ○ ● ○ ● 2 
WBGene00016271 C30G4.6 n/a n/a n/a membrane ○ ● ○ ● 2 
WBGene00022093 
Y69A2AR.
22 
n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00011383 T02E9.5 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00014132 ZK896.1 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00017260 F08F3.1 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00000138 amx-2 n/a Catalytic metabolism n/a ○ ● ○ ● 2 
WBGene00045381 F28B1.9 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00019009 clec-90 n/a binding n/a membrane ○ ● ○ ● 2 
WBGene00045403 K10H10.12 n/a n/a n/a membrane ○ ● ● ○ 2 
WBGene00010994 lgc-25 
Neurotransmitter-
gated ion-channel 
transport transport ion membrane ○ ● ○ ● 2 
WBGene00013573 
Y75B12B.1
1 
n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00010760 K10H10.4 n/a n/a n/a membrane ○ ● ● ○ 2 
WBGene00007591 C14H10.1 
Yeast YIL023C-
like protein 
transport transport ion membrane ○ ● ○ ● 2 
WBGene00045508 D1081.10 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00045482 T03F6.9 n/a n/a n/a membrane ○ ● ● ○ 2 
WBGene00013982 ZK512.1 n/a n/a n/a membrane ○ ● ● ○ 2 
WBGene00004023 pho-4 n/a Catalytic n/a n/a ○ ● ○ ● 2 
WBGene00013126 
Y52B11A.
7 
n/a n/a n/a membrane ○ ● ○ ● 2 
WBGene00012718 Y39E4B.7 n/a binding n/a membrane ● ○ ○ ● 2 
WBGene00019676 K12D9.12 n/a n/a n/a membrane ○ ● ○ ● 2 
WBGene00012445 Y16B4A.2 
serine 
carboxypeptidase 
Catalytic metabolism n/a ○ ● ○ ● 2 
WBGene00011262 pho-8 
histidine acid 
phosphatase 
Catalytic n/a n/a ○ ● ○ ● 2 
WBGene00004017 phg-1 
growth arrest 
protein 
extracellular 
domain 
n/a development n/a ● ○ ○ ● 2 
WBGene00008277 C53B4.8 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00017815 F26B1.1 n/a n/a n/a membrane ● ○ ○ ● 2 
WBGene00022474 Y119C1B.9 n/a n/a n/a n/a ● ● ○ ○ 2 
WBGene00017695 fip-1 
Environmental 
stress 
n/a n/a membrane ○ ● ○ ○ 1 
WBGene00010074 F54G8.1 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00015125 B0303.3 
Acetyl-coa 
acetyltransferase 
Catalytic development n/a ○ ● ○ ○ 1 
WBGene00007139 mnp-1 Aminopeptidase Catalytic metabolism membrane ○ ○ ● ○ 1 
WBGene00018133 F37A4.3 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00015163 B0361.9 n/a n/a regulation n/a ○ ● ○ ○ 1 
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WBGene00009450 ugt-58 
UDP-
glucuronosyltransf
erase 
Catalytic metabolism membrane ○ ○ ○ ● 1 
WBGene00010314 F59B2.12 n/a n/a n/a n/a ○ ○ ○ ● 1 
WBGene00017127 E04F6.8 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00019332 K02F3.9 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00020603 T20B12.5 n/a n/a regulation n/a ○ ● ○ ○ 1 
WBGene00000616 col-39 collagen structural development membrane ○ ○ ○ ● 1 
WBGene00016681 C45G9.10 n/a n/a regulation n/a ○ ○ ○ ● 1 
WBGene00001262 emb-8 
NADPH-
cytochrome P450 
binding metabolism membrane ○ ○ ○ ● 1 
WBGene00007191 lgc-20 n/a transport transport ion membrane ○ ● ○ ○ 1 
WBGene00007560 C14A4.9 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00018048 clec-137 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00018532 F47B7.1 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00008803 lips-10 n/a n/a development n/a ○ ● ○ ○ 1 
WBGene00009504 F37B12.1 n/a n/a development membrane ○ ● ○ ○ 1 
WBGene00006979 zig-2  
IG-like C2-type 
domains 
n/a n/a n/a ○ ● ○ ○ 1 
WBGene00009876 F49C12.6 n/a transport 
transport 
carbohydrate 
membrane ○ ● ○ ○ 1 
WBGene00015142 B0310.6 n/a n/a Signalling n/a ○ ● ○ ○ 1 
WBGene00015496 C05E11.7 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00016132 C26B9.2 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00004993 spp-8 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00016596 C42D4.3 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00018237 F40F4.6 EGF-like repeats binding regulation n/a ○ ● ○ ○ 1 
WBGene00018484 F46C8.1 n/a n/a n/a n/a ○ ○ ○ ● 1 
WBGene00020043 R13A1.5 n/a n/a n/a n/a ○ ○ ○ ● 1 
WBGene00020582 T19D12.7 n/a n/a n/a membrane ○ ○ ● ○ 1 
WBGene00020690 T22E5.1 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00020738 T23F2.5 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00000524 clc-3 n/a n/a n/a membrane ● ○ ○ ○ 1 
WBGene00007535 ttr-19 
Transthyretin-like 
family 
n/a n/a n/a ○ ● ○ ○ 1 
WBGene00008036 C40C9.3 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00004060 pmp-3 
peroxisomal 
membrane protein 
(PMP70) 
binding transport membrane ○ ○ ○ ● 1 
WBGene00008320 C54G10.4 
mitochondrial 
carrier protein 
transport transport membrane ○ ● ○ ○ 1 
WBGene00009331 F32D8.7 
Kunitz/Bovine 
pancreatic trypsin 
inhibitor domain 
Catalytic n/a membrane ○ ● ○ ○ 1 
WBGene00009339 F32G8.3 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00009915 F52A8.1 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00011010 R04D3.2 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00011089 R07B7.5 Monooxygenase Catalytic metabolism membrane ○ ● ○ ○ 1 
WBGene00005198 srg-41 n/a binding Signalling membrane ○ ● ○ ○ 1 
WBGene00001730 grl-21  n/a n/a n/a n/a ○ ● ○ ○ 1 
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WBGene00015300 C01F1.5 n/a n/a n/a n/a ○ ○ ○ ● 1 
WBGene00017654 F21C10.4 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00017655 F21C10.5 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00018333 cyp-33E3 n/a binding metabolism membrane ○ ● ○ ○ 1 
WBGene00006948 wrt-2  n/a n/a regulation membrane ○ ● ○ ○ 1 
WBGene00019059 F58F9.6 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00019066 sdz-23 n/a n/a regulation membrane ○ ● ○ ○ 1 
WBGene00019754 M03E7.2 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00020807 T25F10.4 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00020826 T26A8.3 n/a n/a n/a n/a ○ ○ ○ ● 1 
WBGene00000540 cln-3.2 n/a n/a development membrane ○ ● ○ ○ 1 
WBGene00015340 C02E7.7 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00005602 srj-14 
7TM 
chemoreceptor, srj 
family 
n/a n/a membrane ○ ● ○ ○ 1 
WBGene00005643 srp-2 
serine protease 
inhibitor 
Catalytic n/a n/a ○ ● ○ ○ 1 
WBGene00015577 ugt-64 ugt family Catalytic metabolism membrane ○ ● ○ ○ 1 
WBGene00005659 srr-8  n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00003573 ncx-8 n/a n/a transport membrane ○ ● ○ ○ 1 
WBGene00015848 C16C8.10 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00007845 C31E10.4 n/a n/a n/a n/a ● ○ ○ ○ 1 
WBGene00016430 C35A11.3 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00000859 cwp-1  n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00000860 cwp-2  n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00016731 C46H11.7 n/a n/a n/a n/a ○ ○ ○ ● 1 
WBGene00016781 C49G7.3 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00016782 phat-3 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00017105 E02H9.7 n/a n/a n/a n/a ○ ○ ● ○ 1 
WBGene00000539 cln-3.1 
Human CLN3 
protein like 
n/a development membrane ○ ○ ○ ● 1 
WBGene00017201 grsp-4 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00001388 far-4  
O.volvulus 
antigen peptide 
like 
binding n/a membrane ○ ● ○ ○ 1 
WBGene00000055 acr-16 
ligand-gated ion 
channel subunit 
transport transport ion membrane ○ ● ○ ○ 1 
WBGene00009134 F25H9.1 
Activin types I 
and II receptor 
domain 
n/a n/a n/a ○ ○ ○ ● 1 
WBGene00009136 F25H9.3 n/a n/a n/a n/a ○ ○ ○ ● 1 
WBGene00017880 F28A12.3 n/a n/a n/a membrane ○ ○ ○ ● 1 
WBGene00017918 F29A7.8 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00009523 clec-165 receptor like binding n/a n/a ○ ● ○ ○ 1 
WBGene00006570 tig-2 n/a 
developme
nt 
regulation extracellular ○ ○ ○ ● 1 
WBGene00018289 F41E6.8 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00006456 tag-83 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00018720 F53A3.1 n/a n/a n/a membrane ○ ● ○ ○ 1 
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WBGene00009990 F53F4.7 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00010135 F55H12.4 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00019036 F58E1.4 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00019077 F59A3.4 n/a transport transport ion membrane ○ ● ○ ○ 1 
WBGene00010514 K02E11.5 n/a Catalytic metabolism n/a ○ ○ ○ ● 1 
WBGene00000254 bli-4 endoprotease Catalytic metabolism nucleus ○ ● ○ ○ 1 
WBGene00001990 hot-5 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00019494 K07E8.1 n/a structural development n/a ○ ● ○ ○ 1 
WBGene00011151 R08H2.10 n/a structural n/a membrane ○ ● ○ ○ 1 
WBGene00000555 cnc-1 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00000556 cnc-2 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00000557 cnc-3 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00000558 cnc-4 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00000559 cnc-5 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00011229 R11.4 n/a n/a n/a membrane ● ○ ○ ○ 1 
WBGene00020076 R52.4 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00000233 avr-15 
glutamate-gated 
chloride channel 
transport transport ion membrane ○ ● ○ ○ 1 
WBGene00020631 T20F7.3 n/a Catalytic n/a n/a ○ ● ○ ○ 1 
WBGene00020741 T23F4.3 n/a Catalytic n/a n/a ○ ● ○ ○ 1 
WBGene00021145 clec-129 n/a binding n/a n/a ○ ○ ○ ● 1 
WBGene00013145 cutl-2  n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00000639 col-63 collagen structural n/a membrane ○ ○ ○ ● 1 
WBGene00007999 tag-297 n/a n/a development n/a ○ ● ○ ○ 1 
WBGene00008635 F10A3.7 n/a n/a n/a membrane ● ○ ○ ○ 1 
WBGene00009422 F35E8.9 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00009710 F44G3.10 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00010023 srbc-51 
7TM receptor, 
srbc family 
n/a n/a membrane ○ ● ○ ○ 1 
WBGene00010169 clec-18 
CUB domain, 
Lectin C-type 
domain short and 
long forms (2 
domains) 
binding regulation n/a ○ ● ○ ○ 1 
WBGene00010798 srbc-76 
7TM receptor, 
srbc family 
n/a n/a membrane ○ ● ○ ○ 1 
WBGene00011020 R05A10.3 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00011877 T21B4.3 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00012362 W09D10.4 
Protein 
phosphatase 2C (2 
domains) 
Catalytic n/a n/a ○ ● ○ ○ 1 
WBGene00003091 lys-2  n/a Catalytic metabolism n/a ○ ● ○ ○ 1 
WBGene00013290 
Y57G11A.
2 
n/a structural development n/a ○ ● ○ ○ 1 
WBGene00013494 Y70C5C.3 n/a n/a n/a membrane ○ ○ ● ○ 1 
WBGene00013779 
Y116A8B.
1 
n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00003765 nlp-27 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00003766 nlp-28 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00003767 nlp-29 n/a n/a n/a membrane ○ ● ○ ○ 1 
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WBGene00015932 C17H12.6 n/a n/a n/a n/a ○ ○ ○ ● 1 
WBGene00016391 C34B2.6 protease Catalytic metabolism n/a ○ ● ○ ○ 1 
WBGene00016433 C35B1.3 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00017120 E04A4.6 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00017480 F15B10.1 n/a transport 
transport 
nucleotide 
membrane ○ ○ ○ ● 1 
WBGene00017485 F15E6.4 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00017488 dct-7 n/a n/a n/a membrane ○ ○ ● ○ 1 
WBGene00017507 F16B4.5 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00017539 F17E9.2 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00015018 srz-85  
7TM 
chemoreceptor, 
srz family 
n/a n/a membrane ● ○ ○ ○ 1 
WBGene00007450 C08F11.1 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00007458 C08F11.11 n/a n/a n/a membrane ○ ○ ○ ● 1 
WBGene00007992 fipr-24 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00010418 H27A22.1 guanylate cyclase Catalytic metabolism membrane ○ ● ○ ○ 1 
WBGene00019507 K07H8.7 n/a n/a n/a membrane ○ ○ ○ ● 1 
WBGene00008492 F01D5.1 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00010118 F55F3.4 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00010127 F55G11.7 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00001148 eat-20 
EGF-like domain 
(3 domains) 
n/a development membrane ○ ○ ○ ● 1 
WBGene00010662 K08E3.2 n/a structural n/a n/a ○ ● ○ ○ 1 
WBGene00010993 R03E1.2 n/a binding development membrane ○ ○ ○ ● 1 
WBGene00012635 Y38H8A.1 n/a n/a development membrane ○ ● ○ ○ 1 
WBGene00002109 ins-26 n/a 
developme
nt 
n/a extracellular ○ ● ○ ○ 1 
WBGene00013931 clec-97 n/a binding n/a n/a ○ ○ ○ ● 1 
WBGene00015821 clec-135 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00017422 F13C5.1 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00018506 F46F5.15 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00019214 H20E11.2 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00019435 K06A9.1 n/a n/a n/a membrane ○ ○ ○ ● 1 
WBGene00019435 K06A9.1 n/a n/a n/a membrane ○ ○ ○ ● 1 
WBGene00015449 ugt-63 ugt family Catalytic metabolism membrane ○ ● ○ ○ 1 
WBGene00007866 C32H11.3 n/a n/a Signalling n/a ○ ● ○ ○ 1 
WBGene00009557 F39B2.7 n/a binding Signalling cytoplasm ○ ● ○ ○ 1 
WBGene00009913 F49H6.12 n/a n/a n/a n/a ○ ○ ● ○ 1 
WBGene00012199 W02B8.3 n/a n/a development membrane ○ ○ ● ○ 1 
WBGene00012759 
Y41C4A.1
3 
n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00013190 Y54E2A.5 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00003790 npp-4 n/a binding cytoskeleton nucleus ○ ● ○ ○ 1 
WBGene00015682 C10G8.3 n/a Catalytic n/a n/a ○ ● ○ ○ 1 
WBGene00016881 C52E2.2 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00008277 C53B4.8 n/a n/a n/a n/a ○ ○ ● ○ 1 
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WBGene00017406 sdz-12 n/a binding n/a cytoplasm ○ ● ○ ○ 1 
WBGene00000955 des-2 
nicotinic 
acetylcholine 
receptor 
transport transport ion membrane ○ ● ○ ○ 1 
WBGene00021162 Y5H2A.1 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00012590 nspe-3 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00012591 nspe-1 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00012594 nspe-5 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00004164 pqn-83 n/a n/a development membrane ● ○ ○ ○ 1 
WBGene00021509 Y41D4A.7 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00003763 nlp-25 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00001133 eat-2 n/a transport transport ion membrane ○ ● ○ ○ 1 
WBGene00004374 rme-2  LDL-like receptor binding development membrane ○ ○ ○ ● 1 
WBGene00021919 cutl-25 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00022070 Y67D8C.6 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00001636 gly-11  
Glycosyl 
transferases 
n/a n/a membrane ○ ○ ○ ● 1 
WBGene00003566 ncx-1 n/a transport transport ion membrane ○ ● ○ ○ 1 
WBGene00013775 
Y116A8A.
4 
n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00008652 F10D11.6 n/a binding development n/a ○ ● ○ ○ 1 
WBGene00018381 F43C11.4 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00010893 cutl-9  cuticulin 1 n/a n/a membrane ○ ● ○ ○ 1 
WBGene00011500 T05G5.5 
Hypothetical 
protein A (T. 
aquaticus) 
binding metabolism membrane ○ ● ○ ○ 1 
WBGene00021981 lgc-26 
ion channel 
protein 
transport transport ion membrane ○ ● ○ ○ 1 
WBGene00006950 wrt-4  Hint module Catalytic metabolism n/a ○ ● ○ ○ 1 
WBGene00004372 rig-5  
Drosophila 
amalgam protein 
like 
n/a n/a n/a ○ ● ○ ○ 1 
WBGene00010245 F58D5.6 n/a n/a n/a n/a ○ ○ ○ ● 1 
WBGene00000053 acr-14 
neuronal 
acetylcholine 
receptor protein 
transport transport ion membrane ○ ● ○ ○ 1 
WBGene00022447 
Y110A2AL
.12 
n/a Catalytic metabolism membrane ○ ● ○ ○ 1 
WBGene00021400 
Y38C1AA.
9 
n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00001046 dnj-28 n/a binding n/a n/a ○ ● ○ ○ 1 
WBGene00006131 str-69 
7TM 
chemoreceptor, str 
family 
n/a n/a membrane ○ ○ ● ○ 1 
WBGene00013828 
Y116F11B.
13 
n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00003575 ncx-10 n/a n/a transport membrane ○ ○ ○ ● 1 
WBGene00020921 W01C8.5 n/a n/a regulation n/a ● ○ ○ ○ 1 
WBGene00009774 F46B6.9 n/a n/a development membrane ○ ○ ○ ● 1 
WBGene00000560 cnc-6 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00021847 
Y54F10AL
.1 
n/a n/a n/a membrane ○ ○ ○ ● 1 
WBGene00022336 
Y82E9BR.
3 
n/a transport transport ion membrane ○ ● ○ ○ 1 
WBGene00006592 dpy-31 
Zinc 
metalloprotease 
Catalytic metabolism n/a ○ ● ○ ○ 1 
  
306 
WBGene00001819 haf-9 transporter protein transport transport 
membrane 
lysosome 
○ ● ○ ○ 1 
WBGene00014091 ZK822.4 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00021325 Y34B4A.9 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00021874 clec-81 
clec family, C-
type lectin 
binding n/a n/a ○ ○ ○ ● 1 
WBGene00022100 
Y69A2AR.
31 
n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00015578 C07G3.10 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00015940 C18A3.2 n/a transport transport ion membrane ○ ● ○ ○ 1 
WBGene00001148 eat-20 
EGF-like domain 
(3 domains) 
n/a development membrane ○ ○ ○ ● 1 
WBGene00017381 ddr-2 tyrosine kinase Catalytic regulation membrane ○ ● ○ ○ 1 
WBGene00000046 acr-7 
Acetylcholine 
receptor 
transport transport ion membrane ○ ● ○ ○ 1 
WBGene00022532 ZC155.4 n/a Catalytic metabolism membrane ○ ● ○ ○ 1 
WBGene00018009 F33D11.12 n/a binding n/a membrane ○ ● ○ ○ 1 
WBGene00001814 haf-4 ABC transporter transport transport 
membrane 
lysosome 
○ ● ○ ○ 1 
WBGene00000061 lgc-11 
Acetylcholine 
receptor 
transport transport ion membrane ○ ● ○ ○ 1 
WBGene00021160 Y4C6B.6 n/a Catalytic metabolism 
membrane 
lysosome 
○ ● ○ ○ 1 
WBGene00020063 R13D11.10 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00012293 W06A7.4 n/a n/a n/a n/a ○ ○ ● ○ 1 
WBGene00016133 C26B9.3 n/a n/a development n/a ○ ● ○ ○ 1 
WBGene00016335 C33C12.3 
Glucosyl-
ceramidase 
Catalytic metabolism 
membrane 
lysosome 
○ ● ○ ○ 1 
WBGene00017294 F09E10.1 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00017299 F09F7.1 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00022580 ZC262.3 
N-CAM IG 
domain 
n/a n/a membrane ○ ● ○ ○ 1 
WBGene00022642 ZK6.7 lipase n/a metabolism n/a ○ ● ○ ○ 1 
WBGene00018272 F41C3.6 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00019127 cgt-3 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00019127 cgt-3 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00002977 lev-10 n/a n/a n/a membrane ● ○ ○ ○ 1 
WBGene00021384 Y37F4.3 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00022033 
Y65B4BL.
1 
n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00022106 lgc-46 
ion channel 
protein 
transport transport ion membrane ○ ● ○ ○ 1 
WBGene00021941 lgc-33 n/a n/a n/a membrane ○ ○ ○ ● 1 
WBGene00016642 C44C1.2 n/a Catalytic metabolism n/a ○ ● ○ ○ 1 
WBGene00020413 T10E9.3 n/a Catalytic metabolism n/a ○ ● ○ ○ 1 
WBGene00000232 avr-14 n/a transport transport membrane ○ ● ○ ○ 1 
WBGene00019127 cgt-3 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00022077 
Y69A2AR.
6 
n/a n/a transport membrane ○ ● ○ ○ 1 
WBGene00000058 acr-19 
nicotinic 
acetylcholine 
receptor 
transport transport ion membrane ○ ● ○ ○ 1 
WBGene00016329 osr-1  n/a n/a development n/a ○ ● ○ ○ 1 
WBGene00015055 B0222.3 
phosphate 
permease 
transport transport ion membrane ○ ● ○ ○ 1 
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WBGene00001479 fmo-4  
flavin-containing 
monoxygenase 
Catalytic metabolism membrane ER ○ ● ○ ○ 1 
WBGene00018206 ugt-61 ugt family Catalytic metabolism membrane ○ ○ ○ ● 1 
WBGene00015786 C15B12.4 n/a n/a n/a n/a ○ ○ ○ ● 1 
WBGene00000988 dhs-25 
short-chain 
alcohol 
dehydrogenase 
Catalytic metabolism n/a ○ ● ○ ○ 1 
WBGene00004017 phg-1 
growth arrest 
protein 
extracellular 
domain 
n/a development n/a ○ ○ ● ○ 1 
WBGene00018411 F44B9.10 n/a Catalytic metabolism membrane ○ ● ○ ○ 1 
WBGene00019401 nuo-4 
NADH 
dehydrogenase 
Catalytic metabolism n/a ○ ● ○ ○ 1 
WBGene00021448 Y39D8A.1 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00015619 C08G9.1 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00019848 R03G5.7 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00016336 C33C12.4 n/a n/a development membrane ○ ● ○ ○ 1 
WBGene00018928 F56B3.2 n/a n/a development n/a ○ ● ○ ○ 1 
WBGene00010342 F59F5.3 
tyrosine-protein 
kinase 
Catalytic regulation membrane ○ ● ○ ○ 1 
WBGene00010597 K06A4.7 n/a n/a n/a n/a ○ ○ ○ ● 1 
WBGene00001476 fmo-1  
flavin-containing 
monoxygenase 
Catalytic metabolism membrane ER ○ ● ○ ○ 1 
WBGene00013225 Y56A3A.2 n/a Catalytic metabolism membrane ○ ● ○ ○ 1 
WBGene00007807 C29F3.7 n/a n/a regulation n/a ○ ● ○ ○ 1 
WBGene00018716 F52H2.4 n/a transport transport membrane ○ ● ○ ○ 1 
WBGene00018977 F56E10.3 n/a binding cytoskeleton membrane ○ ○ ○ ● 1 
WBGene00020984 W03D8.1 n/a n/a n/a n/a ○ ○ ○ ● 1 
WBGene00013574 Y76A2B.2 
Leucine Rich 
Repeat (2 copies) 
(2 domains) 
n/a n/a n/a ○ ○ ○ ● 1 
WBGene00008320 C54G10.4 
mitochondrial 
carrier protein 
transport transport mitochondria ○ ● ○ ○ 1 
WBGene00009971 F53C11.1 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00010573 K04H4.2 
Chitin-binding 
motifs 
binding metabolism extracellular ○ ○ ○ ● 1 
WBGene00012761 
Y41C4A.1
8 
n/a n/a n/a membrane ○ ○ ○ ● 1 
WBGene00009406 F35C11.7 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00007178 B0457.2 elastin precusor n/a n/a n/a ○ ● ○ ○ 1 
WBGene00016193 C28H8.2 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00017312 F09G2.3 permease transport transport ion membrane ○ ○ ○ ● 1 
WBGene00000055 acr-16 
ligand-gated ion 
channel subunit 
transport transport ion membrane ○ ○ ○ ● 1 
WBGene00010901 M28.10 n/a n/a n/a n/a ○ ○ ○ ● 1 
WBGene00018112 F36H9.4 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00000254 bli-4 endoprotease Catalytic metabolism nucleus ○ ● ○ ○ 1 
WBGene00020693 T22E7.1 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00022506 ZC21.6 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00015303 rga-6  n/a n/a Signalling cytoplasm ○ ● ○ ○ 1 
WBGene00017886 F28B3.5 n/a n/a development membrane ○ ● ○ ○ 1 
WBGene00020479 T13C2.3 n/a n/a n/a n/a ● ○ ○ ○ 1 
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WBGene00003519 nac-3 
Yeast ORF 
YCR37C 
transport transport membrane ○ ● ○ ○ 1 
WBGene00017071 D2096.3 n/a Catalytic metabolism n/a ○ ● ○ ○ 1 
WBGene00012718 Y39E4B.7 n/a binding n/a n/a ○ ○ ● ○ 1 
WBGene00001512 gab-1 GABA receptor transport transport ion membrane ○ ● ○ ○ 1 
WBGene00022677 ZK180.3 n/a transport transport lipid membrane ○ ● ○ ○ 1 
WBGene00007325 C05C9.1 
LBP / BPI / CETP 
family 
binding n/a n/a ○ ● ○ ○ 1 
WBGene00007402 ugt-60 
UDP-
glucuronosyl-
transferase 
Catalytic metabolism n/a ○ ● ○ ○ 1 
WBGene00001406 fce-2  n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00010959 MTCE.11 
NADH 
dehydrogenase 
ND1 
n/a n/a n/a ○ ● ○ ○ 1 
WBGene00011084 srsx-21 n/a n/a n/a membrane ○ ○ ○ ● 1 
WBGene00001692 grd-3 n/a binding regulation extracellular ○ ● ○ ○ 1 
WBGene00002975 lev-8  
acetylcholine 
receptor 
transport transport ion membrane ○ ● ○ ○ 1 
WBGene00013684 
Y105E8A.2
7 
n/a n/a n/a membrane ○ ○ ○ ● 1 
WBGene00016732 phat-1 n/a n/a n/a n/a ○ ○ ○ ● 1 
WBGene00019845 R03G5.3 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00007497 C09G9.8 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00016174 C27H5.4 n/a n/a development membrane ○ ○ ○ ● 1 
WBGene00008340 C55A6.11 n/a n/a development membrane ○ ● ○ ○ 1 
WBGene00009528 F38A6.4 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00010723 cpg-7 n/a n/a n/a n/a ○ ○ ○ ● 1 
WBGene00010954 clec-189 n/a binding n/a n/a ○ ● ○ ○ 1 
WBGene00004264 qua-1 
hedgehog-like 
protein 
Catalytic metabolism extracellular ○ ● ○ ○ 1 
WBGene00012152 cnc-10 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00012488 clec-105 n/a binding n/a membrane ○ ○ ○ ● 1 
WBGene00012603 nspe-6 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00012604 nspe-2 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00012371 W09G3.8 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00007055 tag-196 
cysteine protease 
and a protease 
inhibitor 
Catalytic metabolism n/a ○ ● ○ ○ 1 
WBGene00005957 srx-66 
7TM 
chemoreceptor, 
srx family 
n/a n/a membrane ○ ● ○ ○ 1 
WBGene00016641 C44C1.1 n/a n/a development membrane ○ ○ ○ ● 1 
WBGene00017580 lgc-4  
member of the 
ligand-gated ionic 
channels family 
transport transport ion membrane ○ ● ○ ○ 1 
WBGene00017890 F28B4.1 n/a n/a n/a membrane ○ ○ ● ○ 1 
WBGene00018250 F40H3.2 n/a n/a n/a n/a ○ ○ ○ ● 1 
WBGene00010350 H01G02.3 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00010350 H01G02.3 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00010745 dod-17 n/a n/a development n/a ○ ● ○ ○ 1 
WBGene00005120 srd-42 n/a n/a n/a membrane ○ ● ○ ○ 1 
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WBGene00011354 lgc-13 
nitcotinic 
acetylcholine 
receptor 
transport transport ion membrane ○ ● ○ ○ 1 
WBGene00013657 
Y105C5B.1
8 
n/a n/a n/a n/a ○ ○ ○ ● 1 
WBGene00013493 clec-9  
CUB domain, 
Lectin C-type 
domain short and 
long forms 
binding n/a n/a ○ ● ○ ○ 1 
WBGene00020420 T10E10.3 G-protein receptor n/a Signalling membrane ○ ● ○ ○ 1 
WBGene00020863 T27E4.5 n/a inhibitor n/a extracellular ○ ● ○ ○ 1 
WBGene00003525 nas-6 
Zinc-binding 
metalloprotease 
domain 
Catalytic metabolism n/a ○ ○ ○ ● 1 
WBGene00009204 F28C6.4 Yeast YJ10 like Catalytic metabolism membrane ○ ● ○ ○ 1 
WBGene00009204 F28C6.4 Yeast YJ10 like Catalytic metabolism membrane ○ ● ○ ○ 1 
WBGene00011965 T23G7.2 n/a Catalytic n/a membrane ○ ● ○ ○ 1 
WBGene00022443 
Y110A2AL
.6 
n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00022891 ZK1290.10 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00012315 immt-2 
[031110 dl] 
Modified 
prediction based 
on EST data, 
correct splice 
donor from exon 2 
n/a n/a mitochondria ○ ● ○ ○ 1 
WBGene00013013 clec-145 n/a binding n/a n/a ○ ● ○ ○ 1 
WBGene00013412 
Y64G10A.
2 
n/a n/a development n/a ○ ● ○ ○ 1 
WBGene00006027 srx-136 
7TM receptor, srx 
family 
n/a n/a membrane ○ ● ○ ○ 1 
WBGene00044067 hke-4.1 n/a transport transport ion membrane ○ ● ○ ○ 1 
WBGene00005898 srx-7  
7TM 
chemoreceptor, 
srx family 
n/a Signalling membrane ○ ● ○ ○ 1 
WBGene00006006 srx-115 
7TM 
chemoreceptor, 
srx family 
n/a n/a membrane ○ ● ○ ○ 1 
WBGene00010940 M163.8 n/a n/a n/a n/a ○ ○ ○ ● 1 
WBGene00017389 lgc-38 
gamma-
aminobutyric acid 
receptor 
transport transport ion membrane ○ ● ○ ○ 1 
WBGene00002098 ins-15 ins family 
developme
nt 
n/a extracellular ○ ● ○ ○ 1 
WBGene00016663 C45E1.4 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00018865 F55A12.6 n/a n/a n/a membrane ○ ○ ○ ● 1 
WBGene00011355 lgc-14 
nicotinic 
acetylcholine 
receptor 
transport transport ion membrane ○ ● ○ ○ 1 
WBGene00012915 lgc-35 n/a transport transport ion membrane ○ ○ ○ ● 1 
WBGene00021582 clec-71 
clec family, C-
type lectin 
binding n/a n/a ○ ● ○ ○ 1 
WBGene00016079 C24H12.10 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00005297 srh-76 
7TM 
chemoreceptor, 
srh family 
n/a n/a membrane ○ ● ○ ○ 1 
WBGene00000062 acr-23 channel protein receptor transport ion membrane ○ ● ○ ○ 1 
WBGene00014669 C06G8.3 n/a transport transport ion membrane ○ ● ○ ○ 1 
WBGene00016417 C34F11.8 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00002132 inx-10 
type-1 membrane 
protein 
n/a n/a membrane ○ ○ ○ ● 1 
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WBGene00021095 mlt-8 n/a n/a development n/a ○ ○ ○ ● 1 
WBGene00004164 pqn-83 n/a n/a development membrane ○ ● ○ ○ 1 
WBGene00006952 wrt-6  n/a Catalytic metabolism n/a ○ ● ○ ○ 1 
WBGene00015284 C01B10.10 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00016721 C46G7.1 n/a n/a development membrane ○ ● ○ ○ 1 
WBGene00004890 smp-2 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00008583 ugt-65 
UDP-glucuronyl-
transferase like 
Catalytic metabolism n/a ○ ○ ● ○ 1 
WBGene00023504 F26F2.8 n/a n/a n/a n/a ○ ○ ○ ● 1 
WBGene00003762 nlp-24 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00009882 vha-17 n/a transport transport ion membrane ○ ○ ○ ● 1 
WBGene00013601 
Y87G2A.1
3 
n/a n/a n/a membrane ○ ○ ● ○ 1 
WBGene00013601 
Y87G2A.1
3 
n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00010354 cyp-31A2  Cytochrome P450 binding metabolism membrane ○ ○ ○ ● 1 
WBGene00007070 ugt-49 
UDP-
glucuronosyl-
transferase 
Catalytic metabolism membrane ○ ○ ○ ● 1 
WBGene00012200 W02B8.4 n/a n/a development membrane ○ ● ○ ○ 1 
WBGene00044074 W02B8.6 n/a n/a development membrane ○ ● ○ ○ 1 
WBGene00008595 clec-56 
C-type lectin 
domain 
binding n/a n/a ○ ● ○ ○ 1 
WBGene00015315 srbc-29 
7TM 
chemoreceptor, 
srbc family 
n/a n/a membrane ○ ○ ○ ● 1 
WBGene00015316 srbc-30 
7TM 
chemoreceptor, 
srbc family 
n/a n/a membrane ○ ○ ○ ● 1 
WBGene00007954 C35C5.2 n/a Catalytic metabolism membrane ○ ● ○ ○ 1 
WBGene00011971 T23G11.6 
Rat insulin-like 
growth factor 
binding protein 
complex acid 
labile chain like 
binding development membrane ○ ○ ○ ● 1 
WBGene00012847 srxa-15 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00044176 C30G7.2 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00044189 F36D3.14 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00018880 acc-3 
Ligand-gated 
ionic channel 
transport transport ion membrane ○ ● ○ ○ 1 
WBGene00044152 W04G3.10 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00044287 F21H12.7 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00044301 lgc-28 n/a transport transport ion membrane ○ ● ○ ○ 1 
WBGene00044292 F56D6.8 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00044423 F53F10.8 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00006494 hke-4.2 n/a transport transport ion membrane ○ ● ○ ○ 1 
WBGene00044436 
Y47G6A.3
1 
n/a binding development membrane ○ ● ○ ○ 1 
WBGene00044560 C36C9.6 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00044472 dct-8 n/a n/a n/a membrane ○ ○ ● ○ 1 
WBGene00044411 R12B2.8 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00044548 cnc-9 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00017399 lgc-51 
ligand-gated ionic 
channel 
transport transport ion membrane ○ ● ○ ○ 1 
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WBGene00021626 
Y47D7A.1
4 
n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00044637 
Y47D7A.1
6 
n/a n/a development membrane ○ ● ○ ○ 1 
WBGene00003572 ncx-7 
Na/Ca, K 
antiporter 
n/a transport membrane ○ ● ○ ○ 1 
WBGene00015476 C05D9.9 n/a n/a n/a n/a ○ ○ ○ ● 1 
WBGene00016152 pho-12 acid phosphotase Catalytic n/a n/a ○ ○ ● ○ 1 
WBGene00001587 ggr-2  Glycine receptor transport transport ion membrane ○ ● ○ ○ 1 
WBGene00020760 T24C4.4 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00020657 lgc-53 
ligand-gated ionic 
channel 
transport transport ion membrane ○ ● ○ ○ 1 
WBGene00011102 R07E3.1 
cysteine 
proteinase 
Catalytic metabolism membrane ○ ● ○ ○ 1 
WBGene00010655 K08D8.1 n/a n/a n/a membrane ○ ○ ○ ● 1 
WBGene00012789 Y43D4A.3 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00005625 srj-42 
7tm receptor 
protein 
n/a n/a membrane ○ ○ ● ○ 1 
WBGene00044756 F58F12.4 n/a n/a n/a membrane ○ ○ ○ ● 1 
WBGene00044754 
Y119C1B.1
2 
n/a n/a n/a membrane ○ ○ ● ○ 1 
WBGene00022474 Y119C1B.9 n/a n/a n/a n/a ○ ○ ● ○ 1 
WBGene00022255 
Y73B6BL.
36 
n/a n/a transport membrane ○ ● ○ ○ 1 
WBGene00018226 F40B5.2 n/a Catalytic n/a membrane ○ ● ○ ○ 1 
WBGene00018226 F40B5.2 n/a Catalytic n/a membrane ○ ● ○ ○ 1 
WBGene00003566 ncx-1 n/a transport transport ion membrane ○ ● ○ ○ 1 
WBGene00021586 clec-75 n/a binding n/a n/a ○ ● ○ ○ 1 
WBGene00013471 clec-242 n/a binding n/a n/a ○ ● ○ ○ 1 
WBGene00010418 H27A22.1 guanylate cyclase Catalytic metabolism membrane ○ ● ○ ○ 1 
WBGene00044900 cnc-11 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00013451 
Y67A10A.
2 
n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00044922 Y43C5A.7 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00044988 W01A8.8 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00010748 K10D11.4 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00012542 Y37A1B.9 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00044801 ZC262.9 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00011360 lgc-18 
nicotinic 
acetylcholine 
receptor 
transport transport ion membrane ○ ● ○ ○ 1 
WBGene00012814 Y43F8B.3 
Kunitz/Bovine 
pancreatic trypsin 
inhibitor domain 
Catalytic n/a n/a ○ ● ○ ○ 1 
WBGene00001455 flp-12 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00007807 C29F3.7 n/a n/a regulation n/a ○ ● ○ ○ 1 
WBGene00017306 F09F9.1 n/a n/a n/a membrane ○ ○ ○ ● 1 
WBGene00009331 F32D8.7 
Kunitz/Bovine 
pancreatic trypsin 
inhibitor domain 
Catalytic n/a membrane ○ ● ○ ○ 1 
WBGene00011927 T22C8.6 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00012814 Y43F8B.3 
Kunitz/Bovine 
pancreatic trypsin 
inhibitor domain 
Catalytic n/a n/a ○ ● ○ ○ 1 
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WBGene00045397 
Y54G2A.5
2 
n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00045455 F26G1.11 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00045251 F54F7.9 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00019069 lgc-30 n/a transport transport ion membrane ○ ● ○ ○ 1 
WBGene00011328 T01D3.3 
Von Willebrand 
factor-like 
Copper/zinc 
superoxide 
dismutases 
(SODC) 
binding metabolism extracellular ○ ● ○ ○ 1 
WBGene00043066 acr-25 n/a transport transport ion membrane ○ ● ○ ○ 1 
WBGene00013351 
Y59A8B.1
9 
n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00010027 F54B11.4 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00014669 C06G8.3 n/a transport transport ion membrane ○ ● ○ ○ 1 
WBGene00018978 sdz-22 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00045488 F57B1.9 n/a n/a n/a membrane ○ ○ ○ ● 1 
WBGene00045486 K05F6.12 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00011121 R07E5.17 n/a n/a development membrane ○ ● ○ ○ 1 
WBGene00045494 ZK662.6 n/a n/a n/a n/a ○ ○ ○ ● 1 
WBGene00004372 rig-5  
Drosophila 
amalgam protein 
like 
n/a n/a n/a ○ ● ○ ○ 1 
WBGene00013487 tag-336 EGF-like domain Catalytic transport ion membrane ○ ● ○ ○ 1 
WBGene00017569 F18E9.3 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00018278 F41C6.4 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00017885 F28B3.4 n/a binding n/a nucleus ○ ○ ○ ● 1 
WBGene00009762 F46B3.9 n/a n/a n/a n/a ○ ○ ○ ● 1 
WBGene00006624 try-6  peptidase Catalytic metabolism n/a ○ ● ○ ○ 1 
WBGene00019746 M03A1.3 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00012612 Y38H6A.1 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00012391 Y6B3B.7 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00013060 Y51A2A.4 n/a n/a development n/a ○ ● ○ ○ 1 
WBGene00012215 W02D9.9 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00044399 F11F1.8 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00008583 ugt-65 
UDP-glucuronyl-
transferase like 
Catalytic metabolism membrane ○ ● ○ ○ 1 
WBGene00008277 C53B4.8 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00020642 T20H9.6 n/a n/a n/a membrane ○ ○ ○ ● 1 
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Appendix 2.  
All C. elegans proteins that also have C. briggsae orthologues with GPI predictions, 
of which there are 382 proteins. 201 of these have predictions in two programs or 
more. Columns 1 to 3 contain the Wormbase gene ID, gene name and a brief 
description of the protein. Columns 4 to 6 contain the GO terms for the proteins where 
available. Columns 7 to 10 contain the programs with which the protein was predicted, 
with ● indicating a positive prediction and ○ a negative. Column 11 denotes the 
number of prediction programs that gave the protein a positive result. 
 
 
Wormbase gene ID gene name brief description 
Molecular 
function 
Biological 
process 
Cellular 
component 
Big 
PI 
GPI 
SOM 
Frag 
Anchor 
Pred 
GPI 
No. of 
hits 
WBGene00009700 F44F4.1 n/a n/a n/a membrane ● ● ● ● 4 
WBGene00017969 F32A5.3 
Serine 
carboxypeptidase 
Catalytic metabolism n/a ● ● ● ● 4 
WBGene00015803 C15H9.9 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00004370 rig-3  n/a n/a n/a n/a ● ● ● ● 4 
WBGene00009431 dct-17 n/a binding metabolism cytoplasm ● ● ● ● 4 
WBGene00013969 ZK337.1 
Alpha-2-
macroglobulin 
family (3 
domains) 
Catalytic metabolism extracellular ● ● ● ● 4 
WBGene00007299 C04F12.5 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00018787 cutl-20 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00021452 Y39F10A.1 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00009679 F44D12.2 n/a binding n/a membrane ● ● ● ● 4 
WBGene00022246 acp-7 n/a Catalytic n/a n/a ● ● ● ● 4 
WBGene00000038 ace-4 
Acetylcholine-
esterase 
Catalytic n/a membrane ● ● ● ● 4 
WBGene00006869 vab-2 n/a binding Signalling anchored ● ● ● ● 4 
WBGene00007911 C34B7.1 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00020195 T03G6.3 
plasma cell 
membrane protein 
and phosphor-
diesterase I 
(weak) 
Catalytic metabolism n/a ● ● ● ● 4 
WBGene00000037 ace-3 n/a Catalytic Signalling n/a ● ● ● ● 4 
WBGene00018576 F47G3.1 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00001988 hot-3 n/a n/a n/a membrane ● ● ● ● 4 
WBGene00016979 C56G2.4 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00019320 K02E10.6 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00018984 F56F10.1 peptidase Catalytic metabolism n/a ● ● ● ● 4 
WBGene00017594 F19C7.4 
lysosomal 
carboxypeptidase 
Catalytic metabolism n/a ● ● ● ● 4 
WBGene00007722 C25D7.15 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00006621 try-3  peptidase Catalytic metabolism n/a ● ● ● ● 4 
WBGene00011314 T01B7.9 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00015472 C05D9.3 n/a binding cell adhesion membrane ● ● ● ● 4 
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WBGene00003056 lon-2  n/a binding development cell surface ● ● ● ● 4 
WBGene00001163 efn-2  n/a n/a n/a membrane ● ● ● ● 4 
WBGene00008776 F13H10.5 n/a Catalytic metabolism membrane ● ● ● ● 4 
WBGene00009428 F35E12.4 n/a n/a n/a membrane ● ● ● ● 4 
WBGene00021526 Y41G9A.2 n/a n/a n/a membrane ● ● ● ● 4 
WBGene00002181 kal-1 
WAP-type (Whey 
Acidic Protein) 
'four-disulfide 
core', Fibronectin 
type III domain (3 
domains) 
inhibitor n/a cell surface ● ● ● ● 4 
WBGene00021791 
Y51H7C.1
3 
n/a n/a n/a membrane ● ● ● ● 4 
WBGene00012202 W02B12.4 esterase n/a n/a n/a ● ● ● ● 4 
WBGene00044484 C09B9.8 n/a n/a n/a membrane ● ● ● ● 4 
WBGene00044556 F38G1.3 n/a n/a n/a membrane ● ● ● ● 4 
WBGene00045400 C54D10.13 n/a n/a n/a n/a ● ● ● ● 4 
WBGene00009779 F46C5.2 n/a n/a n/a membrane ● ● ● ● 4 
WBGene00016627 C44B7.5 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00020302 T07D1.3 n/a Catalytic metabolism membrane ○ ● ● ● 3 
WBGene00001991 hot-6 n/a n/a n/a membrane ○ ● ● ● 3 
WBGene00008233 C50F4.8 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00015713 C12D12.1 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00017836 F26F12.5 n/a n/a n/a membrane ○ ● ● ● 3 
WBGene00019988 R09F10.5 n/a n/a n/a membrane ○ ● ● ● 3 
WBGene00016752 C48E7.7 n/a n/a n/a n/a ● ● ○ ● 3 
WBGene00008509 F01G10.6 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00003957 pcp-2 
lysosomal 
carboxypeptidase 
Catalytic metabolism membrane ○ ● ● ● 3 
WBGene00001581 gfi-1  n/a n/a regulation n/a ○ ● ● ● 3 
WBGene00019017 F57F4.4 n/a n/a regulation n/a ○ ● ● ● 3 
WBGene00019660 K11H12.4 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00019663 K11H12.7 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00020350 T08B2.12 n/a n/a n/a n/a ● ● ○ ● 3 
WBGene00014135 ZK896.4 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00004173 pqn-94 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00020995 W03F8.6 n/a n/a n/a membrane ○ ● ● ● 3 
WBGene00012439 Y12A6A.1 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00019260 H34I24.1 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00021503 
Y40D12A.
2 
serine 
carboxypeptidase 
Catalytic metabolism membrane ○ ● ● ● 3 
WBGene00012947 Y47H9C.1 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00021519 
Y41D4B.1
7 
n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00021518 
Y41D4B.1
6 
n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00021779 Y51H7C.1 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00003471 mtd-1 n/a n/a n/a membrane ○ ● ● ● 3 
WBGene00003956 pcp-1 n/a Catalytic metabolism n/a ○ ● ● ● 3 
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WBGene00016424 C34H4.1 n/a n/a n/a membrane ○ ● ● ● 3 
WBGene00013911 ZC482.2 n/a n/a n/a membrane ○ ● ● ● 3 
WBGene00020921 W01C8.5 n/a n/a regulation n/a ○ ● ● ● 3 
WBGene00001687 gpn-1 glypican binding n/a membrane ○ ● ● ● 3 
WBGene00021558 
Y45G5AM.
6 
n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00015713 C12D12.1 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00015805 C15H9.11 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00044073 tag-244 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00014136 ZK896.5 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00015328 C02B10.3 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00020497 T14A8.2 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00001165 efn-4  n/a n/a regulation membrane ● ● ○ ● 3 
WBGene00015713 C12D12.1 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00022283 lgc-27 n/a transport transport ion n/a ○ ● ● ● 3 
WBGene00022283 lgc-27 n/a transport transport ion membrane ○ ● ● ● 3 
WBGene00018823 F54E2.1 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00011879 pho-7 
histidine acid 
phosphatase 
Catalytic n/a n/a ○ ● ● ● 3 
WBGene00009432 F35E12.8 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00011487 T05E12.6 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00022645 ZK6.11 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00019662 K11H12.6 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00013969 ZK337.1 
Alpha-2-
macroglobulin 
family (3 
domains) 
Catalytic metabolism extracellular ○ ● ● ● 3 
WBGene00016809 C50D2.6 n/a n/a n/a n/a ● ● ● ○ 3 
WBGene00008369 D1053.4 n/a n/a n/a membrane ● ● ○ ● 3 
WBGene00010239 F58B4.6 n/a n/a n/a n/a ● ● ○ ● 3 
WBGene00012073 T27A8.1 carboxypeptidase Catalytic metabolism n/a ○ ● ● ● 3 
WBGene00007041 tag-180 
calcium channel 
alpha-2 subunit 
n/a n/a membrane ○ ● ● ● 3 
WBGene00017483 lgc-22 n/a transport transport ion membrane ○ ● ● ● 3 
WBGene00001992 hot-7 
glycosylphosphati
dylinositol (GPI)-
linked signalling 
protein, (Ly-6 
superfamily) 
n/a n/a n/a ○ ● ● ● 3 
WBGene00000283 cah-5 
carbonic 
anhydrase 
Catalytic metabolism membrane ○ ● ● ● 3 
WBGene00012009 T25B9.3 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00022645 ZK6.11 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00007339 C05D12.1 n/a n/a n/a membrane ○ ● ● ● 3 
WBGene00016354 rig-6  
fibronectin, IG-
like domains of 
NCAM 
binding development membrane ○ ● ● ● 3 
WBGene00000054 acr-15 
ligand-gated ion 
channel subunit 
receptor transport ion membrane ○ ● ● ● 3 
WBGene00044138 F31F6.8 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00009416 F35E2.9 n/a n/a n/a n/a ○ ● ● ● 3 
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WBGene00009431 dct-17 n/a binding metabolism cytoplasm ○ ● ● ● 3 
WBGene00009431 dct-17 n/a binding metabolism cytoplasm ○ ● ● ● 3 
WBGene00009431 dct-17 n/a binding metabolism cytoplasm ○ ● ● ● 3 
WBGene00010971 R01E6.7 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00021543 
Y43B11AR
.1 
n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00010059 F54E4.3 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00013292 
Y57G11A.
4 
n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00020497 T14A8.2 n/a n/a n/a n/a ○ ● ● ● 3 
WBGene00003958 pcp-3 
lysosomal 
carboxypeptidase 
Catalytic metabolism membrane ○ ● ● ● 3 
WBGene00008275 C53B4.6 
Yeast YEA4 like 
protein 
n/a transport membrane ○ ● ● ○ 2 
WBGene00000525 clc-4 n/a n/a n/a membrane ● ● ○ ○ 2 
WBGene00016354 rig-6  
fibronectin, IG-
like domains of 
NCAM 
binding development membrane ○ ○ ● ● 2 
WBGene00004020 pho-1 n/a Catalytic development membrane ○ ● ● ○ 2 
WBGene00017592 F19C7.2 
lysosomal 
carboxypeptidase 
Catalytic metabolism n/a ● ● ○ ○ 2 
WBGene00007097 B0024.4 n/a n/a regulation n/a ○ ○ ● ● 2 
WBGene00007607 C15C8.5 n/a n/a n/a membrane ○ ○ ● ● 2 
WBGene00003173 mec-9  
mechanosensory 
protein (mec-9) 
binding Signalling extracellular ○ ● ○ ● 2 
WBGene00010236 F58B4.3 n/a n/a n/a n/a ● ● ○ ○ 2 
WBGene00011683 phat-6 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00006609 tre-3  trehalase Catalytic metabolism n/a ○ ● ○ ● 2 
WBGene00000050 acr-11 
ligand-gated ionic 
channel protein 
receptor transport ion membrane ○ ● ● ○ 2 
WBGene00018789 F54C1.1 n/a Catalytic metabolism membrane ○ ● ● ○ 2 
WBGene00010578 K04H8.3 n/a n/a n/a n/a ○ ● ● ○ 2 
WBGene00011329 T01D3.5 n/a transport transport ion membrane ● ● ○ ○ 2 
WBGene00020836 lgc-34 
ionic channel 
protein 
transport transport ion membrane ○ ● ● ○ 2 
WBGene00013882 ZC410.5 
microfilarial 
antigen like 
n/a n/a membrane ○ ● ● ○ 2 
WBGene00022751 ZK484.5 n/a n/a n/a membrane ○ ● ○ ● 2 
WBGene00008698 F11D11.3 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00010086 F55B11.4 n/a binding n/a cytoplasm ○ ● ○ ● 2 
WBGene00013915 ZC482.7 n/a n/a n/a membrane ○ ● ● ○ 2 
WBGene00017493 F15E11.4 n/a n/a n/a membrane ○ ● ○ ● 2 
WBGene00021222 
Y19D10A.
7 
n/a n/a n/a membrane ○ ● ○ ● 2 
WBGene00019067 F58H7.1 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00019213 H20E11.1 n/a n/a n/a membrane ○ ● ○ ● 2 
WBGene00008199 C49C3.9 n/a n/a defence n/a ○ ● ● ○ 2 
WBGene00007056 crn-7 n/a Catalytic metabolism n/a ○ ● ● ○ 2 
WBGene00011592 T07F10.6 n/a n/a n/a n/a ○ ● ● ○ 2 
WBGene00012585 lips-15 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00012827 Y43F8C.5 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00021732 Y49G5B.1 n/a n/a development n/a ○ ● ○ ● 2 
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WBGene00018917 F56A4.9 n/a n/a n/a membrane ○ ● ○ ● 2 
WBGene00010637 K07F5.12 n/a n/a development membrane ○ ● ● ○ 2 
WBGene00021809 
Y53G8AR.
1 
n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00003959 pcp-4 peptidase Catalytic metabolism n/a ○ ● ○ ● 2 
WBGene00000783 cpr-3 cathepsin protease Catalytic metabolism n/a ○ ● ○ ● 2 
WBGene00015768 C14C11.4 n/a n/a development membrane ○ ● ○ ● 2 
WBGene00000036 ace-2 carboxylesterase Catalytic Signalling cell ● ○ ○ ● 2 
WBGene00022644 dod-19 n/a n/a development n/a ○ ● ○ ● 2 
WBGene00000845 cup-4 
Acetylcholine 
receptor 
transport transport ion membrane ○ ● ● ○ 2 
WBGene00000039 acn-1 peptidase Catalytic metabolism membrane ○ ● ○ ● 2 
WBGene00003567 ncx-2 
sodium/calcium 
exchanger protein 
1 
transport transport membrane ○ ● ○ ● 2 
WBGene00003567 ncx-2 
sodium/calcium 
exchanger protein 
1 
transport transport membrane ○ ● ○ ● 2 
WBGene00006942 wrk-1  n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00006942 wrk-1  n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00006942 wrk-1  n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00016425 C34H4.2 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00007652 C17G1.5 n/a n/a n/a n/a ○ ● ● ○ 2 
WBGene00014125 ZK863.8 n/a n/a n/a membrane ○ ● ● ○ 2 
WBGene00006772 unc-36 n/a n/a n/a membrane ○ ● ● ○ 2 
WBGene00007340 C05D12.2 EGF domains n/a n/a n/a ○ ○ ● ● 2 
WBGene00008964 F19H8.4 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00012861 Y45F3A.4 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00015539 C06E7.2 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00011498 T05G5.1 
Caldesmon-like 
repeats 
n/a n/a membrane ○ ○ ● ● 2 
WBGene00011380 T02E1.8 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00007545 C13B4.1 n/a Catalytic metabolism membrane ○ ● ● ○ 2 
WBGene00013882 ZC410.5 
microfilarial 
antigen like 
n/a n/a membrane ○ ● ● ○ 2 
WBGene00008560 pho-13 acid phosphatase Catalytic n/a n/a ○ ● ○ ● 2 
WBGene00007041 tag-180 
calcium channel 
alpha-2 subunit 
n/a n/a membrane ○ ● ● ○ 2 
WBGene00009499 F36H2.2 n/a transport transport membrane ○ ● ● ○ 2 
WBGene00004944 sol-1  CUB domain n/a n/a membrane ○ ● ● ○ 2 
WBGene00019392 K04F1.13 n/a n/a n/a membrane ○ ● ○ ● 2 
WBGene00014666 C05D12.3 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00023432 K12B6.9 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00000039 acn-1 peptidase Catalytic metabolism membrane ○ ● ○ ● 2 
WBGene00000048 acr-9 
acetylcholine 
receptor 
transport transport ion membrane ○ ● ○ ● 2 
WBGene00017888 acl-11 n/a Catalytic metabolism membrane ○ ● ○ ● 2 
WBGene00020096 R144.6 n/a n/a n/a membrane ● ● ○ ○ 2 
WBGene00006942 wrk-1  n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00043156 C27F2.9 n/a n/a n/a n/a ○ ● ○ ● 2 
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WBGene00010660 K08D8.6 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00011829 T19A6.4 n/a n/a n/a membrane ○ ● ● ○ 2 
WBGene00044457 C18H7.11 n/a n/a n/a membrane ○ ● ○ ● 2 
WBGene00044452 Y102E9.5 n/a n/a n/a n/a ○ ○ ● ● 2 
WBGene00017193 F07C3.2 n/a n/a n/a membrane ○ ● ● ○ 2 
WBGene00044683 C36E6.8 n/a n/a n/a membrane ○ ● ● ○ 2 
WBGene00016271 C30G4.6 n/a n/a n/a membrane ○ ● ○ ● 2 
WBGene00011383 T02E9.5 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00014132 ZK896.1 n/a n/a n/a n/a ○ ● ○ ● 2 
WBGene00010747 K10D11.3 n/a n/a n/a n/a ○ ● ● ○ 2 
WBGene00045248 ZK180.7 n/a n/a n/a membrane ○ ● ○ ● 2 
WBGene00000138 amx-2 n/a Catalytic metabolism n/a ○ ● ○ ● 2 
WBGene00045403 K10H10.12 n/a n/a n/a membrane ○ ● ● ○ 2 
WBGene00010994 lgc-25 
Neurotransmitter-
gated ion-channel 
transport transport ion membrane ○ ● ○ ● 2 
WBGene00045482 T03F6.9 n/a n/a n/a membrane ○ ● ● ○ 2 
WBGene00013982 ZK512.1 n/a n/a n/a membrane ○ ● ● ○ 2 
WBGene00004023 pho-4 n/a Catalytic n/a n/a ○ ● ○ ● 2 
WBGene00013126 
Y52B11A.
7 
n/a n/a n/a membrane ○ ● ○ ● 2 
WBGene00017815 F26B1.1 n/a n/a n/a membrane ● ○ ○ ● 2 
WBGene00017695 fip-1 
Environmental 
stress 
n/a n/a membrane ○ ● ○ ○ 1 
WBGene00015125 B0303.3 
Acetyl-coa 
acetyltransferase 
Catalytic development n/a ○ ● ○ ○ 1 
WBGene00015163 B0361.9 n/a n/a regulation n/a ○ ● ○ ○ 1 
WBGene00009450 ugt-58 
UDP-
glucuronosyl-
transferase 
Catalytic metabolism membrane ○ ○ ○ ● 1 
WBGene00010314 F59B2.12 n/a n/a n/a n/a ○ ○ ○ ● 1 
WBGene00017127 E04F6.8 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00019332 K02F3.9 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00000616 col-39 collagen structural development membrane ○ ○ ○ ● 1 
WBGene00007191 lgc-20 n/a transport transport ion membrane ○ ● ○ ○ 1 
WBGene00009798 F46G10.4 lipase Catalytic metabolism membrane ○ ○ ● ○ 1 
WBGene00018532 F47B7.1 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00015142 B0310.6 n/a n/a Signalling n/a ○ ● ○ ○ 1 
WBGene00004993 spp-8 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00016596 C42D4.3 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00020582 T19D12.7 n/a n/a n/a membrane ○ ○ ● ○ 1 
WBGene00020690 T22E5.1 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00020738 T23F2.5 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00009331 F32D8.7 
Kunitz/Bovine 
pancreatic trypsin 
inhibitor domain 
Catalytic n/a membrane ○ ● ○ ○ 1 
WBGene00009339 F32G8.3 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00009915 F52A8.1 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00011011 R04D3.3 n/a n/a n/a n/a ○ ○ ○ ● 1 
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WBGene00001730 grl-21  n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00015300 C01F1.5 n/a n/a n/a n/a ○ ○ ○ ● 1 
WBGene00017654 F21C10.4 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00006948 wrt-2  n/a n/a regulation membrane ○ ● ○ ○ 1 
WBGene00000540 cln-3.2 n/a n/a development membrane ○ ● ○ ○ 1 
WBGene00015340 C02E7.7 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00007264 C02F4.4 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00005643 srp-2 
serine protease 
inhibitor 
Catalytic n/a n/a ○ ● ○ ○ 1 
WBGene00015848 C16C8.10 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00001388 far-4  
O.volvulus 
antigen peptide 
like 
binding n/a membrane ○ ● ○ ○ 1 
WBGene00000055 acr-16 
ligand-gated ion 
channel subunit 
transport transport ion membrane ○ ● ○ ○ 1 
WBGene00009134 F25H9.1 
Activin types I 
and II receptor 
domain 
n/a n/a n/a ○ ○ ○ ● 1 
WBGene00009136 F25H9.3 n/a n/a n/a n/a ○ ○ ○ ● 1 
WBGene00017880 F28A12.3 n/a n/a n/a membrane ○ ○ ○ ● 1 
WBGene00018289 F41E6.8 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00009990 F53F4.7 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00010135 F55H12.4 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00019077 F59A3.4 n/a transport transport ion membrane ○ ● ○ ○ 1 
WBGene00001990 hot-5 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00000556 cnc-2 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00000557 cnc-3 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00000558 cnc-4 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00000559 cnc-5 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00020076 R52.4 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00007999 tag-297 n/a n/a development n/a ○ ● ○ ○ 1 
WBGene00010169 clec-18 
CUB domain, 
Lectin C-type 
domain short and 
long forms (2 
domains) 
binding regulation n/a ○ ● ○ ○ 1 
WBGene00010750 K10D11.6 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00011020 R05A10.3 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00012362 W09D10.4 
Protein 
phosphatase 2C (2 
domains) 
Catalytic n/a n/a ○ ● ○ ○ 1 
WBGene00003765 nlp-27 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00003767 nlp-29 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00016433 C35B1.3 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00017480 F15B10.1 n/a n/a n/a membrane ○ ○ ○ ● 1 
WBGene00017485 F15E6.4 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00007992 fipr-24 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00010118 F55F3.4 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00010127 F55G11.7 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00012635 Y38H8A.1 n/a n/a development membrane ○ ● ○ ○ 1 
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WBGene00009557 F39B2.7 n/a binding Signalling cytoplasm ○ ● ○ ○ 1 
WBGene00010005 cnc-7 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00013190 Y54E2A.5 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00003790 npp-4 n/a binding cytoskeleton nucleus ○ ● ○ ○ 1 
WBGene00000955 des-2 
nicotinic 
acetylcholine 
receptor 
transport transport ion membrane ○ ● ○ ○ 1 
WBGene00012594 nspe-5 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00003763 nlp-25 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00001133 eat-2 n/a transport transport ion membrane ○ ● ○ ○ 1 
WBGene00003566 ncx-1 n/a transport transport ion membrane ○ ● ○ ○ 1 
WBGene00013775 
Y116A8A.
4 
n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00008652 F10D11.6 n/a binding development n/a ○ ● ○ ○ 1 
WBGene00004123 pqn-36 n/a n/a n/a n/a ○ ○ ○ ● 1 
WBGene00018381 F43C11.4 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00021981 lgc-26 
ion channel 
protein 
transport transport ion membrane ○ ● ○ ○ 1 
WBGene00004372 rig-5  
Drosophila 
amalgam protein 
like 
n/a n/a n/a ○ ● ○ ○ 1 
WBGene00021960 
Y57E12A
M.1 
n/a n/a n/a membrane ○ ○ ● ○ 1 
WBGene00003575 ncx-10 n/a n/a transport membrane ○ ○ ○ ● 1 
WBGene00009774 F46B6.9 n/a n/a development membrane ○ ○ ○ ● 1 
WBGene00000560 cnc-6 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00021847 
Y54F10AL
.1 
n/a n/a n/a membrane ○ ○ ○ ● 1 
WBGene00022336 
Y82E9BR.
3 
n/a transport transport ion membrane ○ ● ○ ○ 1 
WBGene00006592 dpy-31 
Zinc 
metalloprotease 
Catalytic metabolism n/a ○ ● ○ ○ 1 
WBGene00001819 haf-9 transporter protein transport transport 
membrane 
lysosome 
○ ● ○ ○ 1 
WBGene00021325 Y34B4A.9 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00015578 C07G3.10 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00015940 C18A3.2 n/a transport transport ion membrane ○ ● ○ ○ 1 
WBGene00000046 acr-7 
Acetylcholine 
receptor 
transport transport ion membrane ○ ● ○ ○ 1 
WBGene00001814 haf-4 ABC transporter transport transport 
membrane 
lysosome 
○ ● ○ ○ 1 
WBGene00000061 lgc-11 
Acetylcholine 
receptor 
transport transport ion membrane ○ ● ○ ○ 1 
WBGene00021160 Y4C6B.6 n/a Catalytic metabolism 
membrane 
lysosome 
○ ● ○ ○ 1 
WBGene00012293 W06A7.4 n/a n/a n/a n/a ○ ○ ● ○ 1 
WBGene00016133 C26B9.3 n/a n/a development n/a ○ ● ○ ○ 1 
WBGene00019127 cgt-3 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00019127 cgt-3 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00021384 Y37F4.3 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00021941 lgc-33 n/a n/a n/a membrane ○ ○ ○ ● 1 
WBGene00019127 cgt-3 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00020487 T13C5.7 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00022077 Y69A2AR. n/a n/a transport membrane ○ ● ○ ○ 1 
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6 
WBGene00016329 osr-1  n/a n/a development n/a ○ ● ○ ○ 1 
WBGene00001479 fmo-4  
flavin-containing 
monoxygenase 
Catalytic metabolism membrane ER ○ ● ○ ○ 1 
WBGene00000988 dhs-25 
short-chain 
alcohol 
dehydrogenase 
Catalytic metabolism n/a ○ ● ○ ○ 1 
WBGene00018411 F44B9.10 n/a Catalytic metabolism membrane ○ ● ○ ○ 1 
WBGene00001476 fmo-1  
flavin-containing 
monoxygenase 
Catalytic metabolism membrane ER ○ ● ○ ○ 1 
WBGene00013225 Y56A3A.2 n/a Catalytic metabolism membrane ○ ● ○ ○ 1 
WBGene00007807 C29F3.7 n/a n/a regulation n/a ○ ● ○ ○ 1 
WBGene00012857 pbo-5 
Neurotransmitter-
gated ion-channel 
transport transport ion membrane ○ ● ○ ○ 1 
WBGene00009971 F53C11.1 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00009406 F35C11.7 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00007178 B0457.2 elastin precusor n/a n/a n/a ○ ● ○ ○ 1 
WBGene00001512 gab-1 GABA receptor transport transport ion membrane ○ ● ○ ○ 1 
WBGene00007325 C05C9.1 
LBP / BPI / CETP 
family 
binding n/a n/a ○ ● ○ ○ 1 
WBGene00007402 ugt-60 
UDP-
glucuronosyl-
transferase 
Catalytic metabolism n/a ○ ● ○ ○ 1 
WBGene00011084 srsx-21 n/a n/a n/a membrane ○ ○ ○ ● 1 
WBGene00013684 
Y105E8A.2
7 
n/a n/a n/a membrane ○ ○ ○ ● 1 
WBGene00009528 F38A6.4 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00009969 F53B7.7 n/a n/a development n/a ○ ● ○ ○ 1 
WBGene00010954 clec-189 n/a binding n/a n/a ○ ● ○ ○ 1 
WBGene00004264 qua-1 
hedgehog-like 
protein 
Catalytic metabolism extracellular ○ ● ○ ○ 1 
WBGene00012152 cnc-10 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00012603 nspe-6 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00012840 grsp-1 n/a n/a regulation membrane ○ ● ○ ○ 1 
WBGene00008675 F11A5.7 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00010350 H01G02.3 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00010350 H01G02.3 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00013657 
Y105C5B.1
8 
n/a n/a n/a n/a ○ ○ ○ ● 1 
WBGene00020484 T13C5.3 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00022443 
Y110A2AL
.6 
n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00013412 
Y64G10A.
2 
n/a n/a development n/a ○ ● ○ ○ 1 
WBGene00006027 srx-136 
7TM receptor, srx 
family 
n/a n/a membrane ○ ● ○ ○ 1 
WBGene00044067 hke-4.1 n/a transport transport ion membrane ○ ● ○ ○ 1 
WBGene00006006 srx-115 
7TM 
chemoreceptor, 
srx family 
n/a n/a membrane ○ ● ○ ○ 1 
WBGene00017389 lgc-38 
gamma-
aminobutyric acid 
receptor 
transport transport ion membrane ○ ● ○ ○ 1 
WBGene00014669 C06G8.3 n/a transport transport ion membrane ○ ● ○ ○ 1 
WBGene00021095 mlt-8 n/a n/a development n/a ○ ○ ○ ● 1 
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WBGene00006952 wrt-6  n/a Catalytic metabolism n/a ○ ● ○ ○ 1 
WBGene00016721 C46G7.1 n/a n/a development membrane ○ ● ○ ○ 1 
WBGene00012857 pbo-5 
Neurotransmitter-
gated ion-channel 
transport transport ion membrane ○ ● ○ ○ 1 
WBGene00004890 smp-2 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00003762 nlp-24 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00009882 vha-17 n/a transport transport ion membrane ○ ○ ○ ● 1 
WBGene00010064 F54F7.2 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00013601 
Y87G2A.1
3 
n/a n/a n/a membrane ○ ○ ● ○ 1 
WBGene00013601 
Y87G2A.1
3 
n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00018880 acc-3 
Ligand-gated 
ionic channel 
transport transport ion membrane ○ ● ○ ○ 1 
WBGene00044152 W04G3.10 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00044287 F21H12.7 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00044292 F56D6.8 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00006494 hke-4.2 n/a transport transport ion membrane ○ ● ○ ○ 1 
WBGene00044548 cnc-9 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00021626 
Y47D7A.1
4 
n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00003572 ncx-7 
Na/Ca, K 
antiporter 
n/a transport membrane ○ ● ○ ○ 1 
WBGene00020760 T24C4.4 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00022474 Y119C1B.9 n/a n/a n/a n/a ○ ○ ● ○ 1 
WBGene00022255 
Y73B6BL.
36 
n/a n/a transport membrane ○ ● ○ ○ 1 
WBGene00018226 F40B5.2 n/a Catalytic n/a membrane ○ ● ○ ○ 1 
WBGene00018226 F40B5.2 n/a Catalytic n/a membrane ○ ● ○ ○ 1 
WBGene00003566 ncx-1 n/a transport transport ion membrane ○ ● ○ ○ 1 
WBGene00044900 cnc-11 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00044922 Y43C5A.7 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00017260 F08F3.1 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00011360 lgc-18 
nicotininc 
acetylcholine 
receptor 
transport transport ion membrane ○ ● ○ ○ 1 
WBGene00007807 C29F3.7 n/a n/a regulation n/a ○ ● ○ ○ 1 
WBGene00009331 F32D8.7 
Kunitz/Bovine 
pancreatic trypsin 
inhibitor domain 
Catalytic n/a membrane ○ ● ○ ○ 1 
WBGene00011927 T22C8.6 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00045397 
Y54G2A.5
2 
n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00013573 
Y75B12B.1
1 
n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00045251 F54F7.9 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00019069 lgc-30 n/a transport transport ion membrane ○ ● ○ ○ 1 
WBGene00043066 acr-25 n/a transport transport ion membrane ○ ● ○ ○ 1 
WBGene00007591 C14H10.1 
Yeast YIL023C-
like protein 
transport transport ion membrane ○ ● ○ ○ 1 
WBGene00014669 C06G8.3 n/a transport transport ion membrane ○ ● ○ ○ 1 
WBGene00011121 R07E5.17 n/a n/a development membrane ○ ● ○ ○ 1 
WBGene00004372 rig-5  
Drosophila 
amalgam protein 
n/a n/a n/a ○ ● ○ ○ 1 
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like 
WBGene00017569 F18E9.3 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00006624 try-6  peptidase Catalytic metabolism n/a ○ ● ○ ○ 1 
WBGene00019746 M03A1.3 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00012391 Y6B3B.7 n/a n/a n/a membrane ○ ● ○ ○ 1 
WBGene00004017 phg-1 
growth arrest 
protein 
extracellular 
domain 
n/a development n/a ● ○ ○ ○ 1 
WBGene00008277 C53B4.8 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00008277 C53B4.8 n/a n/a n/a n/a ○ ● ○ ○ 1 
WBGene00022474 Y119C1B.9 n/a n/a n/a n/a ○ ● ○ ○ 1 
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Appendix 3.  
Results for all of the C. elegans proteins identified with LC MS/MS. A total of 287 
proteins were identified with the MASCOT program. Gene name, public name and 
Wormbase ID were taken from Wormbase. The score and query matched refers to the 
MASCOT output for the total score of the protein and the number of peptides 
assigned to the protein by the program, respectively. Unique peptides refer to the 
number of unique statistically significant peptides assigned to each protein after 
manual curation (for an in-depth description of MASCOT output see Figure 5.7). The 
main band refers to the gel band (from the 1
st
 dimension of separation with SDS-
PAGE, Figure 5.6) from which the protein identification score is the highest, and 
other bands refers to the gel bands that also contain identifications for the protein. 
 
 
Gene name Wormbase gene ID Score Query matched 
Unique 
peptides 
Main 
band 
Other bands 
K10C2.1 WBGene00019617 783 18 12 4 1,2,3,5,7,8 
F54F11.2 WBGene00010070 734 16 11 3 4,5,6 
Y16B4A.2 WBGene00012445 597 16 8 2 1,4,7 
pcp-3 WBGene00003958 593 14 8 4 1,2,3,5 
C29F3.7 WBGene00007807 594 13 7 4 1,2,3 
lec-2 WBGene00002265 487 12 7 9 2,7,8 
lec-4 WBGene00002267 399 8 6 7 1,2,8,9 
ZK6.11 WBGene00022645 395 10 6 5 1,2,3,4,6 
F32A5.3 WBGene00017969 373 10 6 7 4 
pho-1 WBGene00004020 348 9 6 5 4 
pcp-2 WBGene00003957 449 9 5 3 4 
Y41D4B.16 WBGene00021518 347 6 5 3 2 
lec-1 WBGene00002264 340 9 5 9 1,2,3,4,5,7,8,10 
F21D5.3 WBGene00009008 338 6 5 3 1 
F57F4.4 WBGene00019017 337 9 5 1 none 
R05G6.7 WBGene00019900 319 8 5 8 1,2,3,4,5,7,9,10 
F56F10.1 WBGene00018984 358 6 4 4 2,5 
pcp-4 WBGene00003959 354 6 4 5 3,4 
dod-19 WBGene00022644 333 13 4 5 1,2,3,4,7 
C26B9.5 WBGene00016134 252 8 4 5 4 
lec-5 WBGene00002268 262 8 3 7 none 
vps-32.1 WBGene00016961 255 6 3 9 none 
T19D12.4 WBGene00020579 249 5 3 5 none 
tag-10 WBGene00006404 245 4 3 3 4 
stl-1 WBGene00006061 226 3 3 7 9 
F54E2.1 WBGene00018823 210 6 3 5 2,4 
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K08D8.6 WBGene00010660 200 5 3 4 none 
gfi-1 WBGene00001581 181 5 3 2 3 
act-4 WBGene00000066 169 4 3 8 none 
dct-17 WBGene00009431 225 4 2 3 none 
lec-2 WBGene00002265 187 4 2 10 1,4,5 
eft-4 WBGene00001169 162 4 2 9 1,5 
vha-19 WBGene00021952 148 2 2 2 3,5,7,9 
act-4 WBGene00000066 145 3 2 3 none 
F53C11.1 WBGene00009971 144 3 2 4 none 
daf-21 WBGene00000915 140 2 2 9 none 
B0024.4 WBGene00007097 138 3 2 4 5 
Y54G2A.18 WBGene00021883 134 2 2 2 1,6,7,8,10 
vha-1 WBGene00006910 130 3 2 1 none 
F35E12.10 WBGene00009434 125 3 2 5 1 
T25B6.2 WBGene00020788 107 6 2 5 none 
Y40D12A.2 WBGene00021503 107 4 2 9 none 
tre-3 WBGene00006609 89 3 2 3 none 
npp-21 WBGene00019940 85 2 2 8 2,3,5 
Y12A6A.1 WBGene00012439 79 3 2 10 none 
vha-4 WBGene00006913 181 2 1 1 2 
pcp-1 WBGene00003956 132 2 1 4 none 
C18H7.11 WBGene00044457 121 2 1 4 none 
vha-2 WBGene00006911 108 2 1 10 1,2,3,4,5,7,8,9 
C12D12.1 WBGene00015713 89 3 1 1 none 
crn-6 WBGene00000799 89 1 1 5 none 
C02B10.3 WBGene00015328 80 1 1 9 none 
atp-2 WBGene00000229 79 2 1 3 1,4 
C18E9.6 WBGene00007686 77 1 1 5 1,9 
M116.5 WBGene00019792 75 3 1 6 2,7,8,10 
Y47H9C.1 WBGene00012947 75 1 1 5 none 
C48E7.1 WBGene00016749 74 1 1 9 none 
phb-1  WBGene00004014 74 1 1 9 none 
dnc-1 WBGene00001017 67 3 1 6 7,9,10 
nurf-1 WBGene00009180 66 1 1 3 none 
vha-16 WBGene00016258 65 2 1 1 3,5,7,9 
F23F12.8 WBGene00017754 63 3 1 9 none 
unc-54 WBGene00006789 63 1 1 5 none 
Y46D2A.2 WBGene00021590 60 2 1 4 none 
R02F2.9 WBGene00019838 60 2 1 9 1,5 
K04H4.2 WBGene00010573 59 3 1 3 1,2,4,5 
Y32H12A.8 WBGene00021316 59 2 1 6 none 
ftt-2 WBGene00001502 58 1 1 8 none 
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C03F11.3 WBGene00015389 57 2 1 3 none 
F23C8.6 WBGene00017735 54 2 1 9 none 
ZK896.4 WBGene00014135 54 1 1 4 none 
Y51A2D.15 WBGene00013082 52 2 1 2 5,7,10 
rpl-38 WBGene00004452 52 2 1 7 2,5,10 
lmp-1  WBGene00003053 52 1 1 7 none 
W03F9.10 WBGene00021004 52 1 1 7 2,3 
srab-6 WBGene00016479 50 2 1 7 none 
hmg-12 WBGene00001977 49 1 1 6 none 
F22E12.1 WBGene00009058 48 2 1 6 3,7,8,10 
F56E10.3 WBGene00018977 48 2 1 6 8,10 
K02H11.9 WBGene00019350 48 2 1 6 7,8,10 
Y54E10A.6 WBGene00021828 48 2 1 6 7,8,10 
hecd-1 WBGene00016405 48 2 1 7 2,3,5,6 
lys-1 WBGene00003090 47 1 1 9 none 
rpt-6 WBGene00004506 46 2 1 6 7,8,10 
T24C12.4 WBGene00020766 46 1 1 1 5,9 
C34H4.2 WBGene00016425 46 1 1 2 none 
Y105E8B.9 WBGene00013693 46 1 1 2 9 
aman-3  WBGene00018594 45 1 1 3 none 
T06D4.3 WBGene00020292 45 1 1 8 2 
C09E7.4 WBGene00015638 44 2 1 10 2,5,6,7,8 
C32E8.11 WBGene00016326 44 1 1 4 none 
F41G4.7 WBGene00018310 44 1 1 4 none 
pqn-38 WBGene00004125 44 1 1 6 none 
ajm-1  WBGene00000100 44 1 1 9 none 
R148.3 WBGene00020102 44 1 1 9 none 
hint-3 WBGene00016150 42 2 1 2 5,7,10 
Y54E10A.12 WBGene00021832 42 1 1 2 5,10 
col-171 WBGene00000744 42 1 1 2 1 
MTCE.16 WBGene00010961 42 1 1 4 none 
myo-2  WBGene00003514 42 1 1 6 2,3,7 
ZK973.1 WBGene00022830 42 1 1 6 none 
R03E1.2 WBGene00010993 42 1 1 9 1,2 
aptf-1 WBGene00019424 42 1 1 10 none 
H12I13.2 WBGene00019191 41 2 1 6 9 
F55F8.2 WBGene00018890 41 1 1 1 none 
F37A4.6 WBGene00018136 41 1 1 5 none 
lin-3 WBGene00002992 40 2 1 5 2,6,7,8,10 
F58H7.1 WBGene00019067 40 2 1 5 2,10 
H35N09.2 WBGene00019266 40 2 1 7 8 
F36H9.5 WBGene00018113 40 1 1 2 3 
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M05B5.1 WBGene00010869 40 1 1 2 3 
T18D3.1 WBGene00011820 40 1 1 2 5,7 
Y73C8C.8 WBGene00022265 40 1 1 5 none 
F13D2.1 WBGene00008735 40 1 1 6 none 
F59A2.2 WBGene00010302 40 1 1 6 none 
CD4.8 WBGene00016993 40 1 1 7 none 
rfc-2 WBGene00004338 39 2 1 1 2,4,5,8 
C17G10.1 WBGene00015915 39 2 1 2 1 
D1037.1 WBGene00017025 39 1 1 1 none 
F22B5.10 WBGene00009045 39 1 1 2 none 
Y17G7B.17 WBGene00012468 39 1 1 3 none 
F54D5.11 WBGene00010054 39 1 1 4 none 
lev-8 WBGene00002975 39 1 1 8 6 
F54D10.3 WBGene00018804 39 1 1 8 none 
T09B4.4 WBGene00020378 39 1 1 8 none 
R166.2 WBGene00011302 39 1 1 9 none 
Y50D4C.2 WBGene00021747 38 3 1 5 none 
C44E4.4 WBGene00016653 38 2 1 9 5 
F26D2.16 WBGene00009154 38 1 1 2 1,9 
bicd-1 WBGene00016611 38 1 1 3 none 
dct-16 WBGene00012615 38 1 1 3 none 
cuc-1 WBGene00000835 38 1 1 3 none 
otpl-5 WBGene00018478 38 1 1 6 none 
F55C10.4 WBGene00010108 38 1 1 6 none 
T05H10.6 WBGene00011510 38 1 1 6 none 
unc-83 WBGene00006815 38 1 1 6 none 
mig-22 WBGene00003253 38 1 1 8 none 
F15E11.12 WBGene00017498 38 1 1 10 none 
Y41E3.8 WBGene00012766 38 1 1 10 none 
clp-1 WBGene00000542 37 9 1 2 3 
tag-273 WBGene00013289 37 2 1 5 2,10 
ZK795.2 WBGene00014082 37 2 1 8 none 
K09D9.9 WBGene00019567 37 1 1 2 none 
Y47G6A.17 WBGene00021643 37 1 1 2 3 
mig-1  WBGene00003238 37 1 1 4 5 
grl-12 WBGene00001721 37 1 1 6 5 
F31F4.1 WBGene00017957 37 1 1 6 none 
R74.6 WBGene00011280 37 1 1 6 none 
pink-1  WBGene00017137 37 1 1 7 none 
ntl-3 WBGene00003826 37 1 1 7 none 
C34C6.2 WBGene00007915 37 1 1 8 6 
tag-65 WBGene00006442 37 1 1 8 none 
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C32E12.4 WBGene00016330 37 1 1 9 none 
ins-14 WBGene00002097 37 1 1 10 none 
F44F4.10 WBGene00009705 37 1 1 10 none 
cyh-1 WBGene00021714 36 2 1 7 none 
egl-30 WBGene00001196 36 1 1 1 none 
F17H10.3 WBGene00008927 36 1 1 6 none 
ech-8 WBGene00001157 36 1 1 7 none 
zif-1 WBGene00006977 36 1 1 9 none 
ucr-2.1 WBGene00012158 36 1 1 10 none 
ugt-33 WBGene00007946 35 2 1 2 none 
C24A3.1 WBGene00016032 35 2 1 5 none 
srw-42 WBGene00005789 35 2 1 9 none 
ZK484.5 WBGene00022751 35 2 1 9 none 
fbxc-21 WBGene00019042 35 1 1 1 none 
Y34B4A.8 WBGene00021324 35 1 1 2 none 
ugt-42 WBGene00017959 35 1 1 3 none 
glb-24 WBGene00011287 35 1 1 3 none 
Y105E8A.23 WBGene00013680 35 1 1 4 none 
Y40C7B.1 WBGene00021498 35 1 1 4 none 
Y50F7A.2 WBGene00021760 35 1 1 4 none 
usp-14 WBGene00006856 35 1 1 5 none 
F19F10.5 WBGene00017601 35 1 1 5 none 
fcd-2 WBGene00012767 35 1 1 6 none 
T22F7.5 WBGene00020704 34 2 1 3 none 
ugt-64 WBGene00015577 34 2 1 6 none 
lsl-1 WBGene00009937 34 2 1 7 none 
C47F8.6 WBGene00008162 34 1 1 1 none 
srj-16 WBGene00005604 34 1 1 2 none 
mppa-1  WBGene00022159 34 1 1 3 none 
Y56A3A.31 WBGene00013243 34 1 1 6 none 
Y51A2D.7 WBGene00013075 34 1 1 7 none 
gon-4 WBGene00001653 34 1 1 8 none 
kel-8  WBGene00020952 34 1 1 8 none 
catp-7 WBGene00022010 33 3 1 2 1,4,5,6,9,10 
ztf-1 WBGene00018833 33 2 1 6 none 
W08G11.1 WBGene00012346 33 1 1 2 9 
dpy-22 WBGene00001081 33 1 1 4 none 
ZK355.5 WBGene00022715 33 1 1 6 none 
syg-2 WBGene00007750 32 1 1 3 none 
K09H9.5 WBGene00019597 31 1 1 1 none 
K10E9.1 WBGene00019634 74 3 0 3 1,5 
cogc-4 WBGene00021784 55 2 0 2 none 
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nhr-141 WBGene00017787 54 2 0 8 none 
pde-5 WBGene00016328 51 2 0 3 none 
acdh-11 WBGene00012860 51 2 0 6 none 
gei-6 WBGene00001563 50 3 0 4 none 
F39C12.1 WBGene00018193 50 2 0 3 none 
cdh-12 WBGene00022103 50 2 0 5 none 
W05B2.4 WBGene00012272 50 2 0 8 none 
B0524.4 WBGene00015243 50 2 0 10 none 
ztf-4 WBGene00020399 49 2 0 4 none 
acp-7 WBGene00022246 49 2 0 7 5 
unc-89 WBGene00006820 49 2 0 9 1,5 
ZK970.1 WBGene00014171 49 2 0 10 none 
psa-1 WBGene00004203 48 2 0 5 none 
qui-1 WBGene00004265 48 2 0 5 none 
map-2  WBGene00003130 48 2 0 8 2 
unc-68 WBGene00006801 47 3 0 1 5 
twk-30 WBGene00006682 47 2 0 4 none 
sdc-2 WBGene00004746 47 2 0 6 none 
prp-8 WBGene00004187 47 2 0 7 none 
F55F10.1 WBGene00018898 46 4 0 5 none 
C34C12.2 WBGene00007921 46 2 0 4 none 
C55A6.3 WBGene00008332 46 2 0 4 none 
R06C7.5 WBGene00011064 46 2 0 6 none 
cpna-2 WBGene00015061 46 2 0 8 none 
nsy-1 WBGene00003822 45 2 0 6 none 
C49F5.6 WBGene00008210 45 2 0 10 none 
rabs-5 WBGene00021538 44 2 0 2 none 
sdc-3 WBGene00004747 43 2 0 3 none 
larp-1 WBGene00020097 43 2 0 3 none 
lpd-3 WBGene00003060 42 2 0 6 none 
puf-5 WBGene00004241 42 2 0 8 none 
sdc-2 WBGene00004746 41 2 0 4 none 
ZK402.5 WBGene00022731 41 2 0 6 none 
Y110A7A.9 WBGene00022459 41 2 0 10 none 
C05C10.2 WBGene00007329 40 2 0 6 none 
B0207.5 WBGene00015028 37 3 0 3 none 
anc-1 WBGene00000140 37 3 0 5 none 
sma-1  WBGene00004855 36 2 0 7 none 
F59E12.9 WBGene00019124 35 2 0 1 none 
flr-1 WBGene00001465 35 2 0 5 none 
grl-14 WBGene00001723 35 2 0 5 none 
C07E3.3 WBGene00007414 35 1 0 8 10 
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Y57A10A.8 WBGene00013253 34 2 0 3 none 
noah-1 WBGene00016422 34 2 0 6 none 
col-76 WBGene00000652 34 2 0 6 none 
F56H1.3 WBGene00018994 34 2 0 8 none 
lfi-1 WBGene00022500 34 2 0 9 none 
Y55F3BL.1 WBGene00021935 34 1 0 2 5 
T12A2.8 WBGene00020442 34 1 0 3 none 
F15D4.6 WBGene00008863 34 1 0 6 none 
F31C3.2 WBGene00009284 34 1 0 6 none 
lin-35 WBGene00003020 34 1 0 7 none 
F26D11.2 WBGene00017819 34 1 0 8 none 
Y51H7C.5 WBGene00021783 34 1 0 9 none 
tag-233 WBGene00044071 34 1 0 10 none 
K06A5.8 WBGene00019434 34 1 0 10 none 
C49C8.3 WBGene00016767 33 2 0 2 none 
duox-2 WBGene00018771 33 2 0 3 none 
B0284.2 WBGene00007132 33 2 0 9 none 
T28A11.20 WBGene00020882 33 1 0 1 9 
T05A1.3 WBGene00011454 33 1 0 3 none 
Y6B3B.3 WBGene00012388 33 1 0 3 none 
C39F7.1 WBGene00016538 33 1 0 4 none 
C47A4.1 WBGene00008122 33 1 0 4 none 
gcy-6 WBGene00001533 33 1 0 6 none 
twk-5  WBGene00006660 33 1 0 6 none 
F47G9.4 WBGene00009831 33 1 0 6 none 
try-2 WBGene00006620 33 1 0 7 none 
T24B8.7 WBGene00011980 33 1 0 7 none 
Y104H12D.2 WBGene00022426 33 1 0 8 3 
Y38C1AB.4 WBGene00021406 33 1 0 9 none 
F26F12.3 WBGene00017834 33 1 0 10 none 
T27A8.3 WBGene00012075 33 1 0 10 none 
ZK945.4 WBGene00014166 32 3 0 2 none 
W02B12.10 WBGene00012205 32 2 0 1 5 
Y56A3A.30 WBGene00013242 32 2 0 1 10 
B0412.3 WBGene00015173 32 2 0 5 none 
ric-4 WBGene00004364 32 1 0 2 none 
glb-14 WBGene00008996 32 1 0 3 none 
fbxb-34 WBGene00021092 32 1 0 3 none 
asg-2 WBGene00000210 32 1 0 4 none 
Y24D9B.1 WBGene00021287 32 1 0 4 none 
C42C1.8 WBGene00016586 32 1 0 5 none 
H11L12.1 WBGene00019189 32 1 0 7 none 
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K09F6.9 WBGene00019592 32 1 0 7 none 
M7.9 WBGene00010885 32 1 0 8 none 
Y37H9A.3 WBGene00012578 32 1 0 8 none 
Y71G12B.5 WBGene00022145 32 1 0 8 none 
tlf-1 WBGene00006577 32 1 0 9 none 
K03E5.2 WBGene00019361 32 1 0 9 none 
sulp-5 WBGene00010789 32 1 0 9 none 
xnd-1  WBGene00001514 31 2 0 1 none 
rsp-5 WBGene00004702 31 2 0 1 none 
Y6E2A.5 WBGene00012399 31 1 0 1 none 
 
